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Abstract 
 
 
Background: Many HIV/AIDS patients experience pain. This is often associated with 
advanced HIV/AIDS infection and side effects of treatment. In sub-Saharan Africa, 
pain management for people with HIV/AIDS is suboptimal. With survival extended as 
a direct consequence of improved access to antiretroviral therapy, the prevalence of 
HIV/AIDS related pain is increasing. As most care is provided at home, the 
management of pain requires patient and family involvement. Pain education is an 
important aspect in the management of pain in HIV/AIDS patients.  
 
Aim: The aim of this study was to evaluate the effects of a pain educational 
intervention on pain severity and pain related outcomes among patients with 
HIV/AIDS and their family carers.  
Methods:  
Two systematic reviews were conducted: (1) to examine the evidence base of the 
effectiveness of educational interventions delivered to people living with HIV/AIDS 
on pain severity, pain interference, quality of life, knowledge of pain management, 
and (2)   
To examine the evidence base of the effectiveness of educational interventions 
delivered to their family carers on knowledge of pain management, quality of life and 
carer motivation.  
A randomised controlled trial was conducted at the HIV and palliative care clinics of 
two public hospitals in Malawi. To be eligible, patient participants had a diagnosis of 
HIV/AIDS (stage III or IV). Carer participants were individuals most involved in the 
SDWLHQW¶VXQSDLGFDUH(OLJLEOHSDUWLFLSDQWVZHUHUDQGRPLVHGWRHLWKHUD-
minute face±to-face educational intervention covering pain assessment and 
management, augmented by a leaflet and follow-up telephone call at two weeks; or 
(2) usual care. Those allocated to the usual care group receive the educational 
intervention after follow-up assessments had been conducted (wait-list control 
group). The primary outcome was average pain severity measured by the Brief Pain 
Inventory. Secondary outcomes were pain interference, patient knowledge of pain 
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management, patient quality of life. Carer outcomes were; carer knowledge of pain 
management, caregiver motivation and carer quality of life. Follow-up assessments 
ZHUHFRQGXFWHGHLJKWZHHNVDIWHUUDQGRPLVDWLRQE\QXUVHV¶EOLQGWRDOORFDWLRQ 
 
Results: 
Systematic review  
Eight published randomised controlled trials of educational interventions among 
patients with HIV/AIDS were identified. Only one study examined the effect on pain 
severity but the results were not statistically significant. Three studies reported 
positive effects in improving severity and frequency of symptoms, three reported 
improvement in quality of life and two studies found improvement in knowledge.  
Seven published studies of family carers of HIV/AIDS patients were identified. Only 
three of which were randomised controlled trials. Five of these reported that 
educational interventions were effective in reducing psychosocial outcomes. Two 
studies reported that the interventions improved knowledge outcomes among family 
carers of HIV/AIDS patients. 
 
Trial  
Of the 182 patients/carers dyads randomised; 167 patients and 157 carers 
completed the trial. At follow-up, patients in the intervention group experienced a 
greater decrease in average pain severity score 21.25 (mean difference 21.25, 95% 
confidence interval 16.7 to 25.8; P <0.001). Patients in the intervention group 
reported, less pain interference (mean difference 24.5, 95% confidence interval 
19.61 to 29.38; P<0.001), had improved knowledge of pain management (mean 
difference 20.39, 95% confidence interval 17.51 to 23.27; P<0.001), and a better 
quality of life (mean difference 28.76, 95% confidence interval 24.62 to 32.91; 
P<0.001). At follow-up carers in the intervention group had improved knowledge 
(mean difference 20.32, 95% confidence interval 17.37 to 23.28; P<0.001), greater 
motivation (mean difference 7.64, 95% confidence interval 5.15 to 10.13; P<0.001) 
and better quality of life (mean difference 34.16, 95% confidence interval 30.15 to 
38.17; P<0.001). 
 
Conclusion:  
Current evidence of educational interventions among HIV/AIDS and family carers on 
pain severity is inconclusive and based on a relatively small number of studies, many 
of which have methodological problems.  
iii 
 
A relatively simple form of pain education is effective in reducing pain and improving 
outcomes for patients with HIV/AIDS and their carers. Greater attention needs to be 
given to incorporating this into the routine care of people with HIV/AIDS in sub-
Saharan Africa. 
 
Trial registration: Current Controlled Trials ISRCTN72861423 
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CHAPTER ONE: INTRODUCTION AND OVERVIEW 
This research study examines and reports the effects of an educational 
intervention consisting of an information leaflet, face-to-face verbal 
discussion and two-week follow-up phone call on pain management for 
people living with HIV/AIDS (PLWHA) and their family carers in Malawi. In 
the first section of this chapter I outline the aims and objectives of the 
study. In the following section I describe the significance of the study, 
conventions and terminology used in the thesis. In the last section of this 
chapter I outline the structure of the thesis.  
 
1.1 Aim of the study  
The study aimed to evaluate the effects of an educational intervention on 
pain severity and perception of pain among people living with HIV/AIDS 
(PLWHA) and their family carers in Malawi. 
 
1.2 Objectives of the study 
The study was conducted in order to test the following hypotheses: 
‚ Compared with usual care, patients with HIV/AIDS who receive a pain 
education intervention will report less severity of pain. 
‚ Compared with usual care, patients with HIV/AIDS who receive a pain 
education intervention will report less interference of pain in their daily 
activities. 
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‚ Compared with usual care, patients with HIV/AIDS who receive a pain 
education intervention will have a greater knowledge of pain management. 
‚ Compared with usual care, patients with HIV/AIDS who receive a pain 
education intervention will have a better quality of life. 
‚ Compared with usual care, carers of patients with HIV/AIDS who receive 
the pain education intervention will have greater knowledge of pain 
management. 
‚ Compared with usual care, carers of patients with HIV/AIDS who receive 
the pain education intervention will have greater motivation to provide 
care. 
‚ Compared with usual care, carers of patients with HIV/AIDS who receive 
the pain education intervention will have a better quality of life. 
 
1.3 Significance of the study 
HIV/AIDS remains a disease of great public health importance particularly 
in sub-Saharan Africa, home to 69% of all people living with HIV/AIDS 
(WHO, 2013). In recent years as a result of improved access to HIV 
treatment and care, and since the publication and introduction of new 
treatment and guidelines for HIV/AIDS (WHO, 2013), there has been a 
dramatic reduction in death rate (UNAIDS, 2010) with people infected with 
HIV/AIDS living longer (Deeks et al., 2013). HIV/AIDS is now classified as 
a chronic illness (Deeks et al., 2013, Scandlyn, 2000). 
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HIV treatment is associated with side effects such as peripheral neuropathy 
(Peltzer et al., 2008, Heath et al., 2003) which has negative effects on the 
quality of life for people living with HIV/AIDS (Hughes et al., 2004, Hughes, 
2004, Hudson et al., 2004, Brechtl et al., 2001). Due to staff shortage in 
Malawi hospitals and due to the chronic nature of the condition of 
HIV/AIDS, most care is provided at home by family members in a familiar 
setting (Ministry of Health, 2011b). This means that family members play a 
significant role in the management of HIV/AIDS including the management 
of pain. 
Pain is a significant problem in HIV/AIDS patients (Newshan and Sherman, 
1999, Newshan, 1997, Harding et al., 2010a). HIV treatment does not cure 
AIDS, but reduces viral load in the body and strengthens the immune 
system (WHO/UNAIDS/UNICEF, 2011). HIV treatment needs to be taken 
for life to prevent drug resistance. Malawi has made good progress in 
improving access to HIV treatment for patients, with more than 52% of the 
population having access to HIV treatment (Malawi Government, 2012a). 
This has helped to reduce mortality among HIV/AIDS patients (UNAIDS, 
2013), but treatment related pain remains an issue. 
Systematic review of pain education among patients with HIV/AIDS 
reported conflicting results. One reported that HIV/AIDS pain education 
helps to improve the patient knowledge of pain management (Goujard et 
al., 2003), reduces symptom severity in men with HIV/AIDS (Gifford et al., 
1998) and another trial found no evidence in women with HIV/AIDS 
(Webel, 2010). Another trial reported that quality of life outcomes were 
worse in the intervention group (Wu et al., 2006). A trial of a pain 
symptom management manual for HIV/AIDS patients found symptom 
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frequency reduced in the intervention group (Wantland et al., 2008). Only 
one study assessed pain as an outcome (Gifford, et al, 1998) and found no 
evidence of a positive effect. These studies were conducted exclusively 
(Gifford et al., 1998, Wu et al., 2006, Webel, 2010) and predominantly 
(Wantland et al., 2008) in western countries where the social and cultural 
context differs to that of Malawi.  
Systematic review of pain education intervention among family carers of 
HIV/AIDS patients reported that psychosocial and psycho-educational 
interventions are effective in reducing depression, anxiety, distress and 
knowledge outcomes. These studies (n=6) were conducted predominantly 
in western countries except one study (Boon et al, 2009) which was 
conducted in South Africa. The outcomes of interest in these studies were 
mainly psychosocial with no study focussing spefically on education 
outcomes. Only one study (Pakenham, 2002) randomised both patients 
and family carers, however the sample size was too small (n=36). The 
educational materials tested such as DVDs, videos, manuals, are not 
accessible to most people in Malawi.  
A pain education intervention, drawing on-adult learning theory was 
designed for both HIV/AIDS patients and family carers based on the 
inconclusive results from the systematic reviews.  The pain education 
intervention study recruited patient and carer dyads. The intervention 
included a verbal face-to-face discussion, and a leaflet-based education 
HQWLWOHG ³$OO DERXW \RXUSDLQ´ and a phone call reminder after two weeks 
following the delivery of the intervention. A randomised controlled trial was 
conducted at two public hospitals in the northern part of Malawi to 
investigate the effects of the intervention on health outcomes of patients 
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and family carers. The primary outcome of this trial was average pain 
severity as reported by patients. Other patient outcomes of interest for this 
trial were the effect of the pain education intervention on patient pain 
interference, patient knowledge of pain management and patient quality of 
life. Carer outcomes for the trial were carer knowledge of pain 
management, care motivation in provision of care and carer quality of life. 
 
1.4 Conventions and terminology used in the thesis 
In this section I will describe and explain the meaning of the terms and 
concepts I use in the thesis. This is to enlighten the reader because some 
of these concepts may have a different meaning elsewhere. 
7KHWHUP µ$QWLUHWURYLUDO WKHUDS\¶ UHIHUVWRGUXJVWKDWVWRSYLUDOUeplication 
so that the weakened immune system can recover in people infected with 
HIV/AIDS. These are drugs given to the people living with HIV/AIDS 
throughout their life span. The drugs are not a cure but reduce 
multiplication of HIV and viral load, and strengthens the immune system 
thereby preventing the development of AIDS. These drugs are normally 
given to people with a low CD4 count (<350 cells/mm3) or with advanced 
+,9$,'6 LQIHFWLRQ FOLQLFDO VWDJHV ,,, DQG ,9 7KH WHUP µKLJKO\ DFWLYH
antiretroviral WKHUDS\¶UHIHUVWRDFRPELQDWLRQRIWZRRUPRUHDQWLUHWURYLUDO
therapy. Previously there was only one antiretroviral therapy 
(monotherapy) known as Zidovudine, which became ineffective because of 
developed resistance. New antiretroviral drugs were developed that 
contains a combination of two or more drugs in order to maximally 
suppress the HIV virus and stop the progression of HIV disease or AIDS. 
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7KH WHUP µRSSRUWXQLVWLF LQIHFWLRQ¶ UHIHUV WR GLVHDVHV RU LQIHFWLRQV WKDW
frequently attack the patient as a result of HIV infection. People living with 
HIV/AIDS can live with HIV for many years without feeling sick, but when 
WKH YLUDO ORDG LQFUHDVHV WKH +,9 GDPDJHV WKH ERG\¶V LPPXQH V\VWHP$
person with a weakened immune system due to HIV will begin to develop 
opportunistic infections specific to people living with HIV/AIDS such as 
VHYHUH EDFWHULDO LQIHFWLRQV VNLQ UDVK .DSRVL¶V VDUFRPD 7KH VHYHULW\ RI
these opportunistic infections is associated with the further weakening and 
destruction of the immune system.  
7KHWHUP µIDPLO\FDUHU¶ UHIHUV WRDSULPDU\FDUHSURYLGHU IRUSHRSOH OLYLQJ
with HIV/AIDS. These are typically family members, relatives, and friends, 
as well as neighbours who are directly and mostly involved in the provision 
of care to chronically or terminally ill persons with HIV/AIDS.  
7KH WHUP µKRPH-EDVHG FDUH¶ UHIHUV WR FDUHSURYLGHG WRSHRSOH OLYLQJZLWK
chronic illnesses such HIV/AIDS, Cancer, and Tuberculosis in their own 
homes. The care may be provided by a family carer or health care staff 
members.  
7KH ZRUG µ,¶ LV XVHG WR HQOLJKWHQ WKH UHDGHU WKDW , ZDV UHVSRQVLEOH IRU
implementing an action or activity in conducting the study. This has helped 
to avoid writing in the third person which would have possibly distanced 
me from the work I did.  
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1.5 structure of the thesis 
The thesis has eight chapters. Chapter one introduces the study and 
provides the reader with a justification for conducting the randomised 
controlled trial and includes an overview of the thesis. Chapter two looks at 
the contextual background of HIV/AIDS. This chapter describes the 
epidemiology of HIV/AIDS globally, in the sub-Saharan region and Malawi. 
This chapter includes an explanation of the health care delivery system in 
Malawi and the challenges the country faces in providing care to people 
living with HIV/AIDS. Palliative care provision to people living with 
HIV/AIDS, an outline of the HIV/AIDS treatment for people living with 
HIV/AIDS and the clinic journey they travel is also outlined in this chapter. 
Chapters three, four and five contains a review of the literature about 
HIV/AIDS and pain in HIV/AIDS. Chapter three reviews literature about the 
prevalence of pain in HIV/AIDS, the significance of pain in HIV/AIDS, and 
the needs of patients and family carers of people living with HIV/AIDS. 
Care by family carers to people living with HIV/AIDS is outlined in this 
chapter. Chapter four reviews evidence from randomised controlled trials 
on the effects of educational interventions on pain management for people 
living with HIV/AIDS. This chapter contains a critical review and appraisal 
of the evidence reported from trials using a two or three group comparison 
design. Chapter five reviews evidence from randomised controlled trials on 
the effects of psychosocial and psycho-educational interventions on pain 
management for family carers of people living with HIV/AIDS. In this 
chapter I critically review and appraise studies conducted both in western 
countries and sub-Saharan Africa. 
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Chapter six contains the methodology and methods of the study. The 
UDWLRQDOH IRU WKH VWXG\ GHVLJQ LV GLVFXVVHG 3DUWLFLSDQW¶V UHFUXLWPHQW
baseline assessments, the process of randomisation, the development, 
delivery and implementation of the pain education intervention, and follow-
up assessments are discussed in this chapter. In the last section of this 
chapter I will discuss ethical considerations made in relation to the design 
and implementation of the pain education intervention. 
Chapter seven reports the results of the randomised controlled trial. The 
recruitment and participants flow for the trial, baseline characteristics of 
study participants of the two parallel groups, uptake and adherence of the 
interventions, the differences observed between the two groups in terms of 
primary and secondary outcomes.  
Chapter eight contains the strengths and limitations of the trial. The results 
are compared with other studies conducted elsewhere in HIV/AIDS field 
and other similar chronic conditions. Finally in this chapter I discuss the 
implications of the pain education intervention study for practice, policy 
and education for HIV/AIDS care, recommendations are provided for future 
research.  
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CHAPTER TWO: CONTEXTUAL INTRODUCTION AND BACKGROUND 
This section contains the significance of HIV/AIDS globally, in African and 
more specifically in the sub-Saharan region of Africa, and in Malawi, 
including the social, economic, and psychological impacts of HIV/AIDS on 
society. The clinical staging of HIV/AIDS is explained according to the 
World Health Organisation (WHO) and Centre for Disease Control (CDC) 
eligibility criteria for HIV treatment. The next section describes the health 
care delivery system in Malawi, and the challenges experienced in the 
health sector. The last section describes the role of palliative care for 
people living with HIV/AIDS, antiretroviral therapy, the clinic journey of 
people living with HIV/AIDS and health education provision among 
HIV/AIDS patients and their family carers in Malawi.  
 
2.1 Background  
2.1.1 HIV/AIDS  
Acquired immunodeficiency syndrome (AIDS) is a surveillance definition 
based on signs, symptoms, infections, and cancers associated with the 
deficiency of the immune system that stems from infection with HIV (Kemp 
et al., 2003). AIDS is a collection of signs and symptoms associated with 
life-threatening immune deficiency caused by Human Immune Deficiency 
Virus (HIV), a human retrovirus (Kemp et al., 2003). HIV/AIDS has existed 
for more than three decades, the first AIDS cases were reported in 1981 in 
the USA. HIV/AIDS remains a disease of public health importance and one 
of the highest causes of mortality and morbidity in the modern world 
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(WHO, 2011b). AIDS is not simply a medical problem but due to its 
associated morELGLW\ DQG PRUWDOLW\ HYHU\ DVSHFW RI DQ LQGLYLGXDO¶V OLIH LV
vulnerable (Morrison, 1993). HIV is a virus (of the type called retrovirus) 
that infects cells of the human immune system (mainly CD4 T-cells and 
macrophages²key components of the cellular immune system), and 
destroys or impairs their function. HIV mostly is asymptomatic; as such it 
is not possible to know whether or not one has HIV without a blood test to 
confirm the status. Infection with this virus results in the progressive 
deterioration of the immune system, leading to immune deficiency (Kemp 
et al., 2003, Kaplan et al., 2009). 
The immune system is considered deficient when it can no longer fulfil its 
role of fighting off infections and diseases. Immune deficient people are 
more susceptible to a wide range of infections, most of which are otherwise 
rare among people with a strong immune system (Cairns et al., 2006). 
Infections associated with severe immunodeficiency are known as 
'opportunistic infections', because they take advantage of a weakened 
immune system (Kaplan et al., 2000). At this point, the individual presents 
with signs and symptoms and is said to have AIDS (WHO, 2007). 
HIV is staged on the basis of certain signs, symptoms, infections, and 
cancers grouped by the World Health Organization (WHO). There are four 
stages of HIV/AIDS infection: 
‚ Clinical stage 1 - asymptomatic or generalized swelling of the lymph nodes. 
‚ Clinical stage 2 - includes minor weight loss, development of shingles and 
recurrent upper respiratory tract infections. 
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‚ Clinical stage 3 - includes unexplained chronic diarrhoea, unexplained 
persistent fever, oral candidiasis, severe bacterial infections like 
pneumonia, weight loss more than 10% unintentionally, pulmonary 
tuberculosis and acute necrotizing inflammation in the mouth. 
‚ Clinical stage 4- where there is HIV wasting syndrome with extra 
SXOPRQDU\ WXEHUFXORVLV 2HVRSKDJHDO FDQGLGLDVLV .DSRVL¶V 6DUFRPD RU
Pneumocystis carinii pneumonia (WHO, 2007, WHO, 2005). 
The Centre for Disease Control and Prevention (CDC) and WHO have 
developed critical tools for monitoring HIV epidemic and also for use by 
clinicians to provide appropriate care to patients. CDC uses the CD4 count 
system. Patients with low CD4 count (<350 cells or CD4 percentage 
<14%) should be put on HIV medication known as antiretroviral therapy 
(ART) or Highly Active Antiretroviral therapy (HAART) (Centre for Disease 
Control, 1993, WHO, 2007), although according to new WHO guidelines 
(WHO, 2013) anyone who has tested HIV positive needs to start HIV 
treatment regardless of their CD4 count. 
The WHO system is applicable in resource poor countries like Malawi where 
CD4 count equipment is not available in most health facilities, and even 
where available they are not accessible to many patients, since facilities 
may not have the necessary reagents to conduct the tests. 
 
2.1.2 The Global epidemiology of HIV/AIDS 
In this section I explain the HIV/AIDS situation in the world. 
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According to global estimates from (UNAIDS, 2013, WHO, 2013) around 
35.3 million people (32.1 million adults and 3.3 million children under 15 
years of age) were living with HIV at the end of 2012. More than half (17.7 
million) of the infected adults were women. The year 2012 also saw 1.6 
million deaths from AIDS, a reduction from 2.3 million deaths in 2005. 
There were 2.3 million newly infected globally, showing a 33% decline in 
number of new infections from 3.4 million in 2001. This has been due to 
expansion in prevention efforts like health education and treatment. In 
2010 alone 1.4 million people were started on HIV medication globally, 
increasing the number of people receiving treatment by 27% in a single 
year. This expansion of treatment led to a 19% decline in deaths among 
PLWHA between 2004 and 2009 (UNAIDS, 2010).  
In summary there were globally, 35.3 million PLWHA at the end of 2012 
compared to 26.2 million PLWHA in 1999, a 28% increase in the number of 
PLWHA, however the death rate and infection rate decreased due to the 
significant scale-up of treatment with HIV medication (UNAIDS, 2010, 
WHO, 2011b, WHO, 2013). 
 
Table 1 Global HIV/AIDS Estimates as of end 2012 (WHO 2011b, 
WHO, 2013) 
 
Item Estimate 
People living with HIV 35.3 million 
Adults with HIV 32.1 million 
Children with HIV 3.3 million 
Newly infected  2.3 million 
Deaths 1.6 million 
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2.1.3 The epidemiology of HIV/AIDS in Sub-Saharan Africa 
In this section I highlight the HIV/AIDS situation in the sub-Saharan 
region. I also highlight the most affected countries in the sub-Saharan 
region including Malawi. 
The overwhelming majority of people with HIV, some 95% of the global 
total, live in resource poor countries (UNAIDS, 2010). Sub-Saharan Africa 
(SSA) is by far the worst-affected region. It has 10% of the world 
population, but is home to 69% of all people living with HIV. AIDS killed 
about 1.3 million people in 2010 in this region. Antiretroviral therapy (ART) 
dramatically extends survival, allowing many years of healthy life, but 
remains unavailable in many parts of the region (UNAIDS, 2010). However 
in SSA at the end of 2010, the number of people treated with antiretroviral 
drugs increased from 37% in 2009 (Callaghan et al., 2010) to 49% of the 
population eligible for treatment (WHO/UNAIDS/UNICEF, 2011).  
The worst affected countries in SSA are: South Africa, Zimbabwe, Lesotho, 
Malawi, Zambia, Namibia, Swaziland, Angola, Mozambique, and Botswana. 
In these countries, by the end of 2009, there were 11.3 million PLWHA, 
which comprises 34% of the global total, 31% of new infections and 34% 
of AIDS related deaths (UNAIDS, 2010). However in these countries there 
has been a decrease in AIDS related deaths by 18% (UNAIDS, 2010, WHO, 
2011b). This has implications for the practice and delivery of home based 
care and palliative care for PLWHA, since there are some who have no 
access to treatment, while those who are accessing treatment need better 
quality care (including supportive care) as they are living longer. 
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Table 2 HIV/AIDS in SSA and Malawi as of end 2012 (WHO, 2011b, 
WHO, 2013) 
 
2.1.4 The Burden of HIV/AIDS in Malawi 
This section contains a highlight of the situation of HIV/AIDS in Malawi 
where this study was conducted. The burden of HIV/AIDS to the country, 
family and individual including the social and economic effects is explained 
in this section. 
Malawi is one of the 47 countries in the sub-Saharan region of southern 
Africa (see figure 1). There is a high prevalence of HIV/AIDS with an 
estimated 910,000 people living with the disease at the end of year 2012. 
This represents 11 % of the population of those aged between 15 and 49 
years (WHO, 2013). The year also saw 51,000 deaths, with 650,000 
children orphaned due to AIDS deaths (UNAIDS, 2010, WHO, 2011b). 
Item  Estimate Proportion of global HIV 
cases 
   
SSA   
   
People living with HIV 25 million 69% 
Newly infected 1.6 million  
Deaths 1.2 million  
   
Malawi   
   
People living with HIV 910,000 11% 
New infections 250/day  
Deaths 51,000  
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The observed and adjusted HIV prevalence among women and men aged 
15-49 years were 11.8% and 12.7% respectively (UNAIDS, 2010). 
Approximately 250 new people are infected each day, and at least 70% of 
Malawi's hospital beds are occupied by HIV/AIDS patients (Kumwenda, 
2005), making Malawi the 10th -worst country affected with HIV/AIDS 
worldwide (Central Intelligence Agency, 2013). Life expectancy at birth is  
 
Figure 1: Map of Africa in relation to Malawi 
 
58 years for males and 62 years for females. In comparison with UK, males 
have a life expectancy of 78 years while females have 83 years. Malawi has 
a low life expectancy, its ranked on 194th position worldwide (Central 
Intelligence Agency, 2013). 
The high prevalence of HIV/AIDS is a drain on the labour force and 
government expenditures, with an estimated 5.8% of the farm labour force 
Mzuzu city 
Capital city 
Lilongwe 
Blantyre city 
Ekwendeni 
hospital 
Zomba city 
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G\LQJRIWKHGLVHDVH+,9$,'6ZDVH[SHFWHGWRORZHUWKHFRXQWU\¶VJURVV
domestic product by at least 10% by 2010 (WHO, 2006a). The government 
spends over U$120,000 each year on funerals for civil servants who die of 
the disease (Matewele, 2004, United Nations Development Programme, 
2002).  
Substantial progress has been made in the provision of ART/HAART. By the 
end of 2011, an estimated 325,000 people had been started on 
ART/HAART compared to 13,200 in 2004 (UNAIDS, 2012). However due to 
inequitable health system access to ART/HAART still remains a problem for 
others who need it (Makombe et al., 2008a, Ministry of Health, 2004, 
McCoy, 2003, Sabin, 2002). One mechanism Malawi has put in place to 
deal with the challenge of accessing HIV medication is by involving nurses 
to prescribe and administer these drugs. In addition the country has 
trained health assistants to provide HIV counselling services to patients 
rather than waiting for nurse counsellors, and this has resulted in some 
patients starting HIV medication within three weeks rather than waiting for 
three months after HIV diagnosis (WHO, 2011b). 
There is a significant shortage of human resource in Malawi. The nurse and 
doctor to patient ratio is low; there are only 38 nurses and 2 physicians -
per 100,000 populations (Ministry of Health, 2008a). Health professionals 
in the districts face high workloads: as many as 150 to 200 consultations a 
day. These shortages make it nearly impossible to provide good-quality 
healthcare and improve HIV services. It has recently been reported that 
Malawi has only 25% of the required number of nurses (Mphande, 2014). 
Other reasons why staff numbers are so low is sickness and death among 
health care workers that is often HIV-related, migration of doctors and 
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nurses to private sectors and overseas (Lawson et al., 2008). In 2010, the 
vacancy rate for nurses was 74% (Central Intelligence Agency, 2011). The 
National Organisation of Nurses and Midwives of Malawi, estimates that 
every month four nurses die due to HIV related conditions (The Daily 
Times, 2008). Morbidity and mortality is high among health workers 
(Swartz and Dick, 2002). In Malawi it is estimated that one in four hospital 
workers were lost to TB and AIDS over 10 years (Harries et al., 2001).  
In an effort to address some of these issues, the government of Malawi in 
conjunction with its development partners such as DFID implemented a 5-
pronged 6-year Emergency Human Resources Plan from 2005- 2010 which 
included: 
‚ A 52% salary top up to 11 cadres of health professionals, and provision of 
incentives to health workers practising in rural areas. 
‚ Expanding domestic capacity training for nurses and doctors. 
‚ Use of international volunteer doctors and nurse tutors to cover up in the 
hospitals and training institutions. 
‚ Provision of international technical assistance.  
‚ Strengthening monitoring and evaluation capacity (WHO, 2011a, Manafa et 
al., 2009). 
This resulted in a 50% increase in healthcare work-force and enrolment in 
training institutions 2¶1HLOHWDO. The challenge now is to maintain 
progress (WHO, 2011a).  
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2.2 Health care services in Malawi 
Malawi is a developing landlocked country in Southern Africa occupying 
over 118,484 square km (Ministry of Health, 2005), with an estimated 
population of 15,879,252 (Central Intelligence Agency, 2011). It borders 
Tanzania in the north and north east (475 km), Zambia in the west and 
north west (837 km) and Mozambique in the east and south west (1569 
km). It was under the British protectorate from 1891, until 1964 when it 
became independent. In terms of development in all aspects like economy, 
health care services, infrastructure Malawi is ranked number 165 of 223 
countries worldwide, and it is number 33rd of 47 countries in Africa,(United 
Nations Development Programme, 2002). Malawi is one of the poorest 
nations in the world with 65.3% of the population living below the poverty 
line (National Statistical Office, 2003, Ministry of Health, 2005).  
Malawi has four main cities: Mzuzu city in the northern region; Lilongwe 
WKHQDWLRQ¶VFDSLWDOFLW\LQWKHFHQWUDOUHJLRQ=RPEDDQG%ODQW\UHLQWKH
southern region. Blantyre is the biggest and the most commercial city of 
Malawi (Figure 2). 
Malawi is divided into three regions (northern, central and southern) and it 
has 28 districts in total. There are 6 districts in the north, 9 districts in the 
centre and 13 districts in the south. Each district has a hospital named 
after the name of that district. Within each district, there are administrative 
sub-divisions known as Traditional Authorities which are presided over by 
the chiefs. The smallest administrative unit is the village. There are four 
central hospitals in Malawi, two in the south, namely Zomba central 
hospital in Zomba city and Queen Elizabeth central hospital in Blantyre city. 
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There is also one in the centre (Kamuzu central hospital in Lilongwe city) 
and one in the north (Mzuzu central hospital in Mzuzu city). 
 
2.2.1 Health care delivery systems in Malawi 
0DODZL¶VKHDOWKSROLF\DLPVDWXSOLIWLQJWKHKHDOWKVWDQGDUGVRIWKHFLWL]HQU\
through a sound health care delivery system (Ministry of Health, 1995). 
The delivery of health care services is structured into three main levels 
(Figure1) primary (health posts, health centres, dispensaries, 
rural/community hospitals), secondary (district hospitals and some 
community hospitals), and tertiary (central hospitals and specialised 
hospitals) (Global AIDS Programme, 2006). The Ministry of Health provides 
60% of health services, followed by the Christian Health Association of 
Malawi (CHAM) (35%). Local authorities, large companies and private 
clinics provide the rest of health care services (Ministry of Health, 1999). 
Unlike CHAM, which charges user fees for its services, the bulk of health 
services provided by the government are free of charge (Global AIDS 
Programme, 2006).  
As most health facilities in rural areas are under staffed in comparison with 
urban areas the poor are often disadvantaged in accessing essential 
services (Ministry of Health, 1995, Kemp et al., 2003, Gwatkin et al., 
2004). The provision of HIV medication is not available in most parts of the 
rural areas as such patients and their family members have to travel long 
distances, often more than 20km, in order to receive medical attention. 
Some community hospitals in rural areas do provide HIV medication, but 
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they do not have CD4 count facilities, thereby relying on WHO clinical 
stages.  
Health care delivered by church institutions are implemented through 
Christian Health Association of Malawi (CHAM). This was established in 
1966 to advise the churches on health issues, it also complements 
government efforts in providing health care services to local communities. 
CHAM has 171 member health facilities (including 10 teaching hospitals, 20 
major hospitals, 30 community hospitals and health centres with or without 
maternity facilities). The facilities employ around 7000 employees country-
widea. 
Figure 2: Levels in the health system in Malawi 
 
2.3 Socio-economic impact of HIV/AIDS 
 
                                          
a http://www.actalliance.org/about/actmembers/christian-health-
association-of-malawi- 
Tertiary level:
central hospitals 
and specialist hospitals
Secondary level:
District hospitals and some 
community hospitals 
Primary level: 
includes health posts, health centres, 
dispensaries and rural/community hospitals
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2.3 Socio-economic impact of HIV/AIDS 
Taking care of a person sick with AIDS is not only an emotional strain for 
household members, but also a major strain on household resources 
(Chimwaza and Watkins, 2004, Kipp et al., 2007b). Loss of income, 
additional care-related expenses, the reduced ability of caregivers to work, 
and mounting medical fees push affected households deeper into poverty 
(Casale and Whiteside, 2006, Greener et al., 2000). It is estimated that, on 
average, HIV-related care can absorb one-WKLUGRI DKRXVHKROG¶VPRQWKO\
income (Salinas and Haacker, 2006, Casale and Whiteside, 2006). 
The financial burden of death can also be considerable, with some families 
in Malawi easily spending seven times their total household monthly 
income on a funeral (Rabson et al., 2007). Funerals are expensive because 
sometimes it takes three days for the ceremony to be conducted and in 
Malawi mourners will gather at the house of the bereaved/deceased, 
meaning that food and shelter need to be provided by the bereaved family 
(Mtika, 1998). HIV/AIDS has also increased the workload of hospitals 
where more than 70% of bed occupancy is due to AIDS related illnesses 
(Government of Malawi, 2009). HIV/AIDS results in deaths of a productive 
demographic group like teachers, health care workers, and other civil 
servants (Malawi Institute of Management, 2008). 
The HIV/AIDS virus has disproportionately infected the economically active 
age group (15-49 years) and this is the group that works hard in the field. 
The long period of HIV/AIDS illness therefore reduces labour production 
both in agriculture and companies (Haacker, 2004). This negatively affects 
WKH FRXQWU\¶V HFRQRP\ (Mtika, 1998, Hemrich and Schneider, 1997). The 
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AIDS epidemic adds to food insecurity in many areas, as agricultural work 
is neglected or abandoned due to household illness. In Malawi where food 
shortages have had a devastating effect, it has been recognised that HIV 
DQG $,'6 KDYH GLPLQLVKHG WKH FRXQWU\¶V DJULFXOWXUDO RXWSXW (UNAIDS, 
2010, Bollinger et al., 2000). There is a loss of agricultural productivity, it 
has been recognised that HIV/AIDS is diminLVKLQJWKHFRXQWU\¶VDJULFXOWXUDO
RXWSXW ,W ZDV FDOFXODWHG LQ  WKDW E\  0DODZL¶V DJULFXOWXUDO
workforce will be 14% smaller than it would have been without HIV and 
AIDS (Government of Malawi, 2009, WHO, 2006a). This is a big threat and 
challenge to the economy since Malawi relies on agriculture for its 
economic growth and labour for agricultural production.  
Apart from the financial burden, providing home-based care and palliative 
care can impose demands on the physical, mental and general health of 
carers, usually family and friends of the sick person. Such risks are 
amplified if carers are untrained or unsupported by a home-based care 
organisation (Lindsey et al., 2003, Kipp et al., 2007a). Despite looking 
after the sick, in many households HIV/AIDS children are orphaned at a 
young age. The United Nations define an orphan as a child 18 years or less 
who has lost one or both parents (UNAIDS, 2006). These children are often 
looked after by their grandparents who may not have adequate income to 
support them for their education, food, shelter and other basic needs 
(Jones, 1997, Jones, 2006, Norse, 1992). Worldwide it is estimated that 16 
million children under the age of 18 have lost one or both parents due to 
AIDS, and around 14.8 million of these live in SSA (UNAIDS, 2010).  
In Malawi, by the end of 2009, it was estimated that over half a million of 
children are orphans due to AIDS (UNAIDS, 2010). An important aspect of 
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the government's strategy has been to promote and support community 
based programmes. In both rural and urban areas across Malawi, 
communities are developing a variety of ways to cope with the growing 
crisis of AIDS orphans. In many villages orphan committees have been 
established to monitor the local situation and to take collective action to 
assist those in need (Rowan and Kabwira, 2009, Phiri and Webb, 2002). 
However my personal observation is that funding is a problem to sustain 
such projects and previous literature (Mutume, 2001) reports that success 
is dependent on volunteers, a strategy that threatens its sustainability.  
The Malawi Government in 2005 launched The National Plan for Orphans 
and other Vulnerable Children as a way to further its commitment to AIDS 
orphans, with the aim to increase access to essential services and to help 
families and communities provide support for such children (Government of 
Malawi, 2005), but implementation has suffered extensively due to delays 
(Sibale and Nthambi, 2008). 
 
2.4 Antiretroviral therapy (ART) and Highly Active Antiretroviral 
therapy (HAART) 
Although HIV/AIDS continues to be a problem worldwide, the availability of 
HIV medication through the reduction in prices and scaling up strategies for 
infected individuals in developing countries have made treatment 
accessible to some patients (Sacktor, 2002, WHO, 2011b, WHO, 2013). 
The first HIV medication to be introduced was Zidovudine, but developed 
resistance rendered it ineffective, this is what usually is known as 
antiretroviral therapy (ART). Therefore new HIV medications were 
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developed and put into clinical practice as a combination of Zidovudine and 
other drugs, this combination therapy is what is referred to as Highly 
Active Antiretroviral therapy (HAART). It combines three or more HIV 
medications to counteract the effects of HIV, hence also known as 
combination therapy. HAART slows the spread of HIV in the body, prevents 
illnesses and prolongs life. These drugs are administered to patients with 
advanced HIV infection (stages III and IV) or those with a CD4 count of 
less than 350 cells mm3 (WHO, 2007, WHO, 2010).  
With the introduction of ART/HAART, HIV/AIDS patients are living longer 
(Deeks et al., 2013, Scandlyn, 2000), unlike in the early 1980s when the 
AIDS epidemic began, PLWHA were not likely to live more than a few 
years. Currently available drugs do not cure HIV infection but they do 
prevent the development of AIDS. They can suppress HIV from multiplying 
in the body and this stops the virus from damaging the immune system, 
but these drugs cannot eliminate HIV from the body (Botes, 2003, Hicks et 
al., 2003). Hence, people with HIV need to take HIV medication for life 
(Paredes and Clotet, 2003). 
Since 1996 the use of ART in combinations of three or more drugs in 
countries where they are widely accessible has dramatically improved the 
quality of life for people with HIV and prevented them from premature 
death (Makombe et al., 2006, Makombe et al., 2008a). In Malawi free ART 
started in 2004 and this has brought significant change to PLWHA (Harries 
et al., 2006, Makwiza et al., 2009).  
One of the consequence of increased access to HIV medication is the issue 
of treatment side effects (Subbaraman et al., 2007). HAART dramatically 
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prolongs the lives of PLWHA by reducing viral load, and strengthening the 
immune system, however there are serious side effects such as abdominal 
pain, peripheral neuropathy, nausea and vomiting. These require effective 
management (Collins and Harding, 2007). Neuropathic pain occurs due to 
HIV infection itself as well as due to the side effect of HIV medication 
(Wadley et al., 2011, Wadley et al., 2010), but mainly it occurs due to the 
effects of Stavudine, one of the components of combined therapy (Wadley 
et al., 2011).  
WHO recommends that Stavudine should be phased out, but resource poor 
countries have not been able to find an alternative due to the cost 
alternative components (Long et al., 2010). Therefore as long as patients 
infected with HIV take this medication we should expect them to 
experience neuropathic pain. It has been reported that 57% of those 
treated with HIV medication had neuropathic pain and 77% of those 
reported that the pain was moderate to severe in a study by (Wadley et 
al., 2011).  
In the year 2012, around 9.7 million people living with HIV had access to 
antiretroviral therapy in low- and middle-income countries. This represents 
61% of people eligible for treatment under the 2010 WHO guidelines 
(WHO/UNAIDS/UNICEF, 2011); and 34% of people eligible under the 2013 
WHO guidelines (UNAIDS, 2013, WHO, 2013). 
In recent years, Malawi has made success in iPSURYLQJWKHFRXQWU\¶V+,9
treatment response by implementing WHO guidelines (Malawi Government, 
2012a). Some patients have been started on more effective drugs with less 
side effects, patients have started treatment earlier and pregnant women 
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who are HIV positive are placed on treatment regardless of the CD4 count 
or WHO clinical stages (Malawi Government, 2012a).  
 
2.4.1 ART/HAART provision in Malawi 
In Malawi the patient is put on ART/HAART after undergoing a number of 
clinical investigations. First the patient goes for HIV counselling and testing 
and after being found positive s/he is tested for CD4 count, and when CD4 
count is <350 cells/mm3 , the patient is placed on ART/HAART. When the 
CDC system is not available, WHO clinical staging is used (Ministry of 
Health, 2006, WHO, 2010, National AIDS Commission, 2003). 
All the patients in Malawi who are to start ART/HAART are requested to 
attend with a carer who together with the patient receives health education 
and information on the importance of treatment compliance and the need 
to take the drugs every day for life (Ministry of Health, 2006, Makombe et 
al., 2008b). The carer in most cases is a close relation of the patient who 
stays with the patient. After a class session about ART/HAART implications 
and importance of treatment compliance the patient can start treatment. 
Usually the patient is seen after 2 weeks following therapy initiation and 
then routinely every month for clinical assessment and drug dispensing or 
drug refill (Ministry of Health, 2006). Figure 3 is a summary of the 
ART/HAART clinic journey which patients and their carers have to travel 
through. 
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HIV Counselling and Testing Negative for HIV 
Normal CD4 count 
and stages 1 or 2 
for HIV/AIDS 
Monthly follow-up to the clinic for 
supply of HIV medication for life. 
Therapy is commenced and reviewed 
after 2 weeks with a guardian/carer 
Education and Counselling session on 
ART/HAART with a guardian/carer 
<350 cells or evidence of WHO 
stages 3 or 4 
CD4 count check or WHO Clinical 
staging for HIV/AIDS 
HIV positive 
Figure 3 The ART/HAART Clinic Journey 
 
28 
 
2.5 Health education among HIV/AIDS patients and family carers 
in Malawi 
In Malawi all people living with HIV/AIDS receive health education prior to 
initiation of ART/HAART. Health education is provided by staff nurses, 
clinical officers who have received training about HIV/AIDS treatment and 
care provision to people living with HIV/AIDS. All the patients attend the 
health education session with their family carers (no patient is allowed to 
attend the session without a family carer and therefore cannot start HIV 
treatment). The education session is provided during first registration to 
the HIV clinic and focuses on drug adherence in order to prevent 
development of resistance strains of HIV. Health education emphasises on 
basic facts about HIV/AIDS, the drugs used to treat HIV/AIDS and how the 
drugs work, nutrition in HIV/AIDS, positive living with HIV/AIDS, 
prevention of spread of infection to others and side effects of HIV 
treatment. Usually patients are told to come to the hospital if they 
experience severe side effects such as abdominal pains, jaundice and skin 
rash. 
 
2.6 Palliative care for people living with HIV/AIDS 
Palliative care is an approach that improves the quality of life of patients 
and their families facing the problems associated with life threatening 
illness, through the prevention and relief of suffering by means of early 
identification and impeccable assessment and treatment of pain and other 
problems, physical, psychosocial and spiritual (WHO, 2002). 
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Palliative care is concerned with the assessment and management of pain 
and other symptoms among patients and their families with life limiting 
illnesses including physical, emotional/psychological and spiritual pain 
(Ventafridda, 2006). Palliative care is necessary to provide social, 
emotional and spiritual support for both the patient and their family from 
the time of diagnosis (Sepulveda et al., 2002). A strong body of evidence 
has demonstrated that palliative care can relieve the suffering of patients 
and families with terminal disease (Smalbrugge et al., 2007, Merriman and 
Harding, 2010, Harding et al., 2005). Many patients present late when they 
already have advanced disease and may be suffering from opportunistic 
infections (Harding et al., 2005). About 10% of HIV/AIDS patients develop 
immune reconstitution inflammatory syndromes (IRIS), many other 
patients experience undesired side effects and drug toxicities (Matheny, 
2001) +,9 UHODWHG FDQFHUV VXFK DV .DSRVL¶V VDUFRPD SHUVLVWV LQ VSLWH RI
HIV medication and these are often not treatable in resource poor 
countries (Matheny, 2001). Palliative care is important in order to achieve 
the best quality of life for both the patients and families (Harding et al., 
2003), a very important aspect of quality of life is being free from pain 
(Smalbrugge et al., 2007). 
Palliative care is necessary along with ART/HAART due to the distressing 
and complex symptoms experienced by the patients (Harding et al., 2006, 
Sherr et al., 2007). The cornerstone of palliative care is the relief of pain 
and other distressing symptoms-although palliative care cannot be said to 
be present if pain control is the only intervention available (Merriman and 
Harding, 2010), and hence the need for a holistic approach to palliative 
care. Dame Cicely Saunders recognised that other factors can influence 
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pain and she developed the concept total pain as a way of assessing and 
managing pain in chronic illnesses which looks at the physical, social, 
spiritual and psychological aspect of the human being (Watson et al., 
2009). The pain education study uses a holistic approach into the 
assessment and management of pain among HIV/AIDS patients and their 
family carers. The components of the pain education intervention consisted 
of the biological (pharmacological) management of pain through adequate 
and effective use analgesia, psychological management of pain through 
provision of information, support and knowledge to minimise distress 
associated with poorly controlled pain and social management of pain by 
targeting the intervention at patient/carer dyad level (Nkhoma et al, 2013). 
The pain education intervention is about both pain relief and palliative care. 
This is because relief of pain and suffering is a key component of palliative 
care. Palliative care requires a holistic approach such as provision of 
interventions to minimise discomfort and suffering, psychological support 
to reduce distress due to pain experience and social support to minimise 
social problems such as lack of available family support. Palliative care 
seeks to provide support to the family, as well as relieving pain and 
suffering. The pain education intervention attends to three fundamental 
aspects of palliative care: (1) the relief of pain and suffering, (2) the 
provision of help and support to the family and (3) the use a team 
approach (patient, family carer, health care professional in this instance) to 
improve patient care. 
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2.7 Chapter summary 
HIV/AIDS is still a disease of public health importance particularly in the 
sub-Saharan region, however infection rates are stabilising, access to HIV 
treatment is improving, and people are living longer. HIV/AIDS has social, 
psychological and economic impacts in society, particularly in resource poor 
countries such as Malawi. HIV/AIDS has infected and affected the most 
productive section of the population (15-49 years) and hence loss of 
productivity in agriculture and low exports revenues from the fields. 
HIV/AIDS has become a chronic illness and therefore requires a palliative 
care approach in order to meet the physical, social, psychological and 
spiritual needs of patients and their families. Pain and other symptoms 
experienced by people living with HIV/AIDS are explored in the next 
chapter. 
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CHAPTER THREE: PAIN AND SYMPTOMS AMONG PEOPLE LIVING 
WITH HIV/AIDS 
3.1 Introduction  
In this chapter the significance of pain and its related symptoms in people 
living with HIV/AIDS is examined. The literature around the epidemiology 
of pain in HIV/AIDS and how pain affects quality of life is reviewed. An 
exploration of pain assessment and management in the clinical setting is 
provided. This chapter examines the experiences of family carers of people 
living with HIV/AIDS, their roles and the challenges they experience in 
providing home-based care to patients living with HIV/AIDS. The final 
section of the chapter explores literature on the needs of patients and their 
family carers. 
 
3.2 Pain in people living with HIV/AIDS: defining pain 
Pain is a significant problem for people living with HIV/AIDS (Harding et 
al., 2010a, Newshan, 1997, Newshan and Sherman, 1999). Advanced HIV 
infection and its treatment are associated with intense physical and 
psychological symptoms. These require focused assessment and 
management using locally available resources and interventions to ensure 
good quality of life for patients and their carers. Pain is defined as 
whatever the patient says it is and only exists when the patient says it 
does (Mc Caffery and Beebe, 1989). The International Association for the 
Study of Pain (IASP, 1996) defined pain as an unpleasant sensory and 
emotional experience associated with actual or potential tissue damage or 
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described in terms of such damage. In this study I have adopted the IASP 
definition of pain but mindful that ultimately pain is a unique experience for 
individual patients and therefore the position of McCaffery and Beebe 
(1989) is also taken into account. This is because the outcomes in this 
study were all self-reported by the patients and this is in line with the 
former definition of pain. The theoretical framework for this study 'the 
biopsychosocial model' is in line with the latter definition of pain.  
The two systematic reviews reported in chapters four and five: (1) pain 
educational interventions among HIV/AIDS patients, and (2) pain 
educational interventions among family carers of HIV/AIDS patients 
respectively are both inconclusive. The studies reviewed had 
methodological challenges and were poorly described. It is these 
inconclusive results from the two reviews that informed the decisions 
around the choice of study participants in the current trial (1) HIV/AIDS 
patients and (2) their family carers.  
 
3.3 Epidemiology of pain in HIV/AIDS 
In this section I highlight the significance and prevalence of pain among 
HIV/AIDS patients. 
Pain is one of the most prevalent, frequent and debilitating symptoms in 
patients with HIV/AIDS (Cox and Rice, 2008, Breitbart et al., 1996, Norval, 
2004, Rosenfeld et al., 1996) particularly in its later stages (Collins and 
Harding, 2007, Breitbart, 1996b, Breitbart et al., 1998). Between 30 and 
90 percent of AIDS patients suffer from pain at some point in their illness 
(Solano et al., 2006, Karus et al., 2005, Breitbart et al., 1998).  
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Pain in HIV infection is experienced throughout the disease trajectory 
(Selwyn, 2005, Solano et al., 2006, Peltzer et al., 2008). Pain is mainly 
experienced in advance infection of HIV and it is estimated that 80% of 
people with advanced HIV infection experience severe pain (Solano et al., 
2006), like cancer pain the severity of HIV pain increases as the disease 
progresses (Hewitt et al., 1997, Glare, 2001, Coughlan, 2003). One study 
of models, services and challenges of end of life care provision in 14 
countries in sub-Saharan Africa reported that 98% of the services for 
HIV/AIDS patients are home-based and that 94% of the respondents 
reported that they experienced challenges to providing pain relief (Harding 
et al., 2003). It is suggested that most people in sub-Saharan Africa died 
from AIDS in pain in 2003 (Merriman and Harding, 2010). 
In Malawi pain is the main symptom reported by HIV/AIDS patients 
(Tapsfield and Jane Bates, 2011). In another study HIV/AIDS patients had 
reduced quality of life compared to their counterparts without HIV and 
were in severe pain as the infection advanced (Fan et al., 2011). A recent 
systematic review reported that pain is present among 55 to 67 percent of 
PLWHA at all stages of the disease (Parker et al., 2014). People with HIV 
do experience pain in all parts of the body as the infection advances from 
HIV-related opportunistic infections and from HIV-related cancers such as 
Karposis sarcoma (Grant et al., 2011). Most pain experienced by people 
living with HIV/AIDS has an underlying treatable cause (Hewitt et al., 
1997) such as treatable infections, and reversible medication effects 
(Marcus et al., 2000).  
Types and levels of pain vary by individual and the respective stage of HIV 
infection. In the early stages of infection, around 30 percent of people with 
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a CD4 count of >500 cells mm3 experience mild pain (Rosenfeld et al., 
1996, Breitbart et al., 1996, Larue et al., 1997). Lower CD4 counts are 
associated with higher prevalence of pain (Richardson et al., 2009, 
Aouizerat et al., 2010, Dobalian et al., 2004). Higher prevalence and 
severity of pain is associated with advanced stages (III or IV) of HIV/AIDS 
infection (WHO, 2006b, Martin et al., 1999, Dobalian et al., 2004, Nair et 
al., 2009). However other studies have reported no difference in pain 
prevalence with stage of illness or CD4 (Breitbart et al., 1996, Del Borgo et 
al., 2001, Wahab and Salami, 2011), similarly (Vogl et al., 1999, Wakeham 
et al., 2009, Wakeham et al., 2010) reported that high levels of symptoms 
were observed in all stages of HIV infection suggesting that WHO system 
and CD4 count may not be the only system to predict prevalence of painful 
symptoms in HIV infection. Other studies have reported that there is no 
correlation between levels of CD4 cells and measures of pain in HIV 
infected individuals (Van As et al., 2009, Peltzer and Phaswana-Mafuya, 
2008, Rosen et al., 2008). In a multicentre observational study (Simms et 
al., 2013) HIV patients in all stages reported multidimensional problems at 
the initial HIV diagnosis. In a cross-sectional study it is reported that 66% 
of patients in the study reported pain: predominantly headache, 
nociceptive pain (68%) and neuropathic pain (32%), which significantly 
affected the quality of life of the patients. However this was a small pilot 
study so findings need to be treated with caution (Nair et al., 2009). Lower 
CD4 counts are also associated with experiencing pain in a greater number 
of sites (Martin et al., 1999). HIV patients usually report multiple painful 
sites, most sites reported in literature are lower limbs, headache, 
abdominal pain, musculoskeletal and chest pain (Wahab and Salami, 2011, 
Peltzer and Phaswana-Mafuya, 2008, Makoae et al., 2005).  
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Because HIV is now a chronic illness, the pain experienced by people living 
with HIV/AIDS is also chronic. Studies report that peripheral neuropathy is 
the primary source of chronic pain in HIV which usually occurs due to 
treatment and HIV infection (Kamerman et al., 2012, Wadley et al., 2011).  
 
3.4 Effects of HIV/AIDS pain on the patient 
In this section, I highlight the effects of HIV/AIDS pain on psychological, 
emotional and social aspects of quality of life. I also highlight HIV/AIDS 
pain interference on daily life activities among HIV/AIDS patients.  
The negative impact of pain on quality of life has been reported (Wahab 
and Salami, 2011, Sukati et al., 2005). Severe pain can reduce adherence 
to drugs and the quality of life of HIV/AIDS patients as reported by several 
authors (Holzemer et al., 2001, Hughes et al., 2004, Hughes, 2004, Brechtl 
et al., 2001, Hudson et al., 2004). Pain is the most frequent and main 
cause of psychological distress (Vogl et al., 1999, Marcus et al., 2000, 
Rosenfeld et al., 1996, Rotheram-Borus, 2000) depression and emotional 
distress (Rotheram-Borus, 2000, Lagana et al., 2002, Richardson et al., 
2009, Miaskowski et al., 2011). Greater levels of pain in HIV/AIDS are 
associated with greater levels of psychological distress and lower emotional 
control (Rosenfeld et al., 1996, Rotheram-Borus, 2000, Lagana et al., 
2002) and poorer quality of life (Breitbart et al., 1996). Pain related 
symptoms in patients with HIV/AIDS include headache (51%), thrush 
(42%), painful joints (38%), muscle aches (37%), numbness (37%), 
DEGRPLQDO SDLQ  FKHVW SDLQ  DQG .DSRVL¶V VDUFRPD OHVLRQV
(19%) (Holzemer et al., 1998, Nicholas et al., 2010). In a prospective 
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cohort study conducted in both rural and urban areas in the USA, oral pain, 
numbness of both lower and upper extremities, were associated with worst 
quality of life. Headache was associated with disability days (Lorenz et al, 
2001). A systematic review reported that head, neck and lower limbs were 
the frequent anatomical sites pain is experienced by people living with 
HIV/AIDS (Parker et al., 2014). Multiple pains have been reported to be 
associated with increased disability and greater depressive symptoms 
(Breitbart et al., 1996). Physical pain is as a result of biological processes 
in the body. The feeling of pain itself causes psychological problems such 
as worry, anxiety, and hence the need for social care and support 
(Sepulveda et al., 2002).  
3DLQLQ+,9FDQLQWHUIHUHZLWKHYHU\DVSHFWRIWKHSDWLHQW¶VOLIH (Newshan, 
1997, Larue et al., 1997, Newshan and Sherman, 1999, McCormack et al., 
1993). Since the severity of pain in HIV has been shown to increase with 
the progression of HIV disease, this produces greater interference in the 
performance of daily activities, decreases enjoyment of life and lowers 
mood levels (Mc Cormack et al, 1993; Singer et al, 1993). In a cross-
sectional study conducted in India among 140 HIV/AIDS patients, two-
thirds of HIV/AIDS patients reported that pain interfered with their mood, 
sleep, general activities, and abilities to perform normal work (Nair et al, 
2009). In another cross-sectional study conducted in South Africa among a 
convenient sample of 100 hospitalised HIV/AIDS patients, it was reported 
that pain severity was strongly correlated with pain interference with daily 
life activity, mood, normal work, sleep and enjoyment of life (Narasimooloo 
el at, 2011).  
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3.5 Classification of pain  
HIV-related pain is usually divided into two categories: nociceptive and 
neuropathic (Gray and Berger, 2007, Watson et al., 2009). Nociceptive 
pain is further sub-divided into somatic pain and visceral pain (Wentz, 
2005, Watson et al., 2009). Somatic pain results from injury of structures 
such as muscles, skin, joints and bones. It is easy to locate and often 
experienced as throbbing and stabbing. Visceral pain is associated with 
distension of thoracic or abdominal organs such as liver or spleen and 
usually experienced as sharp and/or cramping (Watson et al., 2009). Some 
patients experience neuropathic pain as a result of opportunistic pathogens 
and side effects of drugs (Wentz, 2005, Lebovits et al., 1989). This pain 
causes injury to the peripheral and central nervous systems (Watson et al., 
2009, Lebovits et al., 1989). Figure 4 summarises the classification of pain 
(Watson et al., 2009).  
 
 
 
 
 
 
 
 
 
 
   Pain 
Nociceptive 
Neuropathic  
Somatic 
Peripheral and CNS Soft tissue, bone, 
joints 
Liver, Spleen, 
Heart, Bowel 
Visceral 
 
Figure 4 Classification of pain 
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3.6 Pain Assessment  
Good pain management requires careful and proper assessment, but 
presents challenges due to the subjective nature of pain. Pain is a 
subjective phenomenon and as such it poses a challenge in terms of 
assessment (Steeds, 2009).  Pain experts recommend routine pain 
assessment at each patient encounter such that pain assessment should be 
treated as part of the vital signs (Campbell and Mitchell, 1996). Pain 
assessment tools are available to assist in pain assessment and are based 
RQWKHSDWLHQW¶VRZQSHUFHSWLRQRIWKHLUSDLQDQGLWVVHYHULW\(Noble et al., 
2005). Due to chronic nature of HIV/AIDS pain assessment requires a 
multidimensional approach (Marcus et al., 2000). 
There is a consensus among experts that for palliative care patients, the 
five most important aspects of the pain experience which should be 
addressed by a pain assessment tool are:  
‚ Pain intensity  
‚ Temporal pattern  
‚ Treatment and exacerbating / relieving factors  
‚ Pain location  
‚ Pain interference.  
 
Other important aspects are pain quality, affective aspects of pain, the 
duration of pain, pain beliefs and pain history (Hølen et al., 2006, Caraceni 
et al., 2002b).  
There are a number of pain measurement tools that have been validated 
for research and treatment of patients with chronic illnesses. The tool to 
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use depends on the factor of pain you wish to evaluate (Frampton and 
Hughes-Webb, 2011). To measure pain intensity and for on-going 
monitoring of pain intensity, a simple visual analogue scale and numerical 
rating scale is appropriate (Hølen et al., 2006). 
There are three main ways to assess pain intensity and relief. These are 
through the use of visual analogue scale, a numerical rating scale, and a 
verbal rating scale. These are all well validated in cancer populations 
(Caraceni et al., 2002b), but there use may be extended beyond this to 
HIV/AIDS populations or those of other chronic illness (Watson et al., 
2009). There is much debate as to the preferred method (Caraceni et al., 
2002b, Brunelli et al., 2010) but a systematic review (Hjermstad et al., 
2011) reported that the numerical rating scale has better compliance, is 
easier to use and has good acceptability compared to visual analogue 
scales and verbal rating scales.  
The visual analogue scale (VAS) Figure 5a comprises a 10 cm line anchored 
by two verbal descriptors, one for no pain, the other one for severe pain 
(Hawker et al., 2011). Patients are asked to place a line perpendicular to 
the VAS at the point that represents their pain severity/intensity. A ruler is 
then used to measure the distance on the line as indicated by the patient. 
A higher score indicates greater pain severity.  
The Numerical rating scale consists of numbers from 0-10 Figure 5b. In 
this scale the intensity of pain increases as the numbers increase, patients 
are asked to indicate on the scale which number relates to the level of pain 
they are experiencing or have been experiencing (Frampton and Hughes-
Webb, 2011). The numerical rating scale is easier to use (Hølen et al., 
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2006), it measures pain intensity and relief both before and after 
treatment (Caraceni et al., 2002b, Hjermstad et al., 2008). Pain can be 
categorised as mild, moderate and severe on the numerical rating scale. 
The verbal rating scale uses words describing pain as experienced by the 
patient. Patients are asked to indicate on the scale the words that best 
describe their pain (Figure 5c).  
In principal based on the severity of pain the patient is prescribed drugs 
according to the WHO analgesic ladder. Pain assessment is therefore very 
important because it provides a basis for pain management (Caraceni et 
al., 2002a).  
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Figure 5 Pain rating scales 
   (Adapted from International Association for the study of pain) 
                   a: Visual analogue scale 
                   b: Numerical rating scale 
                   c: Verbal rating scale 
 
3.7 Pain Management 
Pain management requires a multidimensional model approach (Marcus et 
al., 2000). The available clinical strategies need to be used to assess pain 
and available effective pharmacological and non-pharmacological 
interventions need to be utilised to effectively manage pain in HIV/AIDS 
 a 
 No pain                                          Very severe pain  
b 
c 
43 
 
(Marcus et al., 2000). Experts recommended that non-pharmacological 
interventions should not be used as a substitute for effective pain relief and 
management (Foley, 1985).  
Pain relief should be seen as a vital component of HIV treatment. If painful 
side effects of antiretroviral drugs can be averted through effective pain 
control, people will be more inclined to adhere to their treatment (Clucas et 
al., 2011) and will be able to stop the replication of HIV far more 
effectively.  
The WHO published guidelines for the pharmacological treatment and 
management of cancer pain in form of a ladder (Figure 6). These guidelines 
are referred to as the WHO analgesic ladder. The WHO analgesic ladder 
was developed in 1986 and validated among cancer patients (Ventafridda 
et al., 1987, Grond et al., 1991). Research has shown that those in severe 
pain can safely benefit from step 3 drugs from the start (Maltoni et al., 
2005). Research has shown that in cancer patients 70-90% with pain 
treated according to the 3 step ladder achieves effective analgesia (Zech et 
al., 1995). The three steps WHO analgesic ladder (Figure 6) contains 
detailed information in terms of managing the pain and using appropriate 
drugs basing on the intensity and severity of pain.  
Current evidence on pain management in HIV/AIDS patients is based on 
clinical experience and use of WHO analgesic ladder (Breitbart, 1996b, 
Newshan, 1995). Although the WHO analgesic ladder has not been 
validated in HIV/AIDS pain management, the guidelines on pain 
management in cancer or HIV/AIDS are not different (Frich and Borgbjerg, 
2000), moreover treatment strategies for cancer pain has shown to be 
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beneficial in treating pain syndromes in HIV/AIDS (Ballantyne et al., 2009, 
Merriman, 2006). 
 
 
                                                                           Step 3 (severe pain)        
 
                                     If pain increases                
                                    Step 2 (moderate pain) 
     If pain increases  
     Step 1 (mild pain) 
                                     If pain incr  
   
(Adapted from WHO) 
The figure above explains that if pain occurs, there should be prompt oral 
administration of drugs in the following order: Step 1 (mild pain): non 
opioids (for example Aspirin and Panadol); and if necessary jump to step 2 
(moderate pain): mild opioids (for example Codeine); and if still necessary 
jump to strong opioids such as Morphine for severe pain, until the patient 
is free of pain (WHO, 2006b).  
Non-opioid with or 
without adjuvants 
Weak opioid with or 
without adjuvants 
Strong opioid with or 
without adjuvants 
Figure 6 WHO 3 steps analgesic ladder for pain management 
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In order to relieve the patient from anxiety, fears and other social aspects 
of pain additional drugs, known as adjuvants are often used especially for 
neuropathic pain (Kieburtz et al., 1998, Simpson et al., 2010, Attal et al., 
2010). However a systematic review and meta-analysis (Phillips et al., 
2010) reported that all adjuvant drugs were not better than placebo, 
although some studies included in this review were shown to have serious 
methodological flaws (Kieburtz et al., 1998, Shlay et al., 1998). 
It is important for patients to be kept free of pain, that analgesia is 
administered in an anticipatory way, regularly, around the clock, rather 
than on demand. This three-step approach of administering the right drug 
in the right dose at the right time is inexpensive and 80-90% effective 
(Jadad and Browman, 1995).  
 
3.8 The need for pain relief in HIV/AIDS patients 
In this section, I will hight the need for pain relief among HIV/AIDS 
patients. Freedom from pain is one of the important interventions in the 
provision of palliative care in HIV/AIDS. 
HIV/AIDS patients report that they have several needs, among their needs 
are pain relief and management (Uwimana and Struthers, 2008). There are 
estimates that up to 80% of HIV/AIDS patients have their needs unmet 
(Grant et al., 2003, Harding et al., 2004b, Karus et al., 2005, Kikule, 2003, 
Sepulveda et al., 2002). WHO recommends that nations need to be 
committed to managing pain and other symptoms by training all health 
care workers and informing and educating the public (Stjernsward, 2002). 
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Other than pain relief, the predominant palliative care needs of HIV/AIDS 
patients are symptom management, psychological support, spiritual 
support, nutritional needs and financial support (Harding et al., 2004a, 
Coughlan, 2003). These needs are often not met (Sepulveda et al., 2003, 
Laschinger et al., Uwimana and Struthers, 2007) and where these needs 
are met it is mainly through the support of families and relatives 
(Sepulveda et al., 2003, Beedham and Wilson-Barnett, 1995). 
In the next section, I will describe family carers of patients living with 
HIV/AIDS. I will explain the various roles and responsibilities family carers 
play, the challenges they experience, and the needs of family carers. 
 
3.9 Carers of HIV/AIDS patients: defining carers  
HIV/AIDS patients are mostly looked after at home by parents, a spouse, 
siblings, or any other relation or by friends. Other carers include 
community members providing voluntary care, that is without 
remuneration (Hudson and Payne, 2009b). Carers are lay people in a close 
supportive role who share the illness experience of the patient and who 
undertake vital care work and emotional support (Department of Health, 
2008, Help the Hospices, 2008). Without this many patients will be unable 
to remain at home, but family carers often lack the information and skills 
to prepare them for such a role (Hudson et al., 2009, Oldham and 
Kristjanson, 2004). 
The primary responsibility for the day to day management of pain and 
related symptoms often lies with the patient and family members (Hudson 
and Payne, 2009a). Caregiving is a great responsibility and sometimes 
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TXLWHRYHUZKHOPLQJIRUFDUHJLYHUV¶(Thielemann, 2000). Patients are likely 
to spend more time with their family members in their communities, than 
with health care workers. In Malawi family members are involved in 
providing nursing care to the patients even in hospitals where staff 
shortages are common place. The majority of HIV/AIDS patients receive 
care in the ambulatory care setting with their primary care. Therefore it is 
imperative that primary carers are equipped with knowledge in the 
appropriate assessment, management of pain (Marcus et al., 2000). Family 
carers consistently identify pain management as their primary concern in 
relation to care and support of their loved ones at home (Oldham and 
Kristjanson, 2004). The challenges family carers experience in their day to 
day activities are discussed in the next section. 
 
3.10 Challenges experienced by family carers 
Family caregivers are crucial to health care systems, providing the majority 
of physical and emotional care for individuals with life-threatening and 
terminal illnesses including those who wish to die at home (Gomes and 
Higginson, 2006, Grande and Ewing, 2008, Rabow et al., 2004). Pain 
management is a particular concern of family carers looking after patients 
with chronic illnesses such as Cancer and HIV/AIDS (Oldham and 
Kristjanson, 2004, Pakenham et al., 2002). 
Informal carers are central to the achievement of end of life care and death 
at home, they provide a substantial, yet hidden contribution to the 
economy (Grande et al., 2009, Butters et al., 1993, Help the Hospices, 
2008). This is particularly the case in resource poor countries like Malawi. 
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Carers needs and the adverse effects of caring have been extensively 
researched, however there is little evidence to establish how these adverse 
effects may be prevented through appropriate support (Grande et al., 
2009). These needs include psychological support, information, help with 
personal care, medication administration, respite, domestic and financial 
help (Aoun et al., 2005, Harding and Higginson, 2003). Care giving is 
associated with anxiety, depression, stress, strain, fatigue, and mortality 
(Ndaba-Mbata and Seloilwe, 2000, Chimwaza and Watkins, 2004, Kipp et 
al., 2007a, Kipp et al., 2007b). There is evidence of unmet need for 
information, financial and domestic support (Walsh et al., 2007, Mwinituo 
and Mill, 2006). It has been suggested that the needs of the carers often 
exceed those of the patients (Higginson et al., 1990, Payne, 1999). 
Although these studies were undertaken in non-HIV populations, 
challenges faced by carers may be similar.  
Despite evidence of unmet needs and consistent calls in the literature for 
the development of tailored and specific services for carers such 
interventions have been rare (Harding et al., 2004a). In a systematic 
review there was found to be a considerable body of knowledge about the 
needs of carers, but little was identified and evaluated on the interventions 
and their effectiveness (Harding and Higginson, 2003).  
A review of quantitative studies of family caregiving at the end of life from 
1998±2008 identified the potential for negative emotional, psychological 
and physical outcomes for caregivers, as well as for financial strain and 
occupational and social disruption (Stajduhar et al., 2010)&DUHJLYHUV¶ODFN
of preparation, knowledge and/or ability is a common finding, especially 
regarding symptom, pain, and medication management (Kazanowski, 
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2005, Armes and Addington-Hall, 2003, Oldham and Kristjanson, 2004). 
Family caregivers receive little preparation, information, or support to 
perform their care giving role (Hudson et al., 2008). However, their needs 
must be addressed so they can maintain their own health and continue to 
provide care (Northouse et al., 2010). 
Family caregivers need education about pain management, training in 
problem-solving skills, and recognition from providers about their role in 
pain management (Oldham and Kristjanson, 2004). When clinicians better 
understand and respond to the needs of the family caregivers, they can 
enhance the quality of life and care outcomes for both patients and their 
caregivers (Meeker et al., 2011). The majority of patient care for HIV/AIDS 
LVXQGHUWDNHQ LQSDWLHQWV¶KRPHVDV VXFK WKH HIIHFWLYHQHVVRIDSDWLHQW¶V
pain management is affected by the knowledge and attitudes of patients 
and caregivers (Ministry of Health, 2008b). The experience of caring for a 
IDPLO\ PHPEHU LQ SDLQ SURIRXQGO\ DIIHFWV WKH FDUHJLYHU¶V ZHOO-being, and 
WKHFDUHJLYHU¶VHIIHFWLYHQHVV LQKHOSLQJZLWKSDLQPDQDJHPHQWDIIHFWVWKH
well-being of the patient (Meeker et al., 2011). If family carers do not feel 
confident and knowledgeable about pain assessment and management, 
patients may require more frequent hospital admissions and medical 
treatments. Carers who are unfamiliar with pain management may over or 
under dose patients with opioids (Oldham and Kristjanson, 2004).  
The next section describes home-based care for people living with 
HIV/AIDS. People living with HIV/AIDS are looked after by family members 
in their own homes, and hence home-based care. This high prevalence rate 
has over stretched the health care system due to lack of resources, few 
number of hospital beds and limited number of health workers in the health 
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facilities. Most of the chronically ill patients go home when they are 
discharged while on-going care is still required. For this reason, home 
based care for chronically ill patients is one of the suitable interventions in 
the care and support for HIV and AIDS patients (Tapsfield and Bates, 
2011; Wahab and Salam, 2011). 
 
3.11 Home-based care 
Home-based care is health care provided at home in the home by families, 
volunteers with support and assistance from health workers (Ndaba-Mbata 
and Seloilwe, 2000, Hudson and Payne, 2009a). In Malawi home-based 
care is defined as care provided to chronically, terminally ill patients with 
conditions such as cancer, stroke, HIV/AIDS and any other chronic 
illnesses, with the aim of restoring and promoting maximum health and 
comfort to the patient and family (National AIDS Commission, 2003, 
Ministry of Health, 2011b). Most patients with life limiting illnesses are 
cared for at home by their families in a familiar setting (Ministry of Health, 
2011b, Ministry of Health, 2008b). It is estimated that 90% of the chronic 
illnesses including HIV/AIDS are managed in patient homes by untrained 
family carers (Ogden et al., 2006). Literature on care giving for patients 
with life limiting illnesses and their families suggests that families who 
receive detailed information and training about patient care manifest more 
vigilant coping compared with families who receive little or no information 
(Ndaba-Mbata and Seloilwe, 2000, Help the Hospices, 2008). In addition 
families who receive information about home health care activities, and 
challenges that may be experienced are less anxious and ready to receive 
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and give quality care to their loves ones (Derdiarian, 1986).  
Home-based care is viewed as a cost effective response to managing the 
problems experienced by patients. However adequate training, resource 
supply and support is often neglected among family carers (Hunt, 2009). 
Less attention has been paid to the role of patient and carers in managing 
the patients pain despite the fact that HIV/AIDS pain is managed on an 
outpatient basis and in patients own homes (de Wit et al., 1997).  
International health organizations such as (WHO, 1990) and the American 
Pain Society (Gordon et al., 2005), emphasise the importance of education 
on pain and the involvement of patients and carers in managing pain. 
However few studies have fully considered the importance of this 
involvement. There is shortage of health care workers in Malawi and other 
countries in SSA, and hence the need for home-based care (Grant et al., 
2011). There are also few personnel trained in palliative care (Harding et 
al., 2003). Home-based care provides practical, emotional, physical and 
spiritual support to people in their own homes (Ministry of Health, 2011b).  
Interventions for carers need to provide strong evidence for appropriate 
ways of supporting carers. Lack of a firm empirical and conceptual basis 
has prevented the design of effective interventions and the generation of 
evidence to demonstrate their impact (Grande et al., 2009).  
 
3.12 Chapter summary 
Pain remains a challenge in the population of HIV/AIDS patients and has 
negative effects on their quality of life. Pain is experienced throughout the 
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disease trajectory and it is more severe as the infection advances. Pain is 
also experienced due to the side effects of HIV treatment/medication. 
Currently with the advancement being made to improve the access to HIV 
drugs in resource poor countries, HIV patients are living longer, which 
means they will continue to experience pain throughout their life span. 
Provision of effective interventions to the population of HIV/AIDS patients 
is needed to minimise or reduce the severity of pain.  
Home-based care and palliative care in HIV/AIDS patients is crucial in 
order to reduce the physical, social, psychological and spiritual problems 
that they experience. Family carers of HIV/AIDS patients play a crucial role 
in the implementation of home-based care and palliative care services 
particularly in Malawi.  
The next chapter contains a critical review of randomised controlled trials 
evaluating the effects of pain education interventions among patients with 
HIV/AIDS. 
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CHAPTER FOUR: A REVIEW OF EVIDENCE FROM RANDOMISED 
CONTROLLED TRIALS OF EDUCATION INTERVENTIONS ON PAIN 
AND SYMPTOM MANAGEMENT FOR HIV/AIDS PATIENTS 
 
4.1 Introduction 
This chapter provides a detailed review of literature of published studies on 
the effects of educational interventions on pain severity and pain 
management from previous randomised controlled trials. The chapter 
contains the process of conducting the review, inclusion and exclusion 
criteria for the studies, and methodological quality assessment of studies. 
In addition, the presentation of findings from the review, and gaps in 
literature. Although there is evidence that pain education interventions 
have positive effects in reducing the severity of pain, improving knowledge 
and quality of life among people living with HIV/AIDS, little is known about 
their effectiveness in sub-Saharan African contexts. This review critically 
appraises available evidence reported in randomised controlled trials with 
two or more parallel groups.  
This review focuses on pain and education because palliative care nurses 
play a crucial role of educating patients on pain management. Being a 
palliative care nurse one of my roles was to educate patients and families 
on management of pain. 
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4.2 Defining a systematic review 
A systematic review is a process which locates, appraises, and summaries 
evidence from available studies pertinent to a specific question by using an 
explicit, logical and scientific methodology (Khan et al., 2011). Systematic 
reviews are scientific investigations in themselves, with pre-planned 
methods and an assembly of original studies as their "subjects." (Cook et 
al., 1997). They synthesize the results of multiple primary investigations by 
using strategies that limit bias and random error (Cook et al., 1995). These 
strategies include a comprehensive search of all potentially relevant articles 
and the use of explicit, reproducible criteria in the selection of articles for 
review. Primary research designs and study characteristics are appraised, 
data are synthesized, and results are interpreted (Cook et al., 1997, 
Mulrow et al., 1997). 
Typically in a systematic review, a clinical problem is considered, evidence 
evaluated and synthesised so that conclusions can be drawn about 
effective practices. A systematic review is not a literature review; it is a 
methodology of conducting research in itself (Polit and Beck, 2008). It 
brings together and assesses all relevant research evidence to provide 
answers to a particular research question (Evans, 2001, Evans and 
Pearson, 2001). It adheres to a rigorous scientific design to minimise the 
risks of biases and ensure reliability (Cook et al., 1997). This is contrary to 
traditional literature review methods which are conducted without formal 
guidance rules. Such reviews tend to be subjective. Furthermore, 
traditional reviewers are rarely explicit about how studies are selected, 
assessed and integrated (Davies and Crombie, 2001) and the risk of 
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publication bias is increased (Webb and Roe, 2007, Spector and Thompson, 
1991). 
Traditional reviews are not always rigorous; reviewers rarely begin with an 
open mind as to the likely recommendations (Davies and Crombie, 2001). 
Traditional reviews deal with a broad range of issues related to a given 
topic rather than addressing a particular issue in depth (Mulrow et al., 
1997), thus they are useful in obtaining a broad perspective on a topic, 
they are less often useful in furnishing quantitative answers to specific 
clinical questions (Cook et al., 1997) while systematic reviews are 
generated to answer specific, often narrow clinical questions in depth 
(Richardson et al, 1995). 
Systematic reviews overcome these weaknesses of traditional narratives by 
making the review process transparent (Newman and Fleming, 2002). In 
adequately presented systematic reviews, they allow readers to replicate 
the review and are more objective (Egger, et al, 2001). Systematic reviews 
have increasingly replaced traditional reviews as a way of summarising 
evidence for effectiveness of diagnostic and treatment interventions 
(Collins and Fauser, 2005). Systematic reviews of randomised controlled 
trials are considered to be evidence of the highest level in the hierarchy of 
research designs evaluating effectiveness of interventions (Akobeng, 
2005b, Evans, 2003).  
Following an extensive literature search I found no evidence of recent 
systematic review to bring together evidence from published randomised 
controlled trials on pain management among people with HIV/AIDS and 
family carers. Recent systematic reviews of home palliative care services 
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for people with advanced illnesses and their caregivers have focused on a 
number of chronic illnesses such as congestive heart failure and chronic 
obstructive pulmonary disease (Gomes et al., 2013). Another recent 
systematic review on self-management education programs for people 
living with HIV/AIDS included studies conducted in western countries, 
excluding all studies conducted in Africa. The study concluded that self-
management education interventions have short-term effectiveness in 
improving physical, psychosocial, and knowledge among people living with 
HIV/AIDS, but no sufficient evidence on long-term effects of the 
interventions (Millard et al., 2013).  
 
4.3 Aims and objectives of the review 
The aim of this review was to examine and update the synthesised 
evidence regarding the effect of pain education interventions on a range of 
patient outcomes. The review sought to specify the contents and form of 
existing pain education interventions for people living with HIV/AIDS.  
 
4.4 Objectives 
The objectives of the review were to: 
‚ Identify educational interventional studies of pain assessment and 
management for HIV/AIDS patients. 
‚ Identify the educational interventional strategies used in managing pain. 
‚ Identify pain, education, and quality of life outcomes among people living 
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with HIV/AIDS. 
There many interventions that are used to manage pain which include 
psychological, respite care, coping skills, cognitive behavioural therapy and 
educational interventions. I chose studies that focused on educational 
interventions because one of my roles as a palliative care nurse is to 
provide education to patients and family members. Education interventions 
are feasible and easier to design and implement in Malawian context.  
 
4.5 Search strategy 
A comprehensive search strategy was developed and utilised to identify 
relevant studies published in English language only. The following data 
bases were searched: Amed, Assian, CINAHL, Cochrane Library, EMBASE, 
MEDLINE, PsycINFO and Web of Science from 1984 to February 2014, 
because HIV was first reported in 1983. The following key words or subject 
headings were used: HIV, AIDS, pain assessment, pain management, and 
pain education (Table 3). 
As randomised controlled trials is the suitable methodology of evaluating 
LQWHUYHQWLRQV WKHUHIRUH ³UDQGRPLVHG FRQWUROOHG WULDOV´ZDV XVed as a key 
word in the title, abstract, and content (full text) was used to map 
quantitative evidence. 
All articles were screened and duplicates were deleted. Hand search was 
also used by going through the reference list of articles of the identified 
studies that investigated the effect of pain education interventions on 
people living with HIV/AIDS and/or family carers. 
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Table 3 Search terms used 
 
4.6 Inclusion and Exclusion criteria 
4.6.1 Inclusion criteria 
Studies were included if they were:  
  
‚ Randomised and non-randomised controlled trials 
‚ Evaluated educational interventions of any form. 
‚ Compared educational intervention with usual care/standard 
care.  
‚ HIV/AIDS patients were participants  
 
4.6.2 Exclusion criteria 
Studies were excluded if they were: 
‚ Non educational interventions such as psychosocial interventions. 
 
Key concepts Key words 
HIV HIV, human immune deficiency virus 
AIDS AIDS, Acquired immune deficiency 
syndrome 
Pain education  Patient education, patient teach, patient 
learn, patient inform, pain knowledge 
Pain management Self-management, pain, symptom, 
management 
Research methodology Randomised controlled trial 
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Table 4 Summary of Inclusion criteria 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 Inclusion 
Type of participants Patients with HIV/AIDS 
 
Type of studies Randomised controlled trials 
Non-RCT 
Quasi experimental studies. 
Type of intervention Any Educational interventions of any form 
like leaflet, booklet, DVD, tape recording 
on pain assessment and management. 
Psycho-educational interventions were 
also included. 
Outcomes Pain intensity/severity, symptom 
intensity/severity, pain interference, pain 
knowledge, quality of life.  
Articles retrieved from electronic 
databases (N=1256) 
Full-texts articles assessed for 
eligibility (N=19) 
Records after duplicates removed 
(N=1148) 
Records excluded 
(N=1129) 
Title exclusion (N=990) 
+ 
Abstract evaluation 
(N=139) 
Articles included (N=8) 
Full text exclusion 
(N=11) 
Figure 7 PRISMA flow chart of study selection process 
Records screened (N=1148) 
Duplicates (N= 108) 
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4.7 Studies identified  
The full text of 1256 articles were obtained from electronic data bases 
through a comprehensive search. All articles were discarded if they were 
duplicates (N=108) and after reviewing the title of the articles (N=990). 
Abstracts were then reviewed and other studies were also excluded 
(N=140) because they did not meet the inclusion criteria (Figure 7). 
Consequently the final articles which meet the inclusion criteria were 
obtained for evaluation (N=18). After full text extraction ten studies were 
excluded because the intervention was psychosocial, drug adherence, 
cognitive-behavioural therapy, and depressive symptoms. Summary of all 
studies included in the review are presented in the table 7. 
 
4.8 Methodological quality of the trials  
All the eight studies included in the review were critically evaluated on a 
checklist recommended by the Centre for Review and Dissemination 
(Centre for Review and Dissemination, 2009) and Critical Appraisal Skills 
Programme (Critical Appraisal Skills Programme, 2013) for evaluating 
randomised controlled trials (Table 5 check list for assessing validity of 
randomised controlled trials) and Quality assessment for all studies are 
summarised on Table 6.  
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Table 5 check list for assessing validity of randomised controlled 
trials 
 
4.9 Description of the studies 
Participants in general were not blind to group allocation though this was 
not stated clearly in two of the nine studies (Wantland et al., 2008, Webel, 
2010). Given the nature of non-pharmacological interventions, blinding was 
not feasible and this has potential to raise performance bias among 
participants in self-reported outcomes. The sample size ranged from 40 
(Inouye et al., 2000) to 775 (Wantland et al., 2008) participants. In all of 
the nine studies random allocation was performed effectively. One study 
(Lechner et al., 2003) reported that outcome assessors were blind to 
participant group allocation and two studies reported that participants self-
completed the questionnaires (Wantland et al., 2008, Gifford et al., 1998), 
however the rest did not report who conducted follow-up outcomes and 
whether they were blind or not.  
Item No. Topic Checklist item 
1 Randomisation Was the assignment to treatment groups really 
random? 
2 Blinding of participants and 
researchers  
Were participants blinded to treatment groups? 
Were health care workers blinded to treatment 
groups? 
3 Baseline similarity Were the intervention and control groups similar 
at the start of the trial? 
4 Identical except intervention Aside from the intervention were the groups 
treated equally? 
5 Blinding of outcome assessors Were those assessing outcomes blind to the 
treatment groups? 
6 Follow-up Was relatively completed follow-up achieved? 
7 Analysis of data  Was ITTA or modified ITTA performed? 
Were the outcomes of the participants who 
withdrew described and included in the analysis? 
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In general participants were broadly similar at baseline, however two 
studies (Wantland et al., 2008, Inouye et al., 2000) did not clearly report 
this. Of the nine studies reviewed, five achieved 80% follow-up rate. One 
study reported 34.6% attrition (Wantland et al., 2008). One study did not 
clearly state how many participants were lost to follow-up (Inouye et al., 
2000). Two studies followed-up all the participants they recruited and 
performed intention-to-treat analysis (Chiou et al., 2006a, Chiou et al., 
2004). Two studies performed modified intention-to-treat analysis, they 
excluded all participants who were lost to follow-up (Lechner et al., 2003, 
Gifford et al., 1998). In one study missing subscales from questionnaires 
were replaced with group means, but missing data due to lost to follow-up 
was not replaced (Lechner et al., 2003). In one study, some participants in 
the control group deviated from the protocol, they received the 
intervention despite being randomised to control group, however the 
authors did not explain if they performed per protocol analysis or modified 
intention-to-treat analysis (Goujard et al., 2003). One study included 
participants lost to follow-up in the final analysis (Webel, 2010). Two 
studies (Wantland et al., 2008, Inouye et al., 2000) did not report if they 
included or excluded participants lost to follow-up in the analysis. All 
studies provided information about characteristics and reasons for lost to 
follow-up. Excluding study participants who withdrew from the study after 
sustaining severe side effects to the intervention will affect the results of 
the trial and has potential to introduce bias (White et al., 2011, Abraha and 
Montedori, 2010, Ellenberg, 2005). 
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Table 6 Quality assessment of the RCTs included in the review 
(N=9) 
 
 
In table six above, only three of the eight studies included in the review 
were of good quality, with a score of five out of seven (5/7). 
 
Studies Random 
allocation 
Blinding 
of 
patients 
Analysis of 
withdrawal 
Assessor 
blinded? 
Groups 
comparable 
at baseline  
Identical 
except 
intervention 
Complete 
follow-up 
Overall 
quality 
Goujard 
et al 
(2003) 
  
Yes No Withdrawals 
not included, 
but not clear 
if ITTA or per 
protocol 
analysis 
Not stated Yes Yes 80% 
complete 
follow-up 
4/7 
Wantlan
d et al 
(2008) 
 
Yes Not 
stated 
Not stated Self-
completed 
by 
participant 
Not clear Yes No, 34.6 
% attrition 
rate 
3/7 
Luchner 
et al 
(2002) 
Yes No Modified 
ITTA, 
withdrawals 
excluded 
Yes Yes Yes 80% 
completed 
follow-up 
5/7 
Gifford 
et al 
(1998) 
 
Yes No Modified 
ITTA 
Self-
completed 
by 
participant 
Yes Yes 81% 
complete 
follow-up 
5/7 
Chiou et 
al 
(2004) 
 
Yes No N/A Not stated Yes Yes Yes  4/7 
Chiou et 
al 
(2006) 
 
Yes No N/A Not stated Yes Yes Yes 4/7 
Inouye 
et al 
(2000) 
Yes No Not stated Not stated Not clear Yes Not clear 2/7 
Webel et 
al 
(2010) 
Yes Not 
stated 
Yes  Not clear Yes Yes 80% 
completed 
follow-up 
5/7 
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4.10 Nature of Interventions 
In this section the nature of interventions tested is described. The section 
also contains a highlight of the type of education intervention tested, who 
delivered the intervention, how the intervention was deliverd, for how long, 
and how the intervention differs from usual care provided. 
A full description of the interventions tested are summarised in table 7. 
Broadly the nature of the interventions were similar. They were all 
educational interventions provided to patients infected with HIV/AIDS., 
peer educators (Gifford et al., 1998, Webel, 2010) or self-managed by the 
patients (Chiou et al., 2004, Chiou et al., 2006a, Lechner et al., 2003, 
Wantland et al., 2008, Goujard et al., 2003). Some interventions were 
provided to patients in groups (Lechner et al., 2003, Chiou et al., 2004, 
Chiou et al., 2006a). All the studies had two parallel groups, the 
intervention and usual care; except (Chiou et al., 2004, Chiou et al., 
2006a), these had three parallel groups. There were two interventions 
delivered either to patients as individuals (one-to-one teaching) or patients 
were in groups which meant interaction among group members, and the 
control group received usual care only (Chiou et al., 2006a), however in a 
related study (Chiou et al., 2004) the control group received usual care 
and telephone counselling .  
Two studies (Webel, 2010, Lechner et al., 2003) tested two different 
interventions. One tested the effects of a group-based cognitive-
behavioural stress management/expressive-supportive therapy compared 
with a time-matched individual psycho-educational therapy (Lechner et al., 
2003), another tested a peer-based symptom management intervention 
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compared with a self-management symptom manual (Webel, 2010). The 
interventions focused on self-assessment of symptoms (Wantland et al., 
2008, Gifford et al., 1998, Inouye et al., 2000) and self-management of 
symptoms of HIV/AIDS infection or side effects of HAART (Wantland et al., 
2008, Inouye et al., 2000, Chiou et al., 2004, Chiou et al., 2006a, Gifford 
et al., 1998). Skills training (Inouye et al., 2000, Chiou et al., 2004, Chiou 
et al., 2006a, Gifford et al., 1998), promotion of drug adherence and 
improving knowledge levels (Goujard et al., 2003), psycho-educational 
intervention (Lechner et al., 2003). Four studies provided educational 
materials to the participants such as a symptom management manual 
(Wantland et al., 2008, Webel, 2010) and/or a video (Lechner et al., 2003, 
Inouye et al., 2000).  
Five studies invited participants randomised to the control groups to 
receive the intervention upon completion of follow-up assessments (Inouye 
et al., 2000, Chiou et al., 2004, Chiou et al., 2006a, Gifford et al., 1998, 
Goujard et al., 2003).  
In the trial conducted by Inouye et al (2000) participants in the 
intervention group received self-management training and education for 
seven weeks, the intervention was administered twice a week, and 
participants attended a total of 14 sessions, each lasting 60-90 minutes. 
However the authors did not report who facilitated the training education. 
Participants in the control group received usual care provided by their 
primary care providers, and received the intervention upon completion of 
follow-up assessments (Inouye et al., 2000). 
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In two of the five studies with a wait-list control group (Chiou et al., 2004, 
Chiou et al., 2006a) both studies had two treatment groups consisting of 
one-to-one teaching and group teaching on symptom management 
programme once a week followed by three weeks continuity and telephone 
counselling. The control group participants received usual care and were 
invited to receive the intervention upon completion of follow-up 
assessments. However in one of these two studies the control group 
received telephone counselling intervention like other two parallel 
treatment groups (Chiou et al., 2004).  
In another study, participants randomised to the intervention group were 
taught self-management skills of HIV/AIDS symptoms using various means 
such as role playing, information sharing and problem solving skills. This 
was a group based intervention facilitated by peer leaders. Participants 
who were randomised to the control group received usual medical care and 
were invited to participate in the self-management education programme 
after three months of follow-up assessments (Gifford et al., 1998). 
In another study, participants randomised to the intervention group 
received an individualised educational programme focussing on drug 
adherence. Participants in the control group were invited to participate in 
the education programme after 12 months of follow-up assessments 
(Goujard et al., 2003).  
In a trial conducted by (Wantland et al., 2008) participants randomised to 
the intervention group were provided with a symptom management 
manual which focuses on description of HIV/AIDS symptoms, ways of 
treating the symptoms and self-care strategies that may be useful to 
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decrease and resolve the symptoms. Participants in the control group 
received a manual on HIV/AIDS nutritional guidelines.  
Two of the eight studies did not have a usual care control group. They 
compared the effects of two different interventions (Lechner et al., 2003, 
Webel, 2010). In one of these two studies (Lechner et al., 2003) 
participants in one experiment group received a group-based cognitive-
behavioural stress management/expressive-supportive therapy while 
participants in the other experiment group received a time-matched video-
based individual psycho-education. In another study, one intervention 
group attended a self-management skills programme (Webel, 2010) based 
on the previous work (Gifford et al., 1998) on peer education on symptom 
management, although (Gifford et al., 1998) recruited men only, and 
(Webel, 2010) recruited women only. The study (Webel, 2010) compared 
the peer education intervention (Gifford et al., 1998) to the symptom 
management manual (Wantland et al., 2008) among women living with 
HIV/AIDS. 
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Table 7 Summary of RCT Studies included in the review 
 
 
Author/Setting Sample Intervention(s) Comparator Outcomes/measures Results 
 
Inouye, et al 
(2000) in the 
USA 
40 patient 
participants (20 
randomly 
allocated into two 
groups) 
Seven week program of self-
management training and 
education provided twice a 
week 
Usual care (details not 
provided), but also received 
the intervention after 
completion of follow-up 
assessments. 
1.Physical health status: number of physical 
symptoms; Karnofsky performance scale 
(KPS) and CD4 count after seven weeks 
 
2. Quality of life (QOL): quality of life index 
(QLI) after seven weeks 
 
1.No significant differences 
on mean number of 
symptoms and CD4 count 
 
2.No significant effects on 
quality of life 
Gifford et al 
(1998) USA: San 
Francisco bay 
settings. 
71 men with 
HIV/AIDS 
symptoms: (34 
experimental 
group; 37 control 
group) 
randomly 
allocated to 
groups. 
Interactive health education 
group session; 7 sessions in 
total about self-
management skills and 
information on symptom 
assessment and 
management, medication 
use, physical exercise, 
relaxation, communication 
with doctor and nutrition 
facilitated by 2 peer leaders. 
Waiting list and received 
usual care. 
1.Symptom severity assessed with a 14-
item symptom severity index 
 
2.Pain was assessed with 5-item Medical 
Outcomes Study 
 
3. HIV knowledge was assessed with a 10-
item HIV knowledge created for this study. 
All outcomes were assessed at three 
months. 
 
1. Symptom severity 
decreased in the 
experiment group and 
increased in the control 
group (-0.9 versus +0.5; p 
<.03).  
 
2. There were no 
significant differences in 
pain outcome between the 
intervention and groups.  
 
3. control group showed a 
better knowledge 
improvement compared to 
intervention group. 
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Author/setting Sample Intervention(s) Comparator Outcomes/measures Results 
Chiou et al (2004) 
in Taipei (STD 
control centre, 
medical centre and 
Catholic AIDS 
support) 
67 participants: 23 
in the individual 
teaching group, 22 
in the group 
teaching group and 
22 in the usual 
care group 
One-to-one teaching 
attended a 60 minute 
teaching program on HAART 
side effect, safe care 
education and skill training 
weekly, for 3 weeks and 
telephone counselling 
Group teaching, as above 
except it was a 90 minute 
program 
Usual care and telephone 
counselling. 
Received the intervention after 
follow-up assessments.  
1.Medication side-effects safe care 
knowledge assessed with medication 
side effects self-care knowledge 
questionnaire (MSSKQ)  
 
2.self-HVWHHP5RVHQEHUJ¶VVHOI-
esteem scale) 
 
3. Unscheduled hospital visits (UHV). 
All outcomes were evaluated after 3 
months. 
1. Knowledge of management 
of medication side effects in 
the teaching groups was 
statistically significant 
compared to the control group 
(P<0.001).  
 
2. No statistically significant 
differences between the three 
groups on self-esteem.  
 
3. Unscheduled hospital visits: 
one-to- one teaching group 
P=0.017; individual teaching 
group P=0.035; usual care 
group P=0.655. 
 
Lechner et al 
(2002) Miami-Dade 
County, Florida, 
New York and New 
Jersey (USA) 
330 women 
randomly assigned 
to two treatment 
groups 
Group-based cognitive-
behavioural stress 
management/expressive-
supportive therapy (CBSM) 
for 10 weeks (two hour, 
weekly sessions) (n=150) 
Time-matched videotape-based 
individual psycho education two 
hour weekly sessions for 10 
weeks (n=180). 
1.Quality of life assessed with the 
Medical Outcomes Study Health 
Status Questionnaire for HIV (MOS-
HIV-30) after ten weeks 
 
2. CD4 and CD8 lymphocyte counts; 
HIV viral load after ten weeks. 
1. QOL scores increased in 
both groups, but scores were 
statistically significantly 
higher in the CBSM group 
 
2. No significant differences in 
CD4, CD8 and HIV viral load. 
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Author/setting Sample Intervention Comparator  Outcomes/measures Results  
 
Chiou et al 
(2006) Taipei 
medical centre, 
STD control 
centre, and AIDS 
social service 
agency 
 
67 participants: 23 
were on one-on-one 
teaching; 22 in 
teaching group; 22 in 
control group 
Symptom management 
instruction in self-care of the 
symptoms caused by side 
effects, skill training and 
telephone counselling for 
three weeks 
 
Control group received usual 
care (details not provided), 
and received the intervention 
after conclusion of data 
collection 
1.Drug adherence measured with 
The Customised Adherence Self-
Report Questionnaire  
 
2.CD4 count and viral load 
 
3.Quality of life (QOL) measured 
using QOL index 
 
All outcomes were evaluated after 
three months.  
1.Mean differences on the 
Customised Adherence Self-
Report Questionnaire were 
statistically significant in the 
experiment groups 
compared to the control 
group 
 
2.CD4 count and viral load 
were significant in both 
experiment groups 
compared to the control 
groups 
 
3.QOL in both experimental 
groups were statistically 
significantly better than in 
the control group 
 
Webel (2010) 
San Francisco 
Bay (USA) 
89 women  Seven, two-hour peer-led 
sessions over seven weeks 
Interactive health education 
group session; 7 sessions in 
total about self-
management skills and 
information on symptom 
assessment and 
management, medication 
use, physical exercise, 
relaxation, communication 
with doctor and nutrition 
facilitated by 2 peer leaders. 
Copy of symptom 
management strategies 
(Wantland et al, 2008) 
1.Symptom intensity measured 
with the revised version of the HIV 
Sign and Symptom Checklist 
 
2.Medication adherence assessed 
with the revised AIDS Clinical 
Trials Group 
 
3. Quality of life assessed with the 
HIV/AIDS Targeted Quality of Life 
Instrument. 
All outcomes were assessed at 
week 14. 
No statistically significant 
differences between the two 
groups in all outcomes. 
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Author/setting Sample Intervention Comparator Outcomes/measures Results 
 
Goujard et al 
(2003) France. 
367 HIV patients 
(179 control and 188 
experiment). 
 
Individualised educational 
programme based on 
diagnosis of adherence 
problem to HIV medication. 
It used planning card with 
self-adhesive stickers 
showing treatment 
medication, followed by at 
least 1 hour educational 
sessions for 12 months. 
Staff nurses and physicians 
facilitated the program. 
Standard care (no details 
provided). 
Participants were invited to attend 
the education programme upon 
completion of follow-up 
assessments. 
1.Knowledge about HIV and its 
treatment assessed with the 14 
item knowledge questionnaire 
 
2. Adherence to medication 
(PMAQ7) 
 
3.QOL (HIV-46) 
 
4. Therapeutic response (CD4 
count and viral load). 
 
All outcomes were assessed at 
six, 12 and 18 months. 
1. Knowledge score 
increased at 6 months, 12, 
18 in both groups, with a 
higher improvement in the 
experimental group at 6 and 
12 months. 
 
2. Significant differences 
between the intervention 
and control groups on 
adherence score at 6, 12 
and 18 months. 
 
3. QOL scores increased in 
the experimental group over 
time, but no significant 
differences between the two 
groups. 
 
4. No significant differences 
on CD4 count and viral load 
between the two groups. 
 
Wantland et al 
(2008) 
Africa, Puerto, 10 
sites across USA. 
775 HIV patients 
recruited from 
community clinics. 
Experimental group received 
a manual on symptom 
management. 
Control group received a manual 
on general nutrition. 
Frequency and intensity of HIV 
symptoms at baseline, 1 month 
and two months follow ups: 
Revised Sign and Symptom 
Checklist for persons with HIV 
disease (SSC-HIV). 
 
Analysis showed a greater 
decline in symptom 
frequency and intensity for 
the experimental group 
compared to the control 
group (t=2.36, P=0.018). 
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Due to the heterogeneity of the interventions and populations studied meant 
that a meta-analysis was not appropriate and may give misleading/spurious 
findings. Ideally only controlled trials with proper randomisation of patients 
preferably blinded, outcome assessment with strict intention-to-treat principle 
should be included in the meta-analysis. The studies in this systematic review 
had methodological challenges.  
 
4.11 Outcome measures 
This section outlines the outcomes of interests in the studies reviewed. 
Each study included had a variety of outcomes. Broadly the outcomes 
measured in the studies were pain severity, symptom frequency and intensity, 
quality of life, knowledge of pain management and medication side effects, 
and palliative care outcomes. 
Some outcomes were self-reported by the participants and were evaluated 
using questionnaires, while some outcomes were clinical outcomes such as 
CD4 count, viral load, and unscheduled hospital visits. 
The outcomes in the eight studies reviewed were measured using validated 
instruments. The outcomes in the studies are in line with IMMPACT 
recommendations on the main outcomes of interests in studies on pain 
interventions. 
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4.11.1 Pain and symptom outcomes 
Only one of the eight studies examined pain score following the administration 
of the intervention (Gifford et al, 1998). In this study pain outcome was 
measured using the Medical Outcomes Study (MOS) pain severity scale 
(Gifford et al., 1998). The authors reported that there was no significant 
difference between the intervention and control groups after three months of 
follow-up assessments.  
Four of the eight studies assessed HIV symptom severity (Gifford et al., 1998, 
Webel, 2010, Inouye et al., 2000, Wantland et al., 2008). In the trial by 
Gifford et al (1998), symptoms were measured and summarised using a 14-
item symptom severity index to evaluate the overall burden caused by HIV 
symptoms. The symptom severity index decreased significant in the 
intervention group, compared to the control group after three months of 
follow-up assessments (Gifford et al., 1998). In another study HIV symptom 
intensity was evaluated with the HIV Sign and symptom check list, which 
identifies 72 common symptoms experienced by people infected with HIV. The 
questionnaire was administered at 2, 6, 10 and 14 weeks after delivery of the 
intervention. The study found no significant differences in symptom severity 
between the intervention and control groups (Webel, 2010). In another study 
physical symptoms were categorised into either high or low symptoms within 
each of the two groups. Participants with many symptoms were categorised as 
³KLJK´ DQG WKRVH ZLWK D IHZ V\PSWRPV ZHUH FDWHJRULVHG DV ³ORZ ´ 3K\VLFDO
symptoms were evaluated using the Karnofsky performance scale (KPS). The 
intervention found significant effects with the number of symptoms reported 
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after seven weeks of follow-up assessments (Inouye et al., 2000).  
The symptom management manual study (Wantland et al., 2008) evaluated 
the frequency and intensity of HIV symptoms using The Revised Sign and 
Symptom Checklist for Persons with HIV Disease (SSC-HIVrev). The 
questionnaire was administered at baseline, month 1 and month 2. The trial 
reported that symptom frequency and severity significantly declined in the 
intervention group compared to the control group (Wantland et al., 2008).   
In this review there was only one study (Gifford et al, 1998) that examined 
pain as an outcome, and four studies examined symptom severity (Gifford et 
al, 1998; Inouye et al, 2000; Wantland et al, 2008; Webel, 2010) (see Table 
8). This suggests that few educational interventional studies in the field of 
HIV/AIDS have been conducted that evaluate the effects on pain related 
outcomes.  
 
4.11.2 Quality of life outcomes 
All studies included in the review evaluated quality of life outcomes except 
(Wantland et al., 2008, Chiou et al., 2004, Gifford et al., 1998). However 
quality of life was assessed using different measures and findings were not 
consistent.  
Two studies of the nine studies (Webel, 2010, Goujard et al., 2003) concluded 
that educational interventions had no effect on quality of life. One study 
(Goujard et al., 2003) evaluated quality of life using HIV-46 questionnaire and 
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reported that the educational intervention on adherence to HIV medication 
lead to improved quality of life, but there was no significant difference 
between the experiment and control groups at 6,12 and 18 months, likewise 
(Webel, 2010) assessed quality of life using the HIV/AIDS Targeted Quality of 
life. The Target Quality of Life is a 34-item instrument measuring nine 
dimensions of HIV disease-specific quality of life. The study reported that 
there were no significant differences between the intervention and the control 
group at 10 and 14 weeks of follow-up assessments. (Webel, 2010). However, 
three of the nine studies found significant effects of educational interventions 
on quality of life (Inouye et al., 2000, Lechner et al., 2003, Chiou et al., 
2006a). 
Quality of life was assessed with Quality of Life Index (QLI) at baseline 
(Inouye et al., 2000, Chiou et al., 2006a), seven weeks (Inouye et al., 2000) 
and three months (Chiou et al., 2006a) after delivery of the intervention. Self-
management programme significantly increased quality of life among 
HIV/AIDS patients who received the intervention compared to the patients 
who did not receive the intervention (Inouye et al., 2000). The study (Chiou et 
al., 2006a) had three parallel groups. There were two intervention groups. One 
intervention group was delivered on one-to-one or individual basis and the 
other intervention was delivered on group basis). The third group was a 
control group. The study concluded that participants in the two experiment 
groups experienced significant quality of life outcomes compared to 
participants in the control group (Chiou et al., 2006a).  
Another study had two intervention groups with no control group. One 
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intervention group was a group-based, while another intervention group was 
individual-based. Quality of life was assessed with Medical Outcomes Study 
Health Status Questionnaire for HIV (MOS-HIV-30). Both interventions were 
reported to be effective in improving certain aspects of quality of life, although 
the group-based intervention experienced greater and statistically significant 
improvement in quality of life related to mental health aspect (Lechner et al., 
2003). 
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Table 8 Outcomes of pain education interventions among people living 
with HIV/AIDS 
=: No difference between two groups 
  : Significant decrease in the intervention group 
  :  Significant increase in the intervention group 
 
Table 8 above shows that only one study (Gifford at al, 1998) measured pain 
as an outcome and the results were not statistically significant.  
 
Studies 
 
 
Outcomes 
Gifford 
et al 
(1998) 
(n=71 
men) 
Inouye et 
al (2000) 
(n=40) 
Lechner 
et al 
(2002) 
(n=330 
women) 
Goujard 
et al 
(2003) 
(n=367) 
Chiou, 
et al 
(2004) 
(n=67) 
Chiou 
et al 
(2006) 
(n=67) 
Wantland 
et al 
(2008) 
(n=775) 
Webel 
(2010) 
(n=89 
women) 
Physical and 
social 
 
Pain     =        
Symptoms           = 
quality of life       =       = 
Knowledge    =        
Self-esteem         =    
Physiological  
CD4    =  =   =      = 
CD8    =      
Viral load    =  =   =         = 
Other   
Unscheduled 
hospital visit 
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4.11.3 Knowledge outcomes 
Knowledge outcomes were assessed in three of the nine studies reviewed 
(Chiou et al., 2004, Goujard et al., 2003, Gifford et al., 1998). Two studies 
reported that education intervention improved knowledge (Chiou et al., 2004, 
Goujard et al., 2003) while one study reported that the education intervention 
did not improve knowledge levels (Gifford et al., 1998). 
One trial (Chiou et al., 2004) assessed participants knowledge on HIV 
medication side effects and how to manage them using the Medication side 
effects self-care questionnaire (MSSKQ). The trial found statistically significant 
improvement in the knowledge of medication side effects and their 
management in the intervention compared to the control groups after seven 
weeks of follow-up assessments (Chiou et al., 2004). In another study 
knowledge levels were assessed with HIV knowledge questionnaire. Although 
the study reported that knowledge score increased in both groups with higher 
improvements in the intervention group, it is not clearly reported whether this 
improvement was statistically significant between the two groups (Goujard et 
al., 2003). On the contrary another study (Gifford et al., 1998) assessed 
knowledge using a 10-item HIV knowledge questionnaire specifically related to 
information with this study. Participants in the control group reported a greater 
knowledge improvement than participants randomised to the intervention 
group (Gifford et al., 1998), however they did not report whether this result 
was statistically significant between the two groups. 
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4.11.4 Self-esteem outcomes 
Two studies (Wantland et al., 2008, Chiou et al., 2004) evaluated the effects of 
the intervention on self-esteem. The symptom management manual study 
evaluated the usefulness of the symptom management and nutritional 
management manuals. They reported that for both the experiment and control 
groups, individuals who rated the manuals very helpful at one and two months 
of follow-up assessments were significantly more likely to have lower symptom 
intensity scores that decreased rapidly over time compared to those who rated 
the manuals lower, suggesting the manuals were viewed to have a positive 
impact on the patients in decreasing the severity of the symptoms (Wantland 
et al., 2008).  
In another study self-HVWHHP ZDV HYDOXDWHG XVLQJ 5RVHQEHUJ¶V 6HOI-esteem 
Scale (RSES). The intervention group a one-to-one or group teaching on self-
care management skills of HAART side effects and telephone counselling. The 
comparison group received telephone counselling only. They found no 
significant differences between two groups at week seven after the delivery of 
the intervention (Chiou et al., 2004).  
 
4.11.5 Other outcomes 
Other outcomes reported in the studies were effects of the interventions on 
therapeutic response, by evaluating for example viral load levels, CD4 count 
and number of unscheduled hospital visits. Because these are not patient 
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reported outcomes, I wanted to see if the interventions delivered had an effect 
on the immune system bearing in mind that this is also another way to 
evaluate quality of life. CD4 count and viral load were evaluated in five of the 
nine studies (Inouye et al., 2000, Lechner et al., 2003, Goujard et al., 2003, 
Chiou et al., 2006a, Webel, 2010). Broadly the authors reported similar 
findings. 
The self-management training and education programme study found no 
significant differences between the intervention and control group in CD4 cell 
count after seven weeks (Inouye et al., 2000). Likewise another study 
reported that there were no significant differences in CD4 cell count and viral 
load between the intervention and control groups after 14 weeks of follow-up 
assessments (Webel, 2010). Another study also found no significant 
differences in CD4 and CD8 lymphocytes counts and HIV viral load after four 
weeks of follow-up assessments (Lechner et al., 2003).  
Although another trial reported that there was no direct effect of the 
educational intervention on CD4 cell count and viral load, there were increased 
levels of CD4 cells and decreased levels of viral loads in the intervention group 
compared to the control groups after 6 months following the delivery of the 
intervention. The trend was also confirmed after 12 months (Goujard et al., 
2003). On the contrary the symptom management programme (Chiou et al., 
2006a) found statistically significant differences in CD4 counts cells and viral 
load between the two experiments groups and one control group. Participants 
who were randomised to two experiment groups had increased CD4 cell counts 
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and low viral load compared to participants randomised to control groups after 
three months (Chiou et al., 2006a). 
Unscheduled hospital visits were evaluated in one study (Chiou et al., 2004). 
In this study; two intervention groups reported statistically significant 
differences in pre-test and post-test scores indicating the intervention 
programme decreased unscheduled hospital visits, but there were no 
significant differences in pre-test and post-test in the control group (Chiou et 
al., 2004) after three months of follow-up assessments.  
In the following section, I report the findings of qualitative data extracted from 
randomised controlled trials included in the current review. Qualitative studies 
of pain education studies not included in the current review were not 
H[WUDFWHG7KHGDWDH[SORUHVSDWLHQW¶VH[SHULHQFHVDQGYLHZVRIEHLQJSDUWRI
WKH VWXG\ DV ZHOO DV SDWLHQW¶V VXJJHVWLRQV GXULQJ WKH GHYHORSPHQW SKDVH RI
the intervention. 
 
4.12 Qualitative data within trials reviewed 
Medical Research Council (MRC) (Craig et al., 2008) guidelines for 
development and evaluation of complex interventions recommends that 
qualitative interviews should be conducted to elicit views of the patients and 
their caregivers on the content and components of the intervention. 
Qualitative interviews may also be conducted after the intervention has been 
delivered to complement quantitative data and to get participants experiences 
about the intervention. Although the review did not include qualitative studies, 
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qualitative data embedded within educational interventional studies included in 
WKHUHYLHZZHUHH[WUDFWHGLQRUGHUWRHOLFLWSDUWLFLSDQW¶VH[SHULHQFHVDERXWWKH
intervention.  
  
Two studies in the current review conducted qualitative interviews after 
completing follow-up assessments (Webel, 2010; Gifford., et al 1998).  
In the study by Webel (2010), participants reported both positive and negative 
comments which can be summarised into three main themes 
‚ The intervention taught participants how to manage symptoms 
‚ The intervention facilitated a strong sense of community 
‚ Feeling that the facilitators could be better 
Participants also added that other topics could be added to the intervention 
such as discordant couples and relationships, substance abuse, menopause, 
co-morbidities, and stress management. However Webel (2010) has not 
reported how participants were selected for qualitative interviews and how 
many were selected. 
One trial conducted structured, open-ended telephone interviews (Gifford et 
al., 1998) which were published a year later (Gifford and Sengupta, 1999) 
ZLWK SDUWLFLSDQWV ZKR SDUWLFLSDWHG LQ D ³SRVLWLYH VHOI- management 
SURJUDPPH´ 3603 GXULQJ HYDOXDWLRQ RI WKH SURJUDPPH 5HVSRQVHV to the 
programme were generally favourable, emphasizing the importance of the 
contracting process, group social support and the resource book which was 
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provided to the participants. Participants also described variation in HIV 
knowledge and experiences, and emphasized the importance of changes in 
health-related attitudes and behaviours as a result of education programme. 
These responses suggest that a self-management approach to HIV patient 
education was accepted, and could become a useful health education 
technique in patients with chronic HIV infection (Gifford and Sengupta, 1999). 
One study conducted semi-structured interviews to elicit views from the 
patients and caregivers before the intervention (Gifford et al., 1998). Semi-
structured, in-depth interviews were conducted among eight patients and their 
caregivers to identify problems they were experiencing living with HIV/AIDS, 
which have psychological, social and medical impacts on their quality of life. 
Participants raised a number of problems such as difficulties in managing 
symptoms, poor communication with care providers and hence depression and 
IDWLJXH %DVHG RQ WKHVH SUREOHPV DQ HGXFDWLRQ SURJUDPPH ³SRVLWLYH VHOI- 
PDQDJHPHQWSURJUDPPH´3603ZDVGHVLJQHGDQGGHYHORSHGE\SK\VLFLDQV
nurses, health educators, community leaders (Gifford et al., 1998). 
In summary, only two studies included in the current review conducted 
qualitative interviews. One study (Gifford et al, 1998) conducted semi-
structured qualitative interviews during the development phase of the trial to 
elicit patients and carers needs. The same authors (Gifford et al, 1998) also 
conducted structured open-HQGHG LQWHUYLHZV WRH[SORUHSDWLHQW¶V H[SHULHQFHV
of being part of the trial. The other study (Webel, 2010) only conducted 
qualitative interviews after follow-XS DVVHVVPHQWV WR H[SORUH SDWLHQW¶V YLHZV
about the intervention. 
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4.13 Gaps in literature 
The review of literature I have conducted has found inconclusive results on 
effectiveness of education interventions among people living with HIV/AIDS. 
Of all the eight studies reviewed one study evaluated pain as an outcome 
(Gifford et al, 1998). The rest focused on general symptoms that are 
experienced by people living with HIV/AIDS such as fatigue, stress, 
depression. The trial conducted by (Gifford et al., 1998) did not find sufficient 
evidence on the effectiveness of the education intervention in reducing pain 
severity among people living with HIV/AIDS. 
Three of the eight studies that evaluated symptom severity and intensity as an 
outcome (Gifford et al., 1998, Inouye et al., 2000, Wantland et al., 2008) 
found evidence that the education intervention was effective in reducing 
severity, intensity and frequency of HIV/AIDS symptoms. One study found no 
significant differences between the intervention and control groups on 
symptom severity and frequency (Webel, 2010).  
Three of the eight studies reported that educational interventions were 
effective on improving the quality of life of the patients (Chiou et al., 2006a, 
Lechner et al., 2003, Inouye et al., 2000) while two of the nine (Goujard et 
al., 2003, Webel, 2010) found no significant differences on the effects of 
educational interventions between the pain education and the usual care 
groups on quality of life.  
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Knowledge levels were reported to have improved among the participants who 
received the education intervention (Goujard et al., 2003, Chiou et al., 2004) 
while (Gifford et al., 1998) reported improved levels of knowledge among 
participants randomised to the control group.  
Likewise (Wantland et al., 2008) reported improved self-esteem among the 
participants who received the self-symptom management intervention 
compared to the control group which received the nutrition management 
manual; on the contrary (Chiou et al., 2004) found no significant difference 
between the education intervention group and control group. Broadly the 
studies reported that the education intervention has no therapeutic effect that 
is the levels of CD4, CD8 and viral load did not differ between the intervention 
and control groups.  
The results of the current review are not only conflicting, but also inconclusive. 
There are a number of reasons why the results cannot be generalised to a 
wider context. Firstly these studies were conducted exclusively (Gifford et al., 
1998, Inouye et al., 2000, Chiou et al., 2004, Chiou et al., 2006a, Lechner et 
al., 2003, Goujard et al., 2003, Webel, 2010) or predominantly (Wantland et 
al., 2008) in western countries, where culture, delivery of services, 
geographical factors are very different with other countries in SSA. Although 
(Wantland et al., 2008) recruited participants in the USA, Puerto and South 
Africa, the majority of trial centres were in the USA, with small number of trial 
centres in South Africa.  
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Secondly the interventions administered in two of the eight studies I reviewed 
were symptom and nutritional management manuals (Wantland et al., 2008, 
Webel, 2010) and may not be acceptable in Malawi context. Likewise other 
interventions which required participants to attend training twice a week, for 
seven weeks (Inouye et al., 2000), weekly training for three weeks (Chiou et 
al., 2004, Chiou et al., 2006a), two hours weekly attendance for 10 weeks 
(Lechner et al., 2003), and two hour sessions for seven weeks (Gifford et al., 
1998, Webel, 2010) may not be feasible, acceptable and applicable in settings 
like Malawi where participants have a walk long distances such as 30 km to 
access health care. However the important thing I noted is that the 
interventions did not focus much on the use of technology such as DVDs, 
videotapes except (Lechner et al., 2003) who used a videotape. These may 
not be always available in resource poor countries like Malawi and where 
available sustainability may be a challenge. 
None of the authors in any of these eight studies reviewed included family 
carers as participants in their studies, although (Gifford et al., 1998) invited 
family carers to accompany their patients, none of them was actively involved 
as a participant in their study. Family carers are important in the provision of 
pain and symptom management for people living with HIV/AIDS in Malawi who 
are living in their own homes. 
In summary, the review of educational interventions among HIV/ADS patients 
is inconclusive because the studies reviewed have produced conflicting 
ILQGLQJV2QO\WKUHHRIWKHHLJKWVWXGLHVUHYLHZHGZHUHUDWHGDVµJRRG¶LQ
terms of their methodological quality, the rest were considered 
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methodologically poor or not possible to evaluate because of lack of 
methodological detail. Only one study assessed pain as an outcome and found 
no evidence of a positive effect. It is these conclusions that informed the 
design and outcomes of the pain education intervention study among 
HIV/AIDS patients and their family carers that is the basis of this thesis.  
The next chapter reviews literature on supportive interventions targeted at 
family carers of people living with HIV/AIDS.  
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CHAPTER FIVE: REVIEW OF EVIDENCE OF THE EFFECTIVENESS OF 
EDUCATION INTERVENTIONS FOR CAREGIVERS OF PEOPLE LIVING 
WITH HIV/AIDS 
 
5.1 Introduction 
This chapter provides a detailed review of literature of published studies on 
the effects of education interventions for caregivers of people living with 
+,9$,'6 %HFDXVH FDUHUV¶ QHHGV DQG FKDOOHQJHV DUH GLIIHUHQW WR SDWLHQWV
interventions for caregivers¶ LQWHUYHQWLRQV DUH UHYLHZHG VHSDUDWHO\ 7KH
chapter contains the process of conducting the review, inclusion and exclusion 
criteria for the studies, quality assessment of studies. In addition, the 
presentation of findings from the review, and gaps in literature. Although there 
is evidence that psychosocial and psycho-educational interventions have 
positive effects among family carers of people with chronic illnesses (Hudson 
et al., 2010) little is known about their effectiveness among carers of people 
living with HIV/AIDS in sub-Saharan Africa. This review critically appraises 
available evidence reported in randomised controlled trials and quasi 
experiment studies.  
Systematic reviews of family carer interventions have been conducted 
exclusively in the UK and other countries in Europe (Victor, 2009, Stoltz et al., 
2004), Australia (Hudson et al., 2010). The studies included in these reviews 
were for patients with cancer, schizophrenia, dementia, head injury, stroke and 
aphasia. Even though the needs and experiences of carers of patients with 
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chronic and palliative care may be similar, geographical factors may have an 
effect on family carers from other parts of the world, such as SSA where the 
prevalence of HIV/AIDS is very high. The review also aimed to critically 
evaluate the methodological quality of the studies.  
 
5.2 Aims and objectives of the review 
The aim of this review was to examine and update the synthesised evidence 
regarding the effect of pain education interventions on a range of family carer 
outcomes. The review sought to specify the contents and form of existing pain 
education interventions for family carers.  
 
5.3 Objectives 
The objectives of the review were to: 
‚ Identify studies of education interventions for caregivers of people living with 
HIV/AIDS. 
‚ Identify the educational interventional strategies used. 
‚ Identify caregiver knowledge, self-esteem, motivation, and quality of life 
outcomes. 
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5.4 Search strategy 
A comprehensive search strategy was developed and utilised to identify 
relevant studies published in English language only. The following data bases 
were searched: Amed, Assian, CINAHL, Cochrane Library, EMBASE, MEDLINE, 
PsycINFO and Web of Science from inception to February 2014. The following 
key words or subject headings were used: HIV, AIDS, carers, informal carers, 
family carers, education (Table 9). 
All articles were screened and duplicates were deleted. Hand searching was 
also used by going through the reference list of articles of the identified 
studies that investigated the effect of education interventions on caregivers of 
people living with HIV/AIDS. 
Table 9 Search terms used 
 
5.5 Inclusion and Exclusion criteria 
5.5.1 Inclusion criteria 
Studies were included if they were:  
‚ Randomised controlled trials, Non-randomised controlled trials or quasi 
Key concepts Key words 
HIV HIV, human immune deficiency virus 
AIDS AIDS, Acquired immune deficiency syndrome 
Education  carer education, carer teach, carer learn, carer 
inform, knowledge 
Carers Family carers, informal carers, caregivers,  
Research methodology Randomised controlled trial quasi experiment 
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experiment studies. 
‚ Educational interventions of any form. 
‚ Comparison of educational intervention with usual care/standard care. Studies 
that looked at psycho-educational and psychosocial interventions were all 
included.  
‚ Both HIV positive and HIV negative carers were included as long as they cared 
for people living with HIV/AIDS. 
‚ Both caregivers and care recipients as participants. 
‚ Qualitative data from interventional studies included in the current review will 
be extracted. 
 
5.5.2 Exclusion criteria 
Studies were excluded if: 
‚ Participants were paid carers such as nurses and other health care workers. 
‚ Participants were not carers of people living with HIV/AIDS. 
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Table 10 Summary of Inclusion and Exclusion criteria 
 
  
 Inclusion Exclusion 
Type of participants Caregivers of patients with HIV/AIDS 
Family carers, informal carers, or any carer 
providing unpaid care to patients with 
HIV/AIDS.  
Paid carers like nurses, 
doctors or any health 
care workers doing paid 
work, 
Carers of patients with 
other illnesses other 
than HIV/AIDS.  
Type of studies Randomised controlled trials, Non RCT 
(Quasi experiments) 
Quantitative studies with 
different design other 
than RCT or quasi 
experiment 
Qualitative study only 
Type of intervention Any Educational interventions of any form 
like leaflet, booklet, DVD, tape recording. 
Psycho-educational and psychosocial 
interventions. 
 
Outcomes Carer knowledge, QOL, positive caregivers 
experiences, self-esteem, anxiety, 
depression , stress 
Any other outcomes 
other than the outcomes 
stated above. 
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Articles retrieved from 
electronic databases 
(N=777) 
Records screened (N=679) 
Records after duplicates 
removed (N=679) 
Full text studies obtained for 
evaluation (N=16) 
Records excluded (N=663) 
 
Title exlusion (N=519) + 
 Abstract evaluation 
(N=144) 
Articles included (N=7) 
Full text exclusion (N=9) 
Figure 8 Flow Diagram of the study selection process 
Duplicates (N=98) 
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5.6 Studies identified  
The full texts of 777 papers were obtained from electronic data bases through 
a comprehensive and hand search. All articles were discarded if they were 
duplicates (N=98) and after reviewing the title of the articles (N=519). 
Abstracts were then reviewed and other studies were also excluded (N=144) 
because they did not meet the inclusion criteria (figure 8). Consequently the 
final articles which meet the inclusion criteria were obtained for evaluation 
(N=16). After full text extraction nine studies were excluded because they 
were not intervention studies, or the intervention was cognitive-behavioural 
therapy and were caregivers of mental retardation patients, though received 
intervention on HIV/AIDS information. Summary of all studies included in the 
review are presented in table 12. 
All the seven studies included in the review were critically evaluated on a 
checklist recommended by the Centre for Review and Dissemination (Centre 
for Review and Dissemination, 2009) and Critical Appraisal Skills Programme 
(Critical Appraisal Skills Programme, 2013) for evaluating randomised 
controlled trials as explained in chapter four. 
Participants in all the studies were not blind to group allocation. Given the 
nature of the interventions, blinding was not feasible. The sample size ranged 
from 28 (Gordon-Garofalo and Rubin, 2004) to 307 (Rotheram-Borus et al., 
2001) participants. Three of the seven studies in this review were randomised 
controlled trials and random allocation was performed effectively (Hansell et 
al., 1999, Rotheram-Borus et al., 2001, Pakenham et al., 2002). Four of the 
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seven studies were quasi experiment (Pomeroy et al., 1995, Boon et al., 
2009b, Smith Fawzi et al., 2012, Gordon-Garofalo and Rubin, 2004). Two of 
the four quasi experiment studies had a control group (Pomeroy et al., 1995, 
Gordon-Garofalo and Rubin, 2004). Two of the seven studies (Pakenham et 
al., 2002, Boon et al., 2009b) reported that outcome assessors were blind to 
group allocation and two of the seven studies reported that participants self-
completed the questionnaires (Hansell et al., 1999, Pomeroy et al., 1995). 
Only one of the four randomised controlled trails reported that outcome 
assessors were not blind (Smith Fawzi et al., 2012), however (Rotheram-
Borus et al., 2001, Gordon-Garofalo and Rubin, 2004) did not report who 
conducted outcomes and whether they were blind or not.  
Of the five studies which had a control group, participants were broadly similar 
at baseline, except age (Hansell et al., 1999), sex and occupation (Pomeroy et 
al., 1995) differences. All the seven studies achieved 80% follow-up except 
(Hansell et al., 1999) who reported 44.2% attrition. One study (Rotheram-
Borus et al., 2001) did not clearly state how many participants were lost to 
follow-up, although they report that follow-XS UDWH ZDV µYHU\ JRRG¶ 7KUHH
studies stated how data analysis was conducted; one performed intention-to- 
treat analysis (Rotheram-Borus et al., 2001), modified intention-to-treat 
analysis (Pakenham et al., 2002) and per protocol analysis (Boon et al., 
2009b). All studies provided information about characteristics and reasons for 
lost to follow-up. The main reasons were death of the patient, death of the 
caregiver, or carers work commitments. 
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Table 11 Quality assessment of the RCTs included in the review 
 
 
Studies Random 
allocatio
n 
Blindin
g of 
partici
pants 
Analysis of 
withdrawal 
Blinding of 
assessor 
Groups 
comparable 
at baseline  
Identical 
except 
intervent
ion 
Complete 
follow up 
Overall quality 
Hansell et al 
(1999) 
Yes No No Self-
completed by 
participants 
Seronegative 
caregivers 
were older 
than 
seropositive 
caregivers 
Yes No 3/7 
Rotheram-
Borus et al 
(2001) 
Yes No ITTA Not stated Yes Yes Yes 4/7 
Pakenham 
et al (2002) 
Yes No Modified 
ITTA. 
Yes, some 
were self-
completed by 
participants 
Yes Yes Yes, 80% 
completed 
follow-up 
4/7 
Gordon-
Garofalo 
and Rubin 
(2004) 
No No Yes Not stated More 
homosexuals 
and bisexual 
partners in the 
intervention 
group 
More 
participants in 
treatment 
compared to 
control group 
Yes Yes 3/7 
Pomeroy et 
al (1995) 
No No No Self-
completed by 
participants 
Sex and 
occupation 
differences 
Yes 82% 
completed 
follow-up 
3/7 
Fawzi et al 
(2012) 
 
No No No No N/A N/A  Yes  
 
1/7 
Boon et al 
(2009) 
No  No Per protocol 
analysis. 
Yes N/A N/A  Yes, 90% 
completed 
follow-up 
2/7 
$OOWKHVHYHQVWXGLHVLQFOXGHGLQWKHUHYLHZZHUHFRQVLGHUHGRIµSRRU¶TXDOLW\
None of the seven studies scored above four out of seven (a 60% cut-off 
point). The methodology was either poorly described or not clearly stated. 
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5.7 Nature of Interventions 
The interventions tested have been summarised in table 12. Broadly speaking 
the nature of the interventions were similar. They were psychosocial (Smith 
Fawzi et al., 2012, Pakenham et al., 2002) and psycho-educational (Boon et 
al., 2009b, Rotheram-Borus et al., 2001, Hansell et al., 1999, Pomeroy et al., 
1995) interventions delivered to family caregivers of patients infected with 
HIV/AIDS. The caregivers were either blood relations or foster parents or 
extended family members or partners/spouses for the people living with 
HIV/AIDS. The interventions were delivered by social workers (Pomeroy et al., 
1995, Rotheram-Borus et al., 2001, Smith Fawzi et al., 2012, Hansell et al., 
1999), community health workers (Boon et al., 2009b) and clinical 
psychologists (Pakenham et al., 2002). All interventions were group based. 
Three of the seven studies (Hansell et al., 1999, Rotheram-Borus et al., 2001, 
Pakenham et al., 2002) were randomised controlled trials and had two parallel 
groups, the intervention and usual care groups, except (Pakenham et al., 
2002) had three parallel groups. In the first intervention group the 
intervention was delivered to both caregivers and care recipients 
(carer/patient dyads), in the second intervention group the intervention was 
delivered to caregivers only) and in the third group both caregivers and care 
recipients received usual care, but received the intervention after completing 
follow-up assessments (wait list control).  
In these three randomised controlled trials, the interventions were social 
support boosting to reduce experience of stress and enhance coping. 
Participants randomised to the intervention arm received network resources, 
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specific supportive behaviour. The intervention was delivered monthly for 12 
months. Participants randomised to the control group received usual care 
consisting of multidisciplinary team approach and access to medical and 
nursing care (Hansell et al., 1999). The intervention in another study was 
eight weekly sessions, each session lasting one and half hours on 
psychological counselling on emotional problems, social problems, and dealing 
with health/infection concerns and caregiving demands (Pakenham et al., 
2002). All sessions were conducted by clinical psychologists. In another 
randomised controlled trial, participants randomised to the intervention group 
were taught coping skills with HIV/AIDS illness, fear, anger, caregiving 
responsibilities and how to provide care, while the control group received 
standard care. The intervention was delivered by social workers and 
participants attended educational sessions each Saturday. The sessions lasted 
four hours (two hours in the morning, and two hours in the afternoon). In total 
they attended eight sessions (Rotheram-Borus et al., 2001).  
In quasi experimental studies participants allocated to the intervention group 
were taught basic facts about HIV/AIDS, stigma coping skills, management of 
opportunistic infections, management of anger, stress and anxiety, and to be 
assertive. The control group received usual care (no details provided), but 
received the intervention after follow-up assessments were completed. 
Participants attended eight sessions delivered weekly in groups of 8-10. Each 
session lasted 90 minutes (Pomeroy et al., 1995). In another study, a similar 
intervention as described above was delivered to partners and spouses of 
people living with HIV/AIDS. The control group received routine social services 
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such as peer support, and family counselling and were invited to receive the 
intervention after completing follow-up assessments (Gordon-Garofalo and 
Rubin, 2004). 
In another quasi experimental study (Boon et al., 2009b) older caregivers 
attended four workshop sessions delivered monthly each lasting three hours 
on basic information about HIV/AIDS, home-based and nursing care, social 
assistance and support. Participants received the intervention in groups of 10-
12, but there was no control group (Boon et al., 2009b).  
In their study (Smith Fawzi et al., 2012) participants were taught coping skills 
and social support enhancement, positive living, stress reduction strategies, 
HIV risk behaviour reduction. Participants received the intervention in groups 
of 12-15 bi-monthly over a year and there was no control group (Smith Fawzi 
et al., 2012).  
Three of the seven studies (Pomeroy et al., 1995, Pakenham et al., 2002, 
Gordon-Garofalo and Rubin, 2004) invited participants in the control group to 
receive the intervention after completion of follow-up assessments. The use of 
educational materials were not common in the studies reviewed except 
(Pomeroy et al., 1995, Boon et al., 2009b) who provided hand outs to study 
participants.  
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Table 12 Summary of interventional studies included in the review 
 
Author/Setting Sample Intervention(s) Comparator Outcomes/measurers Results 
Hansell, et al 
(1999); New 
York/New Jersey 
70 primary caregivers 
of children with 
HIV/AIDS 
Social support consisting 
of support network 
resources, supportive 
behaviour, and subjective 
appraisal of support 
facilitated by social 
workers 
 
Standard care consisting 
of multidisciplinary team 
approach, medical and 
nursing care, social and 
respite care 
1.Total caregiver stress 
measured with The Derogatis 
Stress Profile (DSP) 
2.Interpersonal relationships 
measured with The Tilden 
Interpersonal Relationship 
Inventory (TILDEN) 
3. Internal and external family 
coping measured with The 
Family Crisis Oriented 
Personal Scales (F-COPES) 
4. Social status evaluated with 
Hollingshead Index of Social 
Position.  
All outcomes were conducted 
at 0,6,12 months 
1-4. No significant differences were 
found between intervention and 
control groups at 6 months in all 
the four outcomes. 
4. When adjusted for HIV status of 
the caregivers, social support for 
HIV negative caregivers was 
significantly different compared to 
the sero positive caregivers 
between the two groups. 
Pakenham et  
al (2002) Australia 
36 caregivers and 
care-recipients with 
HIV/AIDS  
Dyad intervention (DI) 
caregivers and their 
patients: eight weekly 
sessions of one and half 
hours conducted by 
psychologists 
Caregiver Intervention 
(CI) caregivers only: eight 
weekly sessions of one 
and half hours conducted 
by psychologists 
  
Wait list control group 
(WLC); details of 
standard care not 
provided. 
1.Global distress: The Brief 
Symptom Inventory (BSI) 
2.Dyadic adjustment: Dyadic 
Adjustment Scale 
3.Target problem ratings: 
Target problem rating scale 
4.Social adjustment: The 
Psychosocial Adjustment to 
Illness Scale  
5.Subjective health status: 
Global rating of health scale 
6.Knowledge:HIV/AIDS 
knowledge questionnaire (at 
0,2 and 4 months for all six) 
1-3.Caregivers in the DI group 
improved significantly compared to 
CI and WLC on (global adjustment, 
dyadic adjustment and target 
problem) which were maintained at 
four months except global distress 
2-6. Care recipients in the DI group 
improved significantly in all 
outcomes compared to care 
recipients in the CI and WLC which 
were maintained at four months 
except knowledge 
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Author/Setting Sample Intervention(s) Comparator Outcomes/measurers Results 
Boon et al, (2009) 
Port Elizabeth in 
South Africa 
202 older caregivers of 
orphaned and sick 
children with HIV/AIDS 
Four weekly workshop 
sessions, each for three 
hours consisting of 
information about 
HIV/AIDS, communication, 
skills about home-based 
and nursing care, social 
assistance and social 
support. Training was 
facilitated by community 
health workers in groups 
of 10-12 older carers 
No control group 1. perceived ability to provide 
care 8-item questionnaire 
 
2.Knowledge on HIV/AIDS 10-
item questionnaire 
 
3.Depression was measured 
with Hopkins Symptom 
Checklist-25 item 
questionnaire 
 
4. Coping measures was 
assessed with Ways of Coping 
Checklist. 
 
All outcomes were conducted 
at baseline, after intervention 
and three months follow-up 
 
Of the 202 participants, 141 
attended all the sessions, 13 did 
not attend all the four and 48 did 
not attend any sessions. 
 
1. Participants who attended the 
workshop perceived themselves to 
more able to provide nursing care 
(P<0.003) compared to 
participants who did not attend 
 
2. Improved knowledge on 
HIV/AIDS (p<0.003) than those 
who did not attend 
 
4.Caregivers showed higher coping 
skills at post-test and follow-up 
  
Fawzi et al (2012) 
Haiti 
168 HIV affected 
youths and 130 
caregivers 
Enhancing coping skills 
and increasing social 
support sessions held bi-
monthly for one year. 
Groups of 12-15 
participants (parent-child 
pairs) facilitated by social 
workers 
No control group 1.Severity of depression 
symptoms: Hopkins Symptom 
Checklist (HSCL-25) 
 
2.Social support: to examine 
confidence, network size and 
instrumental support 
 
3.HIV-related stigma: HIV-
related stigma questionnaire 
 
4.Level of role functioning: 
ACTG Short Form-21 (SF-21) 
Outcomes were conducted at 
baseline and one year after 
the intervention 
1-3.Caregivers demonstrated 
significant reduction in depressive 
symptoms, improved social support 
and decreased HIV-related stigma 
102 
 
 
Author/Setting Sample Intervention(s) Comparator Outcomes/measurers Results 
Gordon-Garofalo 
and Rubin (2004) 
 
28 partners and 
spouses of people 
living with HIV/AIDS 
Psychoeducation 
intervention on the 
following areas: general 
information about 
HIV/AIDS, Infections 
associated with HIV/AIDS, 
positive, coping, dealing 
with anger, stress, and 
stigma. The intervention 
was delivered weekly for 
eight weeks, each session 
lasting 90 minutes. 
Waiting list control 
received routine social 
services such as peer 
support, and family 
counselling 
1.Depression was measured 
with 21-item Beck Depression 
Inventory (BDI) 
 
2. Anxiety was assessed with 
the State-Trait Anxiety 
Inventory (STAI), A 20-item 
questionnaire. 
 
3. Perceived social support 
was assessed with the Social 
Support Appraisals (SSA) 
 
4.Percieved stress was 
assessed with a 15-item 
measure The Impact of Event 
Scale (IES) 
 
5. Perceived stigma was 
assessed with a 3-item 
questionnaire developed 
Pomeroy et l (1995). 
All outcomes were conducted 
at 0 and 2 months. 
 
1-5.No significant differences 
between two groups in all the five 
outcomes. 
 
1-3. The treatment group mean 
showed a better improvement 
compared to the control group. 
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Author/Setting Sample Intervention(s) Comparator Outcomes/measurers Results 
Pomeroy (1995) 
south-western 
metropolitan area 
33 family carers Eight sessions delivered 
weekly to family 
caregivers in groups of 8-
10. The sessions covered 
topics such as basic facts 
about HIV/AIDS; coping 
with stigma, management 
of opportunistic infections, 
anger management, stress 
management, 
assertiveness, anxiety 
management, and 
nutrition in HIV/AIDS. 
Each sessions lasted 90 
minutes. 
Waiting list control 
received standard care 
1.Depression: The Beck 
depression inventory (BDI) 
was used to assess depression 
2.Stigma: 3-item 
questionnaire  
3.Perceived stress: The 
impact of event (IES) was 
used to measure stress 
4.Anxiety: Trait Anxiety 
Inventory (STAI)  
5.Social support: The health 
and daily living form (HDL) 
assessed social support (all 
assessed at 0,2,4 months) 
1-4. Results were statistically 
significant for stress, stigma, 
depression and anxiety (P<0.001) 
at 2 and 4 months. 
 
 
Rotheram-Borus et 
al (2001) New York 
in the USA 
307 parents and 412 
adolescent children 
with HIV/AIDS (153 
parents and 205 youth 
in the intervention; 
154 parents and 207 
youth in the control 
group) 
Two modules: first 
modules to parents alone 
(four Saturdays); Second 
module: both parents and 
adolescents (eight 
Saturdays). Sessions 
lasted 2 hours in the 
morning and 2 hours in 
the afternoon; with group 
meetings of 8-10 parents 
or adolescents separately. 
Topics mainly focused on 
coping with illness and 
caring for children. 
Standard care 1.Symptoms of emotional 
distress: Brief Symptom 
Inventory (BSI-53)  
 
2.Coping: Five Coping with 
Illness Questionnaire 
Outcomes were conducted at 
three months interval over 24 
months 
1.Significant reduction in emotional 
distress over 3-15 months 
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5.8 Outcome measurers 
Each study included had a variety of outcomes. Broadly the outcomes 
measured in the studies were anxiety, depression, stress, coping, social 
support and HIV/AIDS knowledge. 
In the three randomised controlled trials, the outcomes were total caregiver 
stress measured with the Derogatis stress profile (DSP); interpersonal 
relationships measured with the Tilden Interpersonal relationship Inventory 
(TILDEN); family coping measured with The family Crisis Oriented Personal 
Scale (F-COPES) and social status measured with Hollingshead Index of social 
position. All outcomes were conducted at 0, 6 and 12 months (Hansell et al., 
1999). The trial reported that there were no significant differences between 
the intervention and control groups in all the outcomes, although caregivers 
who were HIV positive had significant greater stress levels and used fewer 
coping strategies compared to caregivers who were HIV negative (Hansell et 
al., 1999). The trial had high attrition rate, only (n=39) of the (n=70) 
caregivers who were recruited remained in the study at 12 months and due to 
small sample size, there was no sufficient power to conduct the analysis at 12 
months of follow-up assessment. In another randomised controlled trial 
(Rotheram-Borus et al., 2001) caregivers were assessed for symptoms of 
emotional distress and anxiety with Brief Symptom Inventory (BSI-53), coping 
with illness was assessed with a five-item coping with illness questionnaire, an 
index of adult problem behaviours was used to evaluated presence of risk 
behaviour such as substance use, degree of distress was evaluated by a 
distress 1-5 Likert scale. The authors reported that caregivers who were 
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randomised to the intervention group experienced significant decrease in 
depression, anxiety, problem behaviours and distress compared to caregivers 
who were randomised to the control group over 3 to 15 months. The changes 
were not significant after 18 to 24 months except for the problem behaviour 
outcome (Rotheram-Borus et al., 2001). The other randomised controlled trial 
(Pakenham et al., 2002), evaluated caregivers in terms of Global distress 
using The Brief Symptom Inventory (BSI), social adjustment using the 
Psychosocial Adjustment to illness Scale, dyadic adjustment using the Dyadic 
Adjustment Scale, health status using the Global Rating of health Scale, 
problem rating using the Target Problem Rating Scale and knowledge using 
the HIV/AIDS knowledge questionnaire. All outcomes were evaluated at 0, 2 
and 4 months. This is the only trial which had three parallel groups. The 
authors reported that both intervention groups (caregivers with their care 
recipients and caregivers only) showed a greater improvement in all the 
outcomes except social adjustment. Care recipients who received the 
intervention with their caregivers showed greater improvement on global 
distress, dyadic adjustment, target problems than care recipients who did not 
receive the intervention (Pakenham et al., 2002).  
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Table 13 Outcomes of interventions among caregivers of people living 
with HIV/AIDS 
Studies 
 
 
 
 
Outcomes 
Hansell 
et all 
(1999) 
(n=70) 
Rotheram-
Borus et al 
(2001) 
(n=307) 
Pakenha
m et al 
(2002) 
(n=36) 
Pomeroy 
et al 
(1995) 
(n=33) 
Fawzi 
et al 
(2012) 
(n=13
0) 
Boon 
et al 
(2009) 
(n=20
2) 
Gordon-
Garofalo 
and 
Rubin 
(2004) 
(n=28) 
Psychological   
Depression          = 
Stress    =         = 
Anxiety            = 
Distress        
Coping    =          
Social    
Stigma               = 
Social support    =       =      = 
Social 
adjustment 
       =          
Dyadic 
adjustment  
         
Knowledge        
 
 =: No difference 
   : Significant decrease in the intervention group 
    : Significant increase in the intervention group 
 
In the four quasi experimental studies (Pomeroy et al., 1995, Boon et al., 
2009b, Smith Fawzi et al., 2012, Gordon-Garofalo and Rubin, 2004) most 
outcomes evaluated were similar such as depression, social support and 
coping. However they all used different tools to evaluate outcomes, and 
broadly the results were similar.  
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In the study Pomeroy et al (1995) evaluated depression with The Beck 
depression inventory (BDI), stigma was evaluated by a questionnaire 
developed by the researchers, perceived stress was measured with the impact 
of event (IES), anxiety was measured with trait anxiety inventory (STA1), and 
social support was assessed with the health and daily living form (HDL). All 
outcomes were conducted at 0, 2 and 4 months. The study reported 
statistically significant findings among participants in the intervention group 
compared to participants in the control group for all outcomes (stress, stigma, 
depression, anxiety), expect social support (Pomeroy et al., 1995).  
In another study among partners and spouses of people living with HIV/AIDS 
Depression was measured with 21-item Beck Depression Inventory (BDI), 
anxiety was assessed with the State-Trait Anxiety Inventory (STAI), a 20-item 
questionnaire, perceived social support was assessed with the Social Support 
Appraisals (SSA), perceived stress was assessed with a 15-item measure. The 
Impact of Event Scale (IES) and perceived stigma was assessed with a 3-item 
questionnaire developed Pomeroy et al (1995) as above. All outcomes were 
conducted at baseline and eight weeks after the intervention. In this study, 
the authors reported that there were no significant differences between the 
partners and spouses who received the intervention and those who did not 
receive the intervention, even though the treatment group mean showed a 
better improvement compared to the control group in depression, anxiety and 
social support (Gordon-Garofalo and Rubin, 2004). 
In another study (Boon et al., 2009b) assessed depression with Hopkins 
Symptom checklist, coping measurers was evaluated with ways of coping 
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checklist. All outcomes were conducted at baseline and three months after 
delivery of the intervention. This study did not have a control group. The 
authors reported that participants who attended the workshop sessions 
perceived themselves to be more able to provide care, perceived more control 
over nursing care activities, had more positive attitudes towards people living 
with HIV/AIDS and showed improved knowledge (Boon et al., 2009b). The 
results were statistically significant when compared with participants who did 
not attend either all or none of the sessions.  
Another study Smith Fawzi et al (2012) evaluated depression sub-scale from 
the Hopkins symptom check list (HSC-25), social support assessment to 
examine having a confidant, network size, and level of instrument support, 
role functioning of parents/caregivers evaluated with ACTG short form-21 (SF-
21) and HIV-related stigma was evaluated with the HIV stigma questionnaire. 
All outcomes were conducted at baseline and a year after the intervention. It 
was reported that caregivers (95%) who were HIV positive themselves 
demonstrated statistical significant reduction in depressive symptoms, 
decreased HIV-related stigma and improved social support, however there was 
no control group in this study (Smith Fawzi et al., 2012).  
In the following section a description of the findings of qualitative data 
extracted from the interventional studies included in the current review is 
provided. The findings include data gathered during the development phase of 
the intervention, and data gathered after carers participated in the 
intervention. 
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5.9 Qualitative data within studies reviewed 
The use of qualitative data was not common in the studies reviewed. Only one 
study Smith Fawzi et al (2012) conducted focus group after the intervention to 
elicit caregivers experiences of being part of the study. Social workers held 
focus group GLVFXVVLRQVWRFRPSLOHLQIRUPDWLRQRQSDUWLFLSDQWV¶LPSUHVVLRQVRI
the sessions, suggestions for improvement, and what they learned from the 
sessions. Individual interviews were also conducted with five caregivers from 
the six study sites. As reported earlier the study was a psychosocial support 
intervention on enhancement of coping skills and increasing social support. 
Participants were evaluated for depressive symptoms, stigma and social 
support. The quantitative data reported that participants demonstrated 
significant decrease in depression, HIV-related stigma and improved social 
support. The qualitative data supported these findings and two main themes 
emerged from the data: 
‚ Renewed sense of hope after the intervention 
‚ Another participant expressed that they learned how to cope after attending 
the group sessions 
‚ Greater confidence in coping with HIV-related stigma  
Findings from the qualitative interviews have supported the quantitative data 
on the improvement in coping with HIV/AIDS illness, reduced depressive 
symptoms and positive attitude on HIV-related stigma, although the authors 
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did not report how the participants were selected for individual qualitative 
interviews. 
Three studies held qualitative interviews before the delivery and 
implementation of the intervention (Smith Fawzi et al., 2012, Boon et al., 
2009b, Rotheram-Borus et al., 2001). There was use of focus groups and 
qualitative interviews among caregivers to develop the curriculum, this was 
facilitated by social workers and psychologists, and through this adaptations 
were made before the intervention was delivered. Initially the curriculum was 
designed to hold group sessions weekly for six month, but it was changed to 
bi-monthly sessions over one year (Smith Fawzi et al., 2012). However it is 
not clear if the caregivers were also asked to give input on the content of the 
intervention. 
The study conducted by Boon et al (2009) recruited older caregivers aged 60 
years and above. To design and develop the intervention focus group 
discussions were conducted among community health workers of Age-in-
Action and interviews were conducted with senior staff of Age-in-Action for 
possible topics and contents to be included. The development of the 
intervention was based on a quantitative survey among older caregivers of 
people living with HIV/AIDS (Boon et al., 2009a). Likewise Rotheram-Borus et 
al, (2001), conducted qualitative study and piloted the intervention before the 
implementation of the intervention, and was designed based on the previous 
experiences of people living with HIV/AIDS.  
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In summary qualitative interviews were conducted only in one study (Smith 
Fawzi et al, 2012) to elicit views ans experiences from carers about the 
intervention on completion of follow-up assessments. Three studies conducted 
qualitative interviews and focus groups during the development phase of the 
intervention (Smith Fawzi et al., 2012, Boon et al., 2009b, Rotheram-Borus et 
al., 2001). 
 
!5.10 Gaps in literature 
The studies reviewed have reported that psychosocial and psycho-educational 
interventions are effective in reducing depression, anxiety, stigma, distress, 
stress and improving social support and knowledge among caregivers of 
people living with HIV/AIDS. Only one study (Hansell et al., 1999) found no 
difference on stress levels, coping skills and social support among caregivers 
randomised to intervention and control groups. This study had a small sample 
size (n=70) and many participants were lost to follow-up (n=31) due to death 
and work commitments and illnesses of both caregivers and patients. Only one 
study; (Pakenham et al., 2002) had caregiver patient dyad group which was 
compared with caregiver only group and wait-list control group. Although the 
study reported significant findings for distress reduction, knowledge 
improvements and dyadic adjustments, there was no difference on social 
adjustment between the caregiver and care recipient/patient group compared 
with the caregiver only or wait-list control group. The study had a small 
sample size (n=36) caregivers randomised to two treatment and one wait-list 
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control groups. The only randomised controlled trial (Rotheram-Borus et al., 
2001) with a larger number of study participants (n=307) and low attrition 
rate, reported significant findings for depression, anxiety and distress among 
participants randomised to the intervention group compared to participants 
randomised to the control group.  
The rest were not randomised controlled trials (Pomeroy et al., 1995, Boon et 
al., 2009b, Smith Fawzi et al., 2012) and did not have a control group (Boon 
et al., 2009b, Smith Fawzi et al., 2012). However all the three studies 
reported significant findings on reducing stigma (Pomeroy et al., 1995, Boon 
et al., 2009b, Smith Fawzi et al., 2012), decreased depression (Smith Fawzi et 
al., 2012, Pomeroy et al., 1995) , stress and anxiety (Pomeroy et al., 1995), 
improved coping and knowledge (Boon et al., 2009b).  
These studies were predominantly conducted in western countries, except 
(Boon et al., 2009b) was conducted in South Africa. The interventions were 
mainly psychosocial and psycho-educational with particular focus on 
psychological outcomes. No study was found with specific focus on education 
interventions on pain among caregivers of people living with HIV/AIDS, 
suggesting there is not much research conducted on this subject. Only one 
study; Boon et al., (2009) conducted outcomes on caregiver motivation to 
provide care, perception to provide care, and ability to provide care to their 
loved ones.  
The methodological quality of the studies included in both systematic reviews 
was  poor.  Only three of the eight studies of educational interventions among 
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HIV/AIDS patients and none of the seven studies of family carers had a 
methodological quality score of five or more out of seven. Only two studies 
included in the review of educational interventions among family carers were 
randomised controlled trials. The rest were either non-randomised or did not 
include a control group. The results of the two systematic reviews were 
therefore inconclusive. On this basis I designed a pain education intervention 
to be used by people with HIV/AIDS and their family carers that was formally 
tested using a randomised controlled trial.  
The next chapter therefore contains a detailed discussion of the methodology 
and methods of conducting the randomised controlled trial for pain education 
intervention on which the current study is based on. 
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CHAPTER SIX: METHODOLOGY 
6.1 Introduction 
This chapter describes the methodological approach and methods of data 
collection employed in this study. This study was a randomised controlled trial 
(RCT) to test the effectiveness of an educational intervention comprising of an 
information leaflet, face-to-face verbal instruction and phone call reminder 
after two weeks following the delivery of the intervention. Effectiveness was 
judged in terms of reducing pain, improving knowledge, improving quality of 
life and improving motivation among people living with HIV/AIDS and their 
family carers at two public hospitals in Malawi.  
This chapter looks at the design of the study, the eligibility criteria for entry 
into the study, the process of identification of study participants, the process 
of recruitment and the process of obtaining and gaining informed consent from 
participants. In this chapter I describe the process of recording baseline 
measures, the process of randomisation and the components of the 
intervention and usual care that constituted the two treatment arms in the 
trial. It also includes a discussion on how the follow-up assessments were 
conducted. In this chapter I also describe the outcomes of interest and tools 
used to measure these outcomes. The ethical considerations relating to the 
decisions made about the design and to the implementation of the study are 
also explored.  
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6.2 Study Design 
A randomised controlled trial is a methodology in which participants are 
allocated to either treatment or control groups at random (Stolberg et al., 
2004). A randomised controlled trial is the gold standard for evaluating the 
effectiveness of an intervention because of its scientific rigour (Lewith and 
Little, 2007, Akobeng, 2005a). Randomised controlled trials provide the best 
evidence for effectiveness of interventions (Stolberg et al., 2004). Random 
allocation is the assigning of participants into either intervention or control 
groups at random (Sibbald and Roland, 1998, Stolberg et al., 2004), in order 
to minimise selection bias, allocation bias and systematic bias (Pocock, 1983, 
Roush, 2008). Selection bias refers to the selection of individuals, groups or 
data for analysis such that proper randomisation is not achieved, thereby 
ensuring that the sample obtained is not representative of the population 
intended to be analyzed. Allocation bias occurs during the process of allocating  
participants to either experiment or control groups. In this study opaque 
sealed envelopes were used to conceal allocation of study participants to 
either the pain education intervention or wait list control groups. Bias can also 
be systematic or performance bias, where there are systematic differences in 
the care provided to study participants in the comparison group other than the 
intervention group, this can be minimised by blinding study participants and 
health care providers so that they do not know about group allocation (Bulpitt, 
1996). Blinding prevents participants, health care workers and researchers 
having knowledge that might influence/favour the results of the experiment 
(Schulz et al., 1995). Blinding can be double or single blinded. Double blinding 
is where both participants, health care workers, researchers, assessors are not 
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aware of group allocation (Chan, 2003). Single blinding is where either 
participants or investigators, or health care workers or assessors are aware 
about group allocation. The pain education intervention study was a single 
blinded study because patients, family carers and I were aware of group 
allocation; however outcome assessors and health care workers were not 
aware.  
Open studies exaggerate effects of treatment by 17% (Schulz et al., 1995), 
however double-blind studies are not always feasible (Campbell et al., 2000). 
Use of placebo controls help to maximise blinding, but in complex 
interventions they are difficult to develop (Jadad and Enkin, 2007). However 
single blinding can be implemented in complex interventions where you may 
blind the assessor to minimise measurement bias (Jadad and Enkin, 2007, 
Bulpitt, 1996).  
Randomisation helps to adjust for known confounders like age, sex, education 
and unknown confounders such as undiagnosed co-morbidity (Day and 
Altman, 2000, Saks and Allsop, 2007) so they are distributed equally within 
the groups so that the differences observed in the outcomes can only be 
explained by the treatment received (Jadad and Enkin, 2007, Stolberg et al., 
2004). The allocation is not determined by the researcher, study participants 
or clinicians (Jadad, 1998). Because of this the findings generated from a 
randomised controlled trial are likely to be closer to the true effect of the 
intervention than the findings generated by other research methods (Gray and 
Pinson, 2003).  
This pain education study was a two-centre wait list controlled trial. 
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Participants in each centre were randomised to either an experimental group 
or a control group. Those allocated to the experimental group received a 
leaflet-based educational intervention and face-to face verbal instructions for 
approximately 30 minutes on pain assessment and management in addition to 
usual care and follow-up phone call reminder after two-weeks. Those allocated 
to the control group received usual care, but received a leaflet on completion 
of follow-up measures for both groups (wait list control) (Polit and Beck, 
2008). Randomisation does not, however protect against other forms of bias 
such as attrition bias (Jadad and Enkin, 2007). This can be minimised by 
performing intention-to-treat analysis, whereby outcomes are analysed with 
respect to the groups they were originally allocated to irrespective of whether 
they experienced the intended intervention or not (Lewith and Little, 2007). 
This maintains the advantage of random allocation which may be lost through 
withdrawal or noncompliance to treatment (Sibbald and Roland, 1998).  
These features in a randomised controlled trial enhances reliability and validity 
(internal and external) of the results by preventing systematic error/bias 
(Moher and Olkin, 1995). Reliability refers to consistency of data obtained 
from a study, for instance how accurate the tool is in performing a procedure 
or collecting required data (Polit and Beck, 2008). Internal validity is 
concerned with the validity of the inferences, that is the confidence that the 
independent variable, rather than other factors caused a change (or not) in 
the outcome (Jadad and Enkin, 2007). External validity concerns the 
generalizability of causal inferences; this is a critical concern for randomised 
controlled trials as it aims to yield evidence based practice (Jadad and Enkin, 
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2007). Randomisation, therefore controls all threats to internal validity and 
reliability (Polit and Beck, 2008). However randomisation does not control all 
threats to external validity.  
The philosophy of evidence-based practice assumes that randomised 
controlled trials offer stronger evidential support (Hjorland, 2011). Evidence 
based medicine was born on the philosophy of empiricism, which stresses that 
our actions and decisions should be based upon the best scientific evidence 
(Hjorland, 2011), using mathematical estimates of probability and risk 
(Samarkos, 2006). Critics argue that evidence-based medicine has inherited 
all the weaknesses of empiricism and there is no strong evidence that 
practising evidence-based medicine improves patient outcomes, practitioners 
autonomy is restricted and practitioners experiences and patients perceptions 
are afforded a low priority (Hjorland, 2011, Cartwright, 2007).  
In this study the two groups were treated and observed identically except that 
one group received the intervention so that any differences detected in 
outcomes might be explained due to the intervention received (Akobeng, 
2005a). The design of the pain education interventional study is illustrated in 
Figure 9. 
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Eligibility criteria assessed by clinical officers and staff nurses 
 Initial approach and informed consent by KN 
Usual care by staff nurses 
Follow-up measurers by staff nurses 
         Randomisation by KN 
Pain education intervention 
Pain education intervention by KN 
Baseline assessments by KN 
Figure 9 The design of the pain education intervention study 
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6.3 Settings and access 
The study took place in two public hospitals in the northern part of Malawi, 
Ekwendeni Mission Hospital and Mzuzu Central Hospital. Both Ekwendeni and 
Mzuzu are teaching hospitals. I obtained access to Ekwendeni Hospital by 
telephoning the HIV clinic co-ordinator at Ekwendeni Hospital during the 
design stage of the trial. This was to explain the overall aims and objectives of 
the study, and potential contribution from the study. Access to Mzuzu Central 
Hospital was obtained after the trial had already commenced. The initial plan 
was to conduct the study at one centre (Ekwendeni Hospital), but during the 
pilot phase of the study, I observed that recruitment was slow, and I thought 
two centres were needed to hasten recruitment as explained later in this 
chapter. I therefore contacted the Chief Nursing Officer at Mzuzu Central 
Hospital by phone and explained to him about the project. He then advised me 
to make a formal application to the ethical committee to review the study at 
Mzuzu Central Hospital. After the committee reviewed the proposal; access to 
conduct data collection at Mzuzu Central Hospital was granted (Appendix 12). 
The population served by these hospitals includes people from both rural and 
urban areas. 
 
6.3.1 Ekwendeni Mission Hospital 
Ekwendeni Mission Hospital is run by the Christian Health Association of 
Malawi (CHAM). It is about 20 km from Mzuzu City (Figure 2 in chapter two). 
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Ekwendeni Hospital is a general hospital and provides secondary level health 
services (Figure 1 in chapter two).  
It has a palliative care clinic which provides palliative care services such as 
pain medication, counselling and psychosocial support to patients with chronic 
conditions like HIV/AIDS, cancer, heart problems and other long term 
illnesses. The palliative care clinic runs every working day and patients report 
with various kinds of problems for which care and support is provided 
depending on the needs of each patient. The palliative care clinic is run by 
clinicians who have basic training in palliative care.  
The hospital has an HIV clinic, which was opened in 2005 where HIV 
PHGLFDWLRQV DUH SURYLGHG 7KH FOLQLF LV NQRZQ DV µ:DQDQJZD¶ FOLQLF 7KLV LV
Tumbuka language, a local language in Malawi which means freedom. The 
clinic opens on Tuesday, Wednesday and Thursday for supply of drugs to 
patients. Wednesday afternoon is the clinic session for the clients who are 
newly registered to attend a health education session before they can start 
treatment. Patients on HIV medication come to the clinic every month for 
assessment and to collect drugs. The clinic has four clinical officers and twelve 
nurses who provide services to patients with HIV/AIDS and their carers. HIV 
clinic nurses and clinicians also provide palliative care services.  
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6.3.2 Mzuzu Central Hospital 
Mzuzu Central Hospital is a referral hospital for the whole of northern Malawi 
comprising of several departments, including the HIV/AIDS clinic known as 
³5DLQERZ&OLQLF´ZKLFKZDVRSHQHGLQ7KLVLVWKHILUVW+,9$,'6FOLQLFLQ
the Northern Malawi. It is supported by the Malawian government. The clinic is 
open from Monday to Friday for all the patients, however Monday and 
Wednesday are special days for Paediatric and staff patients, Tuesday and 
Thursday are for adult patients. Like Ekwendeni Hospital, there is a palliative 
care clinic for all patients with chronic illnesses, and HIV/AIDS being one of 
them, unlike Ekwendeni Hospital, the palliative care clinic has got its own staff 
members. There are three palliative care nurses. The HIV clinic has five nurses 
and four clinical officers, even though only two are full time clinical officers 
based at the HIV clinic.   
Pain medication is not always available, but when available may not always be 
prescribed by health professionals. The pain education intervention was 
designed, developed and delivered to inform the patients how to assess their 
own pain, classify it and report this to health professionals, so that when 
opioids are available they should be available for prescribing. 
 
6.4 Study Participants 
Participants were people living with HIV/AIDS and their family carers.  
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6.4.1 Inclusion criteria for PLWHA 
To be eligible for the trial, participants had a diagnosis of HIV/AIDS. 
Participants with other conditions such as cancer and tuberculosis were 
included if they presented alongside a diagnosis of HIV/AIDS. Eligible 
participants with HIV/AIDS were at WHO clinical stages III or IV of HIV/AIDS, 
or with a CD4 cell count of less than 350 cells, when the presence of pain and 
other symptoms are more likely due to opportunistic infections or side effects 
of HIV treatment. Staging for trial eligibility was assessed from the medical 
records if recorded or through assessment by clinic staff if this information 
was not available in the medical records. All participants were able to read and 
write in English or Tumbuka (the vernacular/local language used in the 
northern part of Malawi). They were adults aged 18 years or over. 
 
6.4.2 Inclusion criteria for carers 
To be eligible for inclusion, carers were those living with the person with 
HIV/AIDS and were identified as the individual most involved in their care.  
 
6.4.3 Exclusion criteria for people living with HIV/AIDS 
People living with HIV/AIDS were excluded if they had a health problem which 
hindered cognition and communication such as HIV-associated dementia. This 
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was assessed by the attending clinical officers during history taking at the 
initial assessment or at clinic review.  
 
6.5 Recruitment of participants 
People living with HIV/AIDS in Malawi typically visit the hospital (Palliative 
care and HIV clinics) with their family members. Posters about the study 
HQWLWOHGµ3DLQ(GXFDWLRQ6WXG\¶$SSHQGL[ZHUHSURPLQently displayed and 
potential participants had the opportunity to be given further information 
about the study directly from clinic staff or myself. All participants routinely 
have their weight checked and recorded during every visit to the clinic before 
they are reviewed by a nurse or clinical officer. During this time the study was 
introduced to potential participants.  
The study was introduced either during the first appointment at the HIV clinic 
for newly registered patients (figure 10a)or during routine appointments at the 
HIV clinics or palliative care clinics for those who are already receiving HIV 
medication (Figure 10b). Participants were informed about the study and were 
provided with an information sheet (appendix 1). 
All newly registered patients attended a health education session with their 
family carers focussing on drug adherence. A further detail about the study 
was provided to the participants when necessary (these sessions were held 
every Tuesday and Thursday at Mzuzu central hospital and every Wednesday 
at Ekwendeni hospital). This was to ensure that participants understood the 
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salient information required for them. Participants were advised that inclusion 
in the study would not affect their treatment at the HIV clinics and that if they 
decide to participate in the study, they were free to withdraw at any time they 
wished.  Potential participants were encouraged to discuss the study with their 
family members before making a decision to take part in the study. Potential 
participants had betweHQ WZRDQG IRXUZHHNV¶ WRFRQVLGHU WDNLQJSDUW LQ WKH
study.  
During their next appointment, participants who were interested in taking part 
in the study came to me to express their interest. Participants were asked if 
they understood what the study is all about and if they have any questions. 
Depending on the responses from the participants, they were briefly reminded 
about the study. Sometimes a detailed explanation was given if participants 
did not understand during the initial introduction of the study and in situations 
where the family carer was not present during the initial introduction of the 
study. If participants understood clearly what the study was about and were 
still interested in taking part in the study, they were asked to provide written 
consent (appendix 2). A checklist was administered to confirm that all criteria 
for study eligibility were met (appendix 3). 
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New HIV patients     HIV routine patients   Recruitment strategy 
Newly diagnosed patient                   Study design 
 
       2 weeks                                                                          
 
 
 
          
        8 weeks                              
 
 
 
 
  
1st appointment at HIV 
clinic 
Follow-up to 
the clinic (2nd 
appointment) 
Routine 
appointment  
Introduced the study (KN) 
Obtained informed consent, 
conducted baseline assessments 
and randomised (by KN) 
Intervention 
delivered by KN 
Assessment of outcomes by nurses 
Wait list control by 
KN 
Intervention 
delivered by KN 
 Figure 10 HIV clinic journey, recruitment strategy and study design for 
newly diagnos d patients with HIV/AIDS 
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Figure 11 HIV clinic journey, recruitment strategy and study design 
for patients already on HIV treatment 
 
Patients already on treatment               Study design 
 
     
    4 weeks 
 
 
 
 
    8 weeks 
 
 
 
 
  
1st routine 
appointment 
Routine 
appointment 2 
Routine 
appointment 3 
Introduced the study (KN) 
Obtained informed consent, 
conducted baseline assessments and 
randomised (by KN) 
Intervention 
delivered by KN 
Assessment of outcomes by nurses 
Wait list control 
by KN 
Intervention 
delivered by KN 
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6.6 Baseline assessments 
After recruitment and obtaining written consent from participants, I conducted 
EDVHOLQHDVVHVVPHQWV%DVHOLQHDVVHVVPHQWVLQFOXGHGWKHSDUWLFLSDQWV¶GHWDLOV
demographic data, and date of diagnosis, current treatment, and presence of 
co-morbidities. Other baseline assessments conducted were in line with the 
outcome interests of the study which were: pain severity, pain interference, 
pain knowledge, quality of life, and motivation/rewards in providing care.  
The pain education intervention study examined the effect of the intervention 
in terms of four patient outcomes (pain severity, pain interference, knowledge 
of pain management and quality of life) and three family carer outcomes 
(knowledge of pain management, quality of life and motivation to provide 
care).  Patient outcomes are in line with IMMPACT (Initiative on Methods, 
Measurement, and Pain Assessment in Clinical Trials) recommendation on core 
outcomes for patients with chronic pain (Dworkin et al., 2008, Dworkin et al., 
2005b, Turk et al., 2003). The pain education intervention study randomised 
patient/carer dyads based on the findings from the two systematic reviews of 
educational interventions that there is insufficient evidence on the 
effectiveness of pain education interventions among patients with HIV/AIDS 
and family carers. The choice of instruments therefore was mainly based on 
the core outcomes used in clinical trials of pain management for patient and 
core outcomes in clinical trials among family carers of patients with chronic 
illnesses such as HIV/AIDS. The effect of HIV/AIDS related pain is experienced 
by both the person with HIV/AIDS and their carer and therefore the 
intervention targeted at improving outcomes for both. Therefore some 
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instruments such as the APCA African POS and patient/family pain 
questionnaires were administered to both the patient and family carer. 
 
Table 14 Contents of baseline assessments 
 
6.6.1 Patient characteristics  
Patient characteristics (Appendix 4) were gathered by asking a list of 
questions about demographic information including name, age, gender, marital 
status, education, religion, employment, address, date of referral, source of 
referral, and date of initial approach. Clinical information recorded included 
presence of co-morbidities such as TB, cancer, current pain treatment, CD4 
count and HIV/AIDS clinical stage. These were obtained by extracting 
information from medical records.  
Participant Area of assessment Questionnaire Mode of 
completion 
People living with 
HIV/AIDS(PLWHA) 
(Patient participants) 
Patient characteristics Demographic 
information 
Clinical information 
 
Face-to-face 
interview 
Review of medical 
records 
 
 Perceived pain Pain severity subscale 
(BPI-PS sub-scale) 
Pain interference 
subscale (BPI-PI-
subscale) 
Self-report 
 Pain Knowledge Patient pain 
questionnaire (PPQ-K 
subscale) 
Self-report 
 Quality of life APCA African POS Self-report 
Family carers (carer 
participants) 
Carers characteristics Demographic 
information 
Self-report 
 Pain knowledge Family pain 
questionnaire (FPQ-K 
subscale) 
Self-report 
 Quality of life APCA African POS Self-report 
 Carers motivation Picot Caregiver 
Rewards Scale 
Self-report 
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6.6.2 Pain assessments  
Pain severity was measured using the single item of the Brief Pain Inventory 
(BPI-PS) (Keller et al., 2004) where patients were asked to rate the severity of 
their pain over the last week in the domain of worst pain, least pain, average 
pain and pain right now (Keller et al., 2004). A rating was made on a zero to 
10 scale with higher scores indicating greater severity of pain. This is 
consistent with the measurement of pain severity in a number of clinical trials 
(Cleeland, 2009). The BPI has been used with patients with cancer and other 
chronic illnesses such as HIV/AIDS (Vogl et al., 1999, Breitbart, 1996a) and to 
study the management of pain in South Africa (Beck and Falkson, 2001). The 
BPI has been linguistically validated in Afrikaans, Xhosa, Zulu in South Africa 
(Mphahlele et al., 2008, Cleeland, 2009) and has been used to study pain 
severity and prevalence in Uganda (Namisango et al., 2012) South Africa 
(Narasimooloo et al., 2011) Nigeria (Ebirim and Otokwala, 2013). Assessment 
of pain was made easier by the use of validated numerical rating scale with 
face validity (Huang et al., 2012). 
Pain interference with daily activities was measured using the mean score of 
the seven pain interference items of the Brief Pain Inventory (BPI-PI). These 
items measure, on a scale of zero to 10, the degree to which the patient 
reports pain interfering with each of seven activities (general activity, walking, 
work, mood, enjoyment of life, relations with others, and sleep) and is the 
recommended method of assessment of pain-related functional impairment in 
clinical trials (Dworkin et al., 2005a) (Appendix 5). BPI has well established 
reliability: Cronbach alpha values ranges from 0.77 to 0.91, and it has been 
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translated into more than three dozen languages by examining the consistency 
of severity and impact of pain (Keller et al., 2004).  
The BPI was chosen because it is easier to administer and simple to 
understand by patients. It takes between three to five minutes to complete 
(Cleeland, 2009). It can be self-administered by patients and it has been 
validated in sub-Saharan Africa among HIV/AIDS and cancer patients. The BPI 
is frequently used to assess pain in HIV/AIDS population. The BPI is the only 
validated instrument to assess pain interference with daily activities. BPI is 
relatively easy to translate into other languages for non-English speaking 
patients. It captures pain severity and impact of pain and improvement in pain 
after changes in analgesic prescription and implementation of new 
interventions or pain treatments. Unlike other instruments such as the Mc Gill 
pain questionnaire (Melzack, 1975), which is highly complex and potentially 
burdensome for patients who experience higher levels of pain.   
 
6.6.3 Patient pain knowledge  
For patients, knowledge of pain management was measured using the 
knowledge sub-scale of the Patient Pain Questionnaire PPQ-K (Ferrell et al., 
1994). The PPQ-K is made up of nine items asking the patient to agree or 
disagree with statements about the effectiveness, timing of pain medication 
dosage, and adequacy of pain medication dosage. Agreement/disagreement is 
rated on a scale of zero to 10. Scores range from zero to 90 with lower scores 
indicating greater patient knowledge of pain management (Appendix 6). The 
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tool has been tested for reliability and validity. Content validity (CVI=.95), 
test-retest reliability (r=.65), internal consistency (alpha=.74), and factor 
analysis established with carers (N=219) (Ferrell et al., 1993b).  
Although this instrument has not been validated in Africa and among 
HIV/AIDS patients, the questions are likely to be relevant to this population. 
)RUH[DPSOHµSDWLHQWVZLWKDFKURQLFLOOQHVVFDQOLYHDSDLQIUHHOLIH¶µ3DLQ
medications should be given oQO\ZKHQSDLQLVVHYHUH¶µ,WLVEHWWHUWRJLYH
SDLQPHGLFDWLRQDURXQGWKHFORFNUDWKHUWKDQRQO\ZKHQQHHGHG¶7KH334LV
not overly burdensome, and freely available for research use. There is a lack 
of validated instruments to assess pain knowledge among people with 
HIV/AIDS.  In a pilot study to assess knowledge levels among HIV/AIDS 
patients Gifford et al (1998) created their own instrument due to a lack of 
instruments available to measure knowledge outcome among HIV/AIDS 
patients.  
 
6.6.4 Patient quality of life 
For patients, quality of life was measured using the APCA African POS patient 
sub-scale (Harding et al., 2010b). The APCA African POS consists of seven 
items relating to patient pain and symptom assessment, psychological, 
spiritual and emotional concerns. Possible scores (with questions 4,5,6 and 7 
reversed) range from zero to 35 with higher scores indicating worse 
outcomes/quality of life. The tool has been developed and tested in three 
African countries (Powell et al., 2007). 
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The African Palliative Care Association (APCA) African Palliative Care Outcome 
Scale (POS): (Appendix 7) was developed in response to a lack of rigorously 
validated instruments to assess palliative care outcomes in people living with 
HIV/AIDS in Africa (Harding and Higginson, 2005). The tool was first 
developed in the UK and was tested and validated for monitoring and 
evaluating palliative care provision among patients with life limiting illnesses 
(Powell et al., 2007). The APCA Africa POS was piloted in three countries in 
Africa (South Africa, Kenya and Uganda) providing specialist palliative care 
services and results suggested that the tool can be used as a monitoring and 
evaluation instrument in palliative care services (Powell et al., 2007).  
Subsequently the tool was validated in five African countries (Malawi, Zambia, 
Tanzania, Botswana, and Zimbabwe) among 682 patients and 437 carers. Face 
validity showed that the tool mapped well to identified needs (N=90 patients, 
and N=38 carers), and cognitive interviews demonstrated good interpretation 
(N=73 patients and N=29 carers)(Harding et al., 2010b). APCA African POS 
was chosen because it is the only tool to have been validated in sub-Saharan 
Africa including Malawi among HIV/AIDS patients. It also has the advantage of 
being able to capture both physical and psychological aspects of pain.  
The tool is simple and easy to administer, contains seven items and takes 
between two to five minutes to complete. Unlike other instruments that 
evaluate quality of life in HIV/AIDS such as HIV/AIDS targeted QOL (Holmes 
and Shea, 1998), QOL index (Ferrans and Powers, 1984) , and Medical 
outcomes study-HIV (Wu et al, 1993), which are complex, difficult to follow 
and quite lengthy. They have items ranging from 35-66 which require 
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considerable time to complete. 
 
6.6.5 Carers characteristics 
&DUHUV¶FKDUDFWHULVWLFV$SSHQGL[ZHUHJDWKHUHGE\DVNLQJDOLVWRI
questions about demographic information such as name, age, gender, marital 
status, education, religion, employment, and address and carer/patient 
relationships.  
 
6.6.6 Carer knowledge about pain management 
For carers, knowledge of pain management was measured using the 
knowledge subscale of the Family Pain Questionnaire (FPQ-K) (Ferrell et al., 
1993a). Like the PPQ-K, the FPQ-K is made up of nine items asking the carer 
to disagree or agree with statements about the effectiveness, timing of pain 
medication dosage, and adequacy of pain medication dosage. 
Agreement/disagreement was rated on a scale of zero to 10. Scores range 
from zero to 90 with lower scores indicating greater carer knowledge of pain 
management (Appendix 8). The tool has been tested with established 
reliability: test, retest and internal consistency, as well as validity: content, 
construct and concurrent. Content validity (CVI=.90), construct validity 
(ANOVA, p<.05), concurrent validity (r=.60, p. <.05), factor analysis and test-
retest reliability (r=.80) established with a retest of carers (N=67) (Ferrell et 
al., 1995, Ferrell et al., 1993a).  Like the PPQ, the FPQ was chosen because it 
is simple and easy to use and therefore likely to be well understood by family 
135 
 
carers. To my knowledge, it is the only validated tool available to assess 
FDUHUV¶NQRZOHGJHRISDLQPDQDJHPHQW(YHQWKRXJKLWZDVYDOLGDWHGDPRQJ
family carers of cancer patients, the experiences and concerns of family carers 
of patients with pain associated with chronic illnesses are likely to be similar. 
 
µ&DUHUV¶PRWLYDWLRQ 
µ&DUHU¶ PRWLYDWLRQ ZDV PHDVXUHG XVLQJ WKH 3LFRW &DUHJLYHU 5HZDUGV 6FDOH
(PCRS) (Fulton Picot et al., 1997). The PCRS is a 16-item scale measuring the 
positive consequences of caregiving. Respondents rate the degree to which 
items describe positive consequences of their caregiving on a 5-point Likert 
scale. Possible scores range from zero to 64 with higher scores indicating more 
positive caregiving experience (Appendix 9). The tool was psychometrically 
tested in a non-random sample of 83 black female caregivers and random 
sample of 256 black and white female and male caregivers. Alphas of 0.83 and 
0.88 demonstrated acceptable internal consistency. Construct validity was 
demonstrated by support of hypothesized relationships with caregiving 
demands, palliative coping, depression and caregiver burden (Picot et al., 
1997, Fulton Picot et al., 1997). The PCRS was chosen due to a lack of 
validated and available tools to evaluate carers motivation in providing care. I 
did an extensive search for instruments to assess carer motivation, but PCRS 
was the one that contained all the important aspects in the caregiving 
experience including feelings of happiness, family growth and strength, 
strength of relationships, and knowledge and skills. Other instruments such as 
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the Derogatis Stress Profile which measures total caregiver stress (Dobkin et 
al., 1991), The Family Crisis Oriented Personal Scales which measures internal 
and external family coping (McCubbin and McCubbin, 1991), and global 
distress measured with the Brief Symptom Inventory (Derogatis and 
Melisaratos, 1983), tend to focus on negative effects of caregiving such as 
stress, depression, anxiety. In contrast, the PCRS is easy to administer and 
language and content are kept simple. The individual items are likely to be 
understood by family carers of people living with HIV/AIDS. However the tool 
has not been validated in Africa, thus geographical setting and location can 
affect particLSDQW¶VUHVSRQVHVGXHWRGLIIHUHQFHVLQFXOWXUH 
 
&DUHUV¶TXDOLW\RIOLIH  
For carers, quality of life was measured using the APCA African POS family 
sub-scale (Harding et al., 2010b). The APCA African POS consists of three 
items directed at carers addressing the adequacy of information the family has 
received, confidence in caring, and level of worry. Possible scores, (with  
questions eight and nine reversed) range from zero to 15 with higher scores 
indicating worse outcomes/quality of life (Appendix 7). Like the APCA African 
POS-patient sub-scale, the tool is easy to understand, taking the carer 
approximately a minute to complete. Other instruments that measure quality 
of life in family carers include the Tilden Interpersonal Relationship Inventory 
(Tilden et al., 1990), Hopkins Symptom checklist (Kaaya et al., 2002), and 
State-Trait Anxiety Inventory (Spielberger et al., 1983). However all of these 
instruments are quite long and contain items which were not the outcomes of 
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interest in the current study such as feeling nervous, worry about misfortunes, 
indecisive feelings, spells of terror, and feelings of being trapped. 
 
6.6.9 Use of instruments in sub-Saharan Africa 
While the BPI (Beck and Falkson, 2001) and APCA African POS (Harding et al., 
2010b) have both been used previously in sub-Saharan African populations, 
use of the PPQ, FPQ and PCRS has been restricted to populations in western 
countries. Even though the PPQ, FPQ and PCRS have not been validated in 
Africa, my experience immediately prior to trial recruitment of piloting these 
scales as part of the questionnaires among 10 patients and 10 carers 
suggested that they were acceptable and understood by members of the 
population of patients and carers from which my sample was to be recruited. 
All the tools were translated into Tumbuka language by two experts. One 
conducted a forward translation and another backward translation; there were 
minor differences between the two translators and these were resolved by 
consensus (Cleeland, 2009)
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Table 15 Summary of tools used for measuring outcomes 
 
Concept/outcome Name of Instrument Scoring Number of 
items 
Validation 
Pain severity Sub-scale of the brief pain 
inventory (BPI) 
0-40 with higher score indicating worse pain 4 Validated in more than three dozen 
languages by examining the 
consistency of its two factor structure 
(severity of pain, impact of pain) 
Pain interference 
with daily activities  
Sub-scale of the brief pain 
inventory (BPI) 
0-70 with higher scores indicating worse interference 
with activities 
7 As above 
Patient pain 
knowledge  
Sub-scale of the patient pain 
questionnaire (PPQ) 
0-90, with a lower score indicating the most positive 
outcome and higher score indicating the most 
negative outcome 
9  Evaluated among 85 cancer patients 
and family carers in California 
community hospital, cancer centre 
and community hospice  
Patient quality of 
life 
Sub-scale of the APCA African 
POS 
0-35 with higher score indicating negative outcomes 
and lower score indicating positive outcomes 
7 Pilot tested in three countries in SSA, 
validated in five countries in SSA 
among 682 patients and 437 family 
carers 
Carers quality of life Sub-scale of the APCA African 
POS 
0-15 with higher score indicating negative outcomes 
and lower score indicating positive outcomes 
3 As the APCA for patients above 
Carers pain 
knowledge 
Sub-scale of the family pain 
questionnaire (FPQ) 
0-90 with a lower score indicating the most positive 
outcome and higher score indicating the most 
negative outcome 
9 As the PPQ above 
Carers motivation in 
caregiving 
Picot caregiver reward scale 
(PCRS) 
0-64 higher score indicating positive experience in 
caregiving 
16 In the USA in a non-random sample 
of 83 black female caregivers and 
random sample of 256 black and 
white female and male caregivers 
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6.7 Randomisation 
After baseline assessments, participants were randomly allocated to the 
pain education intervention group or usual care group. I implemented 
randomisation using a series of consecutively numbered, opaque, sealed 
envelopes. The envelopes were sent to me by post. Each envelope 
FRQWDLQHGDVWXG\QXPEHUDQGWKHDUP³,17´IRU LQWHUYHQWLRQDQG³&21´
for control groups) of the trial to which the participant was to be allocated. 
The envelope was opened in the presence of the participants after baseline 
assessments. Participants had a 50% chance of being allocated to either 
the pain education intervention group or usual care group. In order to limit 
imbalance between the treatment groups, participants were randomly 
DVVLJQHG ZLWK EORFN UDQGRPLVDWLRQ XVLQJ WKH µUDOORF¶ FRPPDQG LQ 6WDWD
version 12 (StataCorp, 2011). This allocates participants at random in 
blocks of sizes 2, 4, 6, 8 and 10 with block sizes allocated unequally in the 
ratio of 1:4:6:4:1 (Pascal's triangle). The block size was hidden to me to 
avoid the possibility of predicting allocation at the end of each block 
(Pocock, 1983).  
Randomisation was stratified by recruiting hospital. I was not involved in 
the preparation of envelopes and I was blind to block size. AA (my 
supervisor) generated the randomisation list, prepared the envelopes and 
had no contact with the study participants.  
After assigning the participants into treatment groups, expectations were 
shared with them based on the groups they were allocated to. It was not 
possible for me and the participants to be blinded to individual allocations 
due to the nature of the study. The baseline assessments were conducted 
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before randomisation to minimise allocation bias. Clinic staff from the two 
recruiting centres were not involved in baseline assessments and were not 
aware of group allocation since all the participants were told not to tell 
anyone. Participants who were allocated in the intervention arm were told 
not to share the face-to-face discussion and leaflet with any other 
participant or clinic staff.  
 
6.8 Interventions 
6.8.1 Description of usual care/wait list  
Both Ekwendeni mission hospital and Mzuzu central hospital have a 
palliative care clinic and HIV/AIDS clinic and care provided to HIV/AIDS 
patients was similar at the time of the study. All the participants in the trial 
received usual care. Both HIV/AIDS clinics conduct a health education 
session to all newly registered clients before they start treatment. The 
health education mainly focussed on description of HIV/AIDS medication, 
how HIV drugs work, and importance of treatment compliance, drug 
adherence and positive living. Assistance with pain management for 
patients with HIV/AIDS is currently provided by hospital-based palliative 
care nurses and typically delivered in either a palliative care clinic or 
HIV/AIDS clinic. Information relating to pain medication is typically 
responsive rather than proactive and ad hoc rather than systematic. 
Information was provided when requested by patients or carers. The focus 
was mostly restricted to pharmacological treatment of pain. Pain 
assessments were not usually conducted in a systematic way and not 
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recorded. It was unusual for this information to be shared with patients 
and/or their carers. Written information materials were not provided. 
 
6.8.2 Description of the intervention 
Patients randomly allocated to the intervention arm received the pain 
education intervention which I delivered. The intervention consisted of a 
leaflet (see appendix 13) and health education session delivered face-to-
face to the participants at the HIV clinic or palliative care clinic (table 17 
and table 18). The face-to-face session took approximately 30 minutes in a 
quite setting. $ OHDIOHW HQWLWOHG ³$OO DERXW \RXU SDLQ´ ZDV JLYHQ WR
participants who were given the opportunity to look through it (Nkhoma et 
al, 2015). I then discussed the contents of the leaflet with the participants 
and they were both encouraged to ask questions. After two weeks, 
participants received a phone call reminder to enquire whether they have 
any further questions after reading the leaflet. The phone call was made to 
remind the participants to make use of the intervention.  
The pain educational intervention was underpinned and guided by the adult 
learning theory (andragogy) (Knowles, 1990, Knowles et al., 2005). Adult 
learning theory is defined as a collection and utilisation of several concepts 
and theories by which adult acquire knowledge and skills such as social 
cognitive theory, personality theory, humanistic theory (Rogers and 
Horrocks, 2010). Adult education has been recognised as the desirable 
process by which adults acquire knowledge and skills which brings about 
change in attitude and behaviour (Knowles et al., 2005). 
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Adult learning theory uses approaches to learning that are collaborative 
and problem-based. The theory emphasises equality between the teacher 
and the student (Dunn, 2002, Zoller and Harrison, 2007). The design of 
the leaflet and the structure of the intervention, the content and the mode 
of delivery enhanced proper discussion between me and the participants 
(patient and carer participants). The structure of the intervention allowed 
active participation of the patients and carers. This allowed them to freely 
ask questions and clarification and make contributions based on their 
previous knowledge and experience. These approaches facilitated 
knowledge acquisition and retention because of active involvement rather 
than just recipient of information. Based on this theory the intention of the 
pain education intervention was to reduce pain severity that patient 
experienced, improve their knowledge in assessing, classifying, and 
managing their own pain, this in turn enabled participants to know what to 
do when they are in pain or to actively make decisions about their own 
pain.  
 
6.9 Development of a pain management information leaflet for 
people living with HIV/AIDS (PLWHA) and their family carers 
Ideally complex interventions should be developed and implemented using 
a transparent and widely used framework such as the Medical Research 
Council (MRC) framework of evaluating complex interventions (Craig et al., 
2008). Designing the study using the MRC framework will help to 
understand the mechanism of action of the intervention.  Complex 
interventions are interventions that contain several interacting components 
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(Bennett and Closs, 2011, Craig et al., 2008); and may act both 
independently or interdependently (Campbell et al., 2000). They are widely 
used in health care services, public health and social sciences (Craig et al., 
2008). In health care complex interventions may also be referred to as 
non-pharmacological interventions, because it is difficult to understand 
their mechanism of action, unlike pharmacological interventions which have 
a more easily identifiable way of exerting their effects. For example some 
pain drugs work by inhibiting the release of enzymes that transmit pain 
impulses, while non-pharmacological interventions like message or 
acupuncture affects the physiological action or psychological or a 
combination of both (Bennett and Closs, 2011). They are orientated 
towards physical, psychological, social, spiritual and clinical aspects of care. 
It is challenging to design and evaluate complex interventions to establish 
their efficacy and effectiveness (Bennett and Closs, 2011). In the current 
study I used the MRC framework to develop the intervention (an 
information leaflet) I involved health care workers (clinical officers and 
palliative care nurses), patients and family carers. A pilot study was 
conducted to assess the feasibility of the intervention. After piloting the 
intervention, the main study was conducted. However qualitative data were 
QRWJDWKHUHGDWWKHHQGRIWKHWULDOWRHOLFLWSDUWLFLSDQW¶VH[SHULHQFHVRI
being part of the trial. 
The design of the current study therefore makes it very difficult to explain 
if the mechanism is related to any of the change in outcomes observed. All 
that can be inferred from the design is that any change in outcomes 
observed is related to one or more components of the intervention rather 
than the action of individual and specific components. 
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A leaflet was designed and developed which contained information about 
HIV/AIDS pain management for people living with HIV/AIDS. This was 
designed after looking at previous literature on cancer pain management 
(SIGN, 2009, Oldham and Kristjanson, 2004) and HIV/AIDS pain 
management in Africa (APCA, 2008, APCA, 2012) and pain management in 
Malawi (Ministry of Health, 2008b). The contents focused on definition of 
HIV/AIDS pain, causes of pain in HIV/AIDS, characteristics of pain in 
HIV/AIDS, beliefs and myths about pain in HIV/AIDS, beliefs and myths 
about pain medication, assessment of pain in HIV/AIDS, pharmacological 
management of pain, and non-pharmacological management of pain.  
The biopsychosocial model (Engel, 1997) was used to guide the 
development of the pain education intervention. The biopsychosocial model 
(Figure 11) states that a human being has biological, psychological and 
social needs which have influence on illness and health (Frankel et al., 
2003, Borrell-Carrió et al., 2004). Pain is a multidimensional phenomenon 
that includes physical, psychological, behavioural, spiritual, social, and 
economic components (Spross et al., 1990) and in agreement with this 
Dame Cicely Saunders describes this as a concept of total pain among 
terminally ill patients (Saunders and Sykes, 1993). Biological factors such 
as HIV cause AIDS which brings illness to an individual. HIV/AIDS is a 
chronic illness which eventually causes chronic pain. The diagnosis of AIDS 
itself brings psychological problems to an individual such as lack of self-
control, anxiety, anger, stigma which further precipitates the condition. The 
social component such as lack of social support also worsens the condition 
(Borrell-Carrió et al., 2004). The management of HIV/AIDS requires a 
holistic approach because it is a chronic illness (Kell and Walley, 2009, 
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Parker et al., 2014). Even though the biopsychosocial model is criticised 
due to lack of structure that would facilitate analysis of weighted 
contribution of variables (Ghaemi, 2009), the model is useful in complex 
construct like pain in HIV/AIDS to explore the causes of HIV/AIDS pain and 
establish the appropriate and effective treatment (Parker et al., 2014). 
This means that when managing pain in HIV/AIDS there is a need to 
provide pain relieving drugs to counteract the effects of biological 
processes, emotional care such as counselling and social support for 
instance presence of a family care. The pain educational intervention 
looked at all these components. The intervention involved a carer provider 
because HIV/AIDS patients in Malawi context need a carer provider from 
the time the illness is diagnosed until death. The clinic journey HIV/AIDS 
patients travel requires both medical and social interventions (Collins and 
Harding, 2007). The HIV/AIDS clinic journey (Figure 3 in chapter two and 
Figure 10 in chapter six) describes that carers of patients with HIV/AIDS 
are involved in managing the illness from the onset of the symptoms, the 
diagnosis of the illness and commencement of HIV treatment and 
continuation of HIV treatment for life.  
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6.10 Patient and public involvement  
During the development phase of the leaflet, five HIV/AIDS patients and 
their family carers were given a leaflet to read at home. They were asked 
to make comments of readability, content, understandability and design of 
the leaflet. They were given two weeks to read and discuss with family 
members and thereafter give feedback to me. Health care workers (three 
clinical officers, and four nurses) were also given the leaflet to read paying 
particular focus on the content, readability, understandability, components 
    Pain 
Psychological 
HIV/AIDS 
diagnosis, 
treatment side 
effects 
Depression, fear, 
anger, anxiety 
Family support, 
religion, culture  
 Figure 12 The Biopsychosocial model of 
pain management 
Social 
Biological 
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and design. They were given one week to give feedback. All the patients, 
family carers were registered service users at Ekwendeni hospital. All 
health care workers were members of staff at Ekwendeni hospital. They 
provided feedback to me verbally through a face-to-face discussion.  
Of the five patients and five carers who were given leaflets to read; four 
patients and four carers reported back to give feedback. Discussion about 
the feedback took place in a quiet setting with each patient and a family 
carer. All healthcare workers gave feedback and I had a face-to-face 
discussion with each healthcare worker. 
 
6.10.1 Comments from patients and family carers 
All the four patients and four carers were happy with the leaflet. They all 
expressed satisfaction with the contents of the leaflet, such as pictures and 
diagrams. All the participants reported that they understood the contents 
of the leaflet. There were no specific changes which they advised needed to 
be made. 
6.10.2 Comments from clinical officers 
Three clinical officers were consulted. All these clinical officers were 
providers of HIV/AIDS medication at Ekwendeni HIV clinic. In general they 
all expressed satisfaction with the leaflet because it covered all the issues 
relating to pain management in HIV/AIDS.  
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6.10.3 Comments from nurses 
Four nurses were consulted. All these nurses were providers of HIV/AIDS 
medication; one was a palliative care nurse, three of which were also HIV 
positive themselves. They reported that the leaflet was somewhat useful to 
them personally because they also experienced pain symptoms due to HIV 
infection. 7KHFRQWHQWZDVFOHDUµ,KDYHSHUVRQDOO\VWDUWHGXVLQJLW¶(This 
nurse was referring to the fact that she started using the leaflet herself 
because she was also HIV positive and taking HIV medication). They were 
all happy with the contents and components in the leaflet. 
 
6.10.4 Comments from home-based care Trainers/Coordinators 
Apart from healthcare workers from Ekwendeni HIV clinic, health care 
workers from other institutions were also consulted. These are not only 
home-based care trainers at national level, but they also coordinate home-
based care activities at their respective institutions. An email was sent to 
each one of them with a leaflet attachment. Two of them gave me 
feedback by email, but one of them gave me face-to-face feedback.  
In general they were all happy with the intervention (leaflet) and made few 
comments and suggestions for example, avoid use of technical words such 
DV µ$QDOJHVLFV¶ WKLV ZDV UHSODFHG ZLWK D VLPSOH ZRUG µSDLQ PHGLFDWLRQ¶, 
³1RQ-SKDUPDFRORJLFDOLQWHUYHQWLRQV´ZDVUHSODFHGZLWKDVLPSOHVHQWHQFH
³RWKHUZD\VRIPDQDJLQJSDLQ´ 
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The final version was made after incorporating all the comments from 
patients, family carers, home based-care providers, nurses and clinical 
officers.  
The leaflet was in the form of a double sided A4 page, formatted and it 
could be gate folded into two to allow ease of use. It was printed in colour 
(Appendix 13). The contents included HIV/AIDS pain description, pain 
assessment, pain classification, pharmacological pain management and 
non-pharmacological pain management. The leaflet had several short 
sections under the following headings: HIV/AIDS pain description, pain 
assessment, World Health Organisation (WHO) pain management ladder, 
misconceptions about pain and pain medication, dispelling the 
misconceptions about pain and pain medication, pharmacological 
management of pain, non-pharmacological management of pain and 
principals of pain management. Photos, pictures and diagrams such as pain 
diagrams, pain scales, WHO analgesic ladder were used to enhance 
understanding about pain location, classification and pain rating. The WHO 
analgesic ladder also helped participants to appreciate the rating of pain 
and approaches to treatment based on the classification of pain. A trial 
(Mansoor and Dowse, 2007) reported that a simple written leaflet 
information with pictograms improved knowledge and understanding 
significantly among HIV/AIDS positive patients compared to two groups 
who received written leaflet information only and no information (usual 
care).  
The leaflet was designed to be short, simple, and easy to understand. A 
Flesch Reading ease (Flesch, 1948) was calculated. This calculates how 
easy the material is to read and understand, a higher score indicate 
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material that is easier to read and understand and lower score indicate 
material that is difficult to read and understand (Flesch, 1948, Walsh and 
Volsko, 2008). Readability scores are useful in assessing overall ease of 
understanding written information (Murphy et al., 1994). Readability score 
states that 0-30% can easily be understood by a university graduate, 60-
70 can easily be understood by a 13 to 15 years old student and 90-100% 
can easily be understood by a 11 year old student (table 16). For this 
leaflet, the readability score ranged from 67.1 to 80.3%. Each section of 
the leaflet was pasted into a Flesch Reading ease calculator and a score 
was obtained. Some authors (Mwingira and Dowse, 2007) reported that 
simplified patient written materials are more likely to be accepted and 
used. 
Table 16 Readability score and interpretation 
 
 
 
The intervention was delivered after completion of baseline assessments. 
Patients and family carers were each given a copy of the leaflet and were 
allowed to browse through briefly. Thereafter each section was read to the 
participants and explanations were made in the process. Practical advice 
was given and participants were allowed to ask questions or clarifications 
and all these were discussed. The components of the interventions are 
summarised in Table 17. The leaflet was developed in line with three issues 
that are supposed to be addressed when creating patient materials; 
purpose, collaboration and design (Ivnik and Jett, 2008).  
Score (%) Notes 
90-100 Easily understood by an average 11 year old 
student 
60-70 Easily understood by 13 to 15 years old 
student 
0-30 Easily understood by a university graduate 
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In order to minimise contamination between the two treatment arms of the 
trial, a leaflet was put in the bag or hand luggage of the participant and the 
carer before they left the room where the intervention was delivered. 
Participants were strongly advised not to share the information discussed 
with anyone else and not to share the information leaflet with friends and 
health care workers.  
Table 17 Components of the pain education intervention 
 
Topics covered Content 
Introductions Participants (patient and carer) welcomed 
Introductions and clarifications as required 
Leaflet provided and participants given time to read through 
Overview of pain in 
HIV/AIDS 
Pain defined in relation to HIV/AIDS 
Possible causes of pain in HIV/AIDS discussed 
Characteristics of pain relating to HIV/AIDS 
Beliefs and myths about pain 
in HIV/AIDS 
Participants given opportunity to share beliefs about pain in 
relation to HIV/AIDS 
Where appropriate misconceptions dispelled  
Beliefs and myths about pain 
medication 
$VNWKHSDUWLFLSDQWV¶EHOLHIVDERXWXVHRISDLQPHGLFDWLRQ 
Summarise and dispel misconceptions as required about pain 
medication 
Assessment of pain in 
HIV/AIDS 
Demonstrate with the help of body diagrams how to locate and 
describe pain 
Demonstrate use of pain assessment tools to rate and record pain 
Demonstrate with pain diagrams how to classify pain 
Explore type of pain experienced and strategies used to manage 
pain 
Discuss ways in which pain may be managed more effectively 
Pharmacological 
management of pain 
Demonstrate, using WHO analgesic ladder, how pain is managed 
with medications 
Give examples of available drugs used on WHO ladder 
Discuss most effective timing of pain medication 
Non-pharmacological 
management of pain 
Identify what non-pharmacological interventions participants are 
aware of and use 
Practical demonstrations on use of non-pharmacological 
interventions as appropriate 
Other items covered Participants given further opportunity to clarify any of the points 
discussed 
Participants encouraged to re-read the leaflet after the end of the 
face-to-face meeting and refer to it whenever the patient 
experiences pain 
Advise participants to ask for clarification about the leaflet and its 
contents by sending a missed call to KN who will then return the 
call 
Routine follow-up call at two weeks 
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The pain management ladder was explained to the patients and family 
carers so that they should know how pain is rated and managed depending 
upon the severity of the pain. Patients and carers were informed which 
drugs are appropriate as severity of pain increases. This information was 
given to the participants in the pain education intervention to make sure 
that they should explain to the doctor that their pain is either mild, 
moderate or severe. They were further informed that should the pain be 
moderate or severe they should seek medical attention and explain to the 
doctor that they need strong analgesia. Presumably this influenced the way 
doctors prescribed the analgesia. The pain ladder is used by doctors and 
nurses to prescribe, however this was extended to patients/carers as a way 
empowering them with basic knowledge on pain management. In Malawi 
usually doctors and nurses do not communicate to the patients and families 
about drugs. Therefore the pain education intervention was designed to 
provide information to the patients/families despite the fact that they 
cannot self-prescribe. 
The features of usual care and the pain education intervention are 
described in Table 18 below to differentiate the usual care from the 
intervention in terms of content, method of delivery, content and general 
description (Guo et al, 2012).  
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Table 18 Features of Usual care and educational intervention 
 
6.11 Pilot study 
Before recruitment for the main study begun, a pilot study was conducted 
to assess delivery of the intervention, understandability of the 
questionnaires and intervention and feasibility of the study. Ten patients 
and ten family carers were recruited for the pilot study. They were 
followed-up after four weeks (one month) after delivery of the intervention.  
Element Usual care/wait list 
control 
Intervention 
General description Unstructured verbal 
information 
Leaflet based information, advice, 
explanation and discussion 
Form General information on the 
treatment prescribed and 
instructions to be followed, 
responsive information from 
palliative care nurses 
,QIRUPDWLRQOHDIOHWGLVWULEXWHG³$OO
DERXW\RXUSDLQ´LQFOXGLQJ
minutes face-to-face verbal 
instructions and advice on pain 
assessment and management.  
Content General information about 
HIV/AIDS medication and 
treatment compliance 
Specific information about procedure 
on pain assessment and 
classification using pain scales and 
pain diagrams, including pain 
management using WHO analgesic 
ladder and specific drugs on each 
step. 
Description in relation to the model: 
(1)Biological-infection with HIV and 
side effects of treatment  
(2) Psychological-depression, anger , 
fear and anxiety effects of HIV/AIDS  
(3) Social-availability of family and 
spiritual support. 
   
Written materials None Leaflet with simplified text 
information and diagrams, 
pictures/photos for quick reference. 
   
Method of delivery General staff members KN 
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Six patients and their family carers were randomly allocated to the pain 
education intervention and they all received the face-to-face discussion and 
a leaflet. Four patients and their family carers were randomly allocated to 
the usual care group and received the leaflet upon completion of follow-up 
assessments. Of the ten patients/carer dyads, nine patients and six family 
carers were followed-up after four weeks; (meaning six patients/carer 
dyads and three patients without their family carers were followed-up) and 
one patient and four family carers were lost to follow-up. The reasons for 
loss to follow-up were patient and carer having transferred to another 
centre (n=1), no transport for the carer (n=3). All the participants who 
completed follow-up assessments were happy with the intervention and 
reported that they did not share the leaflet with anyone else.  
 
6.11.1  Lessons learnt from pilot study 
Even though the pilot study was conducted with the aim to test the 
questionnaires and for me to practice how to administer the intervention, I 
learnt some lessons from this exercise as outlined below which helped in all 
the stages of data collection for the main study:  
‚ Patients who have been on HIV treatment for a period of 12 months and 
above and showed to be compliant and adherent to treatment guidelines 
and standards were able to come to the clinic without their family carers, 
and in some cases only the family carer could come (on behalf of the 
patient) to the clinic to collect HIV medication for the patient. These 
patients were also given a drug supply that could last three or four months, 
and therefore this meant they did not require to come to the HIV clinic until 
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after their treatment has been completed, unless they developed a problem 
which required medical attention before the scheduled date of follow-up. 
While this is good development for the patient because in this case they did 
not have to spend transport (for two people) and it could mean the carer 
provider could do other things at home, however this was a challenge to 
me because I needed both the patient and the family carers as study 
participants in the trial. The longer period of follow-up (three to four 
months) for these patients who were adherent to treatment was also not in 
line with the design of this trial (two months follow-up). I therefore 
recruited mostly newly registered patients because new patients had two 
weeks or one month follow-up schedules to the HIV clinic (figure 10).  
‚ Recruitment was slow during the pilot phase of the study. It took almost 
one month to recruit ten patients/family carers dyads. This concerned me 
because it meant that the main study would take longer to complete than 
originally anticipated. In response to this I made contacts with another 
centre in advance so that should there be a need to extend the study to 
another site, I would have things already in place.  
‚ Some participants were not able to understand how to rate pain on the 
visual analogue scale (zero to 10) or (zero to five) and therefore to assess 
for pain severity posed a challenge. I therefore made a print out of the 
universal pain assessment scale diagram for participants to see the facial 
diagrams and compare themselves with what they see in order to rate their 
pain. This proved to be easy for them to rate their own pain and therefore I 
utilised this process for all the pilot work participants and for the main 
study. Outcome assessors were also trained to conduct assessments in a 
similar manner.  
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‚ Initially there was no plan to make a follow-up phone call reminder to the 
participants randomised to the intervention group, however some 
participants reported that they wanted to ask for clarification a few days 
after they received the intervention, but they could not call me because 
they did not have credit. I therefore included a two weeks follow-up phone 
call reminder as one of the ingredients of the intervention in order to check 
if participants have questions after receiving the intervention and also to 
encourage and remind them to read the leaflet provided.  
 
6.12 Outcome measurers 
In this section I describe how the follow-up assessments were scheduled 
and conducted among study participants randomised to either the pain 
education intervention or usual care groups. Follow-up measures were 
conducted after eight weeks following delivery of the intervention. Two 
QXUVHV¶ EOLQG WR WKH JURXSV FRQGXFWHG WKH IROORZ-up assessments. There 
were two nurses who conducted follow-up assessments one from each 
recruitment centre. This was implemented during the routine appointments 
to the HIV or palliative care clinics. Follow-up assessments were conducted 
using the same assessments tools described in baseline assessments on 
both the patients and carers.  
The primary outcome was average pain severity measured by a subscale of 
the brief pain inventory (BPI-PS) since the intervention was designed to 
evaluate the effects of pain education on reducing pain severity, therefore 
pain score was the main focus of this study. The secondary outcomes 
were: For patients; pain interference with daily activities measured by a 
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subscale of the BPI-PI, patient pain knowledge measured by a subscale of 
the Patient Pain Questionnaire (PPQ-K), patients quality of life was 
measured by a subscale of the APCA African POS. For carers; knowledge of 
pain management was measured using the knowledge subscale of the 
Family Pain Questionnaire (FPQ-K), carer motivation was measured using 
the Picot Caregiver Rewards Scale (PCRS) and carers quality of life was 
measured using the subscale of the APCA African POS. I was not present 
during the follow-up assessments to prevent influencing responses from 
participants. After follow-up assessments were completed a leaflet was 
given to participants who were randomised to the wait list control group. A 
detailed face-to-face discussion was not provided. On exit from the trial 
participants who were randomised to the wait list control group were 
advised to read the leaflet and they were asked not to share it with anyone 
else because the study was still ongoing. Those participants who were 
randomised to the pain education intervention were advised to continue 
referring to the leaflet and they were reminded not to share it with anyone 
else because the study was not yet completed. 
A range of secondary outcomes were chosen due to the complex nature of 
the intervention (Bennett and Closs, 2011). In complex interventions we 
need to have a number of outcomes to be measured, unlike in drug trials 
which usually have biomedical or physiological outcomes (Roland and 
Torgerson, 1998a). A pragmatic trial measures the effectiveness of the 
intervention, that is the benefit the new treatment will produce in routine 
care of the patients. The design of pragmatic trials reflects variations 
between patients that occur in real clinical practice and they aim to inform 
practice which treatment is better than the other (Roland and Torgerson, 
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1998b). The pain education intervention study tested the effect of 
education intervention consisting of an information leaflet, face-to-face 
discussion and phone call reminder compared to usual practice in a real 
world population. Although the challenge in conducting pragmatic trials is 
the need for more outcomes as well as more participants because 
increasing the number of outcomes increases the probability of reaching 
statistical significance by chance (Roland and Torgerson, 1998a). 
Patient outcomes are in line with IMMPACT (Initiative on Methods, 
Measurement, and Pain Assessment in Clinical Trials) recommendation on 
core outcomes for patients with chronic pain (Dworkin et al., 2008, 
Dworkin et al., 2005b, Turk et al., 2003). The time point between delivery 
of the intervention and follow-up assessments was chosen to be consistent 
with other studies of pain education (Clotfelter, 1999, Hudson et al., 2005) 
and based on recommendations from pain research experts (Bennett and 
Closs, 2011).  
 
6.13 Sample size 
A power calculation was based on the primary outcome of average pain 
severity on the BPI (Keller et al., 2004). To be able to detect a mean 
difference of 10% between the treatment groups in the primary outcome 
measure (average pain severity in the BPI). A 10% improvement is the 
difference considered the lower limit of changes considered clinical 
important (Dworkin et al., 2008). Using a p-value cut-off of 0.05 to 
determine a statistically significant result, it was calculated that 76 people 
per arm of the trial were needed to complete the study to give 80% power 
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to detect such a difference. This is based on a review (Bennett et al., 2009) 
that suggests that education-based interventions are able to produce this 
level of improvement in pain reduction, and that a standard deviation of 
2.2 points is a liberal estimate of variability. To allow for 15% attrition, I 
aimed to recruit 182 participants to the trial. However I did not power  
secondary outcomes in this study. 
Power was calculated using the following formula for minimal sample size: 
 
ሺݑ ൅ ݒሻଶሺߪଵଶ ൅ ߪଶଶሻሺߤଵ െ ߤ଴ሻଶ  
Where 
1. ݑ is the one sided percentage point of the normal distribution 
corresponding to 100% minus the power; using 80% power this 
relates to the one-sided percentage point of 20% (100-80), ݑ = 
0.84. 
2. ݒ is the percentage point of the normal distribution corresponding 
to the (two-sided) significance level; using 5% level of significance, ݒ = 1.96. 
3. ߪଵ and ߪଶ are the standard deviations in each of the treatment 
groups; assumed to be the same (2.2 points or 22 on a scale of 0 
to 100). 
4. ߤଵ െ ߤ଴ is the difference between the two means; 10% was the 
difference considered clinically relevant to detect (or 1 on a scale of 
0 to 10). 
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6.14 Data Management 
Each participant had an assessment form (questionnaire) conducted at 
baseline by myself and at follow-up by the nurses. Nurses who conducted 
follow-up assessments returned the questionnaire the same day after 
completing assessments. Every participant was given a trial number (ID 
number). Each questionnaire had an ID number corresponding to the 
participant ID number. Firstly each questionnaire was checked for missing 
responses. Data was then entered into Microsoft excel spread sheet blind 
to the participants group allocation. Data were stored on a personal 
password secured computer and university password secured computer. All 
data were only accessed by my supervisors and I.  
 
6.15 Data analysis plan 
The principles guiding the data analysis for the study were (i) minimisation 
of bias; (ii) transparency; and (iii) drawing statistical inference that was 
true to both study design and data. 
Data was entered into a spreadsheet with allocation codes kept separately 
and linked only by a unique identifier for each patient/carer dyad. These 
spreadsheets were converted into Stata version 12 datasets (StataCorp, 
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2011). $VHULHVRIVHTXHQWLDO6WDWD µGR¶ ILOHV$SSHQGL[ZHUHXVHGWR
conduct the analysis and ensure that there was a clear audit trail of data 
cleaning and produFWLRQ RI UHVXOWV (DFK 6WDWD µGR¶ ILOH ZDV XVHG IRU D
specific element of the analysis: 
1. Organisation of variables and generation of derived variables 
2. Data cleaning 
3. Encoding string variables 
4. Transposing outcome variables 
5. Ordering new variables (patient/carer baseline/follow-up) 
6. Producing output for baseline tables and figures 
7. Analysis of outcomes 
8. Sensitivity analysis and checking model assumptions 
The two treatment groups were examined at baseline in terms of 
demographics, recruiting centre, and baseline values of all study outcomes. 
Categorical variables are presented using frequencies and proportions, and 
continuous variables are presented using means and standard deviations. 
There was no formal testing of differences at baseline. This was deliberate 
and in accordance with the detailed consort guidelines (Moher et al., 2010) 
The authors of the guidelines argue that testing of baseline differences for 
the probability of them being observed by chance is both superfluous and 
potentially misleading as the process of randomisation means that by 
definition, baseline differences are due to chance. 
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All patients and family carers were analysed according to the group they 
ZHUH UDQGRPLVHG WR7KLVDSSURDFK LV VRPHWLPHV UHIHUUHG WRDV µPRGLILHG
intention-to-WUHDW¶ DV the use of strict intention to treat analysis is only 
possible where there is no loss to follow-up (Abraha and Montedori, 2010, 
White et al., 2011). This approach was used for all seven outcomes. It 
involved analysing all the participants as originally allocated to either pain 
education intervention group or usual care group. Lost to follow-up 
participants were excluded from the analyses. 
To minimise bias and ensure that all analyses was carried out according to 
the protocol (Nkhoma et al, 2013) and not driYHQE\UHVXOWVµGR¶ILOHVZHUH
EXLOW XVLQJ D UDQGRPO\ JHQHUDWHG YDULDEOH IRU µDUP ¶ DQG µDUP ¶ 2QO\
once outputs were available to populate tables and figures was this variable 
replaced by the original variable that determined which dyads were 
allocated to which randomised group. 
Treatment groups were compared in terms of the primary outcome 
measure (pain severity using the BPI-PS treated as a continuous measure) 
using a linear regression model with baseline BPI and treatment group and 
recruiting centre as covariates. Adjusted analysis were also conducted for 
primary outcome measure (average pain severity using BPI-PS treated as a 
continuous measure) using linear regression model with baseline BPI, 
treatment group, recruiting centre, age and gender as covariates:  
\L Įǃ[Lǃ[Lǃ[Lǃ[Lǃ[LİL 
where yi is the BPI-PS outcome and ǃto ǃare baseline BPI, treatment 
JURXSUHFUXLWLQJFHQWUHDJHDQGJHQGHUIRUDQLQGLYLGXDOLDQGİLVWKH
error around the prediction. 
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Analysis of each of the six secondary outcomes (BPI-PI, PPQ-K, APCA 
African POS patient score, FPQ-K, PCRS, APCA African POS carer score) 
was conducted using six equivalent models with estimates of treatment 
effect conditional on the value of the outcome at baseline.  
To test for any violations of the assumptions of linear regression, residuals 
ZHUH FDOFXODWHG LQ6WDWDXVLQJ WKH µSUHGLFW¶ FRPPDQG7KLV FDOFXODWHV WKH
difference between the fitted values for each participant and the actual 
outcome value. These were then plotted to examine for departures from 
the assumption of normally distributed residuals that would undermine any 
conclusions inferred from the models. 
The only post-hoc analysis undertaken was that involving medication use. 
This was in an attempt to unpick the mechanism whereby pain education 
might lead to improved outcomes. Treatment groups were compared in 
terms of use of analgesia for treatment of pain at follow-up adjusting for 
baseline pain medication, recruitment centre, age and gender. Treatment 
groups were also compared in terms of type of medication received at 
follow-up adjusting for medication use at baseline, recruitment centre, age 
and gender using a logistic regression model.  
Sensitivity analysis was performed as follows: I conducted secondary 
analyses that (1) adjusted for variables which were considered potential 
predictors of outcome (age, gender, number of pain medications at 
baseline) assuming missing at random and (2) considered plausible 
scenarios for departures from the missing at random assumption using the 
6WDWDFRPPDQGµUFWPLVV¶(White et al., 2011). These scenarios were for all 
outcomes using scores of the mean outcome plus and minus 50 points for 
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both arms and individual arms. All models included recruitment centre as a 
covariate.  
All analyses were conducted using Stata version 12 (StataCorp, 2011). All 
reported P values are two-tailed, with P<0.05 considered statistically 
significant.  
  
6.16 Ethical considerations  
Ethical approval for this study was obtained from the University of 
Nottingham Medical School Ethics Committee (SNMP 11042012) (Appendix 
10) and the National Health Sciences Research Committee of Malawi 
(Appendix 11). The study was registered by Current Controlled Trials 
ISRCTN72861423 in October 2012. The protocol for this study has been 
published (Nkhoma et al., 2013) appendix 15. 
Carrying out research among participants with a chronic illness like 
HIV/AIDS raises a number of ethical issues. People living with HIV/AIDS 
and their family carers experience physical, social, psychological and 
spiritual problems. They are therefore considered a vulnerable group of 
people and require special attention in relation to research (Addington-Hall 
et al., 2007). The following ethical issues were carefully considered when 
designing and implementing the study.  
 
‚ The principle of beneficence which stipulates that the researcher should 
come up with strategies to minimising harm, but maximise benefits (Polit 
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and Beck, 2008). There was no physical harm in this study because the 
trial did not involve invasive procedures in technical sense, so the risk of 
harm was low; however possibly there was psychological harm, because 
the participants had to contribute their time to be involved in the study. In 
addition participants in the control group had to wait for two months before 
they received the intervention. However since the study evaluated the 
effectiveness of the education intervention, I needed a control group in 
order to come up with conclusive results and evidence. In line with this 
(Polit, 2006, Medical Research Council, 2005) argues that considering risk 
versus benefit ratio the study is ethical because the outcomes of the study 
are expected to inform policy and practice in the management of HIV/AIDS 
SDLQLQSDWLHQWV¶KRPHV  
‚ 3DUWLFLSDQW¶V ULJKW WR GHFLGH ZKHWKHU RU QRW WR WDNH SDUW LQ WKH WULDO ZDV
respected. There were no rewards for participants who decided to take part 
in the study. Participants were given information sheets about the study. 
These were available in both English and Tumbuka, the local language in 
Malawi. The language used was simple and clear (Cormack, 2000). The 
information sheets explained details about the study aims and objectives. 
Participants who took part in the study were given an informed consent, 
they were fully informed that they have the right to withdraw from the trial 
at any time without giving reasons and that this was not going to affect 
their routine care. Data were privately, confidentially stored in a password 
protected personal and or university computer. Data was not shared with 
any person apart from my supervisors; each participant was assigned an 
identification number which was used to collect baseline and follow-up 
assessments.  
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‚ The question of equipoise was also taken into consideration. This refers to 
genuine uncertainty that treatment in one arm of the trial is superior over 
treatment from the other arm of the trial (Djulbegovic, 2007, Mann and 
Djulbegovic, 2003). It was not known whether the pain education 
intervention was effective among this population and it was not part of 
routine care. Therefore, no patients or carers were denied a treatment 
through random allocation that they would normally get under the current 
service arrangements. To avoid disappointment for those not randomised to 
the pain education intervention, the intervention was also delivered to 
those randomised to usual care on completion of the trial. Equipoise did 
exist in this study because previous studies reviewed have not produced 
evidence that pain education interventions are effective in the population of 
HIV/AIDS and their family carers (Millard et al., 2013). It would have been 
unethical and unnecessary to conduct this study if I was certain that pain 
education interventions are effective in HIV/AIDS (Djulbegovic et al., 
2000).  
In order to ensure that participants were not burdened greatly due to 
taking part in the study, the intervention was kept simple and short, the 
questionnaires were short. 
 
6.17 Chapter summary 
This thesis is based on a randomised controlled trial evaluating the effects 
of a pain education intervention (consisting of a face-to-face verbal 
discussion, an information leaflet and follow-up phone call reminder at two-
weeks) on pain severity and pain management among HIV/AIDS patients 
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and their family carers. The intervention was specifically designed to 
improve pain severity and pain management among HIV/AIDS and family 
carers. The study design included developing a leaflet on pain management 
WLWOHG³$OODERXW\RXUSDLQ´WKURXJKFRQVXOWDWLRQVZLWKSDWLHQWVIDPLO\
carers, and healthcare workers involved in care provision to HIV/AIDS 
patients, and piloting the tools and the intervention. The design of the 
intervention was guided by the bio-psychosocial model and the adult 
learning theory was used to deliver the intervention. Due to the design of 
this study, it is difficult to know how an education intervention leads to 
pain improvement among patients and carers.  However when 
patient/carer dyads experienced pain or perceived pain they were taught 
how to rate the pain, classify the pain, use self-management interventions 
and how to seek medical care.  
Adult HIV/AIDS patients and their family carers were randomised to either 
usual care/wait list control group or 30 minutes face-to-face verbal 
instructions and discussion on pain management, augmented by a leaflet 
and a phone call reminder after two weeks group. The primary outcome 
was average pain severity measured by a sub-scale of the BPI. Secondary 
outcomes for the patient were pain interference with daily activities of 
living measured by the sub-scale of BPI, patient pain knowledge measured 
by a sub-scale of the patient pain questionnaire, patient quality of life 
measured by a sub-scale of the APCA African POS. Secondary outcomes for 
the carers were pain knowledge measured by a sub-scale of the family pain 
questionnaire, quality of life measured by a sub-scale of the APCA African 
POS and carers motivation measured by Picot Caregiver Rewards Scale. 
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Baseline measurers were conducted two to four weeks after introducing the 
study to potential participants while follow-up measurers were conducted 
eight weeks after randomisation. The next chapter presents the results of 
the trial. 
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CHAPTER SEVEN: TRIAL RESULTS 
7.1 Introduction 
This chapter reports the results of the pain education intervention trial. The 
recruitment and flow of participants, the baseline characteristics of the 
study participants in the two arms of the trial are described. I describe the 
uptake and adherence of the participants to the intervention. The follow-up 
assessments at eight weeks after randomisation and delivery of the 
intervention are reported. In this chapter I report the differences observed 
in primary and secondary outcomes between the two arms of the trial. 
7.2. Recruitment and flow of participants 
The period of recruitment for the trial was between September 2012 and 
June 2013. A total of 308 participants were approached of which 126 
(40.9%) were excluded on the basis of being unable to read or write 
(n=15), had no carer provider (n=45), were outside the catchment area 
(n=15), were cognitively impaired (n=4) or the patient had died before 
recruitment (n=10). Of the remaining 219 participants, 37 (16.9%) of 
them declined to participate. In total 182 patient/carer dyads were 
recruited to the trial. Participant flow through the trial is illustrated in 
Figure 12. 
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Randomised (n=182) 
Followed-up (n=79 patients and carers)  
(n=5 patients) 
Followed-up  
(n=78 patients and carers) 
(n=5 patients) 
Patient and carer loss 
to follow-up (n=7)  
Untraceable (n=2)          
Moved away (n=4)         
Patient unwell (n=1)  
 
Carer loss to follow-
up (n=5) 
Too busy (n=2)  
No transport(n=3)   
Patient and carer loss to 
follow-up (n=8) 
No transport (n=2)        
Patient died (n=4)  
Untraceable (n=1)      
Moved away (n=1) 
 
Carer loss to follow-up 
(n=5) 
Too busy (n=2) 
No transport (n=3)      
Allocated to usual care (n=90) 
Received usual care (n=90) 
 
Allocated to pain education intervention 
(n=92) 
Received allocated intervention (n=92) 
Excluded (n=126) 
 No carer (n=45) 
 Unable to read and write (n=15) 
 Outside catchment area (n=15) 
 Cognitively impaired (n=4) 
 Died before recruitment (n=10) 
 Declined (n=37) 
Assessed for eligibility (n=308) 
 
Figure 13 Flow diagram of the progress through the phases (enrolment, 
randomisation/intervention allocation, follow-up and data analysis) of the 
two arms of the trial 
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Table 19 Baseline characteristics of patient participants (n=182) 
randomised to the pain education intervention and usual care 
Values are numbers (percentages) unless stated otherwise 
Variables Pain education 
intervention (n=92) 
Usual care (n=90) 
Mean (SD) age in years 40.48 (11.30) 41.31 (11.65) 
Male/Female 43 (46.74)/ 49 (53.26) 56 (62.22)/ 34 (37.78) 
Marital status   
  Married 61 (66.30) 58 (64.44) 
  Single 11 (11.96) 13 (14.44) 
  Divorced/separated 11 (11.96) 10 (11.11) 
  Widow/widower  9  (9.78)  9 (10) 
Education   
  Primary school 21 (22.83) 14 (15.56) 
  High school 66 (71.74) 72 (80.00) 
  College/University   5 ( 5.43)  4  (  4.44) 
Occupation   
  Farmer       26 (28.26) 28 (31.11) 
  Civil servant  13 (14.13) 12 (13.33) 
  Housewife  14 (15.22)  6  ( 6.67) 
  Unemployed  6 ( 6.52)  1  ( 1.11) 
  Student           5 ( 5.43)  4  ( 4.44) 
  Skilled manual   8 ( 8.70)  8  ( 8.89) 
  Retired   1 ( 1.09)  1  (1.11) 
  Admin workers  2 ( 2.17)  2  (2.22) 
  Small scale business 10( 10.87) 13 (14.44) 
  Other   7 (  7.61) 15 (16.67) 
Religion   
  Christianity/Islam 88 (95.65)/ 4 ( 4.35) 87 (96.67)/ 3 ( 3.33) 
Recruitment centre   
  Ekwendeni/Mzuzu 53 (57.61)/ 39 (42.39) 53 (58.89)/ 37 (41.11) 
BPI Average pain severity mean (SD) 50.76 (24.86) 51.22 (27.10)a 
BPI Pain interference mean (SD) 49.91 (27.97) 49.46 (29.48)b 
PPQ-K subscale Pain knowledge mean(SD)  67.78 (16.61) 66.24 (18.84)c 
APCA African POS subscale mean (SD) 44.78 (22.79) 48.92 (20.50)d 
 
  
                                          
a BPI average pain severity: scores range from 0-10; higher scores representing 
positive outcomes 
b BPI pain interference: scores range from 0-70; higher scores respresenting positive 
outcomes 
c PPQ: scores range from 0-90; higher scores representing positive outcomes 
d APCA African POS: scores range from 0-35; higher scores (with some items 
reversed) representing positive outcomes 
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7.3 Baseline characteristics 
Baseline data were collected from all 182 patients and 182 carers before 
they were randomly allocated to either the pain education intervention 
group (n=92) or the usual care group (n=90). Table 19 and Table 20 
summarises the comparison of the two groups of patient and carer 
participants in terms of demographic and clinical characteristics at baseline. 
 7.3.1 Patient characteristics 
At baseline the mean age of patient participants in the two treatment 
groups were similar (40.5 years in the pain education group and 41.3 years 
in the usual care group). There were fewer men in the pain education 
intervention group (43/92) compared with the usual care group (56/90). 
There were no obvious differences between the two groups in terms of 
marital status. However, those in the usual care group tended to be more 
educated with only 14 of 90 patients having received no further education 
beyond primary education compared with 21 of the 92 patients in the pain 
education group. 
There were no differences between the two groups in terms of occupation 
except that the pain education intervention group included twice as many 
housewives (14/92 versus 6/90 in the usual care group), and more 
patients with no employment (6/92 versus 1/90 in the usual care group). 
There were no differences in religious background between the two groups. 
At baseline, patients allocated to the usual care group had a slightly higher 
mean quality of life score as measured by the APCA (African Palliative care 
Association) African POS (Palliative care outcome score). The mean APCA 
African POS was 4.14 higher in the usual care group than in the pain 
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education intervention group (48.9 compared with 44.8). Both groups had 
similar mean scores at baseline in terms of average pain severity, pain 
interference, and patient knowledge of pain management.  
In summary the two groups of patients had similar characteristics in terms 
of age, marital status, and religion; however they had some differences in 
terms of gender ratio, education and employment status. Participants in 
the pain education intervention were less likely to be male, but more likely 
to be female, and less likely to be educated beyond primary education. 
Both groups of patients had similar mean scores at baseline regarding 
average pain, pain interference and knowledge. Patient reported quality of 
life was slightly better among patients in the usual care group.  
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Table 20 Baseline characteristics of carer participants (n=182) 
randomised to the pain education intervention and usual care 
 
Values are numbers (percentages) unless stated otherwise 
 
7.3.2 Carer characteristics 
The mean age of the carer participants in the two arms of the trial were 
similar (41.1 years in the pain education intervention and 42.6 years in the 
                                          
a FPQ: scores range from 0-90; higher scores represents positive outcome 
b PCRS: scores range from 0-64; higher scores represents positive outcome 
c APCA African POS: scores range from 0-15; higher scores (with some items 
reversed) represents positive outcomes   
Variables Pain education (n=92) Usual care (n=90) 
Mean (SD) age in years 41.12 (11.70) 42.62 (SD 11.40) 
Male/Female  14 (15.56)/76 (84.44) 19 (21.11)/71 (78.89) 
Marital status   
 Married 78 (84.78) 81 (90) 
 Single 10 (10.87)  6 ( 6.67) 
 Divorced/separated  1 ( 1.09)  1 ( 1.11) 
 Widow/widower  3 ( 3.26)  2 ( 2.22) 
Education   
 Primary 21 (22.83) 22 (24.44) 
 High school 66 (71.74) 64 (71.11) 
 College/University   5 ( 5 .43)   4 (  4.44) 
Occupation   
 Farmer     32 (34.78) 30 (33.33) 
 Civil servant              5  (  5.43)   5 (  5.56) 
 Housewife 24 (26.09) 30 (33.33) 
 Student      5  (  5.43)  1  (  1.11) 
 Skilled manual              2  (  2.17)  3  (  3.33) 
 Admin workers   3  (  3.26)  5  (  5.56) 
 Small scale business  13 (14.13)  8  (  8.89) 
 Other   8 (  8.70)  8  (  8.89) 
Religion   
 Christianity/Islam 88 (95.65)/4 ( 4.35) 89 (98.89)/1 ( 1.11) 
Carer relationship to patient   
 Spouse 35 (38.04) 44 (48.89) 
 Sibling 27 (29.35) 20 (22.22) 
 Son/daughter 10 (10.87)   4  (4.44) 
 Friend            0   2  (2.22) 
 Parent 12 (13.04) 14 (15.56) 
 Other   8 (  8.70)   6 (  6.67) 
FPQ-K subscale Pain knowledge mean(SD) 65.29 (16.93) 64.59 (18.53)a 
PCRS Motivation mean (SD) 78.91 (11.29) 79.41 (11.02)b 
APCA African POS subscale mean (SD) 44.20 (18.95) 45.26 (18.55)c 
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usual care group) but there was a slight difference in terms of gender 
between the two groups. More male carers were randomised to the usual 
care group 19/90 compared with 14/92 in the pain education intervention 
group. There were also no differences with regard to marital status, 
education level and religion.  
There were more carer participants who classed themselves as housewives 
in the usual care group 30/90 compared with 24/92 in the pain education 
intervention group. There were also baseline differences between groups in 
terms of the relationship of carer to patient. In the usual care group 44 of 
90 carer participants were spouses to the patient compared with 35/92 in 
the pain education intervention group. Conversely there were more sibling  
carers in the pain education intervention group 27/92 compared with 20/90 
in the usual care group. There were more sons and daughters of patients 
among the carers in the pain education group 10/92 compared with 4/90 in 
the usual care group. There were no differences at baseline in the mean 
scores regarding carer knowledge of pain management, carer motivation in 
provision of care and quality of life. 
In summary the two groups were broadly similar at baseline in terms of 
age, marital status, level of education, religion and mean outcome scores, 
however carer participants in the pain education group were more likely to 
be female and less likely to be housewives.  
7.4 Uptake and adherence to the interventions 
Patient and carer dyads were randomly allocated to one of the two arms of 
the trial once baseline assessments were conducted. All of the 182 patients 
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and their carers received usual care provided by staff at the hospital from 
which they were recruited. All of the 92 patients and their carers 
randomised to the pain education intervention attended the face-to-face 
discussion which lasted for 30 minutes and received the leaflet immediately 
after randomisation. Of these, 59 participants received the phone call 
reminder intervention at week two. Due to poor telephone network 
coverage some participants did not receive a phone call (n=19) but had 
brief face-to-face contact with KN during their visit to the clinic at week 
two. Of the 59 participants who received a phone call, four also had face-
to-face contact with me at the clinic where I reminded them to read the 
leaflet and clarified any questions they had. 
 
7.5 Follow-up 
Of the 182 patient/carer dyads randomised, 157 patient/carer dyads 
(86.26%) and a further 10 patients (without a carer) were successfully 
followed-up. Of the 15 patient/carer dyads lost to follow-up, 8 were from 
the pain education intervention group, and 7 were from the usual care 
group. Of the additional 10 carers lost to follow-up, 5 were from each arm 
of the study. 
Follow-up assessments were collected from 79 patients/carer dyads 
allocated to the pain education intervention group and from 78 
patients/carer dyads allocated to the usual care group. Follow-up 
assessments were also collected from 5 patients without a carer from each 
group.  
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The reasons for being lost to follow-up were various. In the pain education 
intervention group eight patient/carer dyads were lost to follow-up for the 
following reasons: two had no transport, four patients died before follow-up 
assessments, one patient/carer was untraceable and another patient/carer 
dyad had moved away to another centre. In the usual care group a total of 
seven patients/carer dyads were lost to follow-up for the following reasons: 
four of them moved to another centre, two of them were untraceable and 
one patient was unwell therefore assessments could not be conducted. In 
each group a further five carers were lost to follow-up and the reasons 
were all similar; two carers from each group were too busy to accompany 
the patient to the hospital for follow-up assessments, and three from each 
group had no transport to cater for both the patient and the carer. 
The reasons for loss to follow-up did not differ between the two groups 
except that in the intervention group four patients died, but no death was 
reported in the usual care group. As the intervention did not involve any 
invasive procedures it is unlikely that these were due to the intervention.  
Of the 157 patient/carer dyads and 10 patients without a carer who 
completed the trial, complete data were available for all the outcomes with 
100% response for all outcome scales. All outcomes were conducted at 
baseline and eight weeks after delivery of the intervention and transposed 
WRDWRVFDOHZLWKKLJKHUVFRUHVLQGLFDWLQJDPRUHµSRVLWLYH¶RXWFRPH
KHQFHDSDUWLFLSDQW¶VLQGLYLGXDOVFRUHUHSUHVHQWHGDSHUFHQWDJHRIWKHEHVW
possible score for that outcome.  
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 7.6 Primary outcome-average pain severity 
The primary outcome measure for this trial was change in average pain 
severity between baseline and follow-up in the two arms of the trial 
measured by a sub-scale of the Brief Pain Inventory.  
Both groups had an improved average pain severity at follow-up (Table 
21). However those in the pain education group had a mean change of 
40.95 (SD 23.78) while usual care group had a mean change of 19.27 (SD 
25.27). Participants in the pain education group reported a greater 
improvement in severity of pain compared to those in the usual care group 
(mean difference 21.09, 95% confidence interval 16.56 to 25.63; 
P<0.001). When adjustments were made for baseline average pain 
severity score, recruitment centre, age, gender and medication number, 
the result was similar (mean difference 21.25, 95% confidence interval 
16.7 to 25.8; P <0.001). Regardless of the method of analysis used, the 
participants in the pain education intervention group appeared to have a 
greater improvement in pain severity than those in the usual care group. 
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Table 21 Primary outcome- average pain severity on the BPI-PS for pain education and usual care groups for 
patient participants 
 
aLinear regression: controlling for baseline score, and recruitment centre. 
 bLinear regression: controlling for baseline score, recruitment centre, age, gender and medication number. 
 
Outcome Pain education 
(n=84) 
Usual care 
(n=83) 
Adjusted for baseline average pain 
severity and recruitment centrea 
Adjusted for baseline average pain severity, 
recruitment centre, age, gender and medicationb 
Mean difference (95% 
CI) 
P value Mean difference (95% CI) P 
value 
BPI-PS subscale       
Mean (SD) average pain severity 
score 
      
 At baseline (n=182) 50.76 (24.86) 51.22 (27.1)     
 At follow-up (n=167) 92.62 (8.23) 71.69 (21.18)     
 Mean change (SD) from baseline 40.95 (23.78) 19.27 (25.27) 21.09 (16.56 to 25.63) <0.001 21.25 (16.7 to 25.8) <0.001 
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7.7 Secondary outcomes (patients) 
There were three secondary outcomes for the patients: pain interference 
with activities of daily living, patient pain knowledge of pain management, 
and quality of life. Table 22 presents secondary outcomes for the patients.  
 
 7.7.1 Pain interference 
Both groups experienced improved pain interference score at follow-up: 
mean difference 42.5 (SD 25.91) in the pain education group compared 
with 18.42 (SD 23.92) in the usual care group. Patient participants in the 
pain education group had significantly greater improvement on pain 
interference than the usual care group (mean difference 24.32, 95% 
confidence interval 19.33 to 29.32; P<0.001). When adjusted for baseline 
pain interference score, recruitment centre, age, gender and medication 
number, the result was similar (mean difference 24.5, 95% confidence 
interval 19.61 to 29.38; P<0.001). In both analyses patient participants in 
the pain education intervention had a significantly greater improvement on 
pain interference with daily activities than patient participants in the usual 
care group.  
 
 7.7.2 Pain knowledge 
Both groups reported improved pain knowledge: mean difference 25.63 
(SD 15.5) in the pain education group compared with 6.32 (SD 11) in the 
usual care group. Patients in the pain education group reported greater 
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improvement in knowledge than patients in the usual care group (mean 
difference 20.05, 95% confidence interval 17.25 to 22.86; P<0.001). When 
adjusted for baseline patient pain knowledge score, recruitment centre, 
age, gender and medication number, the result was similar (mean 
difference 20.39, 95% confidence interval 17.51 to 23.27; P<0.001. 
Patient participants in the pain education intervention group had 
significantly more knowledge of pain management than patient participants 
in the usual care group regardless of the method of analysis used.  
 
7.7.3 Quality of life (palliative care outcomes) 
At follow-up both the pain education group and the usual care group 
reported improved quality of life (palliative care outcomes), mean 
difference 45.44 (SD 22.58) in the pain education group compared with 
14.46 (SD 18.77) in the usual care group. Patient participants in the pain 
education group experienced a better quality of life than participants in the 
usual care group (mean difference 28.32, 95% confidence interval 24.12 to 
32.53; P<0.001). After adjustments were made for baseline quality of life 
score, recruitment centre, age, gender and medication number, the result 
was similar (mean difference 28.76, 95% confidence interval 24.62 to 
32.91; P<0.001). In both analyses patient participants in the pain 
education intervention group had significantly a better quality of life than 
participants in the usual care group. 
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 Table 22 Secondary outcomes- pain interference, pain knowledge and quality of life for patient participants 
 
 
aLinear regression: controlling for baseline score and recruitment centre 
bLinear regression: controlling for baseline score, recruitment centre, age, gender and medication number 
Outcome Pain education 
(n=84) 
Usual care (n=83) Adjusted for baseline score and recruitment 
centrea 
Adjusted for baseline score, recruitment centre, age, 
gender and medication numberb 
 Mean difference (95% CI) P value Mean difference (95% CI) P value 
BPI-PI subscale       
Mean (SD) pain interference       
At baseline (n=182) 49.91 (27.97) 49.46 (29.48)     
At follow-up (n=167) 93.67 (9.33) 69.24 (25.21)     
Mean change (SD) from baseline 42.5 (25.91) 18.42 (23.92) 24.32 (19.33 to 29.32) <0.001 24.5 (19.61 to 29.38) <0.001 
PPQ-K subscale Mean pain knowledge       
At baseline (n=182) 67.78 (16.61) 66.24 (18.84)     
At follow-up (n=167) 92.63 (8.16) 71.98 (15.21)     
Mean (SD) change from baseline 25.63 (15.5) 6.32 (11.00) 20.05 (17.25 to 22.86) <0.001 20.39 (17.51 to 23.27) <0.001 
APCA African POS-patient subscale       
Mean (SD) POS        
At baseline (n=182) 44.78 (22.79) 48.92 (20.5)     
At follow-up(n=167) 90.58 (9.0) 63.37 (19.46)     
Mean (SD) change from baseline 45.44 (22.58) 14.46 (18.77) 28.32 (24.12 to 32.53) <0.001 28.76 (24.62 to 32.91) <0.001 
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&DUHUV¶VHFRQGDU\RXWFRPHV 
7KHUHZHUHWKUHHVHFRQGDU\RXWFRPHVIRUWKHFDUHUVFDUHUV¶NQRZOHGJHRI
SDLQ PDQDJHPHQW FDUHUV¶ PRWLYDWLRQ WR SURYLGH FDUH DQG TXDOLW\ RI OLIH
Table 23 presents the secondary outcomes for the carers.  
 
7.8.1 Pain knowledge 
Both groups reported improved pain knowledge: mean difference 27 (SD 
15.8) in the pain education group compared with 7.17 (SD 9.8) in the 
usual care group. Carers in the pain education group reported greater 
improvement in knowledge than carers in the usual care group (mean 
difference 20.51, 95% confidence interval 17.58 to 23.44; P<0.001). When 
DGMXVWHG IRU EDVHOLQH FDUHUV¶ SDLQ NQRZOHGJH VFRUH UHFUXLWPHQW FHQWUH
age, and gender the results were similar (mean difference 20.32, 95% 
confidence interval 17.37 to 23.28; P<0.001). Regardless of the method of 
analysis, carers in the pain education intervention group had a significantly 
improved knowledge of pain management than carers in the usual care 
group.  
 
7.8.2 Motivation 
Both groups reported improved motivation to provide care: mean 
difference 18.01(SD 11.96) in the pain education group compared with 
10.18 (SD 8.48) in the usual care group. Carers in the pain education 
group reported greater motivation to provide care than carers in the usual 
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care group (mean difference 7.7, 95% confidence interval 5.26 to 10.14; 
3 :KHQ DGMXVWHG IRU EDVHOLQH FDUHUV¶ SDLQ NQRZOHGJH VFRUH
recruitment centre, age, and gender the results were similar (mean 
difference 7.74, 95% confidence interval 5.15 to 10.13; P<0.001). Carers 
in the pain education intervention group were more motivated to provide 
care than carers in the usual care group.  
 
7.8.3 Quality of life 
Both groups reported improved quality of life: mean difference 47.68 (SD 
18.86) in the pain education group compared with 13.42 (SD 16.63) in the 
usual care group. Carers in the pain education group reported a better 
quality of life than carers in the usual care group (mean difference 34.13, 
95% confidence interval 30.16 to 38.09; P<0.001). When adjusted for 
EDVHOLQHFDUHUV¶TXDOLW\RI OLIH score, recruitment centre, age, and gender 
the results were similar (mean difference 34.16 95% confidence interval 
30.15 to 38.17; P<0.001). Carers in the pain education intervention had a 
significantly better quality of life than carers in the usual care group, 
regardless of the method of analysis used. 
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Table 23 Secondary outcomes- pain knowledge, motivation and quality of life for carer participants 
 
a Linear regression: controlling for baseline score and recruitment centre. 
b Linear regression: controlling for baseline score, recruitment centre, age and gender.
Outcome Pain education 
(n=79) 
Usual care 
(n=78) 
Adjusted for baseline score and 
recruitment centrea 
Adjusted for baseline score, recruitment 
centre, age, genderb 
Mean difference 
(95% CI) 
P value Mean difference (95% CI) P value 
FPQ-K subscale       
Mean pain knowledge       
 At baseline (n=182) 65.29 (16.93) 64.59 (18.53)     
 At follow-up (n=157) 91.36 (7.8) 70.26 (15.88)     
Mean (SD) change from baseline 27 (15.8)  7.17 (9.8) 20.51 (17.58 to 23.44) <0.001 20.32 (17.37 to 23.28) <0.001 
PCRS motivation Mean (SD)        
 At baseline (n=182) 78.91 (11.29) 79.41 (11.02)     
 At follow-up (n=157) 97.13 (5.87) 89.52 (11.14)     
Mean (SD) change from baseline 18.01 (11.96) 10.18 (8.48) 7.7 (5.26 to 10.14) <0.001 7.64 (5.15 to 10.13) <0.001 
APCA African POS-carer subscale Mean (SD) POS       
At baseline (n=182) 44.2 (18.95) 45.26 (18.55)     
At follow-up (n=157) 92.66 (8.84) 58.55 (17.94)     
Mean (SD) change from baseline 47.68 (18.86) 13.42 (16.63) 34.13 (30.16 to 38.09) <0.001 34.16 (30.15 to 38.17) <0.001 
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7.9 Assumptions of regression analysis 
Figure 14: Histograms of residuals for each fully adjusted model for 
patient outcomes 
 
 
                   BPI-PS subscalea!
 
                                       BPI-PI subscaleb!
 
                            PPQ-K subscale pain knowledgec!
 
                            APCA African POS-patient subscaled!
 
  
                                          
a BPI-PS: Brief pain inventory pain severity  
b BPI-PI: Brief pain inventory pain interference  
c PPQ-K: patient pain questionnaire-knowledge subscale 
d APCA African POS: Palliative care outcomes-patient subscale  
187 
 
Figure 15: Histograms of residuals for each fully adjusted model for 
family carers outcomes 
 
Figures 14 and 15 show the distribution of the residuals (actual values 
minus fitted values using fully adjusted models). While there is some 
evidence of left skew in the BPI-PI subscale and APCA African POS-patient 
subscale models, none appeared to be sufficiently non-normally distributed 
to suggest the model assumptions were violated. 
                                          
a FPQ-K: Family pain questionnaire-Knowledge subscale 
b PCRS: Picot caregivers rewards scale 
c APCA African POS: palliative care outcomes-carer subscale 
 
                                    FPQ-K subscalea 
 
PCRS  motivationb 
 
                    APCA African POS-carer subscalec   
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7.10 Sensitivity analysis 
In sensitivity analysis for each of the seven outcomes, three scenarios were 
tested: (1) a difference of plus or minus 50 points for both arms (2) a 
difference of plus or minus 50 points for the pain education group and (3) a 
difference of plus or minus 50 points for the usual care group. For the first 
scenario this assumes that those lost to follow-up differ to those not lost to 
follow-up but that that this difference is consistent between trial arms. For 
the second scenario the assumption is that differences between those 
followed up and those lost to follow-up is restricted to the pain education 
group. In the third scenario the assumption is that differences between 
those followed up and those lost to follow-up is restricted to the usual care 
group. Figure 16 and Figure 17 summarises the results of sensitivity 
analysis and can be understood as follows. At zero on each axis, the 
estimated differences is that reported on the basis of no differences in 
those lost to follow-up from the fully adjusted models reported in tables 
 DQG  7KH µZKLVNHUV¶ UHSUHVHQW  FRQILGHQFH Lntervals. More 
extreme assumptions can be found with departures from zero along each x 
axis. Departures towards the left-hand side assume those lost to follow-up 
have worse outcomes, and to the right, better outcomes. For all of these 
scenarios and for all outcomes the 95% confidence intervals do not include 
zero on the y axis. In each scenario tested using various departures from 
the missing at random assumption, none altered the interpretation of 
better outcomes for the pain education group.  
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Figure 16: Sensitivity analysis for patient outcomes 
  
                                          
a BPI-PS: Brief pain inventory average pain severity 
b BPI-PI:Brief pain inventory pain interference 
c APCA African POS: Palliative care outcomes; patient subscale 
d PPK-Q: Patient pain knowledge questionnaire 
a b 
c 
d 
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 Figure 17: Sensitivity analysis of carer outcomes 
 
  
                                          
a FPQ-K Family pain questionnaire; care knowledge of pain 
management 
b APCA African POS carers: Palliative care outcomes; carers 
subscale 
c PCRS: Picot caregiver rewards scale; carers motivation to provide 
care 
a 
b 
c 
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7.11 Pain description and location 
At follow-up, of the 92 patients randomised to the pain education group, 76 
patients (82.6%) had pain. At follow-up of the 90 patients randomised to 
the usual care group, 72 patients (80%) had pain.  
The most prevalent pain at follow-up was chest/abdominal pains (44.57%), 
limb/joint pains (31.52%) and general body pains (27.17%), in the pain 
education group compared with chest/abdominal pains (36.67%), general 
body pains (28.89%) and limb/joint pains in the usual care group 
(27.78%).  
The prevalence of back pain, head/neck pain and mouth sores was low in 
both groups at follow-up. In the pain education group the prevalence of 
back pain was 4.35%, head/neck pain was 2.17% and mouth sores was 
1.09%. In the usual care group the prevalence of back pain was 7.78%, 
head/neck pain was 2.22% and mouth sores was 2.22%. Table 24 
summarises the description, location and prevalence of pain symptoms in 
both groups at baseline and follow-up. 
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Table 24 Pain description and location 
 
7.12 Analgesia for treatment of pain 
The odds ratio of the patient participant in the pain education group for 
being on analgesia for treatment of pain at follow-up was 1.57 times (95% 
confidence interval 0.66 to 3.76; P=0.31) less than the odds ratio in the 
usual care group, after adjusting for pain medication at baseline and 
recruitment centre. The odds ratio of the patient participant in the pain 
education group for being on analgesia for treatment of pain was 1.48 
times less (95% confidence interval 0.61 to 3.59; P=0.39) than the odds 
ratio in the usual care group, after adjusting for baseline pain medication, 
recruitment centre, age and gender. Table 25 summarises both adjusted 
and unadjusted analyses. There was no difference between the pain 
education group and the usual care group in both analyses on whether the 
patient was on analgesia for treatment of pain or no analgesia.  
  
 Pain education (N=92) Usual care (N=90) 
Pain description 
and location 
Baseline Follow-up  Baseline Follow-up  
No pain N=2 (2.17%) N=16 (17.39%) N=6 (6.66%) N=18 (20%) 
Complained of pain N=90 (97.8%) N=76 (82.6%) N=84 (93.3%) N=72 (80%) 
General body pain N=18(19.57%) N=25 (27.17%) N=15 (16.67%) N=26 (28.89%) 
Head and neck N=16(17.39%) N= 2 (2.17%) N=20 (22.22%) N= 2 (2.22%) 
Mouth sores N= 3 (3.26%) N= 1 (1.09%) N= 3  (3.33%) N= 2 (2.22%) 
Limb and joint pain N=28(30.43%) N=29 (31.52%) N=24 (26.67%) N= 25(27.78%) 
Chest & abdominal 
pain 
N=41(44.57%) N=41 (44.57%) N=33 (36.67%) N= 33(36.67%) 
Back pain N= 7 (7.61%) N= 4 (4.35%) N= 9 (10%) N= 7 (7.78%) 
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Table 25 Analgesia for treatment of pain 
 Pain education (N=92) Usual care (N=90) Unadjusted 
OR 95% 
CIa 
P 
value  
Adjusted 
OR 95% 
CIb 
P 
value  
Analgesia 
for pain 
Baseline  Follow-up  Baseline  Follow-up     
Yes  N=85 
(92.4%) 
N=82 
(89%) 
N=79 
(87.8%) 
N=75 
(83.3%) 
    
No  N=7 (7.6%) N=10 
(11%) 
N=11 
(12.2%) 
N=15 
(16.7%) 
1.57 (0.66 
to 3.76) 
0.31 1.48 (0.61 
to 3.59) 
0.39 
 aLogistic regression: controlling for baseline medication, and recruitment centre 
b Logistic regression: controlling for baseline medication, recruitment centre, age and gender. 
7.13 Type of pain medication/analgesia for treatment of pain 
The odds ratio of the patient participant in the pain education group for 
receiving Brufen at follow-up was 0.59 (95% confidence interval 0.31 to 
1.11; P=0.10) times less than the odds ratio in the usual care group.  
The odds ratio of the patient participant in the pain education group for 
receiving Codeine at follow-up was 6.18 (95% confidence interval 1.99 to 
19.14; P=0.002) times greater than the odds ratio in the usual care group.  
The odds ratio of the patient participant in the pain education group for 
receiving Diclofenac at follow-up was 5.21 (95% confidence interval 1.86 to 
14.56; P<0.001) times greater than the odds in the usual care group.  
The odds ratio of the patient participant in the pain education group for 
receiving Panadol at follow-up was 0.54 times (95% confidence interval 
0.28 to 1.04; P=0.06) less than the odds ratio in the usual care group. 
Table 26 summarises the type of medication received. 
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Table 26 Type of medication received 
 
 
 aLogistic regression: controlling for type of medication at baseline, recruitment centre, patient 
age and gender. 
 
7.14 Association of baseline factors with outcomes 
An improvement on average pain severity was associated with lower age of 
the patient (regression coefficient -0.28, 95% confidence interval -0.48 to -
0.08; P=0.006). For every one year increase in age, there was an average 
worsening in pain severity score of 0.28 points. There was no evidence that 
change in pain severity was associated with gender (mean difference -
3.70, 95% confidence interval -8.31 to 0.91; P=0.12, recruitment centre 
(mean difference 2.1, 95% confidence interval -2.70 to 7.07; P=0.38) and 
number of medications (mean difference -1.16, 95% confidence interval -
6.27 to 3.95; P=0.65). 
 Pain education (N=92) Usual care group (N=90) OR 95% CIa P 
value 
Type of 
medication 
Baseline  Follow-up  Baseline  Follow-up  
 
  
Amitriptyline N=2(2.17%) N=3(3.26%) N=1(1.11%) N=0 Not 
estimated 
 
 
 
Aspirin  N=1(1.09%) N=0 N=2(2.22%) N=2(2.22%) Not 
estimated 
 
 
Brufen N=6(6.52%) N=30(32.6%) N=7(7.78%) N=38(42.2%) 0.59 (0.31 to 
1.11) 
0.10 
Codeine N=3(3.26%) N=23(25%) N=1(1.11%) N=5(5.56%) 6.18 (1.99 to 
19.14) 
0.002 
Diclofenac  N=5(5.43%) 27(29.35%) N=5(5.56%) 10 (11.11%) 5.21 (1.86 to 
14.56) 
<0.001 
Indocid N=1(1.09%) N=1(1.09%) N=1(1.11%) N=1(1.11%) Not 
estimated 
 
 
 
Panadol N=79(85.9%) N=44(47.8%) N=70(77.8%) N=52(57.8%) 0.54 (0.28 to 
1.04) 
0.06 
Any analgesia N=85(92.4%) N=82(89%) N=79(87.8%) N=75(83.3%) 1.48 (0.61 to 
3.59) 
0.39 
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Change in pain interference score was associated with the age of the 
patient (regression coefficient -0.37, 95% confidence interval -0.59 to -
0.16; P=0.001). For every one year increase in age there was an average 
worsening in pain interference score of 0.37 points. Change in pain 
interference was also associated with gender of the patient. Females 
experienced a significant less improvement in pain interference compared 
to males (mean difference -5.57, 95% confidence interval -10.52 to -0.61; 
P=0.028). The mean improvement in pain interference was lower in 
females with an average score of 5.57 points compared to males after 
adjusting for other factors. There was no evidence that change in pain 
interference was associated with recruitment centre (mean difference -
2.07, 95% confidence interval -7.02 to 2.88; P=0.41) and number of 
medications (mean difference -1.26, 95% confidence interval -6.53 to 
4.01; P=0.64).  
Patient pain knowledge of pain management was not associated with age 
(regression coefficient -0.07, 95% confidence interval -0.20 to 0.05; 
P=0.25), gender (mean difference -1.98, 95% confidence interval -4.92 to 
0.96; P=0.19), recruitment centre (mean difference 2.42, 95% confidence 
interval -0.53 to 5.37; P=0.11) and number of medications (mean 
difference -0.87, 95% confidence interval -3.95 to 2.22; P=0.58). 
Quality of life was associated with the age of the patient (regression 
coefficient -0.29, 95% confidence interval -0.47 to -0.11; P=0.002). For 
every one year increase in age there was an average decrease in quality of 
life score of 0.29 points. There was also borderline statistical significance of 
quality of life in relation to gender of the patient. Females experienced a 
statistically significant worse quality of life compared to males (mean 
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difference -4.21, 95% confidence interval -8.40 to -0.01; P=0.049). The 
mean change in quality of life was lower in females compared to males 
with an average score of 4.21 points after adjusting for other factors. 
There was no evidence that quality of life was associated with recruitment 
centre (mean difference 2.53, 95% confidence interval -1.67 to 6.72; 
P=0.24) and number of medications (mean difference -3.42, 95% 
confidence interval -7.88 to 1.04; P=0.13).  
For carer participants knowledge of pain management was not associated 
with age (regression coefficient -0.13, 95% confidence interval -0.26 to 
0.00; P=0.054), gender (mean difference 0.06, 95% confidence interval -
3.70 to 3.83; P=0.97) and recruitment centre (mean difference -0.17, 95% 
confidence interval -3.17 to 2.82; P=0.91). 
Carer motivation to provide care was not associated with age (regression 
coefficient -0.05, 95% confidence interval -0.16 to 0.06; P=0.40), gender 
(mean difference 0.09, 95% confidence interval -3.09 to 3.27; P=0.96) 
and recruitment centre (mean difference 0.24, 95% confidence interval -
2.31 to 2.79; P=0.85). 
For carer participants quality of life was not associated with age (regression 
coefficient -0.14, 95% confidence interval -0.32 to 0.04; P=0.12), gender 
(mean difference -1.79, 95% confidence interval -6.91 to 3.34; P=0.49) 
and recruitment centre (mean difference -1.79, 95% confidence interval -
5.83 to 2.24; P=0.38). Table 27 summarises associating baseline factors 
with the outcomes. 
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Table 27 Association of baseline factors with outcomes 
 
 aLinear regression: controlling for baseline score, age, gender, recruitment centre and 
number of medication. 
b Linear regression: controlling for baseline score, age, gender and recruitment centre. 
 
7.15 Summary 
Of the 182 participants (patient/carer dyads), 92 were randomised to pain 
education intervention and 90 received usual care. Of these 157 
patient/carer dyads and 10 patients completed all outcome measurers. 
Based on the analyses of these available data, patients in both the pain 
Outcome Adjusted for baseline score, age, gender ,recruitment centre, 
and medication number a 
Patient participants Associating factor Regression coefficient 
(95% CI) 
P value 
Average pain severity (BPI-PS) Age of patient -0.28 (-0.48 to -0.08)  0.006 
 Women vs Men -3.70 (-8.31 to 0.91) 0.12 
 Recruitment centre 2.19 (-2.70 to 7.07) 0.38 
 Medication number -1.16 (-6.27 to 3.95)  0.65 
Pain interference (BPI-PI) Age of patient -0.37 ( -0.59 to -0.16) 0.001 
 Women vs Men -5.57 ( -10.52 to -0.61) 0.028 
 Recruitment centre -2.07 (-7.02 to 2.88) 0.41 
 Medication number -1.26 (-6.53 to 4.01) 0.64 
Pain knowledge (PPQ-K) Age of patient -0.07 (-0.19 to 0.05) 0.25 
 Women vs Men  -1.98 (-4.92 to 0.96) 0.19 
 Recruitment centre  2.42 (-0.53 to 5.37) 0.11 
 Medication number -0.87 (-3.95 to 2.22) 0.58 
Quality of life (APCA African 
POS) 
Age of patient  -0.29 ( -.47 to -.11) 0.002 
 Women vs Men -4.2 (-8.4 to -.01) 0.049 
 Recruitment centre 2.53 (-1.67 to 6.72) 0.24 
 Medication number -3.42 (-7.88 to 1.04) 0.13 
 
Carer participants Adjusted for baseline score, age, gender, and recruitment 
centre b 
Pain knowledge (FPQ-PK) Age of carer  -0.13 (-0.26 to 0.002) 0.054 
 Women vs Men  0.06 (-3.70 to 3.83) 0.97 
 Recruitment centre -0.17 (-3.17 to 2.82) 0.91 
Motivation (PCRS) Age of carer -0.05 (-0.16 to 0.06) 0.40 
 Women vs Men  0.09 (-3.09 to 3.27) 0.96 
 Recruitment centre  0.24 (-2.31 to 2.79) 0.85 
Quality of life (APCA African 
POS) 
Age of carer -0.14 (-0.32 to 0.04) 0.12 
 Women vs Men -1.79 (-6.91 to 3.34) 0.49 
 Recruitment centre -1.79 (-5.83 to 2.24) 0.38 
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education intervention group and the usual care group had reduced pain 
severity, reduced pain interference with daily activities, improved pain 
knowledge and a better quality of life. Likewise carer participants in both 
groups had improved knowledge of pain management, more motivated to 
provide care and a better quality of life, however participants (patient/carer 
dyads) in the pain education intervention had less severity of pain, less 
pain interference, more knowledge of pain management, more motivated 
to provide care and a better quality of life outcomes than participants in 
the usual care group. In the next chapter, the results of the pain education 
trial and the design of the pain education study are discussed. 
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CHAPTER EIGHT: DISCUSSION 
8.1 Introduction 
The aim of this study was to test the effects of a pain educational intervention 
on pain severity among people living with HIV/AIDS in Malawi. The secondary 
aims were to: (1) investigate if the pain education intervention reduces pain 
interference with daily activities, improves knowledge of pain management 
and improves quality of life among people living with HIV/AIDS; and (2) 
investigate if the pain education intervention improves knowledge of pain 
management, improves quality of life, and improves motivation to provide 
care among family carers of patients with HIV/AIDS. In this chapter, the 
results and methodological strengths and limitations of the study are 
discussed. The findings are discussed in the context of other studies of pain 
management in HIV/AIDS, cancer and other related chronic conditions. In this 
chapter I highlight the original contribution this study makes to the field of 
pain management in HIV/AIDS. The implications of the study findings for the 
care of people living with HIV/AIDS in Malawi is discussed.  
 
8.2 Overview of the main study findings 
The findings from this study suggest that the pain education intervention 
which took the form of an information leaflet, face-to-face discussion and a 
follow-up phone call at two weeks had positive effects on both the physical 
and psychological health of people living with HIV/AIDS and their family 
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carers. Patient participants randomised to the pain education intervention 
experienced a greater reduction in pain severity, pain interference with 
general activities, greater knowledge of pain management and a better quality 
of life compared to participants randomised to the usual care group. Carer 
participants randomised to the pain education intervention group reported a 
greater knowledge of pain management, greater motivation to provide care 
and a better quality of life compared to participants in the usual care group.  
 
8.3 Effectiveness of the pain education intervention 
Complex interventions are unlikely to have a simple and linear cause-effect 
relationship with any outcome because they have multiple interacting 
components. It is difficult to know if the components work individually or 
together (Petticrew, 2011). Without testing the individual components 
individually (and thereby losing the combined effect) it is not possible to 
determine which elements trigger the responses observed. If the pain 
HGXFDWLRQLQWHUYHQWLRQLVDGRSWHGLQWRURXWLQHFDUHLW¶VLPSRUWDQWWRGHYHORSDQ
effective monitoring mechanism in order to detect long term outcomes that 
could not be observed through the original study (Craig et al., 2008).  
The pain education intervention was guided by the bio-psychosocial model. 
The contents and individual components of the intervention focused on 
biological, psychological, and social needs. These are the needs that patients 
with HIV/AIDS have frequently reported as not being properly addressed. The 
medical research council framework for development and evaluating complex 
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interventions supports the notion of a theory-based intervention in order to 
understand how change in outcomes occur between the two groups (Craig et 
al., 2008). The presence of the family carer as study participants is likely to 
have strengthened the intervention.  
Another way to understand how the pain education interventiRQµZRUNHG¶LVE\
identifying the techniques, procedures and processes used to generate the 
intervention (Michie and Abraham, 2004). The pain education intervention was 
DOVRXQGHUSLQQHGE\WKHDGXOWOHDUQHU¶VWKHRU\7KHIDFH-to-face discussion 
ensured active participation of study participants which potentially enabled 
them to discuss their pain freely. However the current design of the study 
does not explain the exact mechanism by which the pain education 
intervention worked. This is partly due to absence of qualitative data to 
support the positive benefits observed in the study. 
 
8.4 Strengths and limitations of the study 
8.4.1 Study design 
The randomised controlled trial is the gold standard of evaluating the effect of 
any intervention among patients and family carers of people living with 
HIV/AIDS. To my knowledge this is the first randomised controlled trial to 
investigate the effect of a nurse-led pain education intervention among people 
living with HIV/AIDS and their family carers in Malawi. Previous randomised 
controlled trials among HIV/AIDS patients have been conducted exclusively 
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(Goujard et al., 2003, Wu et al., 2006, Gifford et al., 1998) or predominantly 
(Wantland et al., 2008) in western countries. None of these trials recruited 
patient/care dyads as participants in their studies. The only study which 
recruited patient/carer dyads was conducted in Australia and had a small 
sample size (n=36) (Pakenham et al., 2002). In the Australian study, the 
focus was on the emotional and social problems faced by carers using 
psychological counselling. 
The sample size of 182 in the current study is larger than other trials 
conducted in USA (Gifford et al., 1998, Webel, 2010) and Taiwan (Chiou et al., 
2006a). Other larger randomised controlled trials were either conducted in 
France (Goujard et al., 2003) or were multinational and had many recruitment 
sites in the USA, with a few sites in South Africa (Wantland et al., 2008). 
However I did not power secondary outcomes. 
The current study was conducted in two public hospitals in the northern part of 
Malawi where protocols for usual care were broadly similar at the time the 
study was being conducted. However environmental factors such as attitude of 
staff members and hospital layout may have differed between the two 
hospitals. The study was not large enough to formally test this either through 
sub-group analysis or testing for an interaction effect between hospital and 
intervention. 
Inclusion criteria were restricted to those with CD4 count <350 cells or stages 
III/IV of HIV infection. This is the crucial stage in HIV infection because 
patients are likely to be in pain due to opportunistic infections (Solano et al, 
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2006) and side effects of HIV treatment (Wadley et al, 2011). At both 
recruitment sites CD4 count is tested, but there is a charge to patients of 
around £5 for laboratory services. Many people are poor in Malawi and not 
able to pay for laboratory services and therefore clinicians have to rely on HIV 
clinical staging. A recent systematic review has reported that WHO clinical 
staging misses a high proportion of individuals who are eligible to start HAART 
based on CD4 count (Munthali et al., 2014) suggesting that identifying 
individuals likely to benefit from this intervention does not need to rely on 
costly laboratory tests. 
The pilot study was relatively small and therefore a larger pilot study may 
have thrown up other design issues for the current study.  
 
8.4.2 Recruitment and follow-up 
In spite of the process of recruiting patient/carer dyads who met the criteria 
for this study being challenging, recruitment targets were met. It was 
emphasised to participants that involvement in the study was voluntary. 
Participants were recruited through the HIV/AIDS clinics either during the 
registration to start HIV treatment or during their routine follow-up to the 
HIV/AIDS and palliative care clinics. Participants had between two and four 
weeks to discuss with their family members the possibility of taking part in the 
study. By being involved in some tasks and activities at the clinics such as 
checking weight and height and registration of patients I managed to build 
some rapport with potential study participants. Staff in the HIV/AIDS clinics 
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were involved in giving explanations about the study and information sheets 
and were encouraging without being coercive.  
Attrition for the study was 8 % (15/182) and 14% (25/182) for patients and 
carers respectively. This is low compared to other studies that have reported 
up to 34.6% attrition (Wantland et al., 2008) and 35% attrition (Lovell et al., 
2010). In the current study, the reasons for patient/carer dyads loss to follow-
up being death of the patient, a lack of transport money, having moved away, 
being untraceable and the patient being too unwell. The UHDVRQV IRU FDUHUV¶
loss to follow-up were lack of transport to accompany the patient to the clinic 
and being too busy.   
There were eight patient/carer dyads lost to follow-up in the intervention arm 
and seven patient/carer dyads lost to follow-up in the usual care arm. There 
were five carers in each arm who were lost to follow-up. The reasons for loss 
to follow-up did not differ apart from in one respect. There were four patients 
who were lost to follow-up due to death and all were randomised to the pain 
education intervention. I did not have access to their records to look at the 
causes of death but the nature of the intervention meant it was unlikely to 
have been related.  
Follow-up assessments were conducted once, at week eight after 
randomisation and delivery of the intervention. This was judged to be 
sufficient time to observe the effects of the intervention and is consistent with 
other pain education studies (Clotfelter, 1999, Hudson et al., 2005) and based 
on recommendation from pain research experts (Bennett and Closs, 2011). 
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However, it is not possible to infer from the present study whether the 
observed effects would persist beyond eight weeks period due to the 
limitations on time and resources for further follow-up assessments.  
A range of secondary outcomes were chosen due to the complex nature of the 
intervention (Bennett and Closs, 2011). Patient outcomes are in line with 
IMMPACT (Initiative on Methods, Measurement, and Pain Assessment in 
Clinical Trials) recommendation on core outcomes for patients with chronic 
pain (Dworkin et al., 2008, Dworkin et al., 2005b, Turk et al., 2003). In one 
study of a pain education intervention (Wantland et al., 2008) outcomes were 
conducted at two time points (at one month and two month after delivery of 
the intervention and results were statistically significant at one month and 
were maintained at two month follow-up. In another study (Goujard et al., 
2003) outcomes were assessed at six months and the findings were 
statistically significant for all but one outcome and this was maintained at 12 
and 18 months. In another study of coping strategies among men with 
HIV/AIDS (Chesney et al., 2003) follow-up assessments were conducted at 
three, six and 12 months post intervention. The results were statistically 
significant at three months, but at six and 12 months significant differences 
were maintained for only one outcome. In a randomised controlled trial among 
dementia patients and their family carers (Graff et al., 2006), they conducted 
outcomes at week six and week 12 after delivery of the intervention, the 
results were statistically different for all outcomes at week six and were 
maintained at week 12. From these studies it is difficult to infer that 
educational interventions have longer lasting effects for HIV/AIDS patients. 
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8.4.3 Randomisation, blinding and contamination 
Randomisation was prepared by my supervisor (AA) in the UK using a 
computerised random binary series and block randomisation to ensure that 
there was no great imbalance between the two groups. Randomisation 
appeared to be successful because the number of patients and carer 
participants and their characteristics were broadly similar at baseline. I 
implemented randomisation using opaque sealed and consecutively numbered 
envelopes. I was not involved in the preparation of the envelopes and I did not 
know the block size until after I finished data collection and returned to the UK 
for data analysis. This prevented me from predicting the allocation in advance.  
In this study participants knew to which group they were allocated due to the 
nature of the study. It was not possible to blind study participants. This has 
potential for performance bias. As I also knew the group each participant was 
allocated to, and to minimise assessment bias, I conducted baseline 
DVVHVVPHQWV EHIRUH UDQGRPLVDWLRQ 1XUVHV¶ EOLQG WR WUHDWPHQW DOORFDWLRQ
conducted follow-up assessments. However performance bias cannot be 
excluded because of the fact that some pain education group participants had 
developed a good working relationship with me through a series of verbal 
interactions. Moreover patient reported outcomes such as pain intensity are 
subjective (Bennett and Closs, 2011) and in this study all the outcomes were 
self-reported by patients and family carers. A double-blinded trial, although 
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methodologically superior was not possible in a study of a non-
pharmacological intervention of this type (Bennett and Closs, 2011).  
Contamination between the two arms of the trial cannot be excluded because 
study participants lived in the same community and some were neighbours or 
friends. To minimise this, participants who were allocated to the pain 
education intervention were asked not to share the leaflet with their friends 
and not to report the face-to-face discussion they had with me. The leaflet was 
put in an envelope and participants were asked to keep it safe before they left 
the room where the intervention was delivered. Participants were further 
asked not to speak to healthcare staff about the intervention. As participants 
lived in communities where they would inevitably interact with their friends 
and neighbours with similar problems, I cannot exclude the possibility of 
contamination between groups. Nurses and other health care workers who 
were involved in the development of the intervention (information leaflet) 
were informed not to share the information leaflet with the patients during 
clinical appointments. However it is difficult to know if they did not share the 
information leaflet with the patients because I was not present during clinical 
appointments.  
Clustering the participants and randomising according to some natural 
grouping such as area or clinic could have avoided contamination thereby 
reducing type II error (Torgerson, 2001), but this was not possible for various 
reasons. Cluster randomisation requires larger sample sizes, and sufficient 
number of clusters, more complex design and analysis (Sedgwick, 2012) 
outside of the scope of a doctoral study. 
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A crossover design is another alternative to overcome contamination, where 
participants act as their own controls. This also reduces placebo effects, and 
requires smaller sample sizes than parallel design. However cross over design 
take longer and would have been a challenge in this study where HIV/AIDS 
patients undergo natural fluctuations in their condition such that symptoms 
may be better or worse when participants are in a different arm (i.e. 
treatment order) of the trial (Bennett and Closs, 2011). HIV/AIDS is 
associated with comorbidities such as cancer (Yeguez et al., 2003, Matheny, 
2001), and liver disease (Rabinstein, 2003) and their health can change at any 
time. Participants can easily drop out (Bennett and Closs, 2011), or even 
transfer to other centres for their own reasons. Crossover trials are 
problematic where there are carry over effects (Mills et al., 2009). Although a 
wash out period (no treatment) before crossing to the other arm helps to 
minimise carry over effects (Sibbald and Roberts, 1998), it would have been 
impossible to reverse the effects of an educational intervention after being 
delivered in the experiment arm before crossing to a control arm. 
 
8.4.4 Data analysis 
Data was analysed blind to treatment groups to minimise bias using intention-
to-treat analysis. This is the most robust method of data analysis in clinical 
trials. Intention-to-treat is a strategy for the analysis of randomised controlled 
trials that compares participants in the groups to that which they were 
originally randomly assigned (Hollis and Campbell, 1999, Sedgwick, 2011), 
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promoting internal validity (Sedgwick, 2013). I utilised a modified intention-
to-treat analysis strategy, where participants lost to follow-up were all 
excluded from the analysis because it is only possible to apply a strict 
intention-to-treat analysis where there is no attrition (Hollis and Campbell, 
1999, Abraha and Montedori, 2010).  
Per protocol analysis was not applicable in this study because no participant 
deviated from the treatment randomly allocated to receive treatment to which 
they were not randomised (Montori and Guyatt, 2001, Sedgwick, 2013, 
Sedgwick, 2011). Therefore in this study it is unlikely that there was 
underestimation of the magnitude effect of the treatment because there was 
no problem of adherence that I was aware of (Montori and Guyatt, 2001) or 
an overestimation of the clinical effectiveness due to loss to follow-up (Hollis 
and Campbell, 1999). Findings of the study were robust to the sensitivity 
analysis conducted.  
The pain education intervention study was delivered by myself, a nurse who 
KDVVWXGLHGWRPDVWHU¶VOHYHOLQSDOOLDWLYHDQGHQG-of-life care. This meant that 
the intervention was grounded in the existing literature and built on five years 
of experience in this area. However it is also a limitation because of the 
problem of reproducibility. In Malawi, we have few nurses trained in palliative 
care up to Masters Level. An important question remains as to the level of skill 
required to deliver this intervention effectively.  
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8.5 Comparison with other studies 
The pain education intervention should be considered as a complex 
intervention because it is built up from a number of various components acting 
both interdependently and independently (Craig et al., 2008, Bennett and 
Closs, 2011). The Medical Research Council framework for complex 
interventions was designed for the development, implementation and 
evaluation of randomised controlled trials to improve health care services 
(Craig et al., 2008). Designing and developing the pain education intervention 
was challenging. It needed a substantial amount of time and effort. However 
in this trial few participants declined to take part in the study and attrition was 
also low suggesting that the intervention is feasible and acceptable among 
patients with HIV/AIDS and their family carers. It is challenging to compare 
the results of this study with other studies because most of the pain education 
studies have been conducted in western countries and have produced 
conflicting results. Few studies in the field of HIV/AIDS focussing on pain 
education have been conducted in sub-Saharan Africa. The interventions in 
other studies have also been highly variable and often poorly described. A 
systematic review (Millard et al., 2013) concluded that randomised controlled 
trials of self-management programmes for people living with HIV/AIDS result 
in short-term improvements in physical, psychological, social, health 
knowledge and behavioural outcomes. This review retained eight randomised 
controlled trials, six studies were conducted in the USA and two studies were 
conducted in Taiwan.  
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Table 28 below summaries a comparison of previous intervention studies 
conducted in the field of HIV/AIDS, cancer and other chronic illnesses with the 
current study. In the text that follow this table, I compare the findings of the 
present study with other work in terms of the seven outcome measures. 
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Table 28 Comparison of the findings from the current study with 
previous work 
 
Studies and 
sample  
Outcomes from the current study 
 Patient 
pain 
severity 
Patient pain 
interference 
Patient 
pain 
knowledge 
Patient 
quality 
of life 
Carer pain 
knowledge 
Carer 
motivation 
Carer 
quality 
of life 
Nkhoma (2014) 
(n=182) 
X X X X X X X 
Catz and 
Balderson et al 
(2014) (n=452) 
N/A 
 
N/A N/A X N/A 
 
N/A N/A 
Dowse et al 
(2014) (n=116) 
N/A N/A X N/A N/A N/A N/A 
Henriksson et al 
(2013) (n=125) 
N/A N/A N/A N/A X X × 
Rajesh et al 
(2013) (n=256) 
N/A 
 
N/A X N/A N/A N/A N/A 
Peltzer et al 
(2012) (152) 
N/A N/A X N/A N/A N/A N/A 
Smith Fawzi et al 
(2012) (n=130) 
N/A N/A N/A N/A N/A N/A X 
Oldenmenger et 
al (2011) (n=73) 
X X N/A N/A N/A N/A N/A 
Lovell (2010) 
(n=217) 
X × X × N/A N/A N/A 
Wang et al (2010) 
(n=116) 
N/A 
 
N/A N/A X N/A N/A N/A 
Webel (2010) 
(n=89) 
× N/A N/A` × N/A N/A N/A 
Bennet et al 
(2009) (n=3501) 
X × X N/A N/A N/A N/A 
Ward et al (2009) 
(n=161) 
× × N/A × N/A N/A N/A 
Yildirim et al 
(2009) (n=40) 
X N/A 
 
N/A N/A N/A N/A N/A 
Hudson et al 
(2009, 2008) 
(n=156; n=74) 
N/A N/A N/A N/A N/A X X 
Boon et al (2009) 
(n=202) 
N/A N/A N/A N/A X N/A N/A 
Victor et al (2009) 
(sample not 
given) 
N/A N/A N/A N/A X X X 
Wantland et al 
(2008) (n=775) 
X N/A 
 
N/A N/A N/A N/A N/A 
Ward et al (2008) 
(n=176) 
× × N/A × N/A N/A N/A 
Lin et al (2006) 
(n=61 dyads) 
X X N/A N/A N/A N/A N/A 
Chio et al (2006) 
(n=67) 
N/A N/A N/A X N/A N/A N/A 
Hudson et al 
(2005) (n=106) 
N/A N/A N/A N/A N/A X × 
Chiou et al (2004) N/A N/A X N/A N/A N/A N/A 
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X: Results similar to the current study 
×: results contrary to the current study 
N/A: Not applicable/ outcome not assessed  
Dyads: study recruited both patients and carers 
  
(n=67)  
Studies and 
sample  
Outcomes from the current study 
 Patient 
pain 
severity 
Patient pain 
interference 
Patient 
pain 
knowledge 
Patient 
quality 
of life 
Carer pain 
knowledge 
Carer 
motivation 
Carer 
quality 
of life 
Miaskowski et al 
(2004) (n=174) 
X N/A 
 
N/A N/A N/A N/A N/A 
Lai et al (2004) 
(n=30) 
X × N/A N/A N/A N/A N/A 
Yates et al (2004) 
(n=189) 
× N/A X × N/A N/A N/A 
Gordon-Garofalo 
and Rubin (2004) 
(n=28) 
N/A 
 
N/A N/A N/A N/A N/A × 
Anderson et al 
(2004) (n=97) 
× × N/A × N/A N/A N/A 
Goujard et al 
(2003) (n=367) 
N/A N/A X × N/A N/A N/A 
Wells et al (2003) 
(n=64 dyads) 
× × X N/A X N/A N/A 
Lechner et al 
(2003) (n=330) 
N/A N/A N/A X N/A N/A N/A 
Pakenham et al 
(2002) (n=36 
dyads) 
N/A 
 
N/A N/A X X N/A X 
Rotheram-Borus 
et al (2001) 
(n=307) 
N/A N/A N/A N/A N/A N/A X 
Inouye et al 
(2000) (n=40) 
N/A 
 
N/A N/A X N/A 
 
N/A N/A 
Ward et al (2000) 
(n=43) 
× × N/A × N/A N/A N/A 
Hensell et al 
(1999) (n=70) 
N/A N/A N/A N/A N/A N/A × 
Clotfelter (1999) 
(n=36) 
X N/A 
 
N/A N/A N/A N/A N/A 
Gifford et al 
(1998) (n=71) 
× N/A × × N/A N/A N/A 
de Wit et al 
(1997) (n=313) 
X N/A X X N/A N/A N/A 
Pomeroy et al 
(1995) (n=33) 
N/A N/A N/A N/A N/A N/A X 
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8.5.1 Effect of the pain education intervention on patient pain severity 
Participants randomised to the pain education intervention reported a greater 
reduction in pain severity (mean difference 21.25 percentage points) 
compared to participants randomised to the usual care group after adjusting 
for baseline differences. The pain education intervention appeared to have 
benefitted the patients randomised to the intervention arm of the trial. This is 
consistent with a large trial which recruited participants from 12 sites in the 
USA and a few sites in Puerto Rico and Africa (Wantland et al., 2008). The 
study concluded that a symptom management manual reduced the frequency 
and intensity of HIV/AIDS symptoms compared to a nutrition management 
manual. There was high attrition in this latter study (34.6%) although no 
identified differences between those lost to follow-up in the intervention and 
control groups. It was also not clear if participants and those assessing 
outcomes were blinded in this study and if groups were comparable at 
baseline.  
The results are also consistent with studies of booklet-based educational 
interventions in cancer population conducted in Turkey (Yildirim et al., 2009) 
and Taiwan (Lai et al., 2004) and pyscho-educational intervention study 
conducted in northern California (Miaskowski et al., 2004). Participants 
randomised to the control group received usual care in both the Turkish and 
Taiwanese studies (Yildirim et al., 2009, Lai et al., 2004), however in the 
American study they received a general cancer pain guideline booklet 
(Miaskowski et al., 2004). All studies concluded that participants randomised 
to the pain education group showed a significant decrease in pain severity 
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compared to the control group (Yildirim et al., 2009, Lai et al., 2004, 
Miaskowski et al., 2004). 
However both Turkish and Taiwanese studies were single-site and sample 
sizes were small (Yildirim et al., 2009) and (Lai et al., 2004). These results 
therefore need to be interpreted with caution because the smaller the study 
the higher the risk of type I error. Although the sample size was larger 
(n=174) in the American study and only a small number was lost to follow-up, 
the majority of the participants in this study were white and well educated. It 
is difficult therefore to conclude if this evidence transfers to other ethnic 
groups and less educated populations.  
The results are also consistent with video-based pain education interventions 
conducted among elderly cancer patients in Florida/USA (Clotfelter, 1999) and 
in Australia (Lovell et al., 2010). Participants received a booklet and watched a 
video that presented information contained in the booklet about cancer pain 
management. Both studies concluded that participants who received the 
video-based pain management intervention reported significant reduction in 
pain severity compared to participants who received standard care (Clotfelter, 
1999, Lovell et al., 2010). However follow-up assessments were conducted 
two weeks after randomisation in both studies. Although Lovell et al (2010) 
repeated assessments after four weeks and findings still remained statistically 
significant it is difficult to infer that outcomes will still remain significant 
beyond this time period. In the American study sample size was small (n=36). 
Despite Lovell et al (2010) having a larger sample size (n=217), attrition was 
very high (35% of the participants were lost to follow-up after four weeks). 
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While video-based educational interventions may be appropariate for elderly 
people these may not be feasible and applicable in a Malawian context 
because the majority of the population have extremely limited resources and 
live in rural areas where there is no electricity. In Malawi interventions should 
not be reliant on resources that require equipment and technology that may 
be only infrequently accessible to the population. 
The results are contrary to a comparison of a self-care symptom management 
education intervention (Gifford et al., 1998) and a symptom management 
manual (Wantland et al., 2008) in a trial of women with HIV in the USA 
(Webel, 2010). The study concluded that there were no significant differences 
between the two groups. It is possible that the author did not find significant 
results because the study compared two interventions that have already been 
proven to reduce symptom severity and frequency and moreover the study did 
not take into account specific factors influencing gynaecological symptoms 
such as the menopause and childbearing / rearing (Webel, 2010).  
The results of the current study are also contrary to a trial of video-based and 
booklet intervention (Anderson et al., 2004) and a trial of face-to-face 
discussion approach on steps to cancer pain management (Ward et al., 2008) 
both conducted in the USA. Both studies concluded that there were no 
statistical differences on pain severity between the pain management 
intervention group and the comparison groups (Anderson et al., 2004, Ward et 
al., 2008). The video-based intervention was also proven not to be effective 
when tested again but inclusive of family carers as well as patients (Ward et 
al., 2009). Attrition was low in the former study (14%) (Ward et al., 2008) but 
217 
 
higher in the latter study (32%) (Ward et al., 2009). Perhaps both studies did 
not observe any effect of the intervention tested between the groups because 
the control group was given a similar level of attention to the intervention 
group. Moreover clinical recruitment centres where participants were recruited 
had been involved in pain quality improvement efforts.  
 
8.5.2 Effects of the pain education intervention on patient pain 
interference 
In the current trial participants randomised to the pain education intervention 
reported greater reduction in pain interference with daily activities compared 
to those randomised to usual care. The results are consistent with two small 
trials conducted among cancer patients in Holland (Oldenmenger et al., 2011) 
and patient/carer dyads conducted in Taiwan (Lin et al., 2006). Pain 
interference in the Dutch study was evaluated using multiple teaching 
methods including an information brochure, consultations with pain 
consultants and palliative care nurses (Oldenmenger et al., 2011). In the 
Taiwanese study intervention participants received a pain education booklet, 
an ongoing reiteration and face-to-face discussion. Those who received the 
intervention experienced a significant reduction in pain interference compared 
to patients who received standard care. Perhaps both studies produced 
significant results because in the Taiwanese randomisation was at dyads level 
(patient/family). This is in line with the present study because patient and 
family concerns are often correlated (Lin, 2000). In the Dutch study the 
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results were significant possibly because of using a number of teaching 
methods. More participants were lost to follow-up in the intervention group 
(26%) compared to those lost to follow-up in the control group (11%) in the 
Dutch study. In contrast to the present study, a trial conducted amongst 
women with gynecological cancer in the USA (Ward et al., 2000) and another 
among hospitalised cancer patients in Taiwan (Lai et al., 2004) observed no 
differences in the effect of an information booklet and five consecutive days of 
face-to-face discussions with a nurse respectively. The control group received 
usual care in both studies, but in the study by Lai et al (2004) the control 
group was visited by a research nurse for five days, but did not discuss 
anything about the intervention. This may partly explain the lack of observed 
effect. Both trials had small sample sizes. Moreover Lai et al (2004) conducted 
their study among hospitalised patients so direct comparison with the present 
study in terms of pain interference with activities is difficult. Moreover in both 
studies there was lack of detail provided as to what constitutes usual care.  
Video-based pain educational interventions have been reported to be 
ineffective in reducing pain interference in trials among cancer patients in 
Australia (Lovell et al., 2010) and the USA (Anderson et al., 2004). In both 
studies around a third were lost to follow-up. Anderson et al (2004) conducted 
follow-up assessments up to 10 weeks which meant it was possible to observe 
both short-term and longer term effects of the intervention. Again, a lack of 
an observed effect may be due to the use of video in both groups.  For the 
non-interventional group the content of the video was restricted to nutritional 
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management, but the attention paid to watch the video might in itself reduce 
pain interference (Anderson et al., 2004) .  
A systematic review (Bennett et al., 2009) retained twenty one trials (ninteen 
where treatment was randomised) and concluded that pain educational 
interventions are not effective on improving pain interference among cancer 
patients. However this review excluded pain interference outcomes before and 
after four weeks follow-up. Over two-thirds of the trials included in this review 
had methodological limitations such as lack of details about concealment 
allocation.  
  
8.5.3 Effects of the pain education intervention on patient pain 
knowledge 
Participants in the pain education intervention reported a greater improvement 
in knowledge on pain management compared to participants in the usual care 
group. The results of the current study are consistent with trials examining the 
effects of pain education interventions on knowledge conducted in France 
(Goujard et al., 2003), Taiwan (Chiou et al., 2004) and South Africa (Peltzer 
et al., 2012) delivered through group (Peltzer et al., 2012, Goujard et al., 
2003) or individual sessions (Chiou et al., 2004). Participants who attended 
educational sessions on management of HAART side effects and adherence 
counselling showed a significant improvement compared to participants who 
received usual care (Peltzer et al., 2012, Chiou et al., 2004, Goujard et al., 
2003). Even though there was no attrition in the Taiwanese study, sample size 
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(n=67) was small (Chiou et al., 2004). Attrition was low in the South African 
study (4%) and the sample size appeared adequate (n=152). Blinding of the 
assessor was not described in either study. Contamination was reported in the 
French study, 19 of 179 participants in the usual care group attended 
education sessions, however it is not clear if intention-to-treat analysis was 
conducted (Goujard et al., 2003).  
The results from the current study are consistent with educational intervention 
studies consisting of an information leaflet conducted in South Africa (Dowse 
et al., 2014) and India (Rajesh et al., 2013) on the management of pain due 
to side effects of HAART. However in the study conducted in India an 
information leaflet was augmented by adherence counselling by the 
pharmacists (Rajesh et al., 2013). The authors reported that participants who 
received the intervention showed a significant improvement in knowledge 
about side effects of HIV treatment compared to participants randomised to 
the control group (Dowse et al., 2014; Rajesh et al., 2013). Self-efficacy 
improved significantly in the intervention group (Dowse et al., 2014), 
adherence and attitudes towards HAART improved significantly in the 
intervention group (Rajesh et al., 2013). In the South African study attrition 
was high, 50% of the participants were lost in the intervention group and 39% 
were lost in the control group although it is not clear why there was such high 
attrition. Furthermore the authors did not describe how outcomes were 
measured and whether or not the person conducting these was blind to 
treatment allocation. This was a problem shared by Rajesh et al which also 
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failed to report details of randomisation or any attempts to conceal treatment 
allocation.  
The finding of improved patient pain knowledge from the current study are 
also consistent with the positive results from two trials of pain management 
education programmes conducted for cancer patients conducted in the 
Netherlands (de Wit et al., 1997) and Australia (Yates et al., 2004). The Dutch 
study used a multi-method approach consisting of verbal instructions, written 
materials, audio cassette tape, and pain diaries. In the Australian study 
participants attended education sessions on communicating pain problems, 
personalized pain management plan and addressing barriers to pain 
management including a booklet. In both studies the process of randomisation 
is poorly described. Follow-up assessments were conducted after one week in 
the Australian study. It is not possible to conclude if the positive benefits 
observed will be sustained beyond this very short time period.  
Similarly, a pain educational intervention consisting of a pain hot line toll-free 
number to call or a weekly telephone call group consisting of four telephone 
calls from an oncology nurse specialist over a month has been shown to be 
effective in improving knowledge and beliefs about cancer pain compared with 
standard care (Wells et al., 2003). This study is similar to the current study 
because it recruited both patients and carers as study participants. However 
participants were predominantly white (92%). The sample size was small and 
half of the participants did not complete follow-up assessments after six 
months.  
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The results of the current study are contrary to a randomised controlled trial 
among men with symptoms of HIV/AIDS who were taught skills on self-
management of pain such as relaxation and physical exercise. The control 
group received standard care. The study concluded that knowledge levels 
improved in the control group compared to the experiment group (Gifford et 
al., 1998). Recruitment was restricted to male participants, besides this was a 
pilot study as such it is not appropriate to make conclusions about 
effectiveness.  
 
 
8.5.4 Effects of the pain education intervention on patient quality of 
life 
Participants in the pain education group experienced a better quality of life 
than participants in the usual care group. In the current study quality of life 
was evaluated using the APCA African POS. One aspect of quality of life in the 
APCA African POS is VSLULWXDOLW\0HHWLQJSDWLHQWV¶VSLULWXDOQHHGVLVDVWHS
towards providing holistic care in the pain management of the HIV/AIDS 
population. The WHO recommends holistic management of pain (WHO, 1998). 
This is important because research has shown that people who have been 
diagnosed with HIV/AIDS are more likely to be depressed because they are 
uncertain about their future (Sherr et al., 2011). A mixed-methods study 
(Selman et al., 2013) conducted in South Africa and Uganda among patients 
with chronic conditions such HIV/AIDS and cancer reported that there is 
evidence tKDWPHHWLQJSDWLHQWV¶VSLULWXDOQHHGVFDQLPSURYHWKHLUTXDOLW\RIOLIH
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and satisfaction with care. Perhaps in the current study the improved quality 
of life observed among people in the pain education group was partly 
explained by feeling more cared for by a health care worker who spent time 
with them and, where possible, followed this up with a telephone call. It is 
difficult to know exactly how spiritual well-being played a role here due to the 
absence of qualitative data. Within the APCA African POS spirituality is 
XQGHUVWRRGDVµSHDFHDQGOLIHZRUWKQHVV¶IRUSHRSOHZLWKLQFXUDEOHGLVHDVHVLQ
sub-Saharan Africa (Selman et al., 2013). Participants of the Selman study 
interpreted peace and life worthness as a perception of their own self and their 
place in the world, relationships with others, spiritual beliefs, health and health 
care. Patients may prioritise spiritual wellbeing over physical dimensions of 
quality of life (Selman et al., 2012).  
The results from the current study are consistent with other studies among 
HIV/AIDS patients (Chiou et al., 2006a, Lechner et al., 2003, Inouye et al., 
2000). In a study conducted in Taiwan (Chiou et al., 2006a) and the USA 
(Inouye et al., 2000) quality of life was evaluated using the Quality of life 
Index (Ferrans and Powers, 1985) which measures level of satisfaction with 
different aspects of life. The Taiwanese study consisted of a symptom 
management programme delivered either as one-on-one or in a group 
intervention (Chiou et al., 2006a). The American study consisted of a self-
management training for symptoms of HIV/AIDS (Inouye et al., 2000). Both 
intervention groups showed a significant improvement in quality of life 
compared to the control group (Chiou et al., 2006a, Inouye et al., 2000). 
Sample size was small in the Taiwanese study, and participants were not 
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assigned to groups at random. Therefore allocation bias cannot be excluded. 
Recruitment of participants from one city in Taiwan limits what can be 
generalised from the findings. However all participants were successfully 
followed-up (Chiou et al., 2006a). In the American study, the sample size was 
also small and the level of attrition was unclear (Inouye et al., 2000). 
In another study (Lechner et al., 2003) quality of life was evaluated using the 
Medical Outcomes Study Health Status Questionnaire for HIV. Participants 
were randomised to receive either group-based cognitive-behavioural stress 
management/expressive-supportive therapy or individual psycho-educational 
intervention. The study concluded that group-based intervention was more 
effective in improving quality of life than individual psycho-educational 
intervention. Both interventions were effective in improving cognitive function, 
health distress, mental health and health perceptions (Lechner et al., 2003). 
However despite being a large study (n=330), participation was restricted to 
female participants who were predominantly poor with low socio-economic 
status, this limits generalisation to other women with a stable income,  The 
study design involved two intervention groups without a standard control 
group.  
Findings from the current study are consistent with individualised telephone-
based educational interventions (Wang et al., 2010, Catz and Balderson, 
2014) conducted in China (Wang et al., 2010) and in the USA among older 
patients (Catz and Balderson, 2014) to promote adherence and improve 
quality of life. The studies concluded that a medication adherence intervention 
improves quality of life (Wang et al., 2010, Catz and Balderson, 2014). In the 
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Chinese study participants who received the intervention were more likely to 
be adherent  compared to those who did not receive the intervention (Wang et 
al., 2010). Family carers were also invited and participated in the discussion 
during home visits although they were not participants in the study. However 
adherence was measured through self-report without any objective measure 
such as pill count. These results need to be interpreted with caution due to 
risk of social desirability bias. The American study had a larger sample size 
(n=452) and diverse ethnic group participants, and the authors used a strict 
intention-to-treat strategy (Catz and Balderson, 2014) however it is not clear 
how many participants were lost to follow-up.  
The results are consistent with a large randomised controlled trial (n=1140) of 
a group-based self-management education programme among patients with 
chronic conditions such as cancer, asthma, stroke, heart disease and lung 
disease (Lorig et al., 1999). Participants who were randomised to the control 
group attended the programme after completing follow-up assessments at six 
months. The study concluded that participants who received the intervention 
showed a significant improvement in health behaviour and health status (Lorig 
et al., 1999). Attrition rate was low in this study (18% were lost to follow-up). 
Even though the study had a heterogeneous sample of participants with 
different chronic conditions, none of the study participants had HIV/AIDS. It is 
difficult to conclude if the positive benefits observed is applicable to patients 
with HIV/AIDS.  
Findings from the current study are in sharp contrast to other studies in the 
same HIV/AIDS field (Goujard et al., 2003, Webel, 2010) on the effects of pain 
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education on quality of life. In a study conducted in France participants 
randomised to the intervention group attended individualised education 
sessions while those randomised to the control group received standard care, 
but were invited to attend sessions upon completion of follow-up assessments 
(Goujard et al., 2003). In another study conducted in the USA, HIV positive 
women attended a peer-led group session while the control group received a 
copy of the HIV symptom management manual (Webel, 2010). It was 
concluded that there were no significant differences between the two groups 
on quality of life over three months (Webel, 2010) and over six, 12 and 18 
months (Goujard et al., 2003). This may have been due to a ceiling effect in 
the French study with participants at baseline reporting good quality of life 
(Goujard et al., 2003). Apart from the small sample size (n=89) in the 
American study, the population was restricted to women and the intervention 
did not target the specific pain related gynaecological problems that women 
experience such as menopause. The other explanation as to why the study did 
not observe any difference may be due to participants in the control group 
receiving a pain management manual previously found to be effective in 
reducing the severity and frequency of physical, psychological and 
gynaecological HIV/AIDS related symptoms (Wantland et al., 2008).  
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8.5.5 Effects of the pain education intervention on carers knowledge 
Family carers randomly allocated to the pain education intervention group 
showed a greater improvement in knowledge compared to family carers 
randomly allocated to the control group.  
This is consistent with a psychosocial interventional study conducted in 
Australia among family carers and patients with HIV/AIDS (Pakenham et al., 
2002). The intervention consisted of counselling sessions delivered to either 
family carers with their patients or family carers alone. The control group 
received standard care. The study concluded that family carers who attended 
sessions with their patients showed significant improvement in knowledge 
compared to family carers who attended alone or who did not. Likewise 
patients who attended sessions with their carers showed significant 
improvement in knowledge compared patients who did not. These findings 
suggest that intervening at carer giver/carer recipient level produces better 
outcomes than intervening at individual carer giver level (Pakenham et al., 
2002). There were a number of methodological concerns in the Australian 
study. The sample size was small, thus limiting statistical power and 
generalizability to the wider population. Some participants were not 
randomised, but were assigned to the treatment group because of their 
condition, this has potential for allocation and performance bias.    
Similarly a three-month group-based education session to improve knowledge 
and skills on care provision conducted among 202 elderly family carers in 
South Africa, concluded that participants who attended all the sessions showed 
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improved knowledge and skills in HIV/AIDS management, were more positive 
towards people living with HIV/AIDS, and more willing to provide care to their 
dependants, than participants who attended part of the sessions or none of 
the sessions (Boon et al., 2009b). This study did not have a control group and 
13 participants attended part of the sessions and 48 did not attend any 
sessions at all. It is difficult to infer if the positive benefits observed would still 
be observed if there was a randomised comparison with a control group.  
Similarly a systematic review of interventions for carers in the UK reported 
that educational programmes consisting of written information, interactive 
group sessions and individual sessions for carers of people with dementia are 
effective in improving knowledge levels (Victor, 2009). Although in this review 
only one study was a randomised controlled study and two other studies were 
non-RCT and qualitative designs. Non-RCT and qualitative study designs do 
not provide stronger evidence compared to an RCT because of the risk of bias. 
 
8.5.6 Effects of the pain education intervention on carers quality of life  
Carers in the pain education group reported a better quality of life than carers 
in the usual care group. The results are consistent with other studies among 
carers of people living with HIV/AIDS (Rotheram-Borus et al., 2001, 
Pakenham et al., 2002, Pomeroy et al., 1995, Smith Fawzi et al., 2012) 
although different tools were used in each study to evaluate quality of life. 
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In one study (Rotheram-Borus et al., 2001) conducted in New York parents of 
adolescent children were randomly allocated to attend group-based education 
sessions on topics such as coping with HIV/AIDS illness, coping with fear and 
anger, child caring, creating a positive home, while the control group received 
standard care. The study concluded that participants randomised to the 
intervention group reported a reduction in quality of life in the domain of 
anxiety, depression and distress compared to participants in the control group 
(Rotheram-Borus et al., 2001). However it is not clear who conducted 
outcome assessments and if they were blind or not, so the possibility of 
detection bias cannot be excluded.  
In another study a psychosocial intervention was delivered to family carers of 
HIV/AIDS patients either with their patients or family carers alone in Australia 
(Pakenham et al., 2002). Family carers who received the intervention with 
those they cared for showed a significant improvement in quality of life in the 
domain of global distress, dyadic adjustment. Likewise patients who received 
the intervention with their family carers showed an improvement in quality of 
life in the domain of dyadic adjustment, social adjustment, target problems 
and subjective health status (Pakenham et al., 2002).  
In a quasi-experimental study a psychosocial support intervention was 
delivered among families affected by HIV/AIDS in Haiti (Smith Fawzi et al., 
2012). Caregivers (n=130) most of whom were HIV positive themselves 
(95%) attended a psychosocial intervention on coping with challenges of HIV 
infection, problem solving skills, care provision to children, and reducing 
emotional distress. The study concluded that caregivers demonstrated a 
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significant reduction in depressive symptoms and improved social support 
(Smith Fawzi et al., 2012). Importantly the study did not have a control group 
to provide a definitive estimate of effect of the intervention.  
A psycho-educational group-based interventional study among family 
members of people with HIV/AIDS recruited 33 family members who attended 
eight sessions covering positive living, physical aspects of HIV illness, and 
carer empowerment in care giving, coping skills, and dealing with challenging 
life events. The study reported positive outcomes in the intervention group 
compared to participants in the control group in terms of stress, stigma, 
depression, and anxiety, but there were no significant differences between the 
intervention and control groups in terms of social support (Pomeroy et al., 
1995). This may be due to outcomes being measured immediately after the 
delivery of the intervention, which may not be sufficient for participants to feel 
that other group members were part of the support system. The other 
explanation may be due to the fact that levels of depression were very high 
among study participants, research has shown that depressed people have 
lower levels of perceived social support (Sherr et al., 2011, Eller et al., 2013). 
However in this study participants were not randomised, but self-selected to 
receive the intervention or usual care.  This has potential for selection bias. 
However in this study participants were not randomised, but self-selected to 
receive the intervention or usual care.  This has potential for selection bias. 
Unsurprisingly groups were not equivalent at baseline with systematic 
differences between the two groups other than in terms of the intervention 
received making it impossible to know the reasons for any change in outcome.  
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Because of this groups were not equivalent at baseline with lack of 
randomisation to have generated systematic differences between the two 
groups other than in terms of the intervention received.  
A meta-analysis of psycho-educational, skills training and therapeutic 
counselling interventions for family caregivers of cancer patients examined 19 
randomised controlled trials and concluded that such interventions had small 
to medium effects on reducing caregiver burden, improving caregiver ability to 
cope, increasing their self-efficacy and improving some aspects of quality of 
life (Northouse et al., 2010). However the majority of participants in the 
studies reviewed were Caucasians (84%), this limits generalizability to other 
races and ethinic groups. 
The results of the current study are contrary to studies conducted in the USA 
on the effects of education intervention on carers quality of life, focussing on a 
boosting social support intervention among parents of children with HIV/AIDS 
(Hansell et al., 1999) and a psycho-educational study among partners of 
patients with HIV/AIDS (Gordon-Garofalo and Rubin, 2004). Attrition was 
higher in the former study and all participants who were lost to follow-up were 
excluded from the analysis, this raises questions on attrition bias. 
In the latter study participants were not randomised, but assigned to groups 
basing on their preference resulting in group imbalance and self-selection bias. 
There were (n=19) participants in the intervention group and (n=9) 
participants in the wait list control group (Gordon-Garofalo and Rubin, 2004).  
 
232 
 
8.5.7 Positive aspects of care giving/motivation and other related 
outcomes 
Carers in the pain education group reported greater motivation to provide care 
than carers in the usual care group.  
The results of the current study are consistent with group-based psycho-
educational intervention studies conducted in Australia among family carers of 
patients with advanced cancer (Hudson et al., 2008, Hudson et al., 2009). 
Both studies focussed on caregiving preparation, self-care strategies, 
symptom management strategies and rewards in caregiving. It was reported 
that family carers showed adequate preparation, and were more competent, 
prepared and motivated to provide care after receiving the intervention. 
However neither study included a control comparison group. It is therefore 
impossible to adjust for regression to the mean or social desirability bias 
making it hard to estimate the effect of the intervention.  
Similarly a multi-method psycho-educational intervention study consisting of 
home visits, face-to-face discussion, phone call, booklet and audiotape, 
focussing on carer giver motivation, self-care strategies, and caregiver 
preparation reported that family carers who received the intervention showed 
a significant improvement in motivation to provide care compared to family 
carers who did not. However there were no differences observed on 
preparation to provide care, competence and anxiety (Hudson et al., 2005a). 
Perhaps lack of significant improvements on anxiety and other outcomes was 
because the intervention included both current carers and bereaved carers. 
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Presumably bereaved carers were anxious having lost their loved one. 
Furthermore, the disWULEXWLRQRIFDUHJLYHUV¶VFRUHVZHUHVNHZHGVXJJHVWLQJ
that they typically circled either very high or very low scores on a scale. This 
raises the issue that differences may be obscured by looking at mean 
differences as a result of ceiling and floor effects.   
Similarly a quasi-experimental study conducted in Sweden among family 
carers of patients with life-threatening conditions reported that a group-based 
supportive and educational programme showed a significant improvement in 
caregiving preparation, competence in caregiving and rewards for caregiving 
compared to standard care (Henriksson et al., 2013). However this was not a 
randomised controlled trial and the two groups were non-equivalent. Although 
both groups were similar at baseline it is not possible to exclude unknown 
confounding and allocation bias.  
A qualitative study of 47 primary family caregivers of cancer patients 
conducted in Australia concluded that even though family carers experience 
challenges such as lack of skills to manage symptoms, lack of support from 
health care workers and challenges with their own health, 60% of the 
caregivers reported positive aspects such as having an improved relationship 
with the person they care for, becoming stronger and more confident with care 
provision and improved communication. However, some participants reported 
disliking the act of caring in spite of having a close relationship with the 
person who needed care (Hudson, 2004). - 
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Similarly in a study among family caregivers of patients on palliative care 
conducted in Canada, participants were asked to identify and report any 
positive aspect of their role. Of the 289 family caregivers, 211 (70%) reported 
at least one positive aspect and 20 caregivers (6.9%) reported more than one 
positive aspect. Caregivers who reported more than one positive aspect were 
less likely to report depression, burden or poor health (Cohen et al., 2002). 
 
8.5.8 Effect of the intervention on patients use of medication 
Participants who were randomised to the pain education intervention were six 
times more likely to be prescribed Codeine and five times more likely to 
receive Diclofenac compared to participants randomised to the usual care 
group. In Malawi, Codeine and Diclofenac are usually prescribed and 
administered to patients who do not respond to WHO step one pain medication 
such as Panadol, Brufen and Aspirin. Participants in the pain education group 
were taught how to assess pain and how to classify pain. They were also 
taught how to manage pain and examples of drugs were listed based on the 
severity of pain (See Appendix 13 Information leaflet). Since participants 
showed improvement in knowledge after receiving the intervention it is 
possible that they used this information to express themselves freely to the 
doctor or nurse about their pain and how they responded to treatment. This 
possibly influenced the doctor in the way they prescribed.  
The results of the current study are in contrast with a randomised controlled 
trial among cancer patients conducted in California. In this study patients in 
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the intervention group received a self-management pain education programme 
facilitated by a specialist trained oncology nurses. They were taught how to 
use a pill box, were given written instructions on how to communicate to 
physicians about unrelieved pain and changes to analgesia prescriptions. The 
control group received a cancer pain management guideline booklet. The 
study concluded that there were no significant differences between groups on 
opioid analgesic prescriptions and intake, even though on average the 
intervention group had an increased change of analgesia prescribed compared 
to the control group (Miaskowski et al., 2004). The booklet which the control 
group received might have helped the participants to respond positively like 
the intervention group.  
The results of the current study showed that there were no significant 
differences between the pain education group and the usual care group on 
Brufen and Panadol received at follow-up. Perhaps this is due to the fact that 
in Malawi, it is very common for patients to be prescribed Panadol and Brufen. 
These are also the drugs the patients can easily obtain over the counter.  
 
8.5.9 Association of baseline factors with outcomes 
In the current study, younger participants experienced a greater reduction in 
pain severity compared to older participants. This may be due to the fact that 
with old age people experience other health related problems such as chronic 
arthritis, musculoskeletal pain (Walker et al., 2012) and back pain (Hider et 
al., 2011). Even though arthritis can occur at any age (Walker et al., 2012) 
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people with old age are more likely to have the condition because their 
immune system becomes weaker with age and therefore they become more 
susceptible to inflammatory arthritis. An epidemiological study reported that 
the prevalence of back pain is associated with age (Andersson, 1999), 
however another study (Breitbart et al., 1996) reported no association between 
age and pain severity.  
The results of this trial show that pain interference was associated with age 
and gender of the participants. Participants who were older experienced worst 
pain interference compared to participants who were younger. Females 
experienced worst pain interference compared to males. This may be due to 
the fact that as people become older they are less able to tolerate exercise 
and are less likely to follow an exercise regime if they have painful conditions 
such as back pain and arthritis (Walker et al., 2012), as these are closely 
associated with age (Andersson, 1999). Women experienced worse pain 
interference than men possibly due to the fact that traditionally women are 
more likely to be caregivers. Unlike men, women are more likely to have to 
look after themselves even when they are feeling unwell in the presence of a 
man. Another possible explanation could be due to the fact that the 
intervention did not provide specific information about gynaecological pain 
symptoms which women experience. One trial (Webel, 2010) reported no 
differences on symptom status among women with HIV, but the same 
intervention reported differences in symptom status among men with 
HIV/AIDS (Gifford et al., 1998). Qualitative interviews with women after the 
intervention reported that the intervention did not contain specific information 
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about gynaecological problems (Webel, 2010). Similarly a study of pain 
syndromes among ambulatory AIDS patients found women more likely to be 
diagnosed with headache than men (Hewitt et al., 1997). A review of literature 
on gender variations and clinical pain experience concluded that women are 
more likely to experience recurrent pain than men. They are more likely to 
experience severe headache, abdominal and facial pain than men (Unruh, 
1996). A study to examine the relationship between gender and pain reported 
that women report higher pain ratings, poorly tolerate pain and show more 
concern about how pain affects their daily life (Vallerand and Polomano, 
2000). The experience of pain differs between men and women often due to 
biological, physiological (Zubieta et al., 2002) and psychological (Campbell et 
al., 2003) differences. Men and women may also respond differently to both 
pharmacological and non-pharmacological pain management interventions 
(APCA, 2012).  
The results of the current study showed that quality of life of the patient 
(palliative care outcomes) was associated with age and gender. The mean 
score for females was four points lower (worse) compared to males. Perhaps 
this may be due to the fact that females experienced greater pain interference 
compared to males. In African settings, females are more likely to be under-
treated for pain than males and are likely to be more anxious than males 
which exacerbates poor quality of life (APCA, 2012). Moreover the 
gynecological pain syndrome as a result of HIV infection also contributes to 
poor quality of life (Webel, 2010). 
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8.6 Implication for training in pain education 
The pain education intervention consisting of an information leaflet, face-to-
face discussion and follow-up phone call reminder was simple to design and 
administer. It offered substantial benefits to the HIV/AIDS patients and their 
family carers. It was relatively cheap and simple to design. Nurses put much 
emphasis on medication adherence but sometimes overlook the issue of side 
effects of HIV/AIDS medication and how to manage them particularly when 
they are faced with heavy workloads and limited time. However if patients 
have limited information about managing their pain they are likely to return to 
the hospital to seek advice on how to manage the condition. Nurses tend to 
focus their attention on the pharmacological management of pain. This is 
partly due to the lack of a thorough method of assessment of pain for 
HIV/AIDS patients.  
Comprehensive pain assessment is important because it will help doctors, 
nurses to come up with a proper treatment plan that embraces both 
pharmacological and non-pharmacological management strategies. Pain 
DVVHVVPHQWZLOOHQDEOHGRFWRUVDQGQXUVHVWRUDWHSDWLHQW¶VSDLQDQGFODVVLI\LW
accordingly. This may enable them to select appropriate drugs and other 
interventions for the patients. 
Even though this study did not evaluate the effects of pain assessment, the 
results support the importance of incorporating it into clinical practice so that 
every patient should have a record of pain assessment to provide a guideline 
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for pain management. The evidence produced by this study lends strong 
support to this approach. 
While this study does not provide evidence for the importance of pain 
education among student nurses, in order to improve the practice and care for 
HIV/AIDS in the clinical setting, there is a need to incorporate pain 
assessment and pain management in the training of nurses in Malawi. After 
nurses have qualified they will have knowledge and skills on pain management 
among HIV/AIDS patients. This will enable them to use these skills in clinical 
practice.  
A study conducted in east Africa among nurses who received end of life 
education and training reported that participants rated the curriculum as being 
excellent and they appreciated the knowledge and skills they acquired through 
the three day course (Paice et al., 2010). Similarly a postgraduate course on 
palliative care among medical doctors in South Africa led to participants 
acquiring clinical palliative care skills with a recommendation that the training 
should be introduced to undergraduates (Ens et al., 2011). The training of 
nurses on the management of pain is an important recommendation if the 
evidence from this study is to be incorporated into routine practice. In Malawi, 
nurses and clinical officers who prescribe and administer HIV medication do 
receive training for them to carry out this role; however the training package 
does not include the holistic management of pain in HIV/AIDS (Ministry of 
Health, 2011a, Ministry of Health, 2014).  
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The government in conjunction with the Palliative Care Association of Malawi 
have invested in the training of nurses as palliative care co-ordinators. The 
training package on palliative care includes topics such as symptom 
assessment and management, pain assessment and pain management using 
both pharmacological and non-pharmacological interventions. However despite 
these initiatives, many districts are not effectively providing palliative care 
services due to funding. Furthermore of those few nurses and clinical officers 
who have been trained in palliative care; many do not implement this into the 
routine care of their patients perhaps due to time pressure and workloads. 
However stronger evidence suggest that if busy practices can redesign their 
care, they can provide better care than standard care (Renders et al., 2001). 
Funding for health services in Malawi comes from the central government, but 
as part of decentralised management, each district plans their own services. 
The senior management teams in some districts do not prioritise palliative 
care services. Therefore even though nurses may receive training, 
implementation of their knowledge and skills is vital and calls for additional 
resources and focus (Malawi Government, 2012b).  
The RE-AIM (Reach Efficacy Adoption, Implementation and Maintenance) 
framework (Bonomi et al., 2002) could be adopted to implement the pain 
education intervention that was found to be so effective in the present study. 
RE-AIM is an implementation science model that directs attention to issues or 
challenges faced to disseminate and implement evidence-based programmes 
or policies in the management of chronic illnesses such as HIV/AIDS (ElZarrad 
et al., 2013). Adopting this pain education intervention will require 
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disseminating study findings to the institutions where the study was conducted 
and to HIV/AIDS patients and plan the modalities of implementing the 
intervention into routine care. The nurse-led pain education intervention study 
has been shown to be effective in the management of HIV/AIDS pain in two 
public hospitals in Malawi. Figure 17 below summarises the proposed adoption 
of the RE-AIM model in the management of pain in HIV/AIDS palliative care 
clinics in Malawi. The RE-AIM implementation science model considers both 
individual (Reach and Efficacy) and system (Adoption and Implementation) 
levels and it emphasises both the importance of external (Reach and 
Adoption) and internal (Efficacy and Implementation) validity (Glasgow et al., 
2001). 
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Figure 18: Adoption of the RE-AIM model in the management of pain 
in HIV/AIDS and palliative care clinics in Malawi 
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attitude of some health care workers. One way to deal with this is by asking 
HIV/AIDS Coordinators to develop a monthly or weekly rota for health 
education provision on pain management among HIV/AIDS patients. The clinic 
co-ordinators should ensure that staff members are implementing health 
education, for instance at Ekwendeni hospital the rota was there but there was 
no implementation among staff members. Implementing the pain education 
intervention will require a participatory approach perhaps guided by the theory 
of change (De Silva et al., 2014) and the normalisation model of implementing 
complex interventions (May, 2006). Both approaches suggest bringing 
together different stakeholders such as HIV/AIDS patients, family members, 
and healthcare workers including hospital managers and decision makers to 
discuss the best approach and sustainable way of implementing the 
intervention. The Medical Research Council framework for complex 
interventions suggests that for implementation to take place, evidence from 
the study needs to be presented to decision makers and other stakeholders in 
a persuasive manner (Craig et al., 2008). 
Through my observation at Mzuzu central hospital, health care assistants were 
involved in provision of health education to patients newly registered to start 
treatment. I attended some of the sessions and observed that they were 
conducted and delivered in a similar manner as those delivered by qualified 
staff nurses and clinical officers. I would therefore recommend that the 
institution should actively involve health care assistants to provide health 
education on pain management to the patients in situations where workload is 
high and time is under pressure. Health care assistants would need basic 
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training on pain assessment and management. This will enable patients and 
their family members to acquire skills and knowledge on pain management at 
home. The same model of using health care assistants is utilised in Malawi in 
the provision of counselling and testing services for patients with signs and 
symptoms of HIV/AIDS. The model has helped HIV/AIDS patients to start 
treatment within weeks after diagnosis rather than waiting for three months 
(WHO, 2011b). 
Student nurses need to receive education on pain assessment and 
management. Palliative care training might be effectively delivered using the 
existing nursing and clinical training to reduce overload from new skills and 
frameworks of care (Harding and Higginson, 2005). Palliative care needs to be 
incorporated in the nursing curriculum, so that as nurses graduate they have 
basic skills and knowledge in pain assessment and management. For instance 
student nurses conduct a case study on providing health education and care to 
a client seeking family planning services, the same model could be extended 
to the management of pain in HIV/AIDS.  
While this study does not provide evidence for the importance of pain 
education among student nurses, in order to improve the practice and care for 
HIV/AIDS in the clinical setting, there is a need to incorporate pain 
assessment and pain management in the training of nurses in Malawi. After 
nurses have qualified they have knowledge and skills on pain management 
among HIV/AIDS patients. This will enable them to use these skills in clinical 
practice.  
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Healthcare workers and staff from Non-Governmental organisations provide 
symptom management and basic nursing care to patients and their families. 
However there is no consistency and continuity in implementing such 
activities. It depends on availability of funding. It is therefore recommended 
that health care workers should teach families and patients during home visits 
pain assessment and pain management skills so that patients and families can 
be prepared and be equipped to carry out this role at home. Volunteers and 
other informal carers who are involved in providing home health care need 
basic training on pain assessment and pain management. The training of 
volunteers at present mainly focusses on basic nursing care; moreover some 
volunteers have not been trained. It is recommended that the untrained 
volunteers should also be trained. This may help them to utilise the skills and 
knowledge gained in providing holistic care to patients who are in pain in their 
role as informal caregivers. However this will require resources if training is to 
be conducted. Furthermore some informal carers easily quit if they experience 
carer burden and burn out (Malawi Government, 2011). 
HIV/AIDS staff members need basic training on health education among 
patients and carers on pain management. My experience of working in the 
medical wards as a student nurse and as a qualified member of staff was that 
pain assessments were not conducted with both in patients and out-patients. 
There was nothing like recording the pain scores for monitoring progress. This 
is possibly because staff nurses do not have basic knowledge about pain 
assessment and pain management and use this knowledge to provide care to 
the patients. It should be emphasised to all nurses that assessment of pain 
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should be conducted and recorded in the same manner vital signs such as 
blood pressure, temperature, respirations and heart rate are conducted and 
UHFRUGHG7KLVZLOOHQDEOHSURSHUPRQLWRULQJRIWKHSDWLHQW¶VFRQGLWLRQDQGWKH
management of pain based on the severity of pain (depending on availability 
of treatments). This will also help the nurse to identify other interventions to 
manage pain.  
Non-governmental organisations that are involved in providing training and 
home-based care to informal carers should consider supporting hospitals with 
the implementation of pain management for people living with HIV/AIDS. This 
may be through provision of funding for the hospitals to design and print 
information leaflets on pain assessment and management so that patients, 
family carers and informal carers can use them at home and refer to it as they 
provide care to their patients. Equally the Malawi government through Ministry 
of Health and the HIV/AIDS health education unit together with the National 
HIV/AIDS Commission should consider providing financial support to hospitals 
to design and producing information leaflets and posters on pain assessment 
and management which can be distributed to patients who are HIV positive 
and their families in the HIV clinics and medical wards. 
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8.7 Implications for policy and pain education practice 
8.7.1 Policy formulation 
The WHO public health strategy on palliative care was endorsed by 
organisations in sub-Saharan African (Ddungu, 2011). The policy 
recommendations from the pain education intervention study are based on the 
pillars of the WHO public health strategy for palliative care which calls on 
governments for a national strategy to improve access to palliative care 
services including the management of pain, health education for health care 
workers in HIV and palliative care clinics, health education to patients and 
family members including the community, availability of drugs to treat and 
manage pain, and implementation mechanisms within the health care clinics 
(Stjernswärd et al., 2007). Pain education for patients with HIV/AIDS has not 
received sufficient attention in Malawi hospitals. This is probably due to a lack 
of formulation of policies and financial support from the Ministry of Health, 
specifically the Department of HIV/AIDS. There is a need for evidence-based 
Government policy that will guide the development, design and 
implementation of HIV/AIDS pain education for patients and family carers. The 
Ministry of Health through the National HIV/AIDS Director and National 
Palliative care coordinator need to incorporate pain education among 
HIV/AIDS patients as part of their HIV/AIDS policy.  
The Malawi Government does not have a policy on palliative care. Even though 
there are national guidelines for palliative care (Ministry of Health, 2009) there 
is no clear guideline on pain education and management for HIV/AIDS 
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patients. Additionally the national community home based care policy (Ministry 
of Health, 2011b) does not explicitly define palliative care and outline activities 
or services to improve the delivery of palliative care including pain education 
for people living with HIV/AIDS.  
Many have argued that access to palliative care services including relief from 
pain is a universal human right (Gwyther et al., 2009). The health policy in 
Malawi must take into consideration the scarcity of resources for pain 
education and management and the needs of HIV/AIDS patients and their 
families including community members who are actively involved in providing 
palliative care services. Policy makers need to make decisions based on 
evidence for the needs of HIV/AIDS patients and family carers and 
interventions that are effective in meeting their needs. There is a need for a 
public health approach in the delivery of pain management to people living 
with HIV/AIDS and their families. Due to the dearth of research evaluating 
pain education for HIV/AIDS patients in Malawi and other resource poor 
countries in the sub-Saharan region, policy making in this area is more likely 
to be based on international literature and international practice. There is 
evidence that patient health education in one country may function as a mirror 
for the quality improvement of the delivery of health education on another 
country (Visser et al., 2001).  
Such policies may trigger health institutions in Malawi to acknowledge the 
importance of pain education among patients with HIV/AIDS. The policies may 
trigger the Ministry of Finance through the Department of Treasury to provide 
financial support for the development of pain education materials such as 
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leaflets, posters, booklets to be used in practice, training of health care 
workers, student nurses, patients and family carers, as well as in conducting 
research in pain education and management. The policy will enable health 
managers to support nurses in implementing programmes aimed at 
strengthening palliative care delivery including the management of pain. 
 
8.7.2 Implementation and practice 
The findings from this study have great potential to inform the practice of 
palliative care and HIV/AIDS pain management. Evidence from the study 
suggests that the management of pain for people living with HIV/AIDS 
requires a holistic approach focussing on physical, psychological, social, and 
spiritual aspects of care. In contrast the current practice and delivery of care 
to patients tends to be limited to the physical aspects of care. This calls for the 
need to strengthen service infrastructure development so that palliative care 
and HIV/AIDS management and care is integrated into all forms of care 
including the management of pain for people living with HIV/AIDS through 
pain education.  
Although the pain education intervention was designed to be simple in this 
study, it would take approximately 10 to 15 minutes for each patient from a 
QXUVHV¶ OLPLWHGWLPHLI LWZDVWREH LPSOHPHQWHGURXWLQHO\LQFOLQLFDOSUDFWLFH
Even though this intervention was delivered to patients and family carers 
individually and face-to-face, it can still be implemented and delivered to 
patients and families through groups, moreover all the patients and families 
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who attend health education on HIV treatment receive the health education in 
groups. The pain education intervention may be implemented in a similar 
manner.  
The current practice in hospitals in Malawi including Ekwendeni and Mzuzu 
central hospital regarding opioids prescription requires only medical doctors 
and clinical officers to prescribe. Nurses cannot prescribe and they have to 
refer patients who require an opioid to the doctor or clinical officer. This policy 
needs to be revised, prescription of opioids need to be extended to nurses just 
like they are able to prescribe HIV treatment for the patients. Moreover nurses 
who work in palliative care clinics do prescribe opioids; this can also be 
extended to nurses who work in HIV clinics and inpatient settings. This model 
has been found to be effective in other countries in the sub-Saharan Africa 
such as Uganda where qualified nurses prescribe opioids for pain management 
(Merriman and Harding, 2010). There is a need to make opioids available and 
accessible in rural health centres where HIV treatment is offered. This will 
enable patients who access HIV treatment in rural health centres to also 
access opioids if they need it. Nurses in rural areas who undergo HIV training 
also need training to prescribe opioids. Moreover in some rural health centres 
there are no clinical officers, therefore nurses who work in rural settings 
should prescribe treatment for the patients, to avoid unnecessary referrals. 
Similarly in South Africa opioids drugs have been declared essential drugs in 
primary care settings for the management of cancer pain (Beck and Aocn, 
1999). This is in line with WHO foundation measures for HIV pain relief which 
advocates for the availability of essential drugs, government policy and 
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education and training. These are essential for palliative care development in 
African countries (WHO, 2006b, WHO, 1996). 
A multi-disciplinary team approach is important to meet the needs of 
HIV/AIDS patients and their families. HIV/AIDS clinic and palliative care clinic 
staff need to work with several key players and stakeholders to address the 
various needs in relation to pain management of HIV/AIDS patients and their 
families through pain education. There is a complex relationship between 
physical, social, psychological health of the patients. The intervention tested 
was developed and delivered using a holistic approach with the guide of the 
bio-psychosocial model. Pain being physical and biological brings about 
psychological problems. Pain assessment needs recognising each of these 
components in order to meet the needs of the patient and family. A study 
conducted in five countries in sub-Saharan Africa reported that HIV/AIDS 
patients presented with multidimensional problems (Sepulveda et al., 2003), 
and this calls for the need for integrated palliative care services.  
In the current study Clinical Officers and nurses were involved in the 
management of patients with HIV/AIDS. Family members and patients were 
involved in designing and implementing the intervention. Patients were 
referred for spiritual care if they had a spiritual problem. Even though it is not 
very clear how spirituality played a role in this study, the intervention had a 
spiritual component.  There is a need for a nurse-coordinated multidisciplinary 
pain management team in HIV/AIDS and palliative care clinics in Malawi. Even 
though the pain education intervention did not test the effectiveness of a pain 
management team but this may help in the implementation of pain 
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management in HIV/AIDS and palliative care clinics in Malawi. The team 
should be responsible for developing and designing pain information leaflets, 
train nurses, and other health care workers on pain assessment and 
management and ensure that health care workers are implementing pain 
assessment and management skills in their role. The pain management multi-
disciplinary team will also be responsible for ensuring that they review patients 
with pain syndromes and properly develop a management plan of care for the 
patients. The team should be responsible for monitoring and evaluating pain 
management education for patients, family carers and health care workers. 
Patient involvement is important because they can share experiences on how 
they have handled a particular situation, for instance which non-
pharmacological intervention is better and how exactly they used it. 
Involvement of family carers is also important because not only do they offer 
social support, but they complete the family composition. Family support is an 
important component in the management of pain. The majority of care for 
patients with HIV/AIDS is provided in their own homes. Home care is cheaper 
and culturally acceptable for the patient and family members (Jagwe and 
Barnard, 2002). Additionally in Malawi, family members are involved in caring 
for the patients in the hospitals due to shortage of health care workers. In 
Malawi, just like other countries in Africa, we largely rely on family and 
community support to provide palliative care services (Harding and Higginson, 
2005). Personally I have observed nurses frequently conducting bed baths to 
patients with the support of a family member while working in the hospital. 
Their presence also strengthens the social support for the patient. 
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Involvement of the family member in this study helped the patients to 
remember and reinforce what was discussed during the face-to-face contact. 
Intervening at patient/family care dyad level is therefore likely to be crucial for 
this intervention to be effective. 
The provision of HIV/AIDS treatment as a therapeutic treatment for people 
living with HIV/AIDS leaves some patients with palliative care needs 
unaddressed (Harding et al., 2005, Sacajiu et al., 2009). For instance my 
personal observation through fieldwork and interaction with staff members 
working in the HIV clinics suggested that some patients did not take HAART on 
a regular basis, due to side effects. Pain education is thus important to such 
patients and their families. A qualitative study among advanced HIV/AIDS 
patients and their caregivers concluded that side effects of HIV medication and 
issues surrounding adherence to treatment were the main themes frequently 
reported by study participants (Sacajiu et al., 2009).  
 
8.8 Implications for research 
Findings from the pain education intervention study calls for a number of 
research activities to be conducted. Findings from this research study need to 
be disseminated to policy makers, key stakeholders, academicians in order to 
promote evidence based practice and to examine challenges in 
implementation. I plan to present the results of the pain education trial at the 
annual dissemination conference in Malawi to inform practice using the best 
available evidence. This may enable decision makers to be encouraged to 
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allocate resources for conducting further studies, and support palliative care 
activities. This is in agreement with palliative care researchers who argued for 
a research pillar on the WHO public health strategy (Harding et al., 2013). 
High quality evidence is needed in order to achieve each pillar of the WHO 
public health strategy for palliative care (Harding et al., 2013). Furthermore, 
there is a need to support rigorous and robust palliative care research in Africa 
in order to inform practice and policies (Harding et al., 2008). In line with this, 
further research into pain education is a priority, particularly in areas of the 
world that are resource poor. How this might be successfully implemented is a 
research question that arises from the present study. A cluster randomised 
FRQWUROOHGWULDOFRXOGEHDYHKLFOHIRUGHOLYHULQJµWUDLQWKHWUDLQHU¶LQWHUYHQWLRQV
whereby clinics would be randomised to receive such an intervention or not.  
In the current study I used tools that have been developed and validated in 
western countries. Only the APCA African POS has been developed and 
validated in Africa (Harding et al., 2010b). However for some clients who were 
not able to understand English, the APCA tool was translated to a local 
language. However it will be wrong to conclude that the APCA has been 
validated to the local languages in Malawi, for this reason, I would recommend 
further research of validation of the APCA African POS into the main local 
languages used in Malawi. This will enable health care workers in hospitals, 
HIV/AIDS and palliative care clinics to use the validated tools for monitoring 
and evaluating palliative care outcomes including pain management 
programmes for HIV/AIDS patients. Further research is also needed to 
validate the other tools used in the present study (BPI, Pain Knowledge 
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Questionnaires, and the Rewards in caregivers in order to evaluate and guide 
the practice and delivery of palliative care and home-based care programmes.  
More research is needed that evaluates pain education interventions and 
palliative care services applied by health care providers independent from 
(rather than) research teams. There has been a tendency to underrate the 
capacity of health care workers to carry out studies of complex interventions 
and to understand concepts such as randomisation and blinding. However 
researchers are not frequently involved in clinical practice and implementation 
of research findings becomes a challenge. There is need to involve health care 
providers in research activities and this can be a starting point to encourage 
them to conduct their own studies in future (Mantzoukas, 2008). In addition, 
the success of many research projects can be attributed to the support from 
health care workers. The health care workers in the current study were not 
experienced researchers, but they were highly motivated and maintained 
enthusiasm for this project throughout the introduction of the study and the 
last follow-up assessment. Moreover it was for the first time most of them 
were involved in randomised controlled trial. The successful recruitment of the 
study participants and low attrition rate is attributed to the staff working in 
HIV/AIDS and palliative care clinics of the two study settings.  
The pain education study was feasible and could be safely incorporated into 
routine HIV/AIDS pain management in HIV/AIDS and palliative care clinics. 
Exploring possible ways in which the intervention could be incorporated into 
routine practice is a priority for future research. In addition more research is 
needed regarding the components of the pain education intervention. The 
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current intervention had three main components (1) information leaflet (2) 
face-to-face discussion and (3) phone call reminder. The design of the 
intervention did not attempt to find out how the intervention worked, because 
qualitative interviews were not conducted upon completing follow-up 
assessments, it is therefore difficult to know which part of the intervention was 
responsible for the benefits observed.  
In the current study, follow-up assessments were conducted eight weeks after 
randomisation. Future research should consider conducting follow-up 
assessments at least two or three times and after 12 to 18 weeks to evaluate 
the pattern of response among participants on long term effects of the 
intervention.  
The views of the participants who took part in this study were not elicited after 
follow-up assessments. Their experiences about being part of the intervention 
would have helped to plan and improve the delivery of the intervention. Future 
research should therefore consider conducting interviews from study 
participants in order to examine their experiences about the context and 
process of the intervention and concepts such as randomisation. Such 
qualitative interviews will also help to answer questions regarding how and 
why the intervention worked, and how it can be improved.  
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8.9 Summary of recommendations 
On the basis of conducting the trial of pain education among HIV/AIDS 
patients and their family carers I recommend the following: 
‚ Based on the evidence that pain education intervention reduces 
pain severity among patients with HIV/AIDS, it is recommended 
that palliative care clinic staff should provide health education to 
the patients and their family carers on pain assessment and 
management. HIV clinic staff should use the same model of 
providing health education to patients and family carers on drug 
adherence during registration for new patients and follow-up care 
for routine appointment patients and family carers.  
‚ Based on the evidence that pain education intervention reduces 
pain severity, it is further recommended that the Malawi 
Government should train health care assistants to provide pain 
education in the clinics. This may help to ease the workloads the 
nurses and clinLFDORIILFHUV¶H[SHULHQFH7KHPRGHORIXVLQJKHDOWK
care assistants has been reported to hasten HIV testing services in 
the clinics rather than waiting for nurse counsellors who are 
overloaded with other nursing services. This is about 
implementation of the pain education intervention, even though the 
intervention did not test the effects of using health care assistants. 
‚ The Malawi Government and non-governmental organisations 
should train family carers on pain and symptom management. This 
is on the basis that pain education among family carers improves 
knowledge of pain management. This will equip informal carers to 
provide pain management within their homes confidently. 
‚ Nurses and Midwifery Council of Malawi should review the 
curriculum for training nurses and midwives. They should 
incorporate pain education in the curriculum for the training of 
undergraduate nurses and nurse technicians in all colleges in 
Malawi. This will enable nurses to implement pain education when 
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they qualify as staff nurses. This will enable nurses to implement 
pain education when they qualify as staff nurses. Even though the 
pain education intervention did not test the effects of the 
intervention among student nurses, but as a way of 
implementation, training student nurses will enable them to put 
this into practice. 
 
‚ HIV/AIDS and palliative care clinics should conduct further research 
into pain education to address the questions that have not been 
answered in the current study, for instance how effectively to 
implement pain education in routine care for HIV/AIDS patients. 
Such research will also help to answer the questions of how the 
pain education intervention worked, and which component is more 
feasible.  
 
8.10 Conclusions 
This study is unique because it is the first to investigate the effectiveness and 
feasibility of a nurse-led pain intervention among HIV/AIDS patients and their 
family carers in a resource poor country like Malawi. The study provides strong 
evidence to support the hypotheses that a simple nurse-led pain education 
intervention consisting of an information leaflet, augmented by face-to-face 
discussion and explanation for 30 minutes and a follow-up phone call after two 
weeks is effective in reducing the severity of pain, interference of pain, 
knowledge of pain management and quality of life among patients with 
HIV/AIDS. The study also supports the hypotheses that the intervention can 
be effective in improving the knowledge of pain management, motivation to 
provide care, and quality of life among family carers of patients with 
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HIV/AIDS.  
The feasibility and acceptability of the intervention have been demonstrated 
by the enthusiasm and active support from health care workers from study 
settings, successful recruitment and low attrition among participants. This type 
of intervention could be replicated and implemented in other parts of the 
country and other countries in the sub-Saharan region.  
Pain symptoms have become a major problem among people living with 
HIV/AIDS due to opportunistic infections and side effects of HIV treatment. 
Findings from this study have important implications for nurses and clinicians 
working in HIV/AIDS and palliative care clinics who are looking for effective 
interventions to manage pain symptoms which are highly prevalent among 
patients who receive HIV treatment.  
More research is needed into the best ways to incorporate pain education into 
routine practice, the optimum time to evaluate the effects of the intervention.  
More research is needed to find out whether all the components of the pain 
education intervention were effective or not and which one was the most 
effective component. 
The pain education intervention makes an important contribution to evidence 
for the development of practice in HIV/AIDS and palliative care clinics in 
Malawi and other countries in Sub-Saharan Africa and provides the basis for 
making recommendations to implement it in routine practice. 
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Appendix 1: Participants Information Sheet (for patients and carers) 
University of Nottingham 
School of Nursing, Midwifery and Physiotherapy 
Division of Nursing 
 
Title of project: Managing pain in HIV/AIDS: education for people 
living with HIV/AIDS and their family carers  
Researchers: Kennedy Nkhoma, Prof. Antony Arthur, Prof. Jane Seymour 
Participant Information Sheet (People living with HIV/AIDS) 
We would like to invite you to take part in a research study. Before you decide 
whether to take part it is important that you read the information contained 
below. We encourage you to discuss this information with family members or 
friends. Please contact Kennedy Nkhoma (pain education nurse) or one of the 
clinic staff if there is any clarification you need or any information not 
contained within this document. Please take your time to decide whether you 
wish to take part or not in the study. 
Background and purpose of the study? 
The study aims to investigate the effects of an educational intervention on the 
experience of pain and managing pain among people living with HIV/AIDS. We 
know that pain is frequently experienced and difficult to manage in HIV 
infection; we therefore want to assess if providing people living with HIV/AIDS 
and their family carers with a short educational package will help the way pain 
is managed. It is hoped that this in turn will assist in reducing the pain 
experienced. The study will take two months to complete. 
What does the study involve? 
If you agree to take part we will ask you to sign a consent form. Thereafter 
Kennedy Nkhoma (pain education nurse) will conduct a short series of baseline 
assessments through the administration of a questionnaire about your 
experiences and knowledge of pain. Together with the person who is your 
main carer, you will then be allocated into one of two groups. This allocation is 
determined by a computer (which has no information about participants). This 
means that you will have a 50% chance of being allocated to one particular 
group. In one group participants will receive health education via a face-to-
face meeting with Kennedy Nkhoma and you will be given a leaflet about pain 
assessment and management. The other group will receive usual care. After 
eight weeks, when you come to the HIV clinic (accompanied by your main 
carer) for your routine appointment for HIV medication, a staff nurse will 
conduct follow-up assessments to study participants using the same 
interviewer administered questionnaire used for baseline assessments. If you 
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are allocated to usual care you will still receive the educational package about 
pain, but not until after you have completed the follow-up assessments. 
Why have I been chosen?  
You have been invited to take part in the research study because you are 
living with HIV/AIDS and you are in pain or at risk of experiencing pain. We 
require 179 volunteers like yourself to complete the study. 
Do I have to take part? 
It is entirely up to you whether you decide to take part or not. This 
information is given to you to think about in making that decision. You will 
have access to all services at the hospital that you would if you were not 
taking part in the study and regardless of which group you are allocated to. 
You are free to withdraw from the study at any time, you do not need to give 
a reason should you decide to withdraw, and your treatment will not be 
affected. 
What do I have to do? 
We ask that you take part in the interviewer-administered questionnaire at the 
beginning and end of the study. If you are allocated to the group that initially 
receive the educational package relating to pain, we ask that you do not 
discuss the contents of the leaflet with other patients or carers who may also 
be in the study. There is no need to alter your lifestyle during the duration of 
your involvement in the study. 
What are the benefits of taking part in the study? 
There are no direct benefits in taking part in the study. However this may be 
an opportunity for you to learn ways of assessing the pain you experience and 
how to better manage that pain. 
What are the risks of taking part in the study? 
There are no risks involved if you take part in the study and every effort will 
be made not to inconvenience you or your carer.  
Where will the research take place? 
The research has been designed to limit any inconvenience. The questionnaire 
you will complete at the beginning and end of the study will be administered 
at routine clinic appointments eight weeks apart. When you receive the 
educational package relating to pain management, this will be delivered at a 
place convenient to you and your carer (either at the hospital or in your own 
home depending on your choice).  
What if something goes wrong? 
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If you have any concerns about your participation in the study, contact 
Kennedy Nkhoma, Ekwendeni College of Health Sciences, P.O. Box 49, 
Ekwendeni, phone number: 265991696828. Any issues not appropriately 
addressed by the researcher should be addressed to Dr C. Mwansambo of the 
National Health Sciences Research Committee, P.O. Box 30377, Lilongwe 3, 
Malawi. 
Will my taking part in the study be kept confidential? 
Data will be managed confidentially and securely by the researcher and will 
not be disclosed to anyone at the hospital or elsewhere. You will be given a 
unique number which means it will not be possible for researchers conducting 
the analysis to know the name of the participant. All information collected will 
be kept in a password protected database and will be strictly confidential.  
What will happen to the results of the research study? 
The results of the research study will help to develop educational interventions 
in assessing and managing pain among people living with HIV/AIDS. The 
results will be published in journal articles and conferences and will be written 
as a doctoral thesis. The results will also be shared with Ekwendeni hospital 
and other hospitals in the country which provide home-based care and 
palliative care services. No names and addresses or any personal identifying 
details will be used for publishing the results. 
Who is funding the study? 
The University of Nottingham School of Nursing, Midwifery and Physiotherapy 
and the Malawi Government. The study is being undertaken as a partial 
fulfillment for an educational qualification (PhD). 
Who has reviewed this study? 
The study has been reviewed by the University of Nottingham Medical School 
Ethics Committee and the National Health Sciences Research Committee in 
Malawi. 
What if I want to take part? 
It is very important that you discuss with your family or relevant others about 
taking part in the study. If you decide to take part in the study, please let any 
member of clinic staff know. Your details will be forwarded to Kennedy 
Nkhoma who will contact you at your next appointment. If you are still happy 
to take part you will be asked to complete a consent form. 
Thank you for reading this information sheet 
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University of Nottingham 
School of Nursing, Midwifery and Physiotherapy 
Division of Nursing 
Title of project: Managing pain in HIV/AIDS: 
education for people living with HIV/AIDS and their family carers  
Researchers: Kennedy Nkhoma, Prof. Antony Arthur, Prof. Jane Seymour 
Participant Information Sheet (family carers) 
We would like to invite you to take part in a research study. Before you decide 
whether to take part it is important that you read the information contained 
below. We encourage you to discuss this information with family members or 
friends. Please contact Kennedy Nkhoma (pain education nurse) or one of the 
clinic staff if there is any clarification you need or any information not 
contained within this document. Please take your time to decide whether you 
wish to take part or not in the study. 
Background and purpose of the study? 
The study aims to investigate the effects of an educational intervention on the 
experience of pain and managing pain among people living with HIV/AIDS. We 
know that pain is frequently experienced and difficult to manage in HIV 
infection; we therefore want to assess if providing people living with HIV/AIDS 
and their family carers with a short educational package will help the way pain 
is managed. It is hoped that this in turn will assist in reducing the pain 
experienced. The study will take two months to complete. 
What does the study involve? 
If you agree to take part we will ask you to sign a consent form. Thereafter 
Kennedy Nkhoma (pain education nurse) will conduct a short series of baseline 
assessments through the administration of a questionnaire about your 
experiences and knowledge of caring for someone who has pain. Together with 
the person who you care for, you will then be allocated into one of two groups. 
This allocation is determined by a computer (which has no information about 
participants). This means that you will have a 50% chance of being allocated 
to one particular group. In one group participants will receive health education 
via a face-to-face meeting with Kennedy Nkhoma and you will be given a 
leaflet about pain assessment and management. The other group will receive 
usual care. After eight weeks, when you come to the HIV clinic (accompanied 
by the person you care for) for your routine appointment for HIV medication, a 
staff nurse will conduct follow-up assessments to study participants using the 
same interviewer administered questionnaire used for baseline assessments. If 
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you are allocated to usual care you will still receive the educational package 
about pain, but not until after you have completed the follow-up assessments. 
Why have I been chosen?  
You have been invited to take part in the research study because you are a 
family carer of a person living with HIV/AIDS who is in pain or at risk of 
experiencing pain. We require 179 carers like you to complete the study. 
Do I have to take part? 
It is entirely up to you whether you decide to take part or not. This 
information is given to you to think about in making that decision. Your 
patient will have access to all services at the hospital that you would if you 
were not taking part in the study and regardless of which group you are 
allocated to. You are free to withdraw from the study at any time, you do 
not need to give a reason should you decide to withdraw, and the treatment 
of your patient will not be affected. 
What do I have to do? 
We ask that you take part in the interviewer-administered questionnaire at the 
beginning and end of the study. If you are allocated to the group that initially 
receive the educational package relating to pain, we ask that you do not 
discuss the contents of the leaflet with other patients or family carers who 
may also be in the study. There is no need to alter your lifestyle during the 
duration of your involvement in the study. 
What are the benefits of taking part in the study? 
There are no direct benefits in taking part in the study. However this may be 
an opportunity for you to learn ways of assessing the pain the person you care 
for experiences and how to better manage that pain. 
What are the risks of taking part in the study? 
There are no risks involved if you take part in the study and every effort will 
be made not to inconvenience you or the person you care for.  
Where will the research take place? 
The research has been designed to limit any inconvenience. The questionnaire 
you will complete at the beginning and end of the study will be administered 
at routine clinic appointments eight weeks apart. When you receive the 
educational package relating to pain management, this will be delivered at a 
place convenient to you and the person you care for (either at the hospital or 
in your own home depending on your choice).  
What if something goes wrong? 
302 
 
If you have any concerns about your participation in the study, contact 
Kennedy Nkhoma, Ekwendeni College of Health Sciences, P.O. Box 49, 
Ekwendeni, phone number: 265991696828. Any issues not appropriately 
addressed by the researcher should be addressed to Dr C. Mwansambo of the 
National Health Sciences Research Committee, P.O. Box 30377, Lilongwe 3, 
Malawi. 
Will my taking part in the study be kept confidential? 
Data will be managed confidentially and securely by the researcher and will 
not be disclosed to anyone at the hospital or elsewhere. You will be given a 
unique number which means it will not be possible for researchers conducting 
the analysis to know the name of the participant. All information collected will 
be kept in a password protected database and will be strictly confidential.  
What will happen to the results of the research study? 
The results of the research study will help to develop educational interventions 
in assessing and managing pain among people living with HIV/AIDS. The 
results will be published in journal articles and conferences and will be written 
as a doctoral thesis. The results will also be shared with Ekwendeni hospital 
and other hospitals in the country which provide home-based care and 
palliative care services. No names and addresses or any personal identifying 
details will be used for publishing the results. 
Who is funding the study? 
The University of Nottingham School of Nursing, Midwifery and Physiotherapy 
and the Malawi Government. The study is being undertaken as a partial 
fulfillment for an educational qualification (PhD). 
Who has reviewed this study? 
The study has been reviewed by the University of Nottingham Medical School 
Ethics Committee and the National Health Sciences Research Committee in 
Malawi. 
What if I want to take part? 
It is very important that you discuss with the person you care for and family 
members or relevant others about taking part in the study. If you decide to 
take part in the study, please let any member of clinic staff know. Your details 
will be forwarded to Kennedy Nkhoma who will contact you at your next 
appointment. If you are still happy to take part you will be asked to complete 
a consent form. 
Thank you for reading this information sheet. 
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University of Nottingham  
School of Nursing Midwifery and Physiotherapy 
Division of Nursing 
 
Malonje ghakukhwaksana na kafukufuku 
Mutu wa kafukufuku: Masambiro ghakukhwasyana na umo 
tingamupwelelera mulwali uyo wakupulika ulwilwi chifukwa cha 
matenda gha EDZI 
Bakupanga kafukufuku: Kennedy Nkhoma, Dr Tony Arthur, Professor Jane 
Seymour 
Pakudanga pokelani moni. Talemba kalata uyu kukhumba kumumanyiksani 
kuti tikupanga kafukufuku wa masambiro yakukhwaksana na umo 
tingasamalira munthu uyo wana kachibungu ka EDZI ndipo wakupulika ulwilwi 
muthupi. Sono tati mumanye kuti ndimwe banangwa kutorapo gawo pa 
kafukufuku uyu ndipo mukwenela kudumbiksana na wavwili winu. Pala pali 
chilichose icho mukukhumba kufumba mukhale wakumasuka pakufumba ba 
Kennedy Nkhoma awo wakwendeksa kafukufuku uyu. 
Kasi chakulata cha kafukufuku uyu ntchivichi? 
Chakulata cha kafukufuku uyu ntchakuti tikukhumba kumanya pala 
masambiro kwa banthu awo wakulwala matenda gha EDZI kweniso bavwili 
bawo yangawovwila pakupwelera kweniso kusamalira balwali na kuchepeska 
ulwilwi muthupi. Tikumanya kuti banthu abo wana kachibungu ka EDZI 
kawirikawiri bakupulika kuphwanya na ulwilwi muthupi. 
Kasi kafukufuku wake ngwakuti wuli? 
Pala mwapanga chisankho kuti mutole nawo gawo pa kafukufuku uyu, 
mukwenela kusayina pa kalata. Ndipo Kennedy Nkhoma uyo wakupanga na 
kwendeksa kafukufuku uyu wamufumbeninge mafumbo yakukhwasyana na 
ivyo imwe mukumanyapo paza kuphwanya muthupi, kweniso matenda gha 
EDZI.  
Kufuma apo muzamukhala magulu ghawiri, guru lakwamba lizamupokela 
masambiro kweniso ka buku kakukhwaksana na kusamalira mulwali uyo 
wakupulika ulwilwi. Gulu la chiwiri lizamusambila pala pajumpha miyezi yiwiri, 
ndipo wazamupokelaso ka buku nawoso, kweni pala pajumpha miyesi yiwiri iyi 
mafumbo yala mukafumbika pakwamba yala muzamufumbikaso kuti tione 
pala masambiro yagwila ntchito panji yayi. Ndipo mafumbo aya 
wazamukufumbani ndi dokotala waku Wanangwa clinic. 
Ntchifukwa uli nasankhika? 
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Chifukwa ndimwe yumoza wa awo wakupulika ulwilwi chifukwa cha matenda 
gha EDZI, kweniso chifukwa ndimwe bavwili ba abo wakulwala matenda gha 
EDZI. 
Kasi ntchakuzilwa kutolapo nawo gawo? 
Vyose vili kwa imwe pala mukukhumba kutolapo nawo gawo. Mupange 
chisankho pamoza na wa vwili winu. Sono pala mwazomelezgana kuti 
mutolengepo gawo tikupemphaninge kuti musayine kalata kuti mwapanga 
chisankho kutorapo gawo pa kafukufuku ndipo pala mukukhumba kulekela pa 
nthowa kafukufuku uyu palije sugzo, palije kuchichizgana pakuti ni wanangwa 
winu. 
Kasi phindu la kafukufuku uyu ni vichi? 
Phindu lake pasono pano lingamanyikwa viwi yayi kwa imwe kweni panji 
chingawa chakuzilwa kwa imwe kuti musambile nthowa ziweme zakupwelelera 
mulwali pala wakupulika ulwilwi muthupi 
Kasi ni masuzgo wuli agho ningasangana nagho pala natola gawo pa 
kafukufuku uyu? 
Palije suzgo lililose ilo mungakumana nalo pala mwatolapo gawo pa 
kafukufuku uyu, kweni mukwenela kumanya kuti pazamukhumbika nyengo 
yakuti timufumbeni mafumbo kweniso kuti pazamukhumbika nyengo yakuti 
muzasambile ndipo pala mwasambila muzamupokela ka buku ka masambilo 
ako mwamuwazgila ku nyumba. 
Kweniso awo wali mu gulu lachiwiri wakwenela kulindila miyezi iwiri kuti 
wazapokele masambiro kweniso ka buku ka masambilo. 
Kasi kafukufuku wachitikilenge nkhuni? 
Ku chipatala cha Ekwendeni ku Wanangwa clinic naku chipatala cha Mzuzu 
central ku Rainbow clinic 
Sono pala pali suzgo kwakudandaula ninkhu? 
Pala pali suzgo lililose panji fumbo lililose lakukhwaksana na kafukufuku uyu, 
yimbani phoni pa nambala iyi 0888715056 panji 0991696828, kuti muyowoye 
na Kennedy Nkhoma. Pala mundawovwilike yimbani ku likulu lakuona 
kafukufuku ku Lilongwe pa nambala iyi 0999218630 kuti muyowoye na a Mr 
Bob Majamanda. 
Sono kasi chisisi chilipo? 
Mazina ghose ghazamugwilisyika ntchito yayi, ndipo pakuthandazga 
kafukufuku uyu tizamugwiliksa ntchito mazina yayi.  
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Sono kasi ivyo mwasanga pa kafukufuku uyu muzamuchita navyo uli? 
Vyose ivyo tizamusanga pa kafukufuku uyu, vizamuvwila kuti wanthu wose 
awo wana matenda gha EDZI wasambizgikenge ku chipatala umo 
wangasamalira balwali awo wakupulika ulwilwi ku nyumba. 
Kasi mbanjani awo wakupanga kafukufuku uyu 
Sukulu ya univesite yaku Engilande mwakovwilana na boma la Malawi, ndipo 
kafukufuku uyu wakulongozgeka na mwana wa sukulu ku Engilande. 
Kasi kafukufuku uyu wamuzomelezga? 
Inya bungwe lakuona za kafukufuku muno mu Malawi laku Ministry ya Health, 
kweniso bungwe lakuona za kafukufuku ku sukulu yaku Engilande wose 
wawunika nakuzomelezga kafukufuku uyu. 
Kasi pala tapanga chisankho kuti titole nawo gawo tichite uli? 
Pala mukukhumba kutolapo gawo chakudanga waphalileni wa vwili winu ndipo 
mukwenela kuzomelezgana. Pala mwapulikana wamanyikseni a Kennedy 
Nkhoma panji waliyose uyo mwamusanga ku Wanangwa clinic. 
Tamuwongani chomene pakuwelenga kalata uyu. 
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Appendix 2 Consent forms (for patients and carers) 
 
University of Nottingham  
School of Nursing Midwifery and Physiotherapy 
Division of Nursing 
Title of project: Managing pain in HIV/AIDS: education for people 
living with HIV/AIDS and their family carers  
Researchers: Kennedy Nkhoma, Prof. Antony Arthur, Prof. Jane 
Seymour 
Consent form (for people living with HIV/AIDS) 
Please read this form and sign it if you wish to participate in the study. 
 
 
 
 
 
 
 
 
  
I voluntarily agree to participate in the study.  
I confirm that I have been given a full explanation by the 
researcher. I have read and understood the information 
sheet. 
 
I have had the opportunity to ask questions and discuss the 
aims of the study with the researcher and I have understood 
the information and advice given as a result. 
 
I agree to comply with the reasonable instructions of the 
supervising investigator and will notify him immediately of 
any unexpected unusual symptoms or deterioration of health. 
 
I agree to use the results from the study in published reports, 
and presentations. 
 
I understand that my personal details will not be included in 
the results and publication or any other output from the 
research. 
 
I understand that information about me recorded during the 
study will be kept in a secure database. If data is transferred 
to others it will be made anonymous. Data will be kept for 7 
years after the results of this study have been published. 
 
I understand that I can ask for further clarification at any 
time. 
 
I understand that I can withdraw from the study at any given 
time without giving any reason. 
 
I confirm that I have disclosed relevant medical information 
before the study. 
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Name: «««««««««««««««««««««««««««««««««« 
$GGUHVV«««««««««««««««««««««««««««««««« 
Telephone number: «««««««««««««««««««««««««« 
6LJQDWXUH««««««««««««««««'DWH«««««««««« 
I confirm that I have fully explained the purpose of the study and what is 
involved to: 
««««««««««««««««««««««««««««««««««««««« 
 
I have given the above named a copy of this form together with the 
information sheet. 
,QYHVWLJDWRUV6LJQDWXUH«««««««««'DWH«««««««««««« 
,QYHVWLJDWRUV1DPH««««««««««««««««««««««««««««««««««« 
6WXG\9ROXQWHHU1XPEHU««««««««««««««««««««««««« 
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University of Nottingham  
Schoolof Nursing Midwifery and Physiotherapy 
Division of Nursing 
Chiphaso chakuzomelezga kuchita nawo kafukufuku 
Mutu wa kafukufuku: Masambiro ghakukhwaksana na umo 
tingamupwelelera mulwali uyo wakupulika ulwilwi chifukwa cha 
matenda gha EDZI 
Bakupanga kafukufuku: Kennedy Nkhoma, Profesa Tony Arthur, Profesa 
Jane Seymour 
Chonde welengani ndipo masayinile pala mwazomela kutola nawo gawo pa 
kafukufuku 
 
  
Ine napanga chisankho pandekha kutola nawo gawo pa kafukufuku. 
 
 
Nkhusimikizga kuti ndapokela uthenga wakwenelera na wakukwana wakukhwaksana na 
kafukufuku ndipo napulikiksa makola 
 
Nkhapika mwabi na mpata wakufumba mafumbo kwa awo wakupanga kafukufuku uyu 
chomene chomene kukhwaksana na chakulata cha kafukufuku. 
 
 
 
Nkhuzomela kulondezga malamgo gha kafukufuku uyu ndipo nkhusimikizga kuti 
ndizamuwaphalira awo wakwendeksa kafukufuku uyu pala kalikose kaheni kanisanga 
 
 
Nkhuzomela kuti ivyo kafukufuku uyu bazasanga wazalengezge kuti vizawovwile 
kusamalira walwali wanyakhe munthazi 
 
 
Ndine wakupulikiksa kuti wamugwiliksa ntchito zina lane yayi pakulengeza kafukufuku 
uyu 
 
 
Ndine wakupulikiksa kuti vyose vyakukhwaksana na kafukufuku uyu wamusungika mwa 
chisisi vyose ivyo tamudumbiksana 
 
Ndapulikiksa kuti ningafumba chilichose icho nindapulikikse kukhwaksana na kafukufuku 
uyu nyendo yili yose 
 
 
Ndine wakupulikiksa kuti ndingalekezga pa nthowa nyengo yili yose pala nakhumba 
 
 
Nkhuzomelezga kuti ndiyowoyenge matenda ghane kwa awo wakupanga kafukufuku 
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=LQDODPXOZDOL«««««««««««««««««««««««««« 
6LJLQHFKD«««««««««««««'D]L««««««««««««« 
$GGUHVV««««««««««««««3KRQHQXPEHU«««««««««« 
 =LQDODZDNXSDQJDNDIXNXIXNX«««««««««««««««««««««« 
 6LJLQHFKD«««««««««««'D]L«««««««««««««« 
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University of Nottingham  
School of Nursing Midwifery and Physiotherapy 
Division of Nursing 
 
Title of project: Managing pain in HIV/AIDS: education for people 
living with HIV/AIDS and their family carers  
Researchers: Kennedy Nkhoma, Professor Antony Arthur, Prof. Jane Seymour 
Consent form (for family carers) 
Please read this form and sign it if you wish to participate in the study. 
 
  
I voluntarily agree to participate in the study. 
 
 
I confirm that I have been given a full explanation by the researcher. I have read and 
understood the information sheet. 
 
I have had the opportunity to ask questions and discuss the aims of the study with 
the researcher and I have understood the information and advice given as a result. 
 
I agree to comply with the reasonable instructions of the supervising investigator and 
will notify him immediately of any unexpected unusual symptoms or deterioration of 
health. 
 
I agree to use the results from the study in published reports, and presentations. 
 
 
I understand that my personal details will not be included in the results and 
publication or any other output from the research. 
 
I understand that information about me recorded during the study will be kept in a 
secure database. If data is transferred to others it will be made anonymous. Data will 
be kept for 7 years after the results of this study have been published. 
 
I understand that I can ask for further clarification at any time. 
 
 
I understand that I can withdraw from the study at any given time without giving any 
reason. 
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Name: «««««««««««««««««««««««««««««««««« 
$GGUHVV«««««««««««««««««««««««««««««««« 
7HOHSKRQHQXPEHU«««««««««««««««««««««««««««« 
6LJQDWXUH««««««««««««««««'DWH«««««««««««« 
 
I confirm that I have fully explained the purpose of the study and what is 
involved to: 
««««««««««««««««««««««««««««««««««««« 
I have given the above named a copy of this form together with the 
information sheet. 
 
,QYHVWLJDWRUV6LJQDWXUH«««««««««'DWH«««««««««««« 
,QYHVWLJDWRUV1DPH««««««««««««««««««««««««««««««««««« 
StuG\9ROXQWHHU1XPEHU««««««««««««««««««««««««« 
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University of Nottingham  
School of Nursing Midwifery and Physiotherapy 
Division of Nursing 
 
Chiphaso chakuzomelezga kuchita nawo kafukufuku 
Mutu wa kafukufuku: Masambiro ghakukhwaksana na umo 
tingamupwelelera mulwali uyo wakupulika ulwilwi chifukwa cha 
matenda gha EDZI 
Bakupanga kafukufuku: Kennedy Nkhoma, Profesa Tony Arthur , Profesa 
Jane Seymour 
Chonde welengani ndipo masayinile pala mwazomela kutola nawo gawo pa 
kafukufuku. 
 
  
Ine napanga chisankho pandekha kutola nawo gawo pa kafukufuku.  
Nkhusimikizga kuti ndapokela uthenga wakwenelera na wakukwana wakukhwaksana na 
kafukufuku ndipo napulikiksa makola 
 
Nkhapika mwabi na mpata wakufumba mafumbo kwa awo wakupanga kafukufuku uyu 
chomene chomene kukhwaksana na chakulata cha kafukufuku. 
 
 
 
Nkhuzomela kulondezga malamgo gha kafukufuku uyu ndipo nkhusimikizga kuti 
ndizamuwaphalira awo wakwendeksa kafukufuku uyu pala kalikose kaheni kanisanga 
 
 
Nkhuzomela kuti ivyo kafukufuku uyu bazasanga wazalengezge kuti vizawovwile kusamalira 
walwali wanyakhe munthazi 
 
 
Ndine wakupulikiksa kuti wamugwiliksa ntchito zina lane yayi pakulengeza kafukufuku uyu  
Ndine wakupulikiksa kuti vyose vyakukhwaksana na kafukufuku uyu wamusungika mwa 
chisisi vyose ivyo tamudumbiksana 
 
Ndapulikiksa kuti ningafumba chilichose icho nindapulikikse kukhwaksana na kafukufuku uyu 
nyendo yili yose 
 
Ndine wakupulikiksa kuti ndingalekezga pa nthowa nyengo yili yose pala nakhumba  
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   6LJLQHFKD««««««««««««««'D]L«««««««««««««««« 
   $GGUHVV«««««««««««««3KRQHQXPEHU«««««««««««««« 
   =LQDODZDNXSDQJDNDIXNXIXNX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   6LJLQHFKD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Appendix 3: Check list for eligibility 
 
 
 
 
 
 
 
 
 
 
 
  
Inclusion criteria for patients 
 
  
Diagnosis of HIV/AIDS?  
 
 
Aged 18 years and above? 
 
 
Catchment area 20km radius? 
 
 
Stage III or IV HIV/AIDS or CD4 <350 
 
 
Able to read English or Tumbuka? 
 
 
Inclusion criteria for family carers 
 
 
Primary family carer for the patient?   
 
 
Aged 18 years and above?                 
 
 
Able to read English or Tumbuka?   
 
 
Do you stay/live with the patient?      
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Appendix 4: Demographic data for study participants 
Patient characteristics 
3DWLHQWQDPH«««««««««««««««««««««««««««««««« 
'DWHRIELUWKDJH«««««««««««««««««««««««««««««« 
*HQGHU«««««««««««««««««««««««««««««««««««« 
5HOLJLRQ««««««««««««««««««««««««««««««««««« 
2FFXSDWLRQ««««««««««««««««««««««««««««««««« 
$GGUHVV««««««««««««««««««««««««««««««««««« 
6RXUFHRIUHIHUUDO««««««««««««««««««««««««««««« 
'DWHRIUHIHUUDO«««««««««««««««««««««««««««««« 
'DWHRILQLWLDODSSURDFK««««««««««««««««««««««««« 
&XUUHQWWUHDWPHQW«««««««««««««««««««««««««««« 
&OLQLFDOVWDJHRI+,9$,'6«««««««««««««««««««««««« 
Co-PRUELGLW\«««««««««««««««««««««««««««««««« 
 
&DUHUV¶FKDUDFWHULVWLFV 
&DUHUV¶QDPH«««««««««««««««««««««««««««««««« 
'DWHRIELUWKDJH««««««««««««««««««««««««««««« 
*HQGHU««««««««««««««««««««««««««««««««««« 
5HOLJLRQ«««««««««««««««««««««««««««««««««« 
2FFXSDWLRQ«««««««««««««««««««««««««««««««« 
$GGUHVV«««««««««««««««««««««««««««««««««« 
CDUHU¶VUHODWLRQVKLSZLWKWKHSDWLHQW««««««««««««««««« 
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Appendix 5 Brief Pain Inventory 
 
 
Date: ----------------------------------------------- 
Participant Number ------------------------------ 
1. on the diagram, shade in the areas where you feel pain. Put an X on the 
area  that hurts most. 
 
1. Please rate your pain by circling the one number that best 
describes your pain at its worst in the last week. 
0 1 2 3 4 5 6 7 8 9 10 
No pain                          Pain as bad as you can imagine 
2.      Please rate your pain by circling the one number that best describes 
your pain at its least in the last week. 
0 1 2 3 4 5 6 7 8 9 10 
No pain                               Pain as bad as you can imagine 
3.       Please rate your pain by circling the one number that best describes 
your pain on average. 
0 1 2 3 4 5 6 7 8 9 10 
No pain                               Pain as bad as you can imagine 
4. Please rate your pain by circling the one number that tells how much pain 
you have right now. 
0 1 2 3 4 5 6 7 8 9 10 
No pain                                Pain as bad as you can imagine 
5. What treatments or medications are you receiving for your pain
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7.In the last week, how much relief have pain treatments or medications 
provided? Please circle the one percentage that best shows how much relief 
you have received. 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90% 100% 
No relief                                    Complete relief 
8.Circle the one number that describes how, during the past week, pain has 
interfered with your: 
a.    General activity 
0 1 2 3 4 5 6 7 8 9 10 
Does not interfere                                  Completely interferes 
b.    Mood 
0 1 2 3 4 5 6 7 8 9 10 
c.    Walking ability 
0 1 2 3 4 5 6 7 8 9 10 
d.     Normal work (includes both outside the home and housework) 
0 1 2 3 4 5 6 7 8 9 10 
e.    Relations with other people 
0 1 2 3 4 5 6 7 8 9 10 
f .    Sleep 
0 1 2 3 4 5 6 7 8 9 10 
g.   Enjoyment of life 
0 1 2 3 4 5 6 7 8 9 10 
Does not interfere                           Completely interferes 
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Date: ----------------------------------------------- 
Participant Number ------------------------------ 
1. Pa chipikichala ichi longolani ndipo lembani apo mukupulika ulwilwi. 
 
2. Sankhani mulingo wa ulwilwi (kuwinya chomone) umo 
mwajipulikilanga sabata yamalanga iyi 
0 1 2 3 4 5 6 7 8 9 10 
No ulwilwi                              kuwinya chomene nkhanila 
3. Sankhani mulingo wa ulwilwi (kuwinya kachoko) umo mwajipulikilanga 
sabata yamalanga iyi 
0 1 2 3 4 5 6 7 8 9 10 
No ulwilwi                              kuwinya chomene nkhanila 
4. Sankhani mulingo wa ulwilwi (kuwinya mwa pakatikati) umo 
mwajipulikilanga mu sabata yamala iyi 
0 1 2 3 4 5 6 7 8 9 10 
No ulwilwi                               kuwinya chomene nkhanila 
5. Sankhani mulingo wa ulwilwi umo mukujipulikila pasono pano 
 
0 1 2 3 4 5 6 7 8 9 10 
 No ulwilwi                              kuwinya chomene nkhanila                                               
6. Pasono pano mukupokela mankhwala wuli yakumazga ulwilwi?
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7.Sankhani nambala iyo yikulongola mulingo wa ovwili uwo mankhawala 
yakupozga ulwilwi yagwilira ntchito muthupi mwinu 
0% 10%  20%  30%  40%  50%   60%   70%   80%   90% 100% 
Yawovwila yayi                                Yawovwila chomene                                             
8.Sankhani nambala iyo yikulongola umo ulwilwi muthupi 
wangumutimbanizgilani pa vinthu ivi mu sabata yamala iyi: 
h. Ntchito zakupambana pambana 
0 1 2 3 4 5 6 7 8 9 10 
Zangutimbanizgikayayi             zangutimbanizgika chomene                                
Maghanoghano mumutu? 
0 1 2 3 4 5 6 7 8 9 10 
Yayi                                           chomene                      
i . Pakwenda 
0 1 2 3 4 5 6 7 8 9 10  
j . Mulimo yapanyumba  
0 1 2 3 4 5 6 7 8 9 10 
k. Kuchezga kweneso pa makhaliro na wanyane wose 
0 1 2 3 4 5 6 7 8 9 10 
l .  Pa ugonero(kugona tulo) 
0 1 2 3 4 5 6 7 8 9 10 
m. Kukondwela na umoyo 
 0    1 2 3 4 5 6 7 8 9 10 
Nangutimbanizgikayayi             vangunitimbanizga chomene                
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Appendix 6 Patient Pain Questionnaire 
 
Below are a number of statements about cancer pain/HIV/AIDS pain and 
pain relief. Please circle a number on the line to indicate your response. 
Knowledge 
1. HIV/AIDS/Cancer pain can be effectively relieved. 
Agree 0  1  2  3   4 5 6  7   8  9 10 disagree 
2. Pain medicines should be given only when pain is severe. 
Disagree 0  1  2   3  4 5   6   7 8  9  10 agree 
3. Most AIDS/cancer patients on pain medicines will become addicted 
to the medicines over time. 
Disagree 0  1 2  3  4  5   6  7   8    9   10   agree 
4. It is important to give the lowest amount of medicine possible to 
save larger doses for later when the pain is worse. 
Disagree 0   1  2   3   4   5   6  7     8   9  10   agree 
5. It is better to give pain medications around the clock (on a 
schedule) rather than only when needed. 
Agree 0  1  2 3 4 5   6   7  8  9  10    disagree 
6. Treatments other than medications (such as massage, heat, 
relaxation) can be effective for relieving pain. 
Agree 0  1  2  3   4   5  6  7  8 9  10 disagree 
7. Pain medicines can be dangerous and can often interfere with 
breathing. 
Disagree 0   1 2 3 4  5 6  7 8  9 10 agree 
8. Patients are often given too much pain medicine. 
Disagree 0   1 2  3  4 5  6  7  8   9 10 agree 
9. If pain is worse, the cancer/ AIDS must be getting worse. 
 321 
 
Disagree 0  1 2  3  4 5 6 7 8  9 10 agree 
 
Experience 
10. Over the past week, how much pain have you had? 
No pain  0 1  2  3 4  5  6  7 8  9  10 a great deal 
11. How much pain are you having now? 
No pain  0 1  2  3  4   5  6 7 8   9  10 a great deal 
12. How much pain relief are you currently receiving? 
A great deal 0 1 2  3 4  5 6  7 8  9 10 no relief 
13. How distressing is the pain to you? 
Not at all 0  1  2   3 4   5  6   7   8     9   10 extremely 
14. How distressing is your pain to your family members? 
Not at all 0  1  2  3 4 5  6  7  8   9  10 extremely 
15. To what extent do you feel you are able to control your pain? 
Extremely 0   1 2  3  4 5 6  7  8  9 10 not at all 
16. What do you expect will happen with your pain in the future? 
Pain will  0   1 2  3  4 5  6  7  8  9   10 pain will 
get better                                  get worse 
Sono apa tiwonenge vinji mwa vinthu ivyo wanthu wakuyowoya 
vyakukhwaksana na matenda gha kachibungu ka EDZI. 
Ivyo mukumanyapo (Knowledge) 
1 Ulwilwi wa matenda gha EDZI/kansa ungapozgeka. 
Nkhuzomelezga 0 1  2 3  4 5  6 7  8   9  10   Nkhusuksa   
2 Mankhwala yakupozga ulwilwi yapelekeke kwa mulwali pala ulwilwi 
wakwela chomene. 
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Nkhusuksa 0  1  2  3   4  5 6   7  8  9  10   Nkhuzomelezga                
3 Walwali awo wakupokera mankhwala yakupozga ilwilwi kanandi 
kanandi wangakhala yayi kwambula mankhwala chifukwa wakuzgowela 
kukhalira mankhwala pela 
Nkhusuksa 0  1  2  3  4  5   6  7  8  9  10  Nkhuzomelezga        
4  Mankwala yakupozga ulwilwi timupenge mulwali pala ulwilwi 
wakwela chomene 
Nkhusuksa 0  1  2  3  4  5  6  7  8  9  10  Nkhuzomelezga      
5 Ntchiwemi kupereka mankhwala kulingana na nyengo kulekana na 
kulindira kuti ulwilwi uyambe 
Nkhuzomelezga 0  1  2   3 4  5  6  7 8  9  10  Nkhusuksa 
6 Nthowa zinyakhe nthena kukhanda na kasalu ka maji, kunyolora 
malundi, kuchita ma ekisasaizi vikovwila kupozga ulwilwi 
Nkhuzomelezga 0 1  2 3 4  5  6  7   8   9  10  Nkhusuksa  
7 Mankhwala yakupozga ulwilwi yakupangiksa kuti mulwali pala 
wamwa watondeke kuthutha makola 
Nkhusuksa  0  1  2 3  4  5 6 7 8   9   10  Nkhuzomelezga 
8 Kanandi kanandi walwali wakupokela mankwala yanandi chomene 
yakupozga ulwirwi 
Nkhusuksa 0  1  2  3  4  5  6 7 8  9  10   Nkhuzomelezga 
 
Umo mwajipulikilanga 
9 Pala ulwilwi wakwela chomene nikuti EDZI nayo yafala chomene 
Nkhusuksa 0 1  23  4  5  6  7  8 9 10 Nkhuzomelezga 
10 Musabata yamala iyi mwapulika ulwilwi wuli? Sankhani nambala 
yimoza apa 
No ulwilwi  0  1  2  3  4  5  6  7 8  9  10  Ulwilwi chomene 
11 Pasono pano mukupulika mulingo wuli wa ulwilwi, sankhani 
nambala yimoza apa? 
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No ulwilwi  0  1  2  3 4  5  6  7 8  9 10  Ulwilwi chomene 
12 Kasi mankhwala yakupozga ulwilwi yakumuwovwilani? 
Yakovwilachomene 0 1  2  3  4  5  6 7  8 9 10  yayi 
13 Kasi ulwilwi ukumupani maghanoghano imwe? 
Yayi 0  1   2  3   4  5   6   7   8   9   10  chomene 
14 Kasi ulwilwi ukuwapa maghanoghano wabale winu na wavwili winu? 
Yayi 0  1  2  3    4   5 6  7  8  9 10 chomene 
15 Kasi pa imwe mwekha mukukwaniksa kujiwovwila kuti ilwilwi upole 
muthupi mwinu? 
Nkhukwaniksa 0   1 2  3   4  5  6  7   9 10 Nkhukwaniksa 
yayi 
16 Kasi munthazi ulwilwi winu upolenge umo mukuwonela imwe? 
Inya upolenge 0 1  2 3  4 5  6 7   8    9   10 Yayinthe   
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Appendix 7: APCA African POS 
 
 
 
  
ASK THE PATIENT 
Q1.Please rate your pain (from 0 = no pain to 5 = 
worst/overwhelming pain) during the last 3 days 
0 (no pain) 
- 5 (worst/overwhelming pain) 
Q2. Have any other symptoms (e.g. nausea, coughing 
or constipation) been affecting how you feel in the last 
3 days? 
0 (not at all) 
- 5 (overwhelmingly) 
Q.3 Have you been feeling worried about your illness 
in the past 3 days? 
0 (not at all) 
- 5 (overwhelming worry) 
Q.4 Over the past 3 days, have you been able to 
share how you are feeling with your family or friends? 
0 (not at all) 
- \HV,¶YHWDONHGIUHHO\ 
Q5. Over the past 3 days have you felt that life was 
worthwhile? 
0 (no, not at all) 
- 5 (Yes, all the time) 
Q6. Over the past 3 days, have you felt at peace? 0 (no, not at all) 
- 5 (Yes, all the time) 
Q7. Have you had enough help and advice for your 
family to plan for the future? 
0 (not at all) 
- 5 (as much as wanted) 
ASK THE FAMILY CARER 
Q.8 How much information have you and your family 
been given? 
0 (none) 
- 5 (as much as wanted) 
N/A 
Q9. How confident does the family feel caring for 
____? 
0 (not at all) 
- 5 (very confident) 
N/A 
Q.10 Has the family been feeling worried about the 
Client over the last 3 days? 
0 (not at all) 
- 5 (severe worry) 
N/A 
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African palliative care scale 
Q1 Yowoyani mulingo wa ulwilwi (0 = no ulwilwi to 5 = kuwinya chomene) pa 
madazi yatatu yaluta agha? 
[ ] 0 No ulwilwi 
[ ] 1 Pachoko waka mwakuti nkhughanaghanako yayi 
[ ] 2 Ulwilwi wapachoko mwakuti nkhutondeka tumilimo tunyakhe  
[ ] 3 Ulwilwi ukuluko mwakuti nkhutondeka milimo 
[ ] 4 Ulwilwi ukulu mwakuti nkhutondeka milimo kweneso kuteghelezga 
nkhutondeka 
[ ] 5 Ulwilwi ukulu chomene nkhanila, nkhutondeka kuchita chilichose 
Q2 Kasi mwanguwapo na masuzgo ghalighose nthena agha (muselu, 
kubokola, chikhose) mumadazi yatatu yaluta agha? 
0 Yayi 
1 Pachoko waka,  
2 Mwapakatikati,  
3 Chomene,  
4 Chomene mwakujumphizga,  
5 chomene mwakuti natondekanga kuchita mulimo 
Q3. Kasi mwanguwa na maghanoghano/kukhumudwa na matenda ghinu 
pa madazi tatatu yaluta agha?  
[ ] 0 Yayi 
[ ] 1 Panyengopanyengo 
[ ] 2 Panyengopanyengo mwakuti nkhutondeka kuti nichite milimo makola 
[ ] 3 Nyengo yili yose maghanoghano mwapakati kati 
[ ] 4 nyengo yilo yose maghanoghano yanandiko 
[ ] 5 maghanoghano yakulu nadi, nyengo yili yose 
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Q4. Kasi mwawaphalirapo umo mukujipulikila na maghanoghano 
wanyinu/wanwezi kweneso wachibale winu? 
[ ] 0 Yayi  
[ ] 1 Pachoko waka  
[ ] 2 Enya pakuti wakanifumba 
[ ] 3 Enya kwene wangupulikiksa yayi 
[ ] 4 Enya ndipo wangupulikiksa chomene 
[ ] 5 Enya nanguwaphalira mwakumasuka chomene, ndipo wangupulikiksa 
Q5. Pa madizi yatatu yaluta agha mwangujipulika kuti umoyo nguwemi, panji 
mwangujipulika makola? 
[ ] 0 Yayi nthe 
[ ] 1 Pa choko waka 
[ ] 2 Munyengo-munyengo 
[ ] 3 Nyengo zinyakhe enya 
[ ] 4 Enya nyengo zose 
[ ] 5 Enya nyengo zose, chomene nkhanila 
Q6. Kasi pa madazi yatatu yaluta aya mwangukhala mwa mtende?  
[ ] 0 Yayi 
[ ] 1 panyengo panyengo/patali patali 
[ ] 2 Nyengo zinyakhe enya 
[ ] 3 Enya mwakukwanira 
[ ] 4 Enya yengo zinandi 
[ ] 5 Enya chomene, nyengo zose 
Q7. Kasi mwapokela wovwili na malangizo na banja linu za umo mungakhalira 
umoyo wa munthazi? 
 [ ] 0 Yayi 
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 [ ] 1 panyengo, panyengo/ mwapatali patali 
 [ ] 2 Enya nyengo zinyakhe 
 [ ] 3 Enya mwakukwanira 
 [ ] 4 Enya, nyengo zinandi 
 [ ] 5 Enya chomene umo nkhukhumbila 
Q8. Kasi mwapokelapo visambizgo vyakukwana imwe na walwali winu?  
[ ] 0 Yayi 
[ ] 1 Enya, panyengo panyengo,  
[ ] 2 Enya nyengo zinyakhe,  
[ ] 3 Enya kwene mwakukhanila yayi,  
[ ] 4 Enya mwakukwanila  
[ ] 5 Enya chomene mwakukwanila umo nkhukhumbila 
Q9. Kasi ndimwe wakulimba mtima ndiposo wakukhwima kupwelera mulwali 
winu? 
[ ] 0 Yayi 
[ ] 1 pachoko weka  
[ ] 2 enya nyengo zinyakhe kwene mwakukayikila chomene , 
[ ] 3 Enya kwene mwakukayikila pachoko,  
[ ] 4 Enya, 
[ ] 5 Enya chomene 
Q10. Kasi mwanguwapo na maghanoghano chifukwa cha matenda gha mulwali 
winu pa madazi ghatatu ghaluta agha?  
[ ] 0 Yayi,  
[ ] 1 panyengo, panyengo,  
[ ] 2 Enya nyengo zinyakha- 
[ ] 3 Enya, nyengo zose,  
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[ ] 4 Enya, chomene  
[ ] 5 Enya chomene nkhanila, nkhukhalira waka maghonghano 
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Appendix 8 Family Pain Questionnaire 
Below are a number of statements about HIV/AIDS/cancer pain and pain 
relief. Please circle a number on the line to indicate your response. 
Knowledge 
1. Cancer pain can be effectively relieved. 
Agree 0  1   2  3   4 5  6  7  8   9   10  disagree 
2. Pain medicines should be given only when pain is severe. 
Disagree 0  1 2  3   4 5   6   7 8  9 10 agree 
3. Most cancer patients on pain medicines will become addicted to the 
medicines over time. 
Disagree 0   1   2   3   4   5    6   7  8    9   10 agree 
4. It is important to give the lowest amount of medicine possible to 
save larger doses for later when the  pain is worse. 
Disagree 0  1  2  3   4  5  6  7   8     9     10 agree 
5. It is better to give pain medications around the clock (on a 
schedule) rather than only when needed. 
Agree 0 1 2  3   4 5 6 7   8   9   10 disagree 
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6. Treatments other than medications (such as massage, heat, 
relaxation) can be effective for relieving pain. 
Agree 0   1  2    3  4   5  6   7  8   9   10  disagree 
7. Pain medicines can be dangerous and can often interfere with 
breathing. 
Disagree 0  1 2 3  4  5  6     7   8    9    10 agree 
8. Patients are often given too much pain medicine. 
Disagree 0  1 2  3   4  5  6   7   8   9    10  agree 
9. If pain is worse, the cancer must be getting worse. 
Disagree 0   1   2    3  4   5   6   7  8  9 10  agree 
Experience 
10. Over the past week, how much pain do you feel your family member 
has had? 
No pain 0 1   2   3  4  5  6   7 8   9  10 a great deal 
11. How much pain is your family member having now? 
No pain 0  1 2   3   4  5  6  7 8  9   10 a great deal 
12. How much pain relief is your family member currently receiving? 
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a great deal  0  1   2  3  4   5  6   7    8   9   10 no relief 
13. How distressing do you think the pain is to your family member? 
Not at all 0  1   2  3  4  5   6  7  8     9    10 a great deal 
14. How distressing is your family members' pain to you? 
Not at all 0  1   2 3  4 5   6   7  8  9   10 a great deal 
15. To what extent do you feel you are able to control the patient's pain? 
a great deal 0  1 2  3  4  5  6   7   8    9    10 not at all 
16. What do you expect will happen with your family member's pain in 
the future? 
will get better 0 1  2  3  4  5 6 7 8 9 10 will get worse 
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Mafumbo kwa wabale wa mulwali panji wovwili wa mulwali 
Ivyo mukumanyapo pa matenda gha EDZI (Knowledge) 
1 Ulwilwi wa matenda gha kansa/EDZI ungapozgeka. 
Nkhuzomelezga  0  1  2 3 4 5  6  7  8 9  10    Nkhusuksa  
2 Mankhwala yakupozga ulwilwi yapelekeke kwa mulwali pala ulwilwi 
wakwela chomene. 
Nkhusuksa  0  1  2 3  4  5  6  7  8  9  10  Nkhuzomelezga    
3 Walwali awo wakupokela mankhwala wakupozga ilwilwi kanandi kanandi 
wangakhala yayi kwambula kumwa mankhwala chifukwa wakuzgowela 
kukhalira mankhwala pela 
Nkhusuksa 0  1  2  3  4  5  6 7  8  9 10  Nkhuzomelezga        
4 Ntchiwemi kusunga mankwala ndipo kuti timupe mulwali pala ulwilwi 
wakwela chomene 
Nkhusuksa 0  1   2 3  4 5 6  7  8  9  10   Nkhuzomelezga     
Ntchiwemi kupereka mankhwala kulingana na nyengo kulekana na 
kupereka pala ulwilwi wayamba 
Nkhuzomelezga 0  1 2 3 4  5 6  7 8  9  10   Nkhusuksa 
5 Ntchowa zinyakhe nthena kukhanda na kasalu ka maji, kunyolora malundi, 
kuchita ma ekisasaizi vikovwila kupozga ulwilwi 
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Nkhuzomelezga 0 1  2 3  4 5  6 7  8   9    10  Nkhusuksa  
6 Mankhwala yakupozga ulwilwi yakupangiksa kuti mulwali pala wamwa 
watondeke kuthutha makola 
Nkhusuksa  0  1  2 3  4  5 6  7  8  9  10   Nkhuzomelezga 
7 Kanandi kanandi walwali wakupokela mankwala yanandi chomene 
yakupozga ulwirwi 
Nkhusuksa 0  1  2  3  4  5 6   7   8   9  10   Nkhuzomelezga 
8 Pala ulwilwi wakwela chomene nikuti EDZI nayo yafala chomene muthipi 
Nkhusuksa 0 1  2  3  4  5  6  7  8   9  10  Nkhuzomelezga 
Ivyo mwaviwona pa mulwali winu (Experience) 
10 Musabata yamalanga iyi, kasi mulwali winu wangupulika ulwilwi wa 
mulingo wuli? 
No ulwilwi 0  1 2 3 4 5  6  7    8    9    10 Ulwilwi chomene 
11 Pasono pano mulwali winu wana ulwilwi wa mulingo wuli? 
 No ulwilwi 0  1  2  3  4  5  6  7  8   9 10 Ulwilwichomene 
12 Kasi mankhwala yakupozga ulwilwi yakovwila uli? 
 Chomene 0   1 2  3 4  5 6  7  8    9  10  yakovwilayayi 
13 Kasi ulwilwi ukumupasa maghanoghano mulwali winu? 
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Yayi 0  1   2  3   4 5   6     7    8  9  10   chomene 
14  Kasi ulwilwi wa mulwali winu ukumupani maghanoghani imwe? 
Yayi 0   1  2 3 4  5  6 7  8  9  10  chomene 
15  Kasi pa imwe mwekha mukukwaniksa kupozga ulwilwi wa mulwali winu? 
Chomene 0  1  2  3  4 5  6  7   8  9    10  Yayinthe 
16 Kasi mukuwona kuti ulwilwi wa mulwali winu muthazi umu upolenge? 
Ulwilwi upolenge 0   1  2  3 4  5 6   7   8   9 10  ulutililenge 
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Appendix 9 Picot caregiver Rewards Scale 
 
Now I'd like to talk to you about some of the ways people feel about 
caring for another person. Please tell me how you feel now about 
caring for your [SPOUSE]. Choose only one answer for each statement 
from the following: A great deal [4], Quite a lot [3], Somewhat [2], A 
little [1], or Not at all [0]. 
 
  Great deal Quite a 
lot 
Some 
what 
A 
little 
 
Not at 
all 
1. I feel God will bless me. 4 3 2 1 0 
2. I feel better about myself. 4 3 2 1 0 
3. I feel I have become a stronger, tolerant, 
and/or patient person around persons with 
sickness or handicaps. 
 
4 
 
3 
 
2 
 
1 
 
0 
4. I feel having others say that taking care of 
my spouse is the right thing to do is 
important 
 
4 
 
3 
 
2 
 
1 
 
0 
5. I feel someone will take care of me when I 
need it. 
 
4 
 
3 
 
2 
 
1 
 
0 
6. I feel receiving a smile, touch, or eye 
contact from my [spouse] is important. 
 
4 
 
3 
 
2 
 
1 
 
0 
7. I feel I have a closer relationship with my 
[spouse]. 
 
4 
 
3 
 
2 
 
1 
 
0 
8. I feel I have become a better person by 
learning new information. 
 
4 
 
3 
 
2 
 
1 
 
0 
9. I feel I have become a better person by 
learning new ways to care for my spouse. 
 
4 
 
3 
 
2 
 
1 
 
0 
10. I feel that I have made many new friends. 4 3 2 1 0 
11. I feel more important. 4 3 2 1 0 
12. I feel I have the freedom to make 
decisions that matter. 
 
4 
 
3 
 
2 
 
1 
 
0 
13. I feel that receiving praise and admiration 
for my efforts from doctors, nurses and 
social workers is important. 
 
4 
 
3 
 
2 
 
1 
 
0 
14. I feel happier now that I did before I 
started caring for my [spouse]. 
 
4 
 
3 
 
2 
 
1 
 
0 
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15. I feel that caring for my [spouse] has 
made our family grow and work closer 
together. 
 
4 
 
3 
 
2 
 
1 
 
0 
16. I feel my family members now look up to 
me because of my efforts under difficult 
circumstances. 
 
4 
 
3 
 
2 
 
1 
 
0 
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Sono apa pali mafumbo yakukhwaksana umo wanthu wanji 
wakujipulikira pala wakupwelelera mulwali. Chonde imwe namwe 
yowoyani umo mukujipulikira para mukupereka ovwiri ku murwali 
winu. Sankhanipo chimoza pakati pa Chomene nkhanila [4], Chomene 
[3], Chomeneko [2], Pachoko [1], Yayinthe [0]. 
  Chomene 
Nkhanila 
Chomene Chomeneko 
(mwanthena) 
Pachoko 
 
Yayi nthe 
1. Nkhujiwona kuti chiuta 
wanitumbikenge. 
4 3 2 1 0 
2. Nkhujupulika wene 
nawene. 
4 3 2 1 0 
3. Nkhujipulika kuti nina 
nkhongono, ndipo 
nkhuzizipizga, pala 
nkhutewetela wanthu 
walwali. 
 
4 
 
3 
 
2 
 
1 
 
0 
4. Nkhuzomelezga umo 
wanyakhe 
wakuyowoyela kuti 
kupwelelera mulwali 
wane ntchinthu chiwemi 
na chakukhumbikila 
 
4 
 
3 
 
2 
 
1 
 
0 
5. Nkhuwona ndipo 
nkhugomezga kuti nane 
walipo awo 
wazamuniwovwila na 
kunipwelelera pala 
nkhukhumba wovwiri.  
 
4 
 
3 
 
2 
 
1 
 
0 
6. Nkhuwona kuti pala 
mulwali wane 
wakunisekelera, 
kunimwemwetera, 
kwenese kunibeka mwa 
chitemwa ntchinthu 
chiwemi na 
chakukhumbikila. 
 
4 
 
3 
 
2 
 
1 
 
0 
7. Nkhuwona kuti ine na 
mulwali wane 
 
4 
 
3 
 
2 
 
1 
 
0 
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tikukoleranako na 
kupulikana chomene. 
8. Nkhuwona kuti 
nasambilako vinthu 
vinyakhe ndipo sono 
ndine munthu 
wakusinthika. 
 
4 
 
3 
 
2 
 
1 
 
0 
9. Nkhuwona kuti 
nasambila nthowa 
zinyakhe zakupwelelara 
mulwali wane. 
 
4 
 
3 
 
2 
 
1 
 
0 
10. Nkhuwona kuti napanga 
wabwezi wanyakhe 
sono. 
4 3 2 1 0 
11. Nkhuwona ndipo 
nkhujipulika kuti ndine 
wakukhumbikira 
chomene. 
4 3 2 1 0 
12. Nkhuwona kuti nina 
mazaza na wanangwa 
wakupanga ivyo 
nkhukhumba 
kukhwaksana na 
kusamalira mulwali 
wane. 
 
4 
 
3 
 
2 
 
1 
 
0 
13. Ntchakukhumbikira 
ndiposo ntchiwemi kuti 
wa dokotola nama 
nurse wanilumbenge 
ndiposo kunilimbikiksa 
pa ntchito iyo nkhuchita 
yakupwelera mulwali 
wane. 
 
4 
 
3 
 
2 
 
1 
 
0 
14. Ndine wakukondwa 
chomene madazi ghano 
kulekana na kale apo 
nkhawa kuti nindambe 
yayi kupwelelera 
mulwali wane. 
 
4 
 
3 
 
2 
 
1 
 
0 
15. Nkhuwona kuti 
kupwelerera mulwali 
 
4 
 
3 
 
2 
 
1 
 
0 
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C 1995 Sandra J. Fulton Picot 
 
 
 
wane kwapangiksa kuti 
banja lithu likule 
kweneso tikukhala 
makola na kupulikana 
makola na kutewetela 
mulimo limoza. 
16. Nkhuwona kuti sono 
banja lane lose 
likunigomezga chomene 
chifukwa cha milimo iyo 
nkhuteweta chomene 
chomene nyengo za 
matenda. 
 
4 
 
3 
 
2 
 
1 
 
0 
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Appendix 10 Ethical approval from Nottingham Medical 
School Ethics Committee 
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Mr Kennedy Nkhoma
PhD Student
c/o Dr Anthony Arthur
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Room B58, Sue Ryder Care Centre
School of Nursing Midwifery & Physiotherapy
QMC Campus
Nottingham University Hospitals
NG7 2UH
Dear Mr Nkhoma
Ethics Reference No: SNMP11042012 PLWHA Kennedy
Study Title: An educational intervention to reduce pain and improve pain
management for people living with HIV/AIDS and their family carers in Malawi:
randomised controlled trial.
Student Lead Investigator: Mr Kennedy Nkhoma, PhD student, School of Nursing
Midwifery & Physiotherapy.
Supervisor/Chief Investigator: Dr Anthony Arthur, Associate Professor,
Professor Jane Seymour, Sue Ryder Care Professor, School of Nursing, Midwifery and
Physiotherapy
Thank you for the above application dated 11th April 2012 and the following
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‚ Letter for ethics.docx 05 April 2012
‚ Application form.doc 05 April 2012
‚ Information Sheet for family carers.docx 11 April 2012
‚ Consent form for family carersdocx.docx 11 April 2012
‚ Carers administered questionnaire.docx 05 April 2012
‚ Pain Education Poster.pptx final.pdf 05 April 2012
‚ Protocol.docx 05 April 2012
‚ Consent form for PLWHA.docx 11 April 2012
‚ Information Sheet for PLWHA.docx 11 April 2012
‚ Questionnaire for PLWHA.docx 05 April 2012
‚ E-mail response to Ethics queries 18 April 2012
‚ Letter of support from Osborn N.I. Mwalwanda, Chief Clinical Officer, Cordinator,
Wananangwa HIV/AIDs Clinic, Ekwendeni Hospital, Malawi dated 19th April 2012
These have been reviewed and are satisfactory and the study protocol is approved.
Approval is given on the understanding that the Conditions of Approval set out below
are followed.
Ethics Committee approval is sought from the National Health Science Research
Committee in Malawi. Please can you submit a copy of the approval letter when it is
available.
Faculty of Medicine and
Health Sciences
Medical School Research Ethics
Committee
Division of Therapeutics &
Molecular Medicine
D Floor, South Block
Queen's Medical Centre
Nottingham
NG7 2UH
Tel: +44 (0) 115 8231063
Fax: +44 (0) 115 8231059
Conditions of Approval
You must follow the protocol agreed and any changes to the protocol will require
prior Ethics’ Committee approval.
This study is approved for the period of active recruitment requested. The
Committee also provides a further 5 year approval for any necessary work to be
performed on the study which may arise in the process of publication and peer
review.
You promptly inform the Chairman of the Research Ethics Committee of
(i) Deviations from or changes to the protocol which are made to eliminate
immediate hazards to the research subjects.
(ii) Any changes that increase the risk to subjects and/or affect significantly the
conduct of the research.
(iii) All adverse drug reactions that are both serious and unexpected.
(iv) New information that may affect adversely the safety of the subjects or the
conduct of the study.
(v) The attached End of Project Progress Report is completed and returned when
the study has finished.
Yours sincerely
Dr Clodagh Dugdale
Chair, Nottingham University Medical School Research Ethics Committee
Medical School Research Ethics Committee
Membership 2011/2012
Chair Dr Clodagh Dugdale, University Teacher in Sports and Exercise
Medicine, Division of Orthopaedic and Accident Surgery, School
of Clinical Sciences.
School Representative
Biomedical Sciences Dr Vince Wilson, Reader and Basic Scientist.
Dr Liz Simpson, Chief Experimental Officer.
Molecular Medical
Sciences
Dr David Turner, Clinical Associate Professor in Microbiology.
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Sciences
Dr Gill Doddy, Clinical Associate Professor & Reader in General
Adult Psychiatry, Division of Psychiatry
Clinical Sciences
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School
Dr Abdol Nateri, Lecturer, Pre-Clinical Cancer Studies
Division of GI Surgery
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Clinical Sciences
Human Development
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Paediatric Intensive Care Unit and Respiratory Medicine,
Children’s Respiratory Unit, E Floor, East Block, QMC Campus,
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Division of Primary Care, QMC Campus
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Appendix 12 Ethical Approval from Mzuzu Central Hospital 
REQUEST FOR PERMISSION TO CONDUCT A RESEARCH STUDY 
Refer to your letter dated 28th September, 2012 in which you requested for 
permission to carry out a study at Mzuzu Central hospital on the topic "An 
educational intervention to reduce pain and improve pain 
management for people living with HIV/AIDS and their family 
carers in Malawi: a randomised controlled trial". I am pleased to 
inform you that permission has been granted following review of the letter 
and accompanied documents. 
Wishing you a nice study.  
Yours sincerely,  
 
BK Nyirenda 
Research Coordinator  For: THE HOSPITAL DIRECTOR 
  
Telephone: 01 320 916 / 
878 Fax: 
320223/320973/270 
directormch@malawi.net 
 
 
 
 
Kennedy Nkhoma 
C/o Rev. HM Nkhoma 
University of 
Livingstonia P.O. Box 
112 
Mzuzu 
 
Dear Sir, 
 
In reply please quote No.. 
The Hospital Director, Mzuzu 
Central Hospital, Private Bag 
209, Luwinga, 
Mzuzu 2. 
1" October, 2012 
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$SSHQGL[6WDWDµGR¶ILOHV 
Organisation of variables and generation of derived variables 
          *CONVENTIONS 
*Rename variables: PB=Patient before CB=Carer before PF=Patient follow-up 
CF=Carer follow-up DE=Demog DA=Dates 
*Value label sets end with vals e.g. relvals 
*Collapsed variables end with COLL  
 
*Patient before BPI renaming variables 
*Note BPI question 1 are string and we possibly want them to be binary yes/no 
variables 
 
*BPIQ6 is also string, may need to create a numerical variable (receiving meds 
yes/no) and then think about other  
*variables that capture what they are taking, let's discuss 
*19/10 KN working on this with treatment do file 
rename  Area11          BPIA1_PB  
rename Area21          BPIA2_PB       
rename Area31          BPIA3_PB          
rename Area41          BPIA4_PB          
rename Area51          BPIA5_PB    
rename Area61          BPIA6_PB       
rename Area71          BPIA7_PB     
rename Area81          BPIA8_PB 
rename Q2Painworst1   BPIQ2_PB 
rename Q3Painleast1   BPIQ3_PB 
rename Q4Painaverage1 BPIQ4_PB 
rename Q5Painrightnow1 BPIQ5_PB 
rename Q6Treatment1   BPIQ6_PB 
rename Q7Painreliefge1 BPIQ7_PB 
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rename Q8aPaininterf~1 BPIQ8aPB            
rename Q8bMood1       BPIQ8bPB 
rename Q8cwalking1    BPIQ8cPB 
rename Q8dwork1       BPIQ8dPB 
rename Q8erelationsh~1 BPIQ8ePB  
rename Q8fsleep1      BPIQ8fPB 
rename Q8genjoyment1  BPIQ8gPB 
 
*Patient before BPI applying variable labels 
label variable BPIA1_PB "Baseline BPI Question 1 head/neck pain" 
label variable BPIA2_PB "Baseline BPI Question 1 Right arm pain" 
label variable BPIA3_PB "Baseline BPI Question 1 Left arm pain" 
label variable BPIA4_PB "Baseline BPI Question 1 Chest pain" 
label variable BPIA5_PB "Baseline BPI Question 1 Abdominal pain" 
label variable BPIA6_PB "Baseline BPI Question 1 Right leg pain" 
label variable BPIA7_PB "Baseline BPI Question 1 Left leg pain" 
label variable BPIA8_PB "Baseline BPI Question 1 Back pain" 
label variable BPIQ2_PB "Baseline BPI Question 2 Worst pain" 
label variable BPIQ3_PB "Baseline BPI Question 3 Pain least" 
label variable BPIQ4_PB "Baseline BPI Question 4 average pain" 
label variable BPIQ5_PB "Baseline BPI Question 5 current pain" 
label variable BPIQ6_PB "Baseline BPI Question 6 pain treatment" 
label variable BPIQ7_PB "Baseline BPI Question 7 pain relief %ge" 
label variable BPIQ8aPB "Baseline BPI Question 8a pain & activity"  
label variable BPIQ8bPB "Baseline BPI Question 8b pain & mood" 
label variable BPIQ8cPB "Baseline BPI Question 8c pain & walking" 
label variable BPIQ8dPB "Baseline BPI Question 8d pain & work" 
label variable BPIQ8ePB "Baseline BPI Question 8e pain & relationships" 
label variable BPIQ8fPB "Baseline BPI Question 8f pain & sleep" 
label variable BPIQ8gPB "Baseline BPI Question 8g pain & enjoyment" 
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*PPQ patient before 
            *rename PPQ patient before variables 
rename HIVAIDSpainca~1PPQ1_PB 
rename Q9Painmedicin~1 PPQ2_PB 
rename Q10Painmedici~1 PPQ3_PB 
rename Q11largerdose~1 PPQ4_PB 
rename Q12Painmedici~1 PPQ5_PB 
rename Q13Nonpharmac~1PPQ6_PB 
rename Q14Painmedici~1 PPQ7_PB 
rename Q15Patientsar~1 PPQ8_PB 
rename Q16Worstpainw~1PPQ9_PB 
rename Q16Painlastwe~1 PPQ10_PB 
rename Q17Painnow1    PPQ11_PB 
rename Q18Painrelief1 PPQ12_PB 
rename Q19Paindistre~1 PPQ13_PB 
rename Q20Paindistre~1 PPQ14_PB 
rename Q21Paincontro~1 PPQ15_PB 
rename Q22Futurepain1 PPQ16_PB 
 
*Patient before PPQ applying variable labels 
label variable PPQ1_PB "Baseline PPQ Question 1 HIV/AIDS pain can be relieved" 
label variable PPQ2_PB "Baseline PPQ Question 2 pain medication only when pain is 
severe" 
label variable PPQ3_PB "Baseline PPQ Question 3 patients become addicted to 
medication" 
label variable PPQ4_PB "Baseline PPQ Question 4 larger doses for worse pain" 
label variable PPQ5_PB "Baseline PPQ Question 5 pain medication and timing" 
label variable PPQ6_PB "Baseline PPQ Question 6 non-pharmacological interventions" 
label variable PPQ7_PB "Baseline PPQ Question 7 pain medication interfere with 
breathing" 
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label variable PPQ8_PB "Baseline PPQ Question 8 patients are often given too much 
pain medication" 
label variable PPQ9_PB "Baseline PPQ Question 9 worse pain means worse HIV/AIDS" 
label variable PPQ10_PB "Baseline PPQ Question 10 pain last week" 
label variable PPQ11_PB "Baseline PPQ Question 11 pain now" 
label variable PPQ12_PB "Baseline PPQ Question 12 pain relief" 
label variable PPQ13_PB "Baseline PPQ Question 13 pain distress to patient" 
label variable PPQ14_PB "Baseline PPQ Question 14 pain distress to family" 
label variable PPQ15_PB "Baseline PPQ Question 15 pain control ability" 
label variable PPQ16_PB "Baseline PPQ Question 16 future pain" 
 
*POS patient before 
*Renaming variables 
rename Q23Painrating~1 POSQ1_PB 
rename Q24othersympt~1 POSQ2_PB 
rename Q25Worryabout~1 POSQ3_PB 
rename Q26Sharingoff~1 POSQ4_PB 
rename Q27Lifeworthw~1 POSQ5_PB 
rename Q28Feelingpea~1 POSQ6_PB 
rename Q29Helpandadv~1 POSQ7_PB 
 
*POS patient before 
*Applying variable labels 
label variable POSQ1_PB "Baseline POS Question 1 pain rating last three days" 
label variable POSQ2_PB "Baseline POS Question 2 other symptoms last three days" 
label variable POSQ3_PB "Baseline POS Question 3 worry about illness last three 
days" 
label variable POSQ4_PB "Baseline POS Question 4 sharing of feelings" 
label variable POSQ5_PB "Baseline POS Question 5 life worthfulness" 
label variable POSQ6_PB "Baseline POS Question 6 feeling peace" 
label variable POSQ7_PB "Baseline POS Question 7 help and advice" 
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*Renaming Patient identifiable variables including allocation 
*Source of referral will need encoding - KN to do this from spreadsheet. 
*Drop trial status 
rename Patientname1  PN_PB 
rename Address1  Address_PB 
rename Nameofcarer1  CN_PB 
rename sourceofrefer~1 SOR_PB 
rename relationship1 Rel_PCB 
rename Allocation1  A_PB 
rename Statusofthetr~1 TS_PCB 
rename Sitecentre1  SC_PCB 
drop TS_PCB 
 
*Applying labels to patient identifying variables 
label variable PN_PB"Baseline patient name" 
label variable Address_PB "Baseline patient address" 
label variable CN_PB"Baseline carer name" 
label variable SOR_PB"Baseline referring centre" 
label variable A_PB "Baseline patient group allocation" 
label variable Rel_PCB "carer relationship to the patient" 
label variable SC_PCB "Baseline recruitment centre" 
 
*Decided to drop BP1 BR1 BS1 BT1 re text information about assessment and 
telephone call 
drop BP1 BR1 BS1 BT1 
            *FPQ carer before 
*rename FPQ carer before variables 
rename Q1Paincanbere~2 FPQ1_CB 
rename Q2Painmedicin~2 FPQ2_CB 
rename Q3Painmedicin~2 FPQ3_CB 
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rename Q4largerdoses~2 FPQ4_CB 
rename Q5Painmedicin~2 FPQ5_CB 
rename Q6Nonpharmaco~2 FPQ6_CB 
rename Q7Painmedicin~2 FPQ7_CB 
rename Q8Patientsare~2 FPQ8_CB 
rename Q9Worstpainwo~2 FPQ9_CB 
rename Q10painlastwe~2 FPQ10_CB 
rename Q11Painnow2 FPQ11_CB 
rename Q12Painrelief2 FPQ12_CB 
rename Q13Paindistre~2 FPQ13_CB 
rename Q14Paindistre~2 FPQ14_CB 
rename Q15Paincontro~2 FPQ15_CB 
rename Q16Futurepain2 FPQ16_CB 
 
*FPQ carer before 
*Applying variable labels 
label variable FPQ1_CB "Baseline FPQ Question 1 HIV/AIDS pain can be relieved" 
label variable FPQ2_CB "Baseline FPQ Question 2 pain medication and pain 
severity"  
label variable FPQ3_CB "Baseline FPQ Question 3 pain medicine and addiction" 
label variable FPQ4_CB "Baseline FPQ Question 4 larger doses for worst pain" 
label variable FPQ5_CB "Baseline FPQ Question 5 pain medicine and timing" 
label variable FPQ6_CB "Baseline FPQ Question 6 non-pharmacological 
interventions" 
label variable FPQ7_CB "Baseline FPQ Question 7 pain medicine and breathing" 
label variable FPQ8_CB "Baseline FPQ Question 8 patients are often given too 
much pain medicine" 
label variable FPQ9_CB "Baseline FPQ Question 9 worst pain=worst HIV/AIDS" 
label variable FPQ10_CB "Baseline FPQ Question 10 pain last week" 
label variable FPQ11_CB "Baseline FPQ Question 11 pain now" 
label variable FPQ12_CB "Baseline FPQ Question 12 pain relief" 
label variable FPQ13_CB "Baseline FPQ Question 13 pain distress to patient"  
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label variable FPQ14_CB "Baseline FPQ Question 14 pain distress to carer" 
label variable FPQ15_CB "Baseline FPQ Question 15 pain control ability" 
label variable FPQ16_CB "Baseline FPQ Question 16 future pain" 
 
*PCRS carer before 
*rename PCRS carer before variables 
rename Q17Godwillble~2 PCRSQ1_CB 
rename Q18Selffeeling2 PCRSQ2_CB 
rename Q19Feelingstr~2 PCRSQ3_CB 
rename Q20Otherssay2  PCRSQ4_CB 
rename Q21Someonewil~2 PCRSQ5_CB 
rename Q22Receivings~2 PCRSQ6_CB 
rename Q23Closerrela~2 PCRSQ7_CB 
rename Q24Newinforma~2 PCRSQ8_CB 
rename Q25Newwaysofc~2 PCRSQ9_CB 
rename Q26Newfriends2 PCRSQ10_CB 
rename Q27Feelingmor~2 PCRSQ11_CB 
rename Q28Freedomtom~2 PCRSQ12_CB 
rename Q29receptionf~2 PCRSQ13_CB 
rename Q30feelinghap~2 PCRSQ14_CB 
rename Q31Feelingfam~2 PCRSQ15_CB 
rename Q32Familyloop~2 PCRSQ16_CB 
 
*PCRS carer before 
*apply PCRS carer variable labels 
label variable PCRSQ1_CB "Baseline PCRS Question 1 God will bless me"  
label variable PCRSQ2_CB "Baseline PCRS Question 2 better self feeling" 
label variable PCRSQ3_CB "Baseline PCRS Question 3feeling stronger and tolerant" 
label variable PCRSQ4_CB "Baseline PCRS Question 4 caring is right thing" 
label variable PCRSQ5_CB "Baseline PCRS Question 5 someone will care for me" 
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label variable PCRSQ6_CB "Baseline PCRS Question 6 smile, touch eye contact is 
important" 
label variable PCRSQ7_CB "Baseline PCRS Question 7 closer relationship"  
label variable PCRSQ8_CB "Baseline PCRS Question 8 new information" 
label variable PCRSQ9_CB "Baseline PCRS Question 9 news caring ways" 
label variable PCRSQ10_CB "Baseline PCRS Question 10 new friends" 
label variable PCRSQ11_CB "Baseline PCRS Question 11 feeling more important" 
label variable PCRSQ12_CB "Baseline PCRS Question 12 decisions" 
label variable PCRSQ13_CB "Baseline PCRS Question 13 health care workers 
reception" 
label variable PCRSQ14_CB "Baseline PCRS Question 14 feeling happier" 
label variable PCRSQ15_CB "Baseline PCRS Question 15 family growth" 
label variable PCRSQ16_CB "Baseline PCRS Question 16 Family looks up to me" 
 
*POS carer before 
*rename POS carer before variables 
rename Q33Informatio~2 POSQ8_CB 
rename Q34Confidence2 POSQ9_CB 
rename Q35familyworr~2 POSQ10_CB 
 
*POS carer before 
*apply POS carer variable labels 
label variable POSQ8_CB "Baseline POS Question 8 information"  
label variable POSQ9_CB "Baseline POS Question 9 confidence" 
label variable POSQ10_CB "Baseline POS Question 10 family worries" 
 
* Rename and label Allocation variable from carers before dataset 
* Need to check whether same as before 
rename Allocation2  A_CB 
label variable A_CB "Baseline carer group allocation" 
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*Patient after BPI renaming variables 
*As before BPI question 1 are string and we possibly want them to be binary yes/no 
variables, not urgent, let's discuss 
 
*BPIQ6 is also string, may need to create a numerical variable (receiving meds 
yes/no) and then think about other 
*variables that capture what they are taking, let's discuss 
rename Area13          BPIA1_PF         
rename Area23          BPIA2_PF  
rename Area33          BPIA3_PF 
rename Area43          BPIA4_PF 
rename Area53          BPIA5_PF 
rename Area63          BPIA6_PF 
rename Area73          BPIA7_PF 
rename Area83          BPIA8_PF 
rename Q2Painworst3   BPIQ2_PF 
rename Q3Painleast3   BPIQ3_PF 
rename Q4Painaverage3 BPIQ4_PF 
rename Q5Painrightnow3 BPIQ5_PF 
rename Q6Treatment3   BPIQ6_PF  
rename Q7Painreliefge3 BPIQ7_PF 
rename Q8aPaininterf~3 BPIQ8a_PF 
rename Q8bMood3       BPIQ8b_PF 
rename Q8cwalking3    BPIQ8c_PF 
rename Q8dwork3       BPIQ8d_PF 
rename Q8erelationsh~3 BPIQ8e_PF  
rename Q8fsleep3      BPIQ8f_PF 
rename Q8genjoyment3  BPIQ8g_PF 
 
*Patient after BPI applying variable labels 
label variable BPIA1_PF "Follow-up BPI Question 1 head/neck pain"     
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label variable BPIA2_PF "Follow-up BPI Question 1 Right arm pain" 
label variable BPIA3_PF "Follow-up BPI Question 1 Left arm pain" 
label variable BPIA4_PF "Follow-up BPI Question 1 Chest pain" 
label variable BPIA5_PF "Follow-up BPI Question 1 Abdominal pain" 
label variable BPIA6_PF "Follow-up BPI Question 1 Right leg pain"  
label variable BPIA7_PF "Follow-up BPI Question 1 Left leg pain"  
label variable BPIA8_PF "Follow-up BPI Question 1 Back pain" 
label variable BPIQ2_PF "Follow-up BPI Question 2 Worst pain" 
label variable BPIQ3_PF "Follow-up BPI Question3 Pain least" 
label variable BPIQ4_PF "Follow-up BPI Question 4 average pain" 
label variable BPIQ5_PF "Follow-up BPI Question 5 current pain" 
label variable BPIQ6_PF "Follow-up BPI Question 6 pain treatment" 
label variable BPIQ7_PF "Follow-up BPI Question 7 pain relief %ge" 
label variable BPIQ8a_PF "Follow-up BPI Question 8 pain and activity" 
label variable BPIQ8b_PF "Follow-up BPI Question 8b pain & mood" 
label variable BPIQ8c_PF "Follow-up BPI Question 8c pain & walking" 
label variable BPIQ8d_PF "Follow-up BPI Question 8d pain & work" 
label variable BPIQ8e_PF "Follow-up BPI Question 8e pain & relationships" 
label variable BPIQ8f_PF "Follow-up BPI Question 8f pain & sleep" 
label variable BPIQ8g_PF "Follow-up BPI Question 8g pain & enjoyment" 
 
            *PPQ patient after 
*rename PPQ patient before variables 
rename HIVAIDSpainca~3 PPQ1_PF 
rename Q9Painmedicin~3 PPQ2_PF 
rename Q10Painmedici~3 PPQ3_PF 
rename Q11largerdose~3 PPQ4_PF 
rename Q12Painmedici~3 PPQ5_PF 
rename Q13Nonpharmac~3 PPQ6_PF 
rename Q14Painmedici~3 PPQ7_PF 
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rename Q15Patientsar~3 PPQ8_PF 
rename Q16Worstpainw~3 PPQ9_PF 
rename Q16Painlastwe~3 PPQ10_PF 
rename Q17Painnow3 PPQ11_PF 
rename Q18Painrelief3 PPQ12_PF 
rename Q19Paindistre~3 PPQ13_PF 
rename Q20Paindistre~3 PPQ14_PF 
rename Q21Paincontro~3 PPQ15_PF 
rename Q22Futurepain3 PPQ16_PF 
 
*Patient after PPQ applying variable labels 
label variable PPQ1_PF "Follow-up PPQ Question 1 HIV/AIDS pain can be relieved" 
label variable PPQ2_PF "Follow-up PPQ Question 2 pain medication only when pain is 
severe" 
label variable PPQ3_PF "Follow-up PPQ Question 3 patients become addicted to 
medication" 
label variable PPQ4_PF "Follow-up PPQ Question 4 larger doses for worse pain" 
label variable PPQ5_PF "Follow-up PPQ Question 5 pain medication and timing" 
label variable PPQ6_PF "Follow-up PPQ Question 6 non-pharmacological 
interventions" 
label variable PPQ7_PF "Follow-up PPQ Question 7 pain medication interfere with 
breathing" 
label variable PPQ8_PF "Follow-up PPQ Question 8 patients are often given too much 
pain medication" 
label variable PPQ9_PF "Follow-up PPQ Question 9 worse pain means worse 
HIV/AIDS" 
label variable PPQ10_PF "Follow-up PPQ Question 10 pain last week" 
label variable PPQ11_PF "Follow-up PPQ Question 11 pain now" 
label variable PPQ12_PF "Follow-up PPQ Question 12 pain relief" 
label variable PPQ13_PF "Follow-up PPQ Question 13 pain distress to patient" 
label variable PPQ14_PF "Follow-up PPQ Question 14 pain distress to family" 
label variable PPQ15_PF "Follow-up PPQ Question 15 pain control ability" 
label variable PPQ16_PF "Follow-up PPQ Question 16 future pain" 
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*POS patient after 
*Renaming variables 
rename Q23Painrating~3 POSQ1_PF 
rename Q24othersympt~3 POSQ2_PF 
rename Q25Worryabout~3 POSQ3_PF 
rename Q26Sharingoff~3 POSQ4_PF 
rename Q27Lifeworthw~3 POSQ5_PF 
rename Q28Feelingpea~3 POSQ6_PF 
rename Q29Helpandadv~3 POSQ7_PF 
 
*POS patient after 
*Applying variable labels 
label variable POSQ1_PF "Follow-up POS Question 1 pain rating last three days" 
label variable POSQ2_PF "Follow-up POS Question 2 other symptoms last three 
days" 
label variable POSQ3_PF "Follow-up POS Question 3 worry about illness last three 
days" 
label variable POSQ4_PF "Follow-up POS Question 4 sharing of feelings" 
label variable POSQ5_PF "Follow-up POS Question 5 life worthfulness" 
label variable POSQ6_PF "Follow-up POS Question 6 feeling peace" 
label variable POSQ7_PF "Follow-up POS Question 7 help and advice" 
 
*Renaming Patient identifiable variables including allocation from patient after 
drop Statusofthetr~3 
rename Patientname3  PN_PF 
rename Address3  Address_PF 
rename Nameofcarer3  CN_PF 
rename BC3  Address_CF 
rename sourceofrefer~3 SOR_PF 
rename relationship3 Rel_CF 
rename Allocation3  A_PF 
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rename Sitecentre3  SC_PCF 
 
*This variable 'as patient' for all participants: 
drop Address_CF 
 
*Applying labels to patient after identifying variables 
label variable PN_PF "Follow-up patient name" 
label variable Address_PF "Follow-up patient address" 
label variable CN_PF "Follow-up carer name" 
label variable SOR_PF "F/up referring centre" 
label variable Rel_CF "F/up carer relationship to the patient" 
label variable A_PF "Follow-up patient group allocation"  
label variable SC_PCF "F/up recruitment centre" 
 
*FPQ carer after 
*rename FPQ carer after variables 
rename Q1Paincanbere~4 FPQ1_CF 
rename Q2Painmedicin~4 FPQ2_CF 
rename Q3Painmedicin~4 FPQ3_CF 
rename Q4largerdoses~4 FPQ4_CF 
rename Q5Painmedicin~4 FPQ5_CF 
rename Q6Nonpharmaco~4 FPQ6_CF 
rename Q7Painmedicin~4 FPQ7_CF 
rename Q8Patientsare~4 FPQ8_CF 
rename Q9Worstpainwo~4 FPQ9_CF 
rename Q10painlastwe~4 FPQ10_CF 
rename Q11Painnow4 FPQ11_CF 
rename Q12Painrelief4 FPQ12_CF 
rename Q13Paindistre~4 FPQ13_CF 
rename Q14Paindistre~4 FPQ14_CF 
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rename Q15Paincontro~4 FPQ15_CF 
rename Q16Futurepain4 FPQ16_CF 
 
*FPQ carer after 
*Applying variable labels 
label variable FPQ1_CF "Follow-up FPQ Question 1 HIV/AIDS pain can be relieved" 
label variable FPQ2_CF "Follow-up FPQ Question 2 pain medication and pain severity"  
label variable FPQ3_CF "Follow-up FPQ Question 3 pain medicine and addiction" 
label variable FPQ4_CF "Follow-up FPQ Question 4 larger doses for worst pain" 
label variable FPQ5_CF "Follow-up FPQ Question 5 pain medicine and timing" 
label variable FPQ6_CF "Follow-up FPQ Question 6 non-pharmacological 
interventions" 
label variable FPQ7_CF "Follow-up FPQ Question 7 pain medicine and breathing" 
label variable FPQ8_CF "Follow-up FPQ Question 8 patients are often given too much 
pain medicine" 
label variable FPQ9_CF "Follow-up FPQ Question 9 worst pain=worst HIV/AIDS" 
label variable FPQ10_CF "Follow-up FPQ Question 10 pain last week" 
label variable FPQ11_CF "Follow-up FPQ Question 11 pain now" 
label variable FPQ12_CF "Follow-up FPQ Question 12 pain relief" 
label variable FPQ13_CF "Follow-up FPQ Question 13 pain distress to patient"  
label variable FPQ14_CF "Follow-up FPQ Question 14 pain distress to carer" 
label variable FPQ15_CF "Follow-up FPQ Question 15 pain control ability" 
label variable FPQ16_CF "Follow-up FPQ Question 16 future pain"  
 
*PCRS carer after 
*rename PCRS carer after variables 
rename Q17Godwillble~4 PCRSQ1_CF 
rename Q18Selffeeling4 PCRSQ2_CF 
rename Q19Feelingstr~4 PCRSQ3_CF 
rename Q20Otherssay4  PCRSQ4_CF 
rename Q21Someonewil~4 PCRSQ5_CF 
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rename Q22Receivings~4 PCRSQ6_CF 
rename Q23Closerrela~4 PCRSQ7_CF 
rename Q24Newinforma~4 PCRSQ8_CF 
rename Q25Newwaysofc~4 PCRSQ9_CF 
rename Q26Newfriends4 PCRSQ10_CF 
rename Q27Feelingmor~4 PCRSQ11_CF 
rename Q28Freedomtom~4 PCRSQ12_CF 
rename Q29receptionf~4 PCRSQ13_CF 
rename Q30feelinghap~4 PCRSQ14_CF 
rename Q31Feelingfam~4 PCRSQ15_CF 
rename Q32Familyloop~4 PCRSQ16_CF 
 
*PCRS carer after 
*apply PCRS carer after variable labels 
label variable PCRSQ1_CF "Follow-up PCRS Question 1 God will bless me"  
label variable PCRSQ2_CF "Follow-up PCRS Question 2 better self feeling" 
label variable PCRSQ3_CF "Follow-up PCRS Question 3feeling stronger and tolerant" 
label variable PCRSQ4_CF "Follow-up PCRS Question 4 caring is right thing" 
label variable PCRSQ5_CF "Follow-up PCRS Question 5 someone will care for me" 
label variable PCRSQ6_CF "Follow-up PCRS Question 6 smile, touch eye contact is 
important" 
label variable PCRSQ7_CF "Follow-up PCRS Question 7 closer relationship"  
label variable PCRSQ8_CF "Follow-up PCRS Question 8 new information" 
label variable PCRSQ9_CF "Follow-up PCRS Question 9 news caring ways" 
label variable PCRSQ10_CF "Follow-up PCRS Question 10 new friends" 
label variable PCRSQ11_CF "Follow-up PCRS Question 11 feeling more important" 
label variable PCRSQ12_CF "Follow-up PCRS Question 12 decisions" 
label variable PCRSQ13_CF "Follow-up PCRS Question 13health care workers 
reception" 
label variable PCRSQ14_CF "Follow-up PCRS Question 14 feeling happier" 
label variable PCRSQ15_CF "Follow-up PCRS Question 15 family growth" 
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label variable PCRSQ16_CF "Follow-up PCRS Question 16 Family looks up to me" 
 
*POS carer after 
*rename POS carer after variables 
rename Q33Informatio~4 POSQ8_CF 
rename Q34Confidence4 POSQ9_CF 
rename Q35familyworr~4 POSQ10_CF 
 
*POS carer after 
*apply POS carer variable labels 
label variable POSQ8_CF "Follow-up POS Question 8 information"  
label variable POSQ9_CF "Follow-up POS Question 9 confidence" 
label variable POSQ10_CF "Follow-up POS Question 10 family worries" 
 
*Carer follow-up ID variables 
rename Allocation4 A_CF 
label variable A_CF "Follow-up carer group allocation"  
 
*Demographic and ID variables from Copy of Gender file 
*Rename 
rename Patientname5   PN_DE 
rename GenPt5         PG_DE 
rename Nameofcarer5   CN_DE 
rename GenCarer5      CG_DE 
rename relationship5  RELST_DE 
rename Relationship5  REL_DE 
rename Ptmaritalstat~5 PMARITAL_DE 
rename Carersmarital~5 CMARITAL_DE 
rename Patienteducat~5 PE_DE 
rename Carerseducati~5 CE_DE 
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rename Patientreligi~5 PR_DE 
rename Carerreligion5 CR_DE 
rename Patientoccupa~5 PO_DE 
rename Careroccupati~5 CO_DE 
 
*This string variable checked 12/10/13 and does not add anything to REL_DE 
drop RELST_DE 
 
*Demographic and ID variables from Copy of Gender file 
*Label variables 
label variable PN_DE "patient name" 
label variable PG_DE "patient gender" 
label variable CN_DE "carer name" 
label variable CG_DE "carer gender" 
label variable REL_DE "Carers relationship to the patient" 
label variable PMARITAL_DE "patient marital status" 
label variable CMARITAL_DE "carer marital status" 
label variable PE_DE "patient education" 
label variable CE_DE "carer education" 
label variable PR_DE "patient religion" 
label variable CR_DE "carer religion" 
label variable PO_DE "patient occ" 
label variable CO_DE "carer occ" 
             label define genvals 0 "Male" 1 "Female"  
label values PG_DE CG_DE genvals 
             label define edvals 1 "Primary school" 2 "Secondary school" 3 "College/University" 
label values PE_DE CE_DE edvals 
             label define relnvals 1 "Christianity" 2" Muslim"  
label values PR_DE CR_DE relnvals 
           *Date variables from New Dates (2) and dates2.do 
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*Rename 
rename dobp DOBP_DA 
rename dobc DOBC_DA 
rename doia DOIA_DA 
rename doc  DOC_DA 
rename dop  DOP_DA 
rename dofs DOFS_DA 
rename dofa DOFA_DA 
 
*Date variables 
*Apply labels 
label variable DOBP_DA "Patient date of birth" 
label variable DOBC_DA "Carer date of birth" 
label variable DOIA_DA "Date of initial approach" 
label variable DOC_DA "Date of consent" 
label variable DOP_DA "Date of phone contact" 
label variable DOFS_DA "Date of scheduled follow-up" 
label variable DOFA_DA "Date of actual follow-up" 
 
*Generate Patient Attrition codes 
gen p_attrition=0 
recode p_attrition 0=3 if IDNumber==25 
recode p_attrition 0=4 if IDNumber==26 
recode p_attrition 0=3 if IDNumber==42 
recode p_attrition 0=4 if IDNumber==69 
recode p_attrition 0=3 if IDNumber==73 
recode p_attrition 0=3 if IDNumber==75 
recode p_attrition 0=1 if IDNumber==83 
recode p_attrition 0=1 if IDNumber==84 
recode p_attrition 0=3 if IDNumber==86 
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recode p_attrition 0=1 if IDNumber==89 
recode p_attrition 0=4 if IDNumber==94 
recode p_attrition 0=2 if IDNumber==102 
recode p_attrition 0=5 if IDNumber==103 
recode p_attrition 0=1 if IDNumber==148 
recode p_attrition 0=2 if IDNumber==186 
 
*Apply patient attrition value and variable labels 
label define pattvals 0 "Followed-up" 1 "Patient died" 2 "No transport" 3 "Moved 
away" 4 "Not traceable" 5 "Patient unwell" 
label values p_attrition pattvals 
label variable p_attrition "patient attrition" 
 
*Generate Carer Attrition codes 
gen c_attrition=0 
recode c_attrition 0=2 if IDNumber==17 
recode c_attrition 0=3 if IDNumber==25 
recode c_attrition 0=4 if IDNumber==26 
recode c_attrition 0=2 if IDNumber==40 
recode c_attrition 0=3 if IDNumber==42 
recode c_attrition 0=5 if IDNumber==48 
recode c_attrition 0=4 if IDNumber==69 
recode c_attrition 0=2 if IDNumber==70 
recode c_attrition 0=2 if IDNumber==72 
recode c_attrition 0=3 if IDNumber==73 
recode c_attrition 0=3 if IDNumber==75 
recode c_attrition 0=1 if IDNumber==83 
recode c_attrition 0=1 if IDNumber==84 
recode c_attrition 0=3 if IDNumber==86 
recode c_attrition 0=1 if IDNumber==89 
recode c_attrition 0=4 if IDNumber==94 
 372 
 
recode c_attrition 0=2 if IDNumber==102 
recode c_attrition 0=6 if IDNumber==103 
recode c_attrition 0=2 if IDNumber==104 
recode c_attrition 0=2 if IDNumber==110 
recode c_attrition 0=5 if IDNumber==118 
recode c_attrition 0=5 if IDNumber==128 
recode c_attrition 0=1 if IDNumber==148 
recode c_attrition 0=2 if IDNumber==186 
recode c_attrition 0=5 if IDNumber==190 
 
*Apply carer attrition value and variable labels 
label define cattvals 0 "Followed-up" 1 "Patient died" 2 "No transport" 3 "Moved 
away" 4 "Not traceable" 5 "Too busy" 6 "Patient unwell" , replace 
label values c_attrition cattvals 
label variable c_attrition "carer attrition" 
 
*Apply labels to carer relationship and create new collapsed variable 
label define relvals 1 "Husband" 2 "Wife" 3 "Sister" 4 "Brother" 5 "Son" 6 "Daughter" 
7" Friend" 8 "Mother" 9 "Father" 10 "Cousin"  11 "Aunt" 12 "Grandmother" 13 
"Sister-in law" 
label values REL_DE relvals 
gen RELCOLL=REL_DE 
recode RELCOLL 1=1 2=1 3=2 4=2 5=3 6=3 7=4 8=5 9=5 10=6 11=6 12=6 13=6  
label define relcvals 1 "Spouse" 2 "Sibling" 3 "Son/daughter" 4 "Friend" 5 " Parent" 6 
" Other relative", replace  
label values RELCOLL relcvals 
label variable RELCOLL "Carer relationship to patient" 
 
*Create and code a variable for patient marital status (collapsed) 
gen PMARCOLL= PMARITAL_DE 
recode PMARCOLL 1=1 2=2 3=3 4=4 5=4  
label define marvals 1"Single" 2 "Married" 3 "Divorced/separated" 4 
"Widow/widower", replace  
 373 
 
label values PMARCOLL marvals 
label var PMARCOLL "Patient marital status" 
 
*Checked crosstabs OK 12/10/13 
drop PMARITAL_DE 
 
*Create and code a variable for carer marital status (collapsed) 
gen CMARCOLL=CMARITAL_DE 
recode CMARCOLL 1=1 2=2 3=3 4=4 5=4  
label values CMARCOLL marvals 
label var CMARCOLL "Carer marital status" 
 
*Checked crosstabs OK 12/10/13 
drop CMARITAL_DE 
 
*Create and code a variable for patient occupation (collapsed) 
gen POCCOLL=PO_DE 
recode POCCOLL 1=1 2=2 6=2 3=3 7=4 9=5 12=6 13=6 14=6 15=6 18=7 4=10 
5=10 8=9 10=8 11=10 16=10 17=10 18=7 19=2 20=10 21=8 22=6 
label define occvals 1"Farmer" 2"Civil servant" 3"Housewife" 4"Unemployed" 
5"Student" 6"Skilled manual" 7"Retired" 8"Admin workers" 9"Small scale business" 
10"Other", replace 
label values POCCOLL occvals 
label variable POCCOLL "Patient occupation 
 
 
 
*Don't wish to get rid of PO_DE at this stage as 'other' category is so large. Can we 
think about this again? 
 
*Create and code a variable for carer occupation (collapsed) 
gen COCOLL=CO_DE 
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recode COCOLL 1=1 2=2 6=2 3=3 7=4 9=5 12=6 13=6 14=6 15=6 18=7 4=10 
5=10 8=9 10=8 11=10 16=10 17=10 18=7 19=2 20=10 21=8 22=6 
label values COCOLL occvals 
label variable COCOLL "Carer occupation"  
 
* variable for coinfection 
             gen cormobidity=0 
recode cormobidity 0=2 if IDNumber==41 
recode cormobidity 0=1 if IDNumber==47 
recode cormobidity 0=1 if IDNumber==50 
recode cormobidity 0=1 if IDNumber==54 
recode cormobidity 0=1 if IDNumber==55 
recode cormobidity 0=1 if IDNumber==70 
recode cormobidity 0=1 if IDNumber==71 
recode cormobidity 0=1 if IDNumber==72 
recode cormobidity 0=4 if IDNumber==83 
recode cormobidity 0=5 if IDNumber==89 
recode cormobidity 0=1 if IDNumber==90 
recode cormobidity 0=3 if IDNumber==103 
recode cormobidity 0=1 if IDNumber==105 
recode cormobidity 0=1 if IDNumber==106 
recode cormobidity 0=1 if IDNumber==107 
recode cormobidity 0=3 if IDNumber==113 
recode cormobidity 0=1 if IDNumber==118 
recode cormobidity 0=1 if IDNumber==119 
recode cormobidity 0=1 if IDNumber==121 
recode cormobidity 0=1 if IDNumber==131 
recode cormobidity 0=1 if IDNumber==132 
recode cormobidity 0=1 if IDNumber==133 
recode cormobidity 0=1 if IDNumber==134 
recode cormobidity 0=1 if IDNumber==141 
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recode cormobidity 0=2 if IDNumber==143 
recode cormobidity 0=1 if IDNumber==146 
recode cormobidity 0=1 if IDNumber==147 
recode cormobidity 0=1 if IDNumber==150 
recode cormobidity 0=1 if IDNumber==152 
recode cormobidity 0=1 if IDNumber==159 
recode cormobidity 0=1 if IDNumber==161 
recode cormobidity 0=1 if IDNumber==162 
recode cormobidity 0=2 if IDNumber==169 
 
label define cormobidvals 0 "None" 1"Tuberculosis" 2"Karposis Sarcoma/Cancer" 3" 
Hepatitis" 4"Meningitis" 5"Severe Anaemia"  
label values cormobidity cormobidvals 
label variable cormobidity "coinfection" 
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Data cleaning 
 
*ID number 66 - envelope missing so number never allocated 
drop if IDNumber==66 
  
*Gender values restricted to 1 and 0 
recode CG 2=1 if IDNumber==103 
 
*ID number 75 correct allocation 
replace A_PB="CON" if IDNumber==75 
replace A_PF="CON" if IDNumber==75 
 
*To check  all patient names are the same 
list IDNumber PN_PB PN_PF PN_DE if PN_PB!=PN_PF | PN_PF!=PN_DE | 
PN_DE!=PN_PB 
 
*All patient names OK 12/10/13 therefore drop 
drop PN_PF PN_DE 
 
*To check  all patient addresses are the same 
list IDNumber Address_PB Address_PF if Address_PB!=Address_PF 
 
*All patient addresses OK 12/10/13 therefore drop 
drop Address_PF 
 
*To check  all carer names are the same 
list IDNumber CN_PB CN_PF CN_DE if CN_PB!=CN_PF | CN_PF!=CN_DE | 
CN_DE!=CN_PB 
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*All carer names OK 12/10/13 therefore drop 
drop CN_PF CN_DE 
 
*Both source of referral variables OK 12/10/13 therefore drop 
drop SOR_PF 
 
*To check  all carer relationship to patient are the same 
list IDNumber Rel_PCB Rel_CF if Rel_PCB!=Rel_CF 
 
*Both relationships the same 12/10/13 
drop Rel_CF 
 
*Discrepancy identified and now corrected 19/10/13 
replace Rel_PCB="husband-wife" if IDNumber==92 
 
*Check allocation variables are consistent 
list IDNumber A_PB A_CB A_PF A_CF if A_PB!=A_CB | A_PB!=A_PF | A_PB!=A_CF | 
A_CB!=A_PF | A_CB!=A_CF | A_PF!=A_CF 
 
*Allocation variables consistent 12/10/13 
drop A_CB A_PF A_CF 
encode A_PB, gen (Allocation) 
 
*To check recruitment centre's are the same 
list IDNumber SC_PCB SC_PCF if SC_PCB!=SC_PCF 
 
*Centres same 12/10/13 at the same  
drop SC_PCF 
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*Tidying up and encoding recruitment centre variable 
encode SC_PCB, gen (SC_PCBn) 
recode SC_PCBn 2=1 3=2 
label define cenvals 1 "Ekwendeni" 2 "Mzuzu" 
label values SC_PCBn cenvals 
drop SC_PCB 
rename SC_PCBn SC_PCB 
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Encoding string variables 
 
*how to make variables based on number of missing 
*egen rowmean 
*egen rowmiss 
*how to run lists of variables 
*Understand that whenever Stata wants a varlist it can be a list of variables, such as 
 *list length turn  
* or it can be all variables starting with a certain prefix  
* list rep* 
* (meaning all variables named "rep" followed by something), or it can be a range of 
variables 
 *list mpg-weight 
* (meaning all variables mpg through weight in the order that the variables are 
recorded in the dataset). 
 *You can even combine all three syntaxes:  
  * list length turn rep* mpg-weight 
   
  *encoding pain location before 
  encode BPIA1_PB, gen (BPIA1_PBn) 
  encode BPIA2_PB, gen (BPIA2_PBn) 
  encode BPIA3_PB, gen (BPIA3_PBn) 
  encode BPIA4_PB, gen (BPIA4_PBn) 
  encode BPIA5_PB, gen (BPIA5_PBn) 
  encode BPIA6_PB, gen (BPIA6_PBn) 
  encode BPIA7_PB, gen (BPIA7_PBn) 
  encode BPIA8_PB, gen (BPIA8_PBn) 
   
  *encoding pain location after 
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  encode BPIA1_PF, gen (BPIA1_PFn) 
  encode BPIA2_PF, gen (BPIA2_PFn) 
  encode BPIA3_PF, gen (BPIA3_PFn) 
  encode BPIA4_PF, gen (BPIA4_PFn) 
  encode BPIA5_PF, gen (BPIA5_PFn) 
  encode BPIA6_PF, gen (BPIA6_PFn) 
  encode BPIA7_PF, gen (BPIA7_PFn) 
  encode BPIA8_PF, gen (BPIA8_PFn) 
   
  *creating binary measure for pain location before 
  gen GP_PB=0 
  recode GP_PB 0=1 if BPIA1_PBn==2 | BPIA1_PBn==3 
  label variable GP_PB "Generalised Pain before" 
   
  gen HN_PB=0 
  recode HN_PB 0=1 if BPIA1_PBn==4 | BPIA1_PBn==5 | BPIA1_PBn==6 | 
BPIA1_PBn==7 | BPIA1_PBn==8 
  label variable HN_PB "Head & Neck Pain before" 
   
  gen MS_PB=0 
  recode MS_PB 0=1 if BPIA1_PBn==1 | BPIA1_PBn==9 
  label variable MS_PB "Mouth sores before" 
   
  gen LJP_PB=0 
  recode LJP_PB 0=1 if BPIA2_PBn==2 | BPIA2_PBn==3 | BPIA3_PBn<5 | 
BPIA6_PBn!=. | BPIA7_PBn==1 | (BPIA7_PBn>2 & BPIA7_PBn<11) 
  label variable LJP_PB "Limb & Joint Pain before" 
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  gen CA_PB=0 
  recode CA_PB 0=1 if BPIA4_PBn<7| BPIA5_PBn<3 
  recode CA_PB 0=1 if 
BPIA4_PBn==1|BPIA4_PBn==2|BPIA4_PBn==3|BPIA4_PBn==4|BPIA4_PBn==5|BPI
A4_PBn==6 |BPIA5_PBn==1|BPIA5_PBn==2 
  label variable CA_PB "Chest & Abdominal Pain before" 
    
  gen BP_PB=0 
  recode BP_PB 0=1 if BPIA7_PBn==2|BPIA8_PBn<4 
  recode BP_PB 0=1 if BPIA7_PBn==2|BPIA8_PBn==1| 
BPIA8_PBn==2|BPIA8_PBn==3 
  label variable BP_PB "Back pain before"   
   
  *creating binary measure for pain location after 
  gen GP_PF=0 
  recode GP_PF 0=1 if BPIA1_PFn==3 | BPIA1_PFn==4 | BPIA1_PFn==6 
  label variable GP_PF "Generalised Pain after" 
   
  gen HN_PF=0 
  recode HN_PF 0=1 if BPIA1_PFn==5|BPIA1_PFn==6| BPIA1_PFn==7 | 
BPIA1_PFn==8 
  label variable HN_PF "Head & Neck Pain after" 
   
  gen MS_PF=0 
  recode MS_PF 0=1 if BPIA1_PFn==2 | BPIA1_PBn==9 
  label variable MS_PF "Mouth sores after" 
   
  gen LJP_PF=0 
  recode LJP_PF 0=1 if BPIA2_PFn==2 | BPIA2_PFn==3 | BPIA2_PFn==4 | 
BPIA3_PBn!=. | BPIA6_PBn!=.| BPIA7_PBn!=. 
  label variable LJP_PF "Limb & Joint Pain after" 
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  gen CA_PF=0 
  recode CA_PF 0=1 if BPIA4_PBn!=.| BPIA5_PBn!=. 
  label variable CA_PF "Chest & Abdominal Pain after" 
   
  gen BP_PF=0 
  recode BP_PF 0=1 if BPIA8_PFn<4 
  label variable BP_PF "Back pain after"  
   
  *encoding treatment before 
  gen amitrip_PB=0 
  recode amitrip_PB 0=1 if regexm(BPIQ6_PB, "Ami") 
  recode amitrip_PB 0=1 if regexm(BPIQ6_PB, "ami") 
   
  gen panadol_PB=0 
  recode panadol_PB 0=1 if regexm(BPIQ6_PB, "Pan") 
  recode panadol_PB 0=1 if regexm(BPIQ6_PB, "pan") 
   
  gen Brufen_PB=0 
  recode Brufen_PB 0=1 if regexm(BPIQ6_PB, "Bru") 
  recode Brufen_PB 0=1 if regexm(BPIQ6_PB, "bru") 
   
  gen Codeine_PB=0 
  recode Codeine_PB 0=1 if regexm(BPIQ6_PB, "Cod") 
  recode Codeine_PB 0=1 if regexm(BPIQ6_PB, "cod") 
   
  gen Aspirin_PB=0 
  recode Aspirin_PB 0=1 if regexm(BPIQ6_PB, "Asp") 
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  recode Aspirin_PB 0=1 if regexm(BPIQ6_PB, "asp") 
   
  gen Diclofenac_PB=0 
  recode Diclofenac_PB 0=1 if regexm(BPIQ6_PB, "Dic") 
  recode Diclofenac_PB 0=1 if regexm(BPIQ6_PB, "dic") 
  recode Diclofenac_PB 0=1 if regexm(BPIQ6_PB, "Dec") 
  recode Diclofenac_PB 0=1 if regexm(BPIQ6_PB, "dec") 
   
  gen Indocid_PB=0 
  recode Indocid_PB 0=1 if regexm(BPIQ6_PB, "Ind") 
  recode Indocid_PB 0=1 if regexm(BPIQ6_PB, "ind") 
   
  *creating a variable for medication number before 
 gen mednum_PB=amitrip_PB + panadol_PB + Brufen_PB + Codeine_PB + 
Aspirin_PB + Diclofenac_PB + Indocid_PB 
 
*encoding treatment after 
  gen amitrip_PF=0 
  recode amitrip_PF 0=1 if regexm(BPIQ6_PF, "Ami") 
  recode amitrip_PF 0=1 if regexm(BPIQ6_PF, "ami") 
 
  gen panadol_PF=0 
  recode panadol_PF 0=1 if regexm(BPIQ6_PF, "Pan") 
  recode panadol_PF 0=1 if regexm(BPIQ6_PF, "pan") 
 
  gen Brufen_PF=0 
  recode Brufen_PF 0=1 if regexm(BPIQ6_PF, "Bru") 
  recode Brufen_PF 0=1 if regexm(BPIQ6_PF, "bru") 
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  gen Codeine_PF=0 
  recode Codeine_PF 0=1 if regexm(BPIQ6_PF, "Cod") 
  recode Codeine_PF 0=1 if regexm(BPIQ6_PF, "cod") 
   
  gen Aspirin_PF=0 
  recode Aspirin_PF 0=1 if regexm(BPIQ6_PF, "Asp") 
  recode Aspirin_PF 0=1 if regexm(BPIQ6_PF, "asp") 
   
  gen Diclofenac_PF=0 
  recode Diclofenac_PF 0=1 if regexm(BPIQ6_PF, "Dic") 
  recode Diclofenac_PF 0=1 if regexm(BPIQ6_PF, "dic") 
  recode Diclofenac_PF 0=1 if regexm(BPIQ6_PF, "Dec") 
  recode Diclofenac_PF 0=1 if regexm(BPIQ6_PF, "dec") 
   
  gen Indocid_PF=0 
  recode Indocid_PF 0=1 if regexm(BPIQ6_PF, "Ind") 
  recode Indocid_PF 0=1 if regexm(BPIQ6_PF, "ind") 
   
  gen Morphine_PF=0 
  recode Morphine_PF 0=1 if regexm(BPIQ6_PF, "Mor") 
  recode Morphine_PF 0=1 if regexm(BPIQ6_PF, "mor") 
   
  * creating a variable for medication number after 
  gen mednum_PF=amitrip_PF + panadol_PF + Brufen_PF + Codeine_PF + 
Aspirin_PF + Diclofenac_PF + Indocid_PF + Morphine_PF 
 
*creating a binary variable for type of medication at baseline  
gen Meds_PB= mednum_PB 
recode Meds_PB 0=0 1=1 2=1 
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label values Meds_PB medsPB 
label define Meds_PB 0 "No" 1"Yes"  
label var Meds_PB "Medication at baseline"  
 
*creating a binary variable for type of medication at follow-up 
gen Meds_PF=mednum_PF 
recode Meds_PF 0=0 1=1 2=1 3=1 
label values Meds_PF medsPF 
label define Meds_PF 0 "No" 1"Yes" 
label var Meds_PF "Medication as follow-up" 
 
*creating new code for referring centre 
 gen SOR_PBn=0 
 recode SOR_PBn 0=1 if regexm(SOR_PB, "Ant") 
 recode SOR_PBn 0=1 if regexm(SOR_PB, "HIV") 
 recode SOR_PBn 0=1 if regexm(SOR_PB, "HTC") 
 recode SOR_PBn 0=2 if regexm(SOR_PB, "Fem") 
 recode SOR_PBn 0=2 if regexm(SOR_PB, "Ekw") 
 recode SOR_PBn 0=2 if regexm(SOR_PB, "Mal") 
 recode SOR_PBn 0=3 if regexm(SOR_PB, "TB") 
 recode SOR_PBn 0=4 if regexm(SOR_PB, "Pal") 
 recode SOR_PBn 0=4 if regexm(SOR_PB, "Wan") 
 recode SOR_PBn 0=5 if regexm(SOR_PB, "Rai") 
 recode SOR_PBn 0=5 if regexm(SOR_PB, "Mzu") 
 label define SOR_PBn 1 "HIV testing clinic" 2"Medical wards" 3"TB ward" 
4"Ekwendeni/Wanangwa clinic" 5"Mzuzu/Rainbow clinic"  
 label values SOR_PBn SOR_PBn 
 label variable SOR_PBn "referring centre" 
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 gen Ptage=(DOC_DA - DOBP_DA)/365.25 
 gen Crage=(DOC_DA - DOBC_DA)/365.25 
 *Time between approach and consent 
 gen AppCon=DOC_DA - DOIA_DA 
 *Time between consent (randomisation) and follow-up 
 gen ConFup= DOFA_DA - DOC_DA if p_attrition==0 
  
tab IDNumber if GP_PB==1|HN_PB==1| MS_PB==1|LJP_PB==1|CA_PB==1| 
BP_PB==1 
 bysort Allocation:tab IDNumber if GP_PB==1|HN_PB==1| 
MS_PB==1|LJP_PB==1|CA_PB==1| BP_PB==1 
 bysort Allocation:tab IDNumber if GP_PF==1|HN_PF==1| 
MS_PF==1|LJP_PF==1|CA_PF==1| BP_PF==1 
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Transposing outcome variables 
 
*patient outcomes before 
 
*Outcome 1  
*This is BPIQ4 item relating to average pain severity 
*If we are to make this on a scale of 1 to 100 with 100 being better then... 
generate double u = runiform() 
sort u 
gen PrimaryB=100-(10*BPIQ4_PB) 
label variable PrimaryB "Patient BPI average pain before (O1)" 
list PrimaryB BPIQ4_PB IDNumber if _n<10 
drop u 
 
*Outcome 2 
*BPI 7 items relating to interference, converted to a 0 to 100 scale with higher 
scores indicating less interference. Calculated for patients with no more than 2 
missing items 
generate double u = runiform() 
sort u 
egen BPImiss_PB= rowmiss (BPIQ8aPB - BPIQ8gPB) 
egen BPImean_PB= rowmean (BPIQ8aPB - BPIQ8gPB) if BPImiss_PB<3 
gen  BPItotal_PB= 100*((10-BPImean_PB)/10) 
label variable BPItotal_PB "Patient BPI pain interference before (O2)" 
list IDNumber BPImean_PB BPItotal_PB BPIQ8aPB-BPIQ8gPB if _n<10 
tab BPImiss_PB 
drop u 
 
*Outcome 3 
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*PPQ-K 9 items relating to pain management knowledge, converted to 0 to 100, 
higher scores indicating greater knowledge. Calculated for patients with no more 
than 3 missing items. 
generate double u = runiform() 
sort u 
egen PPQmiss_PB= rowmiss (PPQ1_PB - PPQ9_PB) 
egen PPQmean_PB= rowmean (PPQ1_PB - PPQ9_PB) if PPQmiss_PB<4 
gen  PPQtotal_PB= 100*((10-PPQmean_PB)/10) 
label variable PPQtotal_PB "Patient pain knowledge before (O3)" 
list IDNumber PPQmean_PB PPQtotal_PB PPQ1_PB-PPQ9_PB if _n<10 
tab PPQmiss_PB 
drop u 
 
*Outcome 4 
*POS 7 items, converted to a 0 to 100 scale with higher scores indicating better QOL. 
Calculated for patients with no more than 2 missing items. 
generate double u = runiform() 
sort u 
egen POSmiss_PB = rowmiss (POSQ1_PB - POSQ7_PB) 
egen POSmean_PB = rowmean (POSQ1_PB - POSQ7_PB) if POSmiss_PB<3 
gen POStotal_PB = 100*((5-POSmean_PB)/5) 
label variable POStotal_PB "Patient QOL before (O4)" 
list POSmiss_PB POSmean_PB POStotal_PB POSQ1_PB - POSQ7_PB if _n<10 
tab POSmiss_PB 
drop u 
 
*Carers outcomes before 
*Outcome 5 
*FPQ-K 9 items relating to carer pain management knowledge, converted to a 0 to 
100 scale, higher scores indicating greater knowledge. Calculated for carers with no 
more than 3 missing items 
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generate double u = runiform() 
sort u 
egen FPQmiss_CB= rowmiss (FPQ1_CB - FPQ9_CB) 
egen FPQmean_CB= rowmean (FPQ1_CB - FPQ9_CB) if FPQmiss_CB<4 
gen  FPQtotal_CB= 100*((10-FPQmean_CB)/10) 
label variable FPQtotal_CB "Carer pain knowledge before (O5)" 
list FPQmean_CB FPQtotal_CB FPQ1_CB-FPQ9_CB if _n<10 
tab FPQmiss_CB 
drop u 
 
*Outcome 6 
*PCRS 16 items relating to carer motivation, converted to a 0 to 100 scale, with 
higher scores indicating greater motivation. Calculated for carers with no more than 
5 missing items 
generate double u = runiform() 
sort u 
egen PCRSmiss_CB= rowmiss (PCRSQ1_CB - PCRSQ16_CB) 
egen PCRSmean_CB= rowmean (PCRSQ1_CB - PCRSQ16_CB) if PCRSmiss_CB<6 
gen  PCRStotal_CB= 100*((PCRSmean_CB)/4) 
label variable PCRStotal_CB "Carer motivation before (O6)" 
list PCRSmiss_CB PCRSmean_CB PCRStotal_CB PCRSQ1_CB - PCRSQ16_CB if _n<10 
tab PCRSmiss_CB 
drop u 
 
*Outcome 7 
*POS 3 items, converted to a 0 to 100 scale with higher scores indicating better 
carer QOL. Calculated for carers with no more than 1 missing item. 
generate double u = runiform() 
sort u 
egen POSmiss_CB = rowmiss (POSQ8_CB - POSQ10_CB) 
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egen POSmean_CB = rowmean (POSQ8_CB - POSQ10_CB) if POSmiss_CB<2 
gen POStotal_CB = 100*((5-POSmean_CB)/5) 
label variable POStotal_CB "Carer QOL before (O7)" 
list POSmiss_CB POSmean_CB POStotal_CB POSQ8_CB - POSQ10_CB if _n<10 
tab POSmiss_CB 
drop u 
 
*Patient outcomes after 
*Outcome 1 
generate double u = runiform() 
sort u 
gen FollowupB=100-(10*BPIQ4_PF) 
label variable FollowupB "Patient BPI average pain after (O1)" 
list FollowupB BPIQ4_PF IDNumber if _n<10 
drop u 
 
*Outcome 2 
*BPI 7 items relating to interference, converted to a 0 to 100 scale with higher 
scores indicating less interference. Calculated for patients with no more than 2 
missing items 
generate double u = runiform() 
sort u 
egen BPImiss_PF= rowmiss (BPIQ8a_PF - BPIQ8g_PF) 
egen BPImean_PF= rowmean (BPIQ8a_PF - BPIQ8g_PF) if BPImiss_PF<3 
gen  BPItotal_PF= 100*((10-BPImean_PF)/10) 
label variable BPItotal_PF "Patient BPI pain interference after (O2)" 
list IDNumber BPImean_PF BPItotal_PF BPIQ8a_PF-BPIQ8g_PF if _n<10 
tab BPImiss_PF 
drop u 
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*Outcome 3 
*PPQ-K 9 items relating to pain management knowledge, converted to 0 to 100, 
higher scores indicating greater knowledge. Calculated for patients with no more 
than 3 missing items. 
generate double u = runiform() 
sort u 
egen PPQmiss_PF= rowmiss (PPQ1_PF - PPQ9_PF) 
egen PPQmean_PF= rowmean (PPQ1_PF - PPQ9_PF) if PPQmiss_PF<4 
gen  PPQtotal_PF= 100*((10-PPQmean_PF)/10) 
label variable PPQtotal_PF "Patient pain knowledge after (O3)" 
list IDNumber PPQmean_PF PPQtotal_PF PPQ1_PF-PPQ9_PF if _n<10 
tab PPQmiss_PF 
drop u 
 
*Outcome 4 
*POS 7 items, converted to a 0 to 100 scale with higher scores indicating better QOL. 
Calculated for patients with no more than 2 missing items. 
generate double u = runiform() 
sort u 
egen POSmiss_PF = rowmiss (POSQ1_PF - POSQ7_PF) 
egen POSmean_PF = rowmean (POSQ1_PF - POSQ7_PF) if POSmiss_PF<3 
gen POStotal_PF = 100*((5-POSmean_PF)/5) 
label variable POStotal_PF "Patient QOL after (O4)" 
list IDNumber POSmiss_PF POSmean_PF POStotal_PF POSQ1_PF - POSQ7_PF if 
_n<10 
tab POSmiss_PF 
drop u 
 
*Carers outcomes after 
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*Outcome 5 
*FPQ-K 9 items relating to carer pain management knowledge, converted to a 0 to 
100 scale, higher scores indicating greater knowledge. Calculated for carers with no 
more than 3 missing items 
generate double u = runiform() 
sort u 
egen FPQmiss_CF= rowmiss (FPQ1_CF - FPQ9_CF) 
egen FPQmean_CF= rowmean (FPQ1_CF - FPQ9_CF) if FPQmiss_CF<4 
gen  FPQtotal_CF= 100*((10-FPQmean_CF)/10) 
label variable FPQtotal_CF "Carer pain knowledge after (O5)" 
list IDNumber FPQmean_CF FPQtotal_CF FPQ1_CF-FPQ9_CF if _n<10 
tab FPQmiss_CF 
drop u 
 
*Outcome 6 
*PCRS 16 items relating to carer motivation, converted to a 0 to 100 scale, with 
higher scores indicating greater motivation. Calculated for carers with no more than 
5 missing items 
generate double u = runiform() 
sort u 
egen PCRSmiss_CF= rowmiss (PCRSQ1_CF - PCRSQ16_CF) 
egen PCRSmean_CF= rowmean (PCRSQ1_CF - PCRSQ16_CF) if PCRSmiss_CF<6 
gen  PCRStotal_CF= 100*((PCRSmean_CF)/4) 
label variable PCRStotal_CF "Carer motivation after (O6)" 
list IDNumber PCRSmiss_CF PCRSmean_CF PCRStotal_CF PCRSQ1_CF - 
PCRSQ16_CF if _n<10 
tab PCRSmiss_CF 
drop u 
 
*Outcome 7 
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*POS 3 items, converted to a 0 to 100 scale with higher scores indicating better 
carer QOL. Calculated for carers with no more than 1 missing item. 
generate double u = runiform() 
sort u 
egen POSmiss_CF = rowmiss (POSQ8_CF - POSQ10_CF) 
egen POSmean_CF = rowmean (POSQ8_CF - POSQ10_CF) if POSmiss_CF<2 
gen POStotal_CF = 100*((5-POSmean_CF)/5) 
label variable POStotal_CF "Carer QOL after (O7)" 
list IDNumber POSmiss_CF POSmean_CF POStotal_CF POSQ8_CF - POSQ10_CF if 
_n<10 
tab POSmiss_CF 
drop u 
 
**** Create change scores for seven outcomes 
*Outcome 1 
gen change1 = FollowupB - PrimaryB 
 
*Outcome 2 
gen change2 = BPItotal_PF - BPItotal_PB 
  
*Outcome 3 
 gen change3 = PPQtotal_PF - PPQtotal_PB 
  
*Outcome 4 
gen change4 = POStotal_PF - POStotal_PB 
 
*Outcome 5 
gen change5 = FPQtotal_CF - FPQtotal_CB 
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*Outcome6 
gen change6 = PCRStotal_CF - PCRStotal_CB 
 
*Outcome7 
gen change7 = POStotal_CF - POStotal_CB 
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Ordering new variables (patient/carer baseline/follow-up) 
order IDNumber Allocation SC_PCB DOBP_DA DOBC_DA DOIA_DA DOC_DA DOFS_DA   
DOFA_DA RELCOLL PN_PB Address_PB CN_PB SOR_PB SOR_PBn Rel_PCB A_PB > PMARCOLL 
CMARCOLL POCCOLL COCOLL PG_DE CG_DE REL_DE PE_DE CE_DE PR_DE CR_DE PO_DE 
CO_DE DOP_DA PN_PB Address_PB CN_PB SOR_PB Rel_PCB A_PB B> PIA1_PB BPIA2_PB 
BPIA3_PB BPIA4_PB BPIA5_PB BPIA6_PB BPIA7_PB BPIA8_PB BPIA1_PBn BPIA2_PBn 
BPIA3_PBn BPIA4_PBn BPIA5_PBn BPIA6_PBn BPIA7_PB> n BPIA8_PBn GP_PB HN_PB MS_PB 
LJP_PB CA_PB BP_PB BPIQ2_PB BPIQ3_PB BPIQ4_PB BPIQ5_PB BPIQ6_PB amitrip_PB 
panadol_PB Brufen_PB Codeine_PB Aspirin_PB Diclofenac_PB Indocid_PB BPIQ7_PB BPIQ8aPB 
BPIQ8bPB BPIQ8cPB BPIQ8dPB BPIQ8ePB BPIQ8fPB BPIQ8gPB PPQ1_PB PPQ2_PB PPQ3_PB 
PPQ4_PB P> PQ5_PB PPQ6_PB PPQ7_PB PPQ8_PB PPQ9_PB PPQ10_PB PPQ11_PB PPQ12_PB 
PPQ13_PB PPQ14_PB PPQ15_PB PPQ16_PB POSQ1_PB POSQ2_PB POSQ3_PB POSQ4_PB P> 
OSQ5_PB POSQ6_PB POSQ7_PB FPQ1_CB FPQ2_CB FPQ3_CB FPQ4_CB FPQ5_CB FPQ6_CB 
FPQ7_CB FPQ8_CB FPQ9_CB FPQ10_CB FPQ11_CB FPQ12_CB FPQ13_CB FPQ14> _CB 
FPQ15_CB FPQ16_CB PCRSQ1_CB PCRSQ2_CB PCRSQ3_CB PCRSQ4_CB PCRSQ5_CB 
PCRSQ6_CB PCRSQ7_CB PCRSQ8_CB PCRSQ9_CB PCRSQ10_CB PCRSQ11_CB PCRSQ> 
12_CB PCRSQ13_CB PCRSQ14_CB PCRSQ15_CB PCRSQ16_CB POSQ8_CB POSQ9_CB 
POSQ10_CB BPIA1_PF BPIA2_PF BPIA3_PF BPIA4_PF BPIA5_PF BPIA6_PF BPIA7_P> F 
BPIA8_PF BPIA1_PFn BPIA2_PFn BPIA3_PFn BPIA4_PFn BPIA5_PFn BPIA6_PFn BPIA7_PFn 
BPIA8_PFn GP_PF HN_PF MS_PF LJP_PF CA_PF BP_PF BPIQ2_PF BP> IQ3_PF BPIQ4_PF 
BPIQ5_PF BPIQ6_PF amitrip_PF panadol_PF Brufen_PF Codeine_PF Aspirin_PF Diclofenac_PF 
Indocid_PF Morphine_PF BPIQ7_PF BPIQ8> a_PF BPIQ8b_PF BPIQ8c_PF BPIQ8d_PF 
BPIQ8e_PF BPIQ8f_PF BPIQ8g_PF PPQ1_PF PPQ2_PF PPQ3_PF PPQ4_PF PPQ5_PF PPQ6_PF 
PPQ7_PF PPQ8_PF PPQ9_PF PP> Q10_PF PPQ11_PF PPQ12_PF PPQ13_PF PPQ14_PF PPQ15_PF 
PPQ16_PF POSQ1_PF POSQ2_PF POSQ3_PF POSQ4_PF POSQ5_PF POSQ6_PF POSQ7_PF 
FPQ1_CF FPQ2_CF>  FPQ3_CF FPQ4_CF FPQ5_CF FPQ6_CF FPQ7_CF FPQ8_CF FPQ9_CF 
FPQ10_CF FPQ11_CF FPQ12_CF FPQ13_CF FPQ14_CF FPQ15_CF FPQ16_CF PCRSQ1_CF 
PCRSQ2_CF>  PCRSQ3_CF PCRSQ4_CF PCRSQ5_CF PCRSQ6_CF PCRSQ7_CF PCRSQ8_CF 
PCRSQ9_CF PCRSQ10_CF, first. 
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        Producing output for baseline tables and figures 
 
tab Allocation 
tab c_attrition if Allocation==2 & p_attrition==0 & c_attrition!=0 
tab p_attrition if Allocation==2 & p_attrition!=0 & c_attrition!=0 
  
             tab c_attrition if Allocation==1 & p_attrition==0 & c_attrition!=0 
tab p_attrition if Allocation==1 & p_attrition!=0 & c_attrition!=0 
 
*Table 1 Groups at baseline (patients) 
bysort Allocation: summ Ptage  
bysort Allocation: tab PG_DE 
bysort Allocation: tab PMARCOLL 
bysort Allocation: tab PE_DE 
bysort Allocation: tab PR_DE 
bysort Allocation: tab POCCOLL 
bysort Allocation: summ PrimaryB 
bysort Allocation: summ BPItotal_PB 
bysort Allocation: summ PPQtotal_PB 
bysort Allocation: summ POStotal_PB 
 
bysort Allocation:tab Meds_PB 
bysort Allocation:tab Meds_PF 
 
bysort Allocation:tab GP_PB 
bysort Allocation:tab HN_PB 
bysort Allocation:tab MS_PB 
bysort Allocation:tab LJP_PB 
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bysort Allocation:tab CA_PB  
bysort Allocation:tab BP_PB 
 
bysort Allocation:tab GP_PF 
bysort Allocation:tab HN_PF 
bysort Allocation:tab MS_PF 
bysort Allocation:tab LJP_PF 
bysort Allocation:tab CA_PF  
bysort Allocation:tab BP_PF 
 
         *Table 1 Groups at baseline (carers) 
bysort Allocation: summ Crage 
bysort Allocation: tab CG_DE 
bysort Allocation: tab CMARCOLL 
bysort Allocation: tab CE_DE 
bysort Allocation: tab CR_DE 
bysort Allocation: tab COCOLL 
bysort Allocation: tab RELCOLL 
bysort Allocation: summ FPQtotal_CB 
bysort Allocation: summ PCRStotal_CB 
bysort Allocation: summ POStotal_CB 
 
*Table 1 Groups at baseline (patients and carers) 
bysort Allocation: tab SOR_PBn 
bysort Allocation: tab SC_PCB 
 
bysort Allocation: summ FollowupB 
bysort Allocation: summ BPItotal_PF 
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bysort Allocation: summ PPQtotal_PF 
bysort Allocation: summ POStotal_PF 
 
bysort Allocation: summ FPQtotal_CF 
bysort Allocation: summ PCRStotal_CF 
bysort Allocation: summ POStotal_CF 
 
           *means 
bysort Allocation: summ change1 - change7 
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Analysis of outcomes 
  
*patient unadjusted analyses 
             regress FollowupB PrimaryB Allocation SC_PCB  
regress BPItotal_PF BPItotal_PB Allocation SC_PCB 
regress PPQtotal_PF PPQtotal_PB Allocation SC_PCB 
regress POStotal_PF POStotal_PB Allocation SC_PCB 
 
*carers unadjusted analyses 
             regress FPQtotal_CF FPQtotal_CB Allocation SC_PCB 
regress PCRStotal_CF PCRStotal_CB Allocation SC_PCB 
regress POStotal_CF POStotal_CB Allocation SC_PCB 
 
            *adjusted analysis, as above but include age, gender, total number of pain meds 
             *Patient analyses 
 
                                      regress FollowupB PrimaryB Allocation SC_PCB Ptage PG_DE  mednum_PB  
regress BPItotal_PF BPItotal_PB Allocation SC_PCB Ptage PG_DE  mednum_PB  
regress PPQtotal_PF PPQtotal_PB Allocation SC_PCB Ptage PG_DE  mednum_PB  
regress POStotal_PF POStotal_PB Allocation SC_PCB Ptage PG_DE  mednum_PB  
 
*Carers analyses 
             regress FPQtotal_CF FPQtotal_CB Allocation SC_PCB Crage CG_DE 
regress PCRStotal_CF PCRStotal_CB Allocation SC_PCB Crage CG_DE 
regress POStotal_CF POStotal_CB Allocation SC_PCB Crage CG_DE 
 
*model for medication for number of medication 
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regress mednum_PF mednum_PB Allocation SC_PCB 
regress mednum_PF mednum_PB Allocation SC_PCB Ptage PG_DE  
 
logistic Meds_PF Meds_PB Allocation SC_PCB  
logistic Meds_PF Meds_PB Allocation SC_PCB Ptage PG_DE 
 
            *model for type of medication adjusted for Allocation,centre, age and gender 
logistic amitrip_PF amitrip_PB Allocation SC_PCB Ptage PG_DE 
logistic panadol_PF panadol_PB Allocation SC_PCB Ptage PG_DE 
logistic Brufen_PF  Brufen_PB Allocation SC_PCB  Ptage PG_DE 
logistic Codeine_PF Codeine_PB Allocation SC_PCB Ptage PG_DE 
logistic Diclofenac_PF Diclofenac_PB Allocation SC_PCB Ptage PG_DE 
logistic Aspirin_PF Aspirin_PB Allocation SC_PCB Ptage PG_DE 
logistic Indocid_PF Indocid_PB Allocation SC_PCB Ptage PG_DE 
 
logistic HN_PF HN_PB Allocation SC_PCB Ptage PG_DE 
logistic MS_PF MS_PB Allocation SC_PCB Ptage PG_DE 
logistic LJP_PF LJP_PB Allocation SC_PCB Ptage PG_DE 
logistic BP_PF BP_PB Allocation SC_PCB Ptage PG_DE 
logistic GP_PF GP_PB Allocation SC_PCB Ptage PG_DE 
logistic CA_PF CA_PB Allocation SC_PCB Ptage PG_DE 
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Sensitivity analysis and checking model assumptions 
 
recode Group 1=0 2=1 
/*  
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) 
title(Sensitivity analysis for Kennedy trial 1) list listopt(sepby(delta)): reg FollowupB 
PrimaryB Group SC_PCB 
xi: rctmiss, sens(Allocation) pmmdelta(-10/0): reg FollowupB PrimaryB Allocation 
SC_PCB 
xi: rctmiss, pmmdelta(-5): reg FollowupB PrimaryB Allocation SC_PCB 
*/ 
 
label define randvals 0 "Usual care" 1 "Pain education", replace 
label values Group randvals 
/* 
label variable c_attrition "carer attrition" 
*/ 
 
*unadjusted analysis (replace square brackets with variable names) 
/* 
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) title(BPI-
PS) list listopt(sepby(delta)):regress FollowupB PrimaryB Group SC_PCB  
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) title(BPI-
PI) list listopt(sepby(delta)):regress BPItotal_PF BPItotal_PB Group SC_PCB 
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) title(PPK-
Q) list listopt(sepby(delta)):regress PPQtotal_PF PPQtotal_PB Group SC_PCB 
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) title(APCA 
African POS) list listopt(sepby(delta)):regress POStotal_PF POStotal_PB Group 
SC_PCB 
 
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) title(FPQ-
PK) list listopt(sepby(delta)):regress FPQtotal_CF FPQtotal_CB Group SC_PCB 
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xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) 
title(PCRS) list listopt(sepby(delta)):regress PCRStotal_CF PCRStotal_CB Group 
SC_PCB 
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) title(APCA 
African POS) list listopt(sepby(delta)):regress POStotal_CF POStotal_CB Group 
SC_PCB 
*/ 
 
*adjusted analysis, as above but include age, gender, total number of pain meds 
 
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) title(BPI-
PS) list listopt(sepby(delta)):regress FollowupB PrimaryB Group SC_PCB Ptage 
PG_DE  mednum_PB  
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) title(BPI-
PI) list listopt(sepby(delta)):regress BPItotal_PF BPItotal_PB Group SC_PCB Ptage 
PG_DE  mednum_PB 
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) title(PPK-
Q) list listopt(sepby(delta)):regress PPQtotal_PF PPQtotal_PB Group SC_PCB Ptage 
PG_DE  mednum_PB 
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) title(APCA 
African POS-Patients) list listopt(sepby(delta)):regress POStotal_PF POStotal_PB 
Group SC_PCB Ptage PG_DE  mednum_PB 
 
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) title(FPQ-
K) list listopt(sepby(delta)):regress FPQtotal_CF FPQtotal_CB Group SC_PCB Crage 
CG_DE 
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) 
title(PCRS) list listopt(sepby(delta)):regress PCRStotal_CF PCRStotal_CB Group 
SC_PCB Crage CG_DE 
xi: rctmiss, sens(Group) pmmdelta(-50/50) legend(rows(3)) stagger(0.05) title(APCA 
African POS-Carers) list listopt(sepby(delta)):regress POStotal_CF POStotal_CB 
Group SC_PCB Crag 
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STUDY PROTOCOL Open Access
An educational intervention to reduce pain and
improve pain management for Malawian people
living with HIV/AIDS and their family carers: study
protocol for a randomised controlled trial
Kennedy Nkhoma1, Jane Seymour1* and Antony Arthur2
Abstract
Background: Many HIV/AIDS patients experience pain often due to advanced HIV/AIDS infection and side effects
of treatment. In sub-Saharan Africa, pain management for people with HIV/AIDS is suboptimal. With survival
extended as a direct consequence of improved access to antiretroviral therapy, the prevalence of HIV/AIDS related
pain is increasing. As most care is provided at home, the management of pain requires patient and family
involvement. Pain education is an important aspect in the management of pain in HIV/AIDS patients. Studies of the
effectiveness of pain education interventions for people with HIV/AIDS have been conducted almost exclusively in
western countries.
Methods/design: A randomised controlled trial is being conducted at the HIV and palliative care clinics of two
public hospitals in Malawi. To be eligible, patient participants must have a diagnosis of HIV/AIDS (stage III or IV).
Carer participants must be the individual most involved in the patient’s unpaid care. Eligible participants are
randomised to either: (1) a 30-minute face-to-face educational intervention covering pain assessment and
management, augmented by a leaflet and follow-up telephone call at two weeks; or (2) usual care. Those allocated
to the usual care group receive the educational intervention after follow-up assessments have been conducted
(wait-list control group). The primary outcome is pain severity measured by the Brief Pain Inventory. Secondary
outcomes are pain interference, patient knowledge of pain management, patient quality of life, carer knowledge of
pain management, caregiver motivation and carer quality of life. Follow-up assessments are conducted eight weeks
after randomisation by palliative care nurses blind to allocation.
Discussion: This randomised controlled trial conducted in sub-Saharan Africa among people living with HIV/AIDS
and their carers will assess whether a pain education intervention is effective in reducing pain and improving pain
management, quality of life and carer motivation.
Trial registration: Current Controlled Trials ISRCTN72861423.
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Background
It is estimated that 34 million people were living with
HIV/AIDS at the end of 2010 [1]. In 2010, there were
1.8 million deaths from AIDS, and 2.7 million people
newly infected globally. In the same year, 1.4 million
people commenced HIV medication, an increase of 27%
in the number of people receiving treatment from the
previous year. Greater access to effective treatment has
led to a 19% decline in deaths among people living with
HIV/AIDS between 2004 and 2009.
Sub-Saharan Africa has 10% of the world’s popula-
tion, but it is home to 67% of all people living with
HIV/AIDS, making it the region worst-affected by
HIV/AIDS [1,2]. Antiretroviral therapy can dramatic-
ally increase survival and years of healthy life, but is
unavailable in some parts of the region [2]. In 2009
in sub-Saharan Africa, 37% of the population eligible for
HIV medication were treated, compared with 2% seven
years earlier [3].
In Malawi the prevalence of HIV/AIDS is estimated at
11% of the population aged between 15 and 49 years,
with around 920,000 people living with HIV/AIDS at the
end of 2010 [1,2]. Approximately 250 people are newly
infected each day, and at least 70% of Malawi's hospital
beds are occupied by HIV/AIDS patients, making Malawi
the 12th worst-affected country with HIV/AIDS worldwide
[4]. Substantial progress has been made in the provision of
HIV medication. By the end of 2010, an estimated 250,000
people had commenced HIV treatment representing 52%
of those in need [1]. However, due to inequities within
Malawi’s health system, access to HIV medication is sub-
optimal [5-8]. One initiative to help deal with the challenge
of accessing HIV medication has been the involvement of
nurses in the prescription and administration of medica-
tions. Trained health assistants now provide HIV counsel-
ling services to patients, and this has resulted in a greater
proportion of patients starting HIV medication within
three weeks of diagnosis [1].
Advanced HIV disease infection and its treatment with
HIV medication are associated with physical and psy-
chological symptoms. These require focused assessment
and management using locally available resources and
interventions to optimise quality of life for patients and
their carers [9]. The negative impact of pain on quality
of life has been documented in many studies [10,11].
Pain is a major problem for people living with HIV/
AIDS [12-14]. Pain is the most frequent and main cause
of psychological distress [15,16]. Experiencing pain can
reduce adherence to drugs and quality of life for HIV/
AIDS patients [17-21].
Inadequate pain control remains a challenge for HIV/
AIDS patients and has an impact on their quality of life
[19,20]. Pain is experienced throughout the disease
trajectory, severity being associated with later World
Health Organisation (WHO) clinical stage, [22-24] with
an estimated 80% of people with advanced HIV infection
experiencing severe pain [25]. Pain is also experienced
due to the effects of HIV medication [26,27]. With ad-
vances being made in improving access to HIV drugs in
resource poor countries, HIV patients are living longer,
and, therefore, experiencing pain over a longer period
[28,29]. For cost-related reasons there is rarely the op-
portunity for second-line antiretroviral medication to
be prescribed when first-line antiretroviral therapy is
poorly tolerated [30]. There is a need to provide effective
interventions to HIV/AIDS patients in alleviating and
managing pain. Previous trials conducted in western
countries of interventions to improve medication adher-
ence have produced conflicting results; one found evi-
dence that medication adherence and knowledge can be
improved [31] and another suggested that quality of life
outcomes were worse in the intervention group [32]. In a
trial of a symptom management manual for people with
HIV/AIDS, symptom frequency was reduced but only a
small number of trial centres were in sub-Saharan Africa
[9]. The majority of centres were in the United States
where the healthcare context is very different. None of
these trials directly involved unpaid carers, a group likely
to play a key role in the management of pain of those for
whom they care.
Aim
The aim of this trial is to evaluate the effect of an educa-
tional intervention for patients with HIV/AIDS and their
carers. The study will test the following hypotheses:
1. Compared with usual care, patients with HIV/AIDS
who receive a pain education intervention will
report less severity of pain.
2. Compared with usual care, patients with HIV/
AIDS who receive a pain education intervention
will report less interference of pain in their daily
activities.
3. Compared with usual care, patients with HIV/
AIDS who receive a pain education intervention
will have a greater knowledge of pain
management.
4. Compared with usual care, patients with HIV/AIDS
who receive a pain education intervention will have
a better quality of life.
5. Compared with usual care, carers of patients
with HIV/AIDS who receive the pain education
intervention will have greater knowledge of pain
management.
6. Compared with usual care, carers of patients with
HIV/AIDS who receive the pain education
intervention will have greater motivation to
provide care.
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7. Compared with usual care, carers of patients with
HIV/AIDS who receive the pain education
intervention will have a better quality of life.
Methods/design
Overview of study design
The study is a two-centre randomised wait-list con-
trolled trial. Participants (patients with HIV/AIDS and
their carers) randomly allocated to a pain education
intervention group receive a leaflet-based educational
intervention and verbal instructions for approximately
30 minutes on pain assessment and management in
addition to usual care. Participants randomly allocated
to the usual care group receive standard care, but re-
ceive the leaflet-based educational intervention on
completion of follow-up measures for both treatment
groups (wait-list control). Participants are assessed at
baseline after providing informed consent and then
randomly allocated to either the pain education inter-
vention or usual care arm of the trial. Follow-up as-
sessments are conducted after eight weeks.
Setting
The trial setting is that of HIV and palliative care
clinics within two public hospitals in northern Malawi.
Both hospitals (Ekwendeni and Mzuzu Central) pro-
vide in-patient, clinic-based and home-based care for
people with HIV/AIDS that includes active treatment
and palliative care. Ekwendeni Hospital provides ser-
vices funded by the government. It was one of the
first hospitals in Malawi to provide free HIV/AIDS
medication. Mzuzu Central Hospital is government-
funded and the largest referral hospital in north Malawi
for people with HIV/AIDS. The population served by
these hospitals includes people from both rural and
urban areas.
Study participants
Participants are people living with HIV/AIDS and their
carers. All participants need to be able to read and write
in English or Tumbuka (the vernacular language used in
the northern part of Malawi). They must be adults aged
18 years or over.
Inclusion criteria for people living with HIV/AIDS
To be eligible for the trial, participants must have
received a diagnosis of HIV/AIDS. Participants with
other conditions, such as cancer and tuberculosis, are
included if these conditions present alongside a diag-
nosis of HIV/AIDS. Eligible participants with HIV/
AIDS must be at WHO clinical stages III or IV of
HIV/AIDS, or with a CD4 cell count of less than 350
cells, when the presence of pain and other symptoms
are more likely due to opportunistic infections or side
effects of HIV treatment. Staging for trial eligibility
is assessed from the medical records if recorded or
through assessment by clinic staff if this information
is not available.
Inclusion criteria for carers
To be eligible for inclusion, carers must be living with
the person with HIV/AIDS and be identified as the indi-
vidual most involved in their care.
Exclusion criteria for people living with HIV/AIDS
People living with HIV/AIDS will be excluded if they have
health problems that may hinder cognition and communi-
cation, such as HIV-associated dementia. This is assessed
by the attending clinical officer during history-taking at the
initial assessment or at clinic review.
Recruitment
People living with HIV/AIDS in Malawi typically visit
the hospital (palliative care clinics and HIV clinics) with
their family members. Posters about the study entitled
‘Pain Education Study’ are prominently displayed and
potential participants have the opportunity to be given
further information about the study directly from KN or
from clinic staff.
The study is introduced either during the first appoint-
ment at the HIV clinic for newly registered patients or
during routine appointments at the HIV clinics or pallia-
tive care clinics for those who are already receiving HIV
medication (see Figure 1). KN or the staff in these clinics
inform patients about the study and provide them with
information sheets. Potential participants are encouraged
by KN or the clinic staff to discuss with family members
before making a decision to take part.
Potential participants have between two and four
weeks to consider taking part in the study. During their
next appointment those who are interested in taking
part in the study are asked to provide written informed
consent by KN. A checklist is administered to confirm
that all criteria for study eligibility are met.
Randomisation
After baseline assessments, participants are randomly allo-
cated to the pain education intervention group or usual
care group. Randomisation is implemented by KN using
opaque, sealed and numbered envelopes. The envelope is
opened in the presence of the participants after baseline as-
sessments. Participants have a 50% chance of being allo-
cated to either the pain education intervention group or
usual care group. In order to limit imbalance between the
treatment groups, participants are randomly assigned with
block randomisation using the ‘ralloc’ command in Stata
version 12 [33] Name of manufacturer: StataCorp, College
Station, Texas, USA. Randomisation is stratified by the
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recruiting hospital. KN is not involved in the preparation
of the envelopes and is blind to block size.
Interventions
Usual care
Assistance with pain management for patients with
HIV/AIDS is currently provided by hospital-based pallia-
tive care nurses and typically delivered in either a pallia-
tive care clinic or HIV clinic. Information relating to
pain medication is typically responsive rather than pro-
active and ad hoc rather than systematic. Information is
provided when requested by patients or carers. The
focus is mostly restricted to pharmacological treatment
of pain. Pain assessments are not usually conducted in a
systematic way and not recorded routinely. It is unusual
for this information to be shared with patients and/or
their carers.
Pain education intervention
The pain education intervention is informed by a
biopsychosocial approach [34] to management of pain
among people with HIV/AIDS. This conceptual frame-
work has guided the development of the intervention
in targeting adequate and effective use of analgesia
(biological), providing support and knowledge to min-
imise distress associated with poorly controlled pain
(psychological), and targeting the intervention at the
level of the patient/carer dyad (social). The
•
•
•
•
•
Figure 1 Flow diagram of study design.
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intervention consists of a leaflet and health education
session delivered face-to-face by KN to the participants
at the HIV clinic or palliative care clinic. The face-to-
face session takes approximately 30 minutes wherein
KN explains the intervention to the patient and carer
and both are given a copy of the leaflet and allowed to
browse through it briefly. KN then discusses the con-
tents of the leaflet with the participants and they are
both encouraged to ask questions. After two weeks,
participants receive a phone call reminder to enquire
whether they have any further questions after reading
the leaflet. The details of the session are reported in
Table 1.
Measures
Baseline
After recruitment and obtaining written consent from par-
ticipants, but prior to randomisation, baseline assessments
are conducted by KN. Baseline assessments include rele-
vant details from medical notes (date of diagnosis, current
treatments) and demographics. Other measures taken at
baseline are those used as outcomes for the trial.
The primary outcome is pain severity measured using
the Brief Pain Inventory [35]. A range of secondary out-
comes have been chosen due to the complex nature of
the intervention. The time point between delivery of the
intervention and follow-up assessments was chosen to be
consistent with other studies of pain education [36,37].
Patients are assessed in terms of pain severity, pain inter-
ference with daily activities, knowledge of pain manage-
ment, and quality of life. Carers are assessed in terms of
knowledge of pain management, caregiver motivation
and quality of life. These are measured as follows:
1. Pain severity is measured using the single item of
the Brief Pain Inventory (BPI-PS) [35] where
patients are asked to rate the severity of their pain
on average over the last week. A rating is made on a
0 to 10 point scale with higher scores indicating
greater severity of pain. This is consistent with the
Table 1 Components of the pain education intervention
Topics to be covered Content
Introductions Participants (patient and carer) welcomed
Introductions and clarifications as required
Leaflet provided and participants given time to read through
Overview of pain in HIV/AIDS Pain defined in relation to HIV/AIDS
Possible causes of pain in HIV/AIDS discussed
Characteristics of pain relating to HIV/AIDS
Beliefs and myths about pain in HIV/AIDS Participants given opportunity to share beliefs about pain in relation to HIV/AIDS
Where appropriate misconceptions dispelled
Beliefs and myths about pain medication Ask the participants’ beliefs about use of pain medication
Summarise and dispel misconceptions as required about pain medication
Assessment of pain in HIV/AIDS Demonstrate with the help of body diagrams how to locate and describe pain
Demonstrate use of pain assessment tools to rate and record pain
Demonstrate with pain diagrams how to classify pain
Explore type of pain experienced and strategies used to manage pain
Discuss ways in which pain may be managed more effectively
Pharmacological management of pain Demonstrate, using the WHO analgesic ladder, how pain is managed with medications
Give examples of available drugs used on the WHO ladder
Discuss most effective timing of pain medication
Non-pharmacological management of pain Identify what non-pharmacological interventions participants are aware of and use
Practical demonstrations on use of non-pharmacological interventions as appropriate
Other items to be covered Participants given further opportunity to clarify any of the points discussed
Participants encouraged to re-read the leaflet after the end of the face-to-face meeting
and refer to it whenever the patient experiences pain
Advise participants to ask for clarification about the leaflet and its contents by sending
a missed call to KN who will then return the call
Routine follow-up call at two weeks
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measurement of pain severity in a number of clinical
trials [38]. The BPI has been used with patients with
cancer and other chronic illnesses such as HIV/
AIDS [15,39] and to study the management of pain
in South Africa [40].
2. Pain interference with daily activities is measured
using the mean score of the seven pain interference
items of the Brief Pain Inventory (BPI-PI). These
items measure, on a scale of 0 to 10, the degree to
which the patient reports pain interfering with each
of seven activities (general activity, walking, work,
mood, enjoyment of life, relations with others and
sleep) and is the recommended method of
assessment of pain-related functional impairment in
clinical trials [41].
3. For patients, knowledge of pain management is
measured using the knowledge subscale of the
Patient Pain Questionnaire (PPQ-K) [42]. The
PPQ-K is made up of nine items asking the patient to
disagree or agree with statements about the
effectiveness, timing of pain medication dosage, and
adequacy of pain medication dosage. Agreement/
disagreement is rated on a scale of 0 to 10. Scores
range from 0 to 90 with higher scores indicating
greater patient knowledge of pain management.
4. For patients, quality of life is measured using the
APCA African POS [43]. The APCA African POS
consists of seven items directed at patients
addressing pain and symptom assessment,
psychological and emotional concerns. Possible
scores range from 0 to 35 with higher scores
indicating worse outcomes/quality of life. The tool
has been developed and tested in three African
countries [44].
5. For carers, knowledge of pain management is
measured using the knowledge subscale of the
Family Pain Questionnaire (FPQ-K) [45]. Like the
PPQ-K, the FPQ-K is made up of nine items asking
the carer to disagree or agree with statements about
the effectiveness, timing of pain medication dosage,
and adequacy of pain medication dosage. Agreement/
disagreement is rated on a scale of 0 to 10. Scores
range from 0 to 90 with higher scores indicating
greater carer knowledge of pain management.
6. Carer motivation is measured using the Picot
Caregiver Rewards Scale (PCRS) [46]. The PCRS is a
16-item scale measuring the positive consequences
of caregiving. Respondents rate the degree to which
items describe positive consequences of their
caregiving on a 5-point Likert scale. Possible scores
range from 0 to 64 with higher scores indicating
more positive caregiving experience.
7. For carers, quality of life is measured using the
APCA African POS [43]. The APCA African POS
consists of three items directed at carers addressing
the adequacy of information the family has received,
confidence in caring, and level of worry. Possible
scores range from 0 to 15 with higher scores
indicating worse outcomes/quality of life.
While the BPI [40] and APCA African POS [43] have
both been used previously in Sub-Saharan African Popula-
tions, use of the PPQ, FPQ and PCRS has been restricted
to populations in western countries. Our experience imme-
diately prior to trial recruitment of piloting these scales as
part of the questionnaires among 10 patients and 10 carers
suggests that they are acceptable to and understood by
members of the population of patients and carers from
which our sample is being recruited.
Follow-up
Follow-up measures are conducted after eight weeks fol-
lowing delivery of the intervention. Nurses blind to treat-
ment group conduct the follow-up assessments. This is
implemented during the routine appointments to the HIV
or palliative care clinic.
Sample size
We wish to be able to detect a mean difference of 10%
between the treatment groups in the primary outcome
measure (average pain severity in the BPI). A 10% im-
provement is the lower limit of changes considered clin-
ically important [47]. Using a P-value cut-off of 0.05 to
determine a statistically significant result, 76 people per
arm of the trial will be needed to complete the study to
give 80% power to detect such a difference. This is based
on a review [48] that suggests that education-based in-
terventions are able to produce this level of improve-
ment in pain reduction, and that a standard deviation of
2.2 points is a liberal estimate of variability. To allow for
15% attrition, we will attempt to recruit 180 participants
to the trial.
Statistical analysis
We will provide a descriptive account of the two treat-
ment groups at baseline in terms of demographics,
recruiting centre, stage of HIV/AIDS and baseline values
of all study outcomes. All patients and carers will be
analysed according to the group to which they were
randomised. Treatment groups will be compared in
terms of our primary outcome measure (pain severity
using the BPI-PS treated as a continuous measure) using
a linear regression model with baseline BPI and treat-
ment group and recruiting centre as covariates. Analysis
of each of the six secondary outcomes (BPI-PI, PPQ-K,
APCA African POS patient score, FPQ-K, PCRS, APCA
African POS carer score) will be conducted using six
equivalent models with estimates of treatment effect
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conditional on the value of the outcome at baseline. Sen-
sitivity analysis will be reported and performed as fol-
lows: we will conduct secondary analyses that (1) adjust
for variables that are potential predictors of outcome
(for example, age, gender, stage of HIV/AIDS, medi-
cation use at baseline) and (2) make worst-case and best-
case scenario assumptions about participants lost to
follow-up using the Stata command ‘rctmiss’ [49]. Ana-
lysis will be conducted using Stata version 12 [33].
Ethical approval
The study has been approved by the University of
Nottingham Medical School Research Ethics Committee
(SNMP 11042012) and National Health Sciences Research
Committee of Malawi (NHSRC 1023).
Discussion
Findings from this trial will inform the management
of pain experienced by people living with HIV/AIDS.
Previous trials of interventions designed to enhance
self-management for people living with HIV/AIDS have
been conducted either exclusively [31,32,50] or predom-
inantly [9] in western countries. Differences in terms of
culture and healthcare systems mean it is unwise to un-
critically apply evidence for non-pharmacological inter-
ventions from resource rich countries to those that are
resource poor. Our trial also differs from these studies in
intervening at the level of the patient/carer dyad. Family
carers are a crucial component in the delivery of care for
people living with HIV/AIDS in Malawi and other similar
African countries. Most pain management educational
intervention studies have been conducted in cancer pop-
ulations [36,51-53]. Our intervention is targeted at pain
experienced by people living with HIV/AIDS. The inter-
vention is simple and fits within a model of care where
most healthcare contact is between patients and nurses
and is supported by trained health assistants.
Trial status
The trial commenced recruiting in September 2012. We
anticipate reaching our recruitment target by June 2013.
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Original Article
An Educational Intervention to Reduce Pain and Improve Pain
Management for Malawian People Living With HIV/AIDS and Their
Family Carers: A Randomized Controlled Trial
Kennedy Nkhoma, MSc, Jane Seymour, PhD, and Antony Arthur, PhD
Sue Ryder Care Centre for the Study of Supportive, Palliative and End of Life Care (K.N., J.S.), Division of Nursing, Queen’s Medical Centre,
Nottingham; and School of Health Sciences (A.A.), University of East Anglia, Norwich, United Kingdom
Abstract
Context. Advances being made in improving access to HIV drugs in resource-poor countries mean HIV patients are living
longer, and, therefore, experiencing pain over a longer period of time. There is a need to provide effective interventions for
alleviating and managing pain.
Objectives. To assess whether a pain educational intervention compared with usual care reduces pain severity and
improves pain management in patients with HIV/AIDS and their family carers.
Methods. This was a randomized, parallel group, superiority trial conducted at HIV and palliative care clinics of two public
hospitals in Malawi. A total of 182 adults with HIV/AIDS (Stage III or IV) and their family carers participated; carer
participants were those individuals most involved in the patient’s unpaid care. The educational intervention comprised a 30
minute face-to-face meeting, a leaflet, and a follow-up telephone call at two weeks. The content of the educational
intervention covered definition, causes, and characteristics of pain in HIV/AIDS; beliefs and myths about pain and pain
medication; assessment of pain; and pharmacological and nonpharmacological management. The primary outcome was
average pain severity measured by the Brief Pain Inventory-Pain Severity subscale. Assessments were recorded at baseline
before randomization and at eight weeks after randomization.
Results. Of the 182 patient/carer dyads randomly allocated, 157 patient/carer dyads completed the trial. Patients in the
intervention group experienced a greater decrease in pain severity (mean difference ¼ 21.09 points, 95% confidence
interval ¼ 16.56e25.63; P < 0.001).
Conclusion. A short pain education intervention is effective in reducing pain and improving pain management for
Malawian people living with HIV/AIDS and their family carers. J Pain Symptom Manage 2015;-:-e-. ! 2015 American
Academy of Hospice and Palliative Medicine. Published by Elsevier Inc. All rights reserved.
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Introduction
Advanced HIV infection and its treatment with anti-
retroviral therapy are associated with physical and psy-
chological symptoms.1,2 These require focused
assessment and management using locally available re-
sources and interventions to optimize quality of life
for patients and their carers.1,3 The negative impact
of pain on quality of life has been documented in
many studies.4,5 Pain is a major problem for people
living with HIV/AIDS.6e8 Pain is the most frequent
and main cause of psychological distress.9,10 Experi-
encing pain can reduce adherence to drug regimens
and quality of life for HIV/AIDS patients.11e15
It is estimated that 35.3 million people were living
with HIV/AIDS at the end of 2012.16,17 In the same
year, there were 1.6 million deaths from AIDS, a
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reduction from 2.3 million deaths in 2005. In 2010,
1.4 million people began HIV medication, an increase
in the number of people receiving treatment from the
previous year of 27%. Greater access to effective treat-
ment largely explains some of this decline in HIV/
AIDS mortality.18
Sub-Saharan Africa has 10% of the world’s popula-
tion, but it is home to 69% of all people living with
HIV/AIDS, making it the worst affected region.16,17
Antiretroviral therapy can dramatically increase sur-
vival and years of healthy life, but is unavailable in
many parts of the region.18 In 2010 in sub-Saharan
Africa, the number of individuals treated with antire-
troviral medication increased from 37% in 200919 to
49% of the population eligible for treatment.20
In Malawi, the prevalence of HIV/AIDS is esti-
mated at 11% of the population aged 15e49 years,
with around 910,000 people living with HIV/AIDS
at the end of 2011.17 Approximately, 250 people
are newly infected each day,20 and at least 70% of Ma-
lawi’s hospital beds are occupied by HIV/AIDS pa-
tients,21 making Malawi the 12th worst affected
country with HIV/AIDS worldwide.22 However, there
was a decline in HIV/AIDS prevalence from 14% in
2003 to 10% in 2011, predominantly because of
increased access to antiretroviral therapy and preven-
tive strategies.23 Substantial progress has been made
in the provision of HIV medication.24 The involve-
ment of nurses in the prescription and administra-
tion of medications and training health assistants to
provide HIV counseling services have resulted in a
greater proportion of patients starting HIV treat-
ment within three weeks of diagnosis.25 This has re-
sulted in increased antiretroviral coverage to 67%
in 2011.23,24
Adequate pain control remains a challenge for
HIV/AIDS patients and has an impact on their quality
of life.13,14 Pain is experienced throughout the disease
trajectory, severity being associated with later World
Health Organization (WHO) clinical stage,2,26e28
with an estimated 80% of people with advanced HIV
infection experiencing severe pain.29 Pain is also
experienced as an effect of HIV medication.30,31
With advances being made in improving access to
HIV drugs in resource-poor countries, HIV patients
are living longer and, therefore, experiencing pain
over a longer period.32,33 There is a need to provide
effective interventions to HIV/AIDS patients in allevi-
ating and managing pain. A systematic review34 re-
ported that self-management education programs
for people living with HIV/AIDS results in short-
term improvements in physical and psychosocial
health and knowledge. However, all the trials reviewed
were conducted in the U.S. and China where the
health context is very different and none of these tri-
als directly involved unpaid carers, a group likely to
play a key role in the management of pain of those
they care for.
Methods
Study Design
The pain education intervention study was a two-
center, randomized, parallel group, wait-list controlled
superiority trial. A detailed study protocol has been
published.35
Setting and Participants
From October 2012 to June 2013, we recruited par-
ticipants at HIV and palliative care clinics within two
public hospitals (Ekwendeni and Mzuzu Central) in
northern Malawi. Both hospitals provide inpatient,
clinic-based and home-based care for people with
HIV/AIDS that includes active treatment and pallia-
tive care. Participants were people living with HIV/
AIDS who had a primary carer, who was identified as
the individual most involved in their care. They were
adults aged 18 years or older. All participants were
able to read and write in English or Tumbuka (the
vernacular language used in the northern part of
Malawi). Participants were at WHO clinical stages III
or IV of HIV/AIDS, or with a CD4 cell count of less
than 350 cells, when the presence of pain and other
symptoms is more likely because of opportunistic in-
fections or side effects of HIV treatment. We excluded
people living with HIV/AIDS if they had health prob-
lems that hindered cognition and communication
such as HIV-associated dementia.
Recruitment
People living with HIV/AIDS in Malawi typically visit
the hospital (palliative care and HIV clinics) with their
family members. Posters about the study entitled
‘‘Pain Education Study’’ were prominently displayed
in the clinics. Additionally, the first author (K. N.) or
staff in these clinics informed patients about the study
and provided them with information sheets. Potential
participants were encouraged to discuss the study with
family members before making a decision to take part.
Those interested in taking part in the study were asked
by K. N. to provide written informed consent. A check-
list was used to confirm that all criteria for study eligi-
bility were met.
Randomization, Concealment of Allocation, and
Blinding
Baseline assessments were conducted by K. N. before
randomization. Randomization was implemented by K.
N. using opaque, sealed, and consecutively numbered
envelopes. The envelope was opened in the presence
of the participant. Participants had a 50% chance of
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being allocated to either the pain education interven-
tion group or usual care group. To limit imbalance be-
tween the treatment groups, participants were
randomly assigned with block randomization using
the ‘‘ralloc’’ command in Stata Version 12 (StataCorp
LP, College Station, TX).36 This allocates participants
at random in blocks of sizes 2, 4, 6, 8, and 10, with
block sizes allocated unequally in the ratio of
1:4:6:4:1 (Pascal’s triangle).
Randomization was stratified by recruiting hospital.
K. N. was not involved in the preparation of envelopes
and was blinded to block size. A. A. prepared the enve-
lopes and neither had contact with the study partici-
pants nor was he involved in recruitment. Owing to
the nature of the intervention, participants and K. N.
knew the treatment arm to which they were allocated,
but the nurses who conducted follow-up outcomes
were blinded to this information. Participants were
told not to inform the assessors about treatment alloca-
tion. Assessors were asked if participants had told them
of their group allocation after completion of outcome
assessments to assess the success or failure of blinding.
Intervention and Comparator Groups
Pain Education Intervention. The nurse-led pain edu-
cation intervention was informed by a biopsychosocial
approach37 to the management of pain among people
with HIV/AIDS. It was designed to provide a system-
atic and proactive approach to assist people with
HIV/AIDS and their carers to better understand and
manage pain. The intervention consisted of a health
education session delivered face-to-face by K. N., a Ma-
lawian registered nurse and specialist in palliative care,
to the individual patient/carer dyads (Table 1). The
face-to-face session took approximately 30 minutes in
a quiet room within the palliative care or HIV/AIDS
clinic where the participant was recruited. The compo-
nents of the pain education intervention are listed in
detail elsewhere35 but included a discussion of HIV/
AIDS-related pain, beliefs, and myths about pain and
pain medication; ways to assess pain; and potential
pharmacological and nonpharmacological methods
to manage pain. A leaflet entitled ‘‘All About Your
Pain’’ was given to participants, who were given the op-
portunity to look through it (Appendix, available at
jpsmjournal.com). K. N. then discussed the contents
of the leaflet with the participants and they were
both encouraged to ask questions. Participants
received a phone call reminder from K. N. after two
weeks to inquire whether they had any further ques-
tions after the face-to-face discussion and reading
the leaflet. Phone contacts typically lasted no more
than five minutes. To minimize possible contamina-
tion between two groups, participants were asked not
to share the leaflet with others. The features of usual
care and the pain education intervention are ex-
plained in Table 1. There was no intention to system-
atically manage pain differently between the two
groups, but one consequence for those in the pain ed-
ucation intervention group may have been to seek out
additional treatments to manage their pain.
The leaflet drew on the evidence base and related
literature for cancer pain management5,38 and HIV/
AIDS pain management in Africa39,40 and pain man-
agement in Malawi.41 Health care workers, HIV/
AIDS patients, and family carers were involved in the
development of the leaflet in terms of its design, con-
tent, technical characteristics, and readability.
The leaflet was in the form of a double-sided A4 page
formatted so that it could be gate-folded into two for
ease of use. It was printed in color and had illustrations
to improve clarity and understanding. Diagrams and
pictures were used to enhance understanding and to
motivate the reader. The leaflet was pilot tested among
10 patients and 10 family carers to ensure that the con-
tent was readable and understandable.
Usual Care. Information relating to pain manage-
ment is typically provided in a responsive rather than
proactive manner and ad hoc rather than systematic,
Table 1
Features of Usual Care and the Pain Educational Intervention
Element Usual Care/Wait-List Control Pain Education Intervention
General description Unstructured verbal information Leaflet-based information, advice, explanation, and
discussion
Form General information on the treatment prescribed and
instructions to be followed, responsive information
from staff nurses
Information leaflet distributed ‘‘All About Your Pain’’
including 30 minute face-to-face verbal instructions
and advice on pain assessment and management,
phone call reminder after two weeks
Content General information about HIV/AIDS medication and
treatment compliance
Specific information about procedure on pain
assessment and classification using pain scales and
pain diagrams, including pain management using
WHO analgesic ladder and specific drugs on each
step
Written materials None Leaflet with simplified text information and diagrams,
pictures/photos for quick reference
Method of delivery General staff members K. N.
WHO ¼ World Health Organization.
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with the focus restricted to pharmacological treatment
of pain. Pain assessments are not usually conducted in
a systematic way and not recorded routinely. It is un-
usual for this information to be routinely shared
with patients and/or their carers.
Outcomes
The primary outcome was average pain severity
measured using the Brief Pain Inventory (BPI; BPI-
PS).42 Secondary outcomes were pain interference
with daily activities measured using the mean score
of the seven pain interference items of the BPI (BPI-
PI),43 knowledge of pain management measured
using the knowledge subscale of the Patient Pain
Questionnaire (PPQ; PPQ-K),44 and quality of life
measured using the African Palliative Care Association
(APCA) African Palliative Care Outcomes Scale
(POS).45,46 For carers, knowledge of pain manage-
ment was measured using the knowledge subscale of
the Family Pain Questionnaire (FPQ; FPQ-K),47 carer
motivation was measured using the Picot Caregiver Re-
wards Scale (PCRS),48 and quality of life was measured
using the APCA African POS.45 All outcomes were self-
reported. If participants were unable to self-complete
after careful and standardized explanation of individ-
ual items, they were asked the question verbally and
interviewers recorded their responses. Although the
BPI49 and APCA African POS45 have both been used
previously in sub-Saharan African populations, use of
the PPQ, FPQ, and PCRS has been restricted to popu-
lations in Western countries. Our experience immedi-
ately before trial recruitment of piloting these scales as
part of the questionnaire among 10 patients and 10
carers suggests that they are acceptable to and under-
stood by members of the population of patients and
carers from which our sample was recruited.
All outcome measures were conducted at baseline
and eight weeks after delivery of the intervention.
Eight weeks was considered sufficient time to observe
any effect of the intervention and long enough to be
considered clinically important. Outcomes were trans-
posed to a zero to 100 scale, with higher scores indi-
cating a more ‘‘positive’’ outcome; hence, a
participant’s individual score represented a percent-
age of the best possible score for that outcome.
Sample Size
We wished to be able to detect a mean difference of
10% between the treatment groups in the primary
outcome measure (average pain severity on the BPI).
A 10% improvement is considered the lower limit of
change of clinical importance.50 Using a P-value cutoff
of 0.05 to determine a statistically significant result, 76
people per arm of the trial were needed to complete
the study to give 80% power to detect such a difference.
This is based on a review51 that suggests that education-
based interventions are able to produce this level of
improvement in pain reduction, and that a standard
deviation of 2.2 points is a liberal estimate of variability.
To allow for 15% attrition, we aimed to recruit 182 par-
ticipants to the trial.
Statistical Analysis
All patients and carers were analyzed according to
the group to which they were randomized, although
the use of strict intention-to-treat analysis is only
possible where there is no loss to follow-up.52,53 We
compared treatment groups in terms of our primary
outcome measure (average pain severity using the
BPI-PS treated as a continuous measure) using a linear
regression model, with baseline BPI-PS and treatment
group and recruitment center as covariates. Analysis of
each of the six secondary outcomes (BPI-PI, PPQ-K,
APCA African POS patient score, FPQ-K, PCRS, and
APCA African POS-carer score) were conducted using
six equivalent models, with estimates of treatment ef-
fect conditional on the value of the outcome at base-
line. Sensitivity analysis was performed as follows: we
conducted secondary analyses that 1) adjusted for vari-
ables that were considered potential predictors of
outcome (age, gender, and number of pain medica-
tions at baseline) assuming missing at random; and
2) considered plausible scenarios for departures
from the missing at random assumption using the Sta-
ta command ‘‘rctmiss.’’53 These scenarios were for all
outcomes using scores of the mean outcome plus
and minus 20 points for both arms and individual
arms. All models included recruitment center as a co-
variate. All analyses were conducted using Stata
Version 12.36
Ethical Approval
The study was approved by the University of Not-
tingham Medical School Research Ethics Committee
(SNMP 11042012) and the National Health Sciences
Research Committee of Malawi (NHSRC 1023).
Results
Of the 308 potential patient/carer dyads assessed,
182 were eligible, consented to participate, and
completed the baseline measures (Fig. 1). A total of
92 were randomized to the pain education interven-
tion and 90 were randomized to usual care. Of these,
15 patient/carer dyads and 10 carers were lost to
follow-up. Reasons for attrition in the pain education
group were patient having died before follow-up as-
sessments (n ¼ 4), no transport (n ¼ 2), untraceable
(n ¼ 1), and moved away (n ¼ 1). Reasons for attrition
in the usual care group were: untraceable (n ¼ 2),
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moved away (n ¼ 4), and patient too unwell (n ¼ 1).
Reasons for carer loss to follow-up in the pain educa-
tion group and usual care group were the same: carer
too busy (n ¼ 2) and no transport (n ¼ 3). Of the 167
patients and 157 carers who completed the trial, com-
plete data were available for all outcomes.
Baseline Characteristics
Pain education and usual care groups were similar
at baseline in terms of sociodemographic profile
except for gender; there were 43 (46.7%) male pa-
tients in the pain education group compared with
56 (62.2%) male patients in the usual care group
(Table 2). There were also differences in carer rela-
tionship to the patient; there were 35 (38.0%)
spousal carers in the pain education group and 44
(48.9%) spousal carers in the usual care group. At
baseline, the two groups of patient/carer dyads
were broadly similar in terms of the seven outcome
measures.
Delivery and Receipt of the Intervention
The intervention was delivered by K. N. All the par-
ticipants (n ¼ 92) randomized to the pain education
intervention attended a 30 minute face-to-face discus-
sion and received a leaflet. Of these, 59 participants
received the phone call reminder intervention at
Week 2. Because of poor telephone network coverage,
some participants did not receive a phone call
(n ¼ 19) but had physical contact with K. N. during
their visit to the clinic at Week 2. Of the 59 partici-
pants who received a phone call, four also had face-
to-face contact with K. N. at the clinic, where they
were reminded to read the leaflet, and clarification
was provided in response to their questions.
Primary Outcome
Both groups had reduced average pain severity at
follow-up. However, those in the pain education group
had a mean change of 40.95 (SD ¼ 23.78), whereas
the usual care group had a mean change of
Assessed for eligibility (n = 308)
Excluded (n = 126) 
 No carer (n = 45) 
 Unable to read and write (n = 15) 
 Outside catchment area (n = 15) 
 Cognitively impaired (n = 4)
 Died before recruitment (n = 10) 
 Declined (n = 37) 
Allocated to usual 
care (n = 90) 
Received usual care 
(n = 90) 
Patient and carer lost to 
follow-up (n = 7)  
   Untraceable (n = 2)
   Moved away (n = 4)
   Patient unwell (n = 1)
Carer loss to follow-up 
(n = 5)
 Too busy (n = 2) 
  No transport (n = 3)
Patient and carer lost to 
follow-up (n = 8)  
  No transport (n = 2)
  Patient died (n = 4)
  Untraceable (n = 1)
  Moved away (n = 1)
Carer loss to follow-up 
(n = 5)
   Too busy (n = 2)
   No transport (n = 3)
Randomized (n = 182)
Allocated to pain 
education intervention 
(n = 92) 
Received allocated 
intervention (n = 92) 
Followed-up and analyzed 
(n = 78 patients and carers) 
(n = 5 patients) 
Followed-up and analyzed 
 (n = 79 patients and carers) 
 (n = 5 patients) 
Fig. 1. Consolidated Standards of Reporting Trials (CONSORT) flow diagram of patients and carers throughout the study.
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19.27(SD ¼ 25.27; Table 3). When adjustments were
made for baseline average pain severity score, recruit-
ment center, age, gender, and number of pain medica-
tions, participants in the pain education group
reported less severity of pain compared with those in
the usual care group (mean difference ¼ 21.25, 95%
CI ¼ 16.7e25.8; P < 0.001).
Secondary Outcomes
Participants in the pain education group had signifi-
cantly less pain interference than the usual care group
at follow-up (adjusted mean difference ¼ 24.5, 95%
CI ¼ 19.61e29.38; P < 0.001). Patients in the pain ed-
ucation group reported greater improvement in knowl-
edge than patients in the usual care group at
follow-up (adjusted mean difference ¼ 20.39, 95%
CI ¼ 17.51e23.27; P < 0.001). At follow-up, partici-
pants in the pain education group experienced better
quality of life than participants in the usual care
group (adjusted mean difference ¼ 28.76, 95%
CI ¼ 24.62e32.91; P < 0.001; Table 3).
Carers in the pain education group reported
greater improvement in knowledge than carers in
the usual care group at follow-up (adjusted mean
difference ¼ 20.32, 95% CI ¼ 17.37e23.28;
P < 0.001; Table 4). Carers in the pain education
group reported greater motivation to provide care
than carers in the usual care group at follow-up
(adjusted mean differenc ¼ 7.64, 95%
CI ¼ 5.15e10.13; P < 0.001), as well as a better quality
of life (adjusted mean difference ¼ 34.16, 95%
CI ¼ 30.15e38.17; P < 0.001).
Sensitivity Analysis
In all the scenarios tested using various departures
from the missing at random assumption, none altered
the interpretation of better outcomes for the pain ed-
ucation group.
Discussion
In this randomized controlled trial, we found evi-
dence that pain education intervention consisting
of a face-to-face discussion, leaflet, and two-week
follow-up phone call reduced pain severity, reduced
pain interference with daily activities, improved pa-
tient knowledge of pain management, and patient
quality of life. We also found evidence that the inter-
vention improved carers’ pain knowledge of pain
management, quality of life, and motivation to pro-
vide care. The results are consistent with other
studies of interventions to enhance self-care that
have found improvement in pain management,54,55
better knowledge about pain,56e58 improved pain
control,55,56,59,60 and less pain interference with daily
activities,59,60 although the form, content, and
context of these interventions were different and
were administered among cancer patients. Our find-
ings are different from those of a study conducted
among HIV/AIDS patients61 that found decreased
quality of life when medication reminders were given,
and to a trial that found no effect of an educational
intervention to enhance self-management skills.62
Table 2
Baseline Characteristics of Participants (N ¼ 182)
Randomized to the Pain Education Intervention or Usual
Care
Variables
Pain Education
Intervention
(N ¼ 92), Mean (SD)
Usual Care
(N ¼ 90),
Mean (SD)
Patient participants
Age, yrs 40.5 (11.3) 41.3 (11.65)
Gender
Male 43 (46.74) 56 (62.22)
Female 49 (53.26) 34 (37.78)
Marital status
Married 61 (66.3) 58 (64.44)
Single 11 (11.96) 13 (14.44)
Divorced/separated 11 (11.96) 10 (11.11)
Widow/widower 9 (9.78) 9 (10)
Education
Primary school 21 (22.83) 14 (15.56)
High school 66 (71.74) 72 (80)
College/university 5 (5.43) 4 (4.44)
BPI pain measures
Average pain severity 50.76 (24.86) 51.22 (27.1)
Pain interference 49.91 (27.97) 49.46 (29.48)
Pain knowledge
PPQ-K subscale 67.78 (16.61) 66.24 (18.84)
Quality of life
APCA African
POS subscale
44.78 (22.79) 48.92 (20.5)
Carer participants
Age, yrs 41.1 (11.7) 42.6 (11.4)
Gender
Male 14 (15.56) 19 (21.11)
Female 76 (84.44) 71 (78.89)
Marital status
Married 78 (84.78) 81 (90)
Single 10 (10.87) 6 (6.67)
Divorced/separated 1 (1.09) 1 (1.11)
Widow/widower 3 (3.26) 2 (2.22)
Education
Primary 21 (22.8) 22 (24.4)
High school 66 (71.7) 64 (71.1)
College/university 5 (5.4) 4 (4.4)
Carer relationship
to patient
Spouse 35 (38.04) 44 (48.9)
Sibling 27 (29.4) 20 (22.2)
Son/daughter 10 (10.9) 4 (4.4)
Friend 0 2 (2.2)
Parent 12 (13) 14 (15.6)
Other 8 (8.7) 6 (6.7)
Pain knowledge
FPQ-K subscale 65.29 (16.93) 64.59 (18.53)
Motivation
PCRS 78.91 (11.29) 79.41 (11.02)
Quality of life
APCA African
POS subscale
44.2 (18.95) 45.26 (18.55)
BPI ¼ Brief Pain Inventory; PPQ-K ¼ Patient Pain Questionnaire-Knowledge;
APCA ¼ African Palliative Care Association; POS ¼ Palliative Care Outcomes
Scale.
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Our finding of improved knowledge about pain
among people with HIV/AIDS is consistent with a
large trial63 that found significant improvement in
knowledge among HIV/AIDS participants after a
HIV medication adherence intervention. The effect
of the intervention on family carers is also consistent
with other studies among family carers of people with
cancer64 and dementia.65 Previous studies of family
carers also found that family members feel rewarded
and more prepared in their caregiving role if educa-
tion is provided to them.66,67
Strengths and Limitations
To our knowledge, this is the first randomized
controlled trial to be conducted in sub-Saharan Africa
to recruit patient and carer dyads. The dearth of
research into HIV/AIDS-related pain in African popu-
lations means that, for some outcomes, we have had to
infer validity from validation studies conducted
outside Africa. The sample size of 182 was larger
than other trials of pain education interventions,
which have, hitherto, been conducted in Western
countries and targeting cancer patients54,55,59 or can-
cer patients and their carers.57,60 Recruitment to our
trial was successful and attrition relatively low at 15%
loss to follow-up. The main reasons for loss to follow-
up were death of the patient, patient transferred to
another center, lack of transport, and carer being
too busy.
This was a complex intervention, and the nature of
the intervention meant that it was not possible to blind
participants of group allocation; we cannot exclude the
possibility that patients and carers in the pain educa-
tion intervention group may have responded more
positively as a result of getting greater attention. How-
ever, social desirability bias is likely to have been limited
by the use of staff nurses, blinded to allocation, con-
ducting outcomes, although we cannot be sure that
participants did not divulge that information.
The follow-up measures were conducted eight weeks
after randomization; this was sufficient time to observe
the effects of the intervention and is consistent with
other pain education studies.68,69 However, we do not
know whether the positive results we observed are likely
Table 3
Patient Outcomes: Average Pain Severity on the BPI-PS for Pain Education and Usual Care Groups
Primary Outcome
Pain Education
(N ¼ 84)
Usual Care
(N ¼ 83)
Adjusted for Baseline
Average Pain Severity and
Recruitment Center
Adjusted for Baseline Average Pain
Severity, Recruitment Center, Age,
Gender, and Number of Pain
Medications
Mean Difference (95% CI) P-value Mean Difference (95% CI) P-value
BPI-PS subscale
Mean (SD) average pain
severity score
At baseline (n ¼ 182) 50.76 (24.86) 51.22 (27.1)
At follow-up (n ¼ 167) 92.62 (8.23) 71.69 (21.18)
Mean change (SD)
from baseline
40.95 (23.78) 19.27 (25.27) 21.09 (16.56e25.63) <0.001 21.25 (16.7e25.8) <0.001
Secondary Outcomes Pain Education
(N ¼ 84)
Usual Care
(N ¼ 83)
Adjusted for Baseline Score and
Recruitment Center
Adjusted for Baseline Score,
Recruitment Center, Age, Gender,
and Number of Pain Medications
BPI-PI subscale
Mean (SD) pain interference
At baseline (n ¼ 182) 49.91 (27.97) 49.46 (29.48)
At follow-up (n ¼ 167) 93.67 (9.33) 69.24 (25.21)
Mean change (SD)
from baseline
42.5 (25.91) 18.42 (23.92) 24.32 (19.33e29.32) <0.001 24.5 (19.61e29.38) <0.001
PPQ-K subscale
Mean pain knowledge
At baseline (n ¼ 182) 67.78 (16.61) 66.24 (18.84)
At follow-up (n ¼ 167) 92.63 (8.16) 71.98 (15.21)
Mean (SD) change
from baseline
25.63 (15.5) 6.32 (11.00) 20.05 (17.25e22.86) <0.001 20.39 (17.51e23.27) <0.001
APCA African POS-patient
subscale
POS, mean (SD)
At baseline (n ¼ 182) 44.78 (22.79) 48.92 (20.5)
At follow-up (n ¼ 167) 90.58 (9.0) 63.37 (19.46)
Mean (SD) change
from baseline
45.44 (22.58) 14.46 (18.77) 28.32 (24.12e32.53) <0.001 28.76 (24.62e32.91) <0.001
BPI-PS/PI ¼ Brief Pain Inventory-Pain Severity/Pain Interference; PPQ-K ¼ Patient Pain Questionnaire-Knowledge; APCA ¼ African Palliative Care Association;
POS ¼ Palliative Care Outcomes Scale.
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to be sustained beyond that time frame. Pain education
participants were asked not to report the face-to-face
discussion and not to pass the leaflet to any staff mem-
ber or other patients to minimize contamination be-
tween two groups. However, the possibility of
contamination cannot be excluded because partici-
pants lived in the same community where we had no
means to prevent them from sharing the leaflet. Clus-
tering the participants and randomizing according to
some natural grouping such as area or clinic could
have avoided contamination, thereby reducing Type
II error,70 but the scale of such a study would have
required resources exceeding those available to us.
Conclusion
The current practice in HIV/AIDS and palliative
care clinics in much of sub-Saharan Africa does not pri-
oritize the provision of health-related information
among patients. This study, conducted in Malawi, has
provided strong evidence that a simple pain education
intervention comprising a leaflet and verbal advice can
reduce pain severity and interference, and improve
pain knowledge and quality-of-life outcomes among
HIV/AIDS patients. To build on these important find-
ings, future research should include a health economic
analysis. This would establish whether the benefits
observed for patients and carers are accompanied by
benefits to the wider health economy.
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